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SUMMARY 
Zinc plays critical roles as an essential trace micronutrient in biology by participat-
ing in multifarious biological processes that include protein synthesis, gene regulation, 
metabolic reactions, and DNA repair.  While the majority of intracellular Zn(II) is tightly 
bound to endogenous proteins, there is growing evidence that cells regulate a buffered, 
kinetically labile pool of Zn(II).  At present, the mechanisms that control Zn(II) regulation 
and distribution during cell growth and development largely remain unexplored, in part due 
to the challenges associated with phototoxicity and photobleaching of fluorescent probes 
that are used as indicators for detecting labile Zn(II) when utilized over extended periods 
of time.  Providing an attractive solution over conventional linear optics, two-photon exci-
tation microscopy (TPEM) allows fluorophores to be excited in the near-infrared region, 
thus offering improved depth penetration combined with reduced phototoxicity and photo-
bleaching, as only fluorophores in the focal plane are excited.  In order to take advantage 
of TPEM, a series of emission-ratiometric two-photon-excitable fluorescent probes that 
selectively bind Zn(II) with a 1:1 stoichiometry was developed and optimized for TPEM.  
Designed based on a non-centrosymmetric donor-π-acceptor architecture, the inherent 
fluorophore platform results in a balanced two photon cross section and a significant chro-
matic shift upon saturation with Zn(II). Using these optimized probes, the dynamics of 
labile Zn(II) pools in proliferating 3T3 mouse fibroblast cells using live-cell TPEM were 
investigated, with potential application in higher organisms, such as zebrafish and mice.   
Chapter 1 provides a comprehensive overview of the roles of zinc biology, with 
emphasis in mammalian cells.  This chapter also discusses the advantages of fluores-
cence microscopy as a powerful microanalytical technique for detecting labile Zn(II) in live 
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mammalian cells, as well as the photophysical and thermodynamic strategies for design-
ing synthetic, metal-responsive fluorescent probes for facilitating the detection of labile 
Zn(II).  Lastly, the objectives and overall approach to the work performed in this thesis are 
outlined.   
Chapter 2 describes the synthesis and characterization of chromis-1, the first wa-
ter-soluble, emission-ratiometric, Zn(II)-selective fluorescent probe whose photophysical 
properties were optimized specifically for TPEM.  The inherent chemical properties of the 
fluorescent probe enabled robust emission-ratiometric capabilities in live 3T3 mouse fibro-
blast cells using TPEM.   
Chapter 3 investigates the intrinsic photobasicity of chromis-1, as well as photo-
physical strategies to remedy the propensity for its pyridyl acceptor to undergo protonation 
in the excited state.  Through the development of a model compound of chromis-1, the 
basicity of the pyridyl acceptor was explored, which was found to be 107-fold stronger in 
the excited state compared to the ground state.  Rearrangement of the acceptor pyridine 
led to the development of a constitutional isomer of chromis-1 with a supposed reduced 
pH sensitivity. While the structural modification did exhibit a reduction in the pH sensitivity 
compared to chromis-1, the metal-binding ligand was found to play a substantial role in 
excited-state protonation, which led to the development and synthesis of a brand-new, 
metal-binding ligand that was incorporated in to the fluorophore core of the isomerized 
probe to afford the next-generation, pH-insensitive, Zn(II)-responsive ratiometric fluores-
cent probe chromis-2.   
Chapter 4 explores the development of affinity-tuned fluorescent probes that pro-
vide a broad dynamic range of affinities for measuring potential changes in buffered Zn(II) 
present at varying concentrations and in various redistribution processes within the cell.  
Exploiting the aldehyde functionality of the fluorophore core developed for the synthesis 
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of chromis-2, the coupling of various metal-binding ligands to the fluorophore afforded a 
series of fluorophores whose Zn(II) stability constants span ten orders of magnitude from 
logK of 5.4 to 15.1.  In addition, these fluorescent probes all demonstrate strong chromatic 
shifts in both their excitation and emission spectra upon binding Zn(II), as well as excellent 
metal-ion selectivity for Zn(II).   
Chapter 5 investigates the dependence of the emission response on the polarity 
of the environment in which fluorescent probes, particularly those developed for probing 
biologically relevant monovalent copper, are characterized.  As most fluorescent probes 
for Cu(I) are significantly lipophilic, their fluorescence behaviors in the aqueous buffer in 
which they are characterized do not translate well to similar fluorescence signaling re-
sponses observed once applied in the cellular environment.  By fully characterizing their 
photophysical and thermodynamic properties in aqueous buffer supplemented with lipo-
somes, the dichotomy between the lower-polarity liposomes and the polar aqueous buffer 
provides a relevant comparison to the dichotomous environment of the cell.  Of the avail-
able fluorescent probes for monovalent copper, CS3, CTAP-2, and CTAP-3 represent the 
three most innovative developments in the Cu(I) fluorescent probe subfield, with CS3 be-
ing the most widely employed in imaging labile Cu(I).  Therefore, the photophysical prop-
erties of these three probes were measured in the presence of liposomes and compared 
to their properties in aqueous buffer devoid of liposomes.  In addition, the photophysical 
and thermodynamic properties of CTAP-3, as well as a recently developed ratiometric 
Cu(I) fluorescent probe, were meticulously characterized in both aqueous buffer and in 
the presence of liposomes.   
Chapter 6 serves to discuss the overall conclusions of this work, as well as provide 
a possible direction in which to steer the design and development of ratiometric fluorescent 




1.1 Roles of Transition Metals in Biology  
Transition metal ions, especially those of the first-row d-block of the periodic table, 
play an integral role in a myriad of biochemical processes by participating as enzymatic 
cofactors in reaction catalysis and by acting as structural components of proteins.  These 
metals exist as trace elements in living organisms, but, despite their low abundance, the 
role that these micronutrients play is of undisputed importance to ensuring proper cellular 
function.  Bioinformatics studies of the proteome have corroborated the importance of 
metal ions for structure and function.  An examination of over 1,300 enzymes whose three-
dimensional structures are known has approximated that 47% of these enzymes require 
metal cofactors, and 41% of these enzymes coordinate a metal ion in the active site.1  In 
addition, metal-containing enzymes (metalloenzymes) are present in all six of the Enzyme 
Commission (EC) classes across all domains of life, demonstrating their importance for a 
diverse array of functions.  Specifically, these functions entail the activation of nucleophiles 
or the stabilization of intermediates to facilitate catalysis, or they entail the stabilization of 
the proteins’ secondary or tertiary structures, or sometimes both.     
 The relative affinities of metal-binding ligands, including metalloproteins, for diva-
lent metal ions can be understood using the Irving-Williams Series2 shown below, 
Mn2+ < Fe2+ < Co2+ < Ni2+ < Cu2+ > Zn2+ 
such that Cu2+ and Zn2+ exhibit a tighter binding to metal-binding ligands than those of the 
earlier first-row transition metals of biological relevance.  However, the degree of metal-
ligand complex formation depends on the concentrations of the metal ions available for 
 2 
binding.  The ordering of transition metals based on total intracellular concentrations de-
viates from the Irving-Williams order of stability of metal complexes, such that: 
Fe2+, Zn2+ > Cu2+ > Mn2+ > Co2+, Ni2+ 
with iron and zinc being the most abundant and cobalt and nickel being the least abundant 
in cells.  Therefore, cells have evolved to utilize ligands with tighter binding affinities for 
transition metal ions that are significantly less abundant than the later first-row transition 
metal ions.   
  As zinc is the second most abundant transition metal in biological organisms, be-
hind iron, its role in complex biological processes should not be understated.  The next 
section highlights the biological importance of zinc, discussing briefly the key roles that 
the divalent transition metal ion plays in ensuring proper cellular function, as well as its 
implications in disease.     
1.2 Roles of Zinc in Biology 
Zinc is an essential, pervasive micronutrient required for living organisms across all 
three domains of life.3  In humans alone, it is predicted that approximately ten percent of 
the human proteome comprises metalloproteins that require zinc for proper function.3-4  
Zinc is a member of the first-row transitions metals (3d level of the d-block elements) in 
the periodic table.  With an electron configuration of [Ar]4s23d10, zinc is rendered redox-
inactive under physiological conditions due to its d10 electron configuration, and its coor-
dination chemistry and catalytic properties are governed by its stable 2+ oxidation state.5  
In aqueous solution, Zn(II) forms an octahedral, metal-aquo complex with the formula 
[Zn(H2O)6]2+, which is a species of Zn(II) likely present at very low concentrations inside 
cells when not bound to endogenous ligands.  The ability to lose its outer shell 4s2 elec-
trons gives rise to its versatile reactivity and its Lewis acidity.  Because of its d10 electron 
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configuration, Zn(II) has a ligand field stabilization energy of zero and thus its flexible co-
ordination sphere tolerates a broad range of coordination geometries. With coordination 
numbers between four and six, Zn(II) complexes adopt various coordination geometries, 
including tetrahedral, octahedral, and trigonal bipyramidal, of similar energy and stability.6-
7 
According to the Hard-Soft Acid-Base (HSAB) theory, Zn(II) is considered a border-
line Lewis acid based on its intermediate polarizability and charge density.8  The HSAB 
theory is also used to predict the preference of metal ions, such as Zn(II), for ligands con-
taining various donor groups.  Therefore, borderline, intermediate Lewis acids, such as 
Zn(II), have a donor atom preference for other borderline, intermediate Lewis bases, such 
as nitrogen-containing heterocycles like pyridine, imidazole, aniline, etc.  Given the corre-
lation between donor basicity and metal-ligand coordination, it would seem evident that 
increasing the basicity of the donor would result in an increase in the metal-ligand affinity.  
In some instances, however, the increase in the donor basicity leads to an increase in the 
pKa, which may invoke a lower affinity of the ligand for the metal cation at a desired pH in 
aqueous solution (discussed further in Section 1.5), since metal ions and protons compete 
for binding to the donor same donor atom of a ligand.   
Nevertheless, Zn(II)’s Lewis acidity and flexible coordination sphere allow it to form 
very stable complexes with multifarious ligands, exploiting it as an effective cofactor and 
structural component of enzymes and proteins in every organism. The roles that Zn(II) 
plays can be divided into three main categories: as a catalytic cofactor in enzymes, as a 
structural component in proteins, and as regulatory messenger in signaling mechanisms, 
of which the former two will be discussed together in the following subsection.   
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1.2.1 The Catalytic and Structural Roles of Zinc in Enzymes and Proteins 
A detailed analysis of the human proteome’s zinc-binding proteins (ZBP) estimates 
that 60% of these metalloproteins utilize Zn(II) as a catalytic cofactor.4  In addition, of the 
zinc-containing metalloenzymes, hydrolases, which includes phosphatases and pepti-
dases, represents the most populated of the six EC classes.  Both phosphatases and 
peptidases utilize a Zn(II)-activated water molecule as the nucleophile for hydrolysis of the 
substrate.9  Transferases, which largely comprises kinases, make up the second most 
abundant class of zinc-binding metallonenzymes, where Zn(II) functions more as a struc-
tural component rather than a catalytic component.  However, a prominent example of a 
transferase that utilizes Zn(II) as a catalytic cofactor is farnesyltransferase, which dis-
places a pyrophosphate stabilized by both Zn(II) and Mg(II) via a cysteine-mediated SN2 
attack on the farnesyl diphosphate substrate in the active site of the enzyme.10 
Two prominent classes of enzymes that utilize Zn(II) in a catalytic role are carbonic 
anhydrases and alcohol dehydrogenases, whose crystal structures are represented in Fig-
ure 1.1.  Carbonic anhydrases (CA), a class of enzymes found in erythrocytes, are re-
sponsible for catalyzing the hydration of carbon dioxide via the nucleophilic addition of a 
Zn(II)-activated water molecule to produce bicarbonate, a process necessary for regulat-
ing the levels of carbon dioxide in cells.  Conserved throughout all isoforms of CA, three 
histidine residues within the active site are responsible for coordinating and stabilizing the 
Zn(II) ion, which then coordinates a water molecule as a fourth ligand, thereby activating 
the water molecule for nucleophilic addition to CO2.  
On the other hand, alcohol dehydrogenases (ADH), which comprise a group of 
isozymes responsible for catalyzing the interconversion between alcohols and alde-
hydes/ketones using NAD+ as a coenzyme, coordinate two Zn(II) ions per subunit, one 
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involved in catalysis and the other serving as a structural component.11  In the liver isoform, 
the active-site Zn(II) is coordinated by one histidine and two cysteine residues.  Upon 
coordination of the alcohol substrate to Zn(II) to generate a tetracoordinate divalent cation, 
followed by deprotonation of the alcohol hydroxyl group by a serine residue within the 
active site, produces an alkoxide intermediate that is stabilized by the Zn(II) ion.12  The 
Zn(II)-stabilized alkoxide facilitates the collapse of the tetrahedral intermediate and sub-
sequent hydride transfer from the substrate to NAD+.   
Table 1.1 provides a list of additional, selected Zn(II)-dependent enzymes, includ-
ing their functions, that play a crucial role in carrying out metabolic reactions within the 
cell.  While this list is not comprehensive, it serves to demonstrate how diverse the chem-
istries that they catalyze are.  
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Figure 1.1: PyMol representation of two prominent Zn(II)-binding enzymes, carbonic anhydrase 
(A) and alcohol dehydrogenase (B). Carbonic anhydrase is responsible for catalyzing the reversible 
conversion of CO2 and H2O to bicarbonate to maintain a balanced pH, and alcohol dehydrogenase 




Table 1.1: Selected list of Zn(II)-dependent enzymes and their functionsa  
Enzyme Function 
Alcohol Dehydrogenase  NAD+-dependent interconversion between alcohols and their cor-
responding aldehydes/ketones 
D-lactate dehydrogenase NAD+/NADH-dependent interconversion of lactate and pyruvate 
in all living organisms.   
Methanol dehydrogen-
ase 
Conversion of methanol to formaldehyde 
Formaldehyde dismutase An oxidoreductase that catalyzes the dismutation of two formal-
dehyde substrates to formate and methanol 
Methionine S-methyl-
transferase 
A transferase enzyme that catalyzes the transfer of a methyl 
group from S-adenosylmethionine to L-methionine to produce S-
methyl-L-methionine in amino acid metabolism. 
Methionine synthase Regeneration of methionine from homocysteine.   
Farnesyltransferase Member of the prenyltransferase group that catalyzes the addi-
tion of a farnesyl group to a protein through the reaction of a pro-
tein’s cysteine residue with farnesyl diphosphate 
Riboflavin kinase Transfer of a phosphate group from ATP to riboflavin to produce 
flavin mononucleotide (FMN)   
Phospholipase C A membrane-assisted enzyme that is responsible for cleaving the 




A family of enzymes responsible for cleaving amino acids from 
the N-terminus of proteins 
Carboxypeptidases A family of enzymes responsible for cleaving amino acids from 
the carboxy (C-) terminus of proteins 
Deaminases A family of enzymes that catalyze the removal of an amino group 
(deamination) from a substrate 
Fructose-Biphosphate 
Aldolase 
An enzyme used in both the Calvin Cycle and in Glycolysis that 
catalyzes the reversible aldol condensation/cleavage of D-fruc-
tose 1,6-bisphosphate into glyceraldehyde 3-phosphate (GAP) 
and dihydroxyacetone phosphate (DHAP) 
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Table 1.1 continued 
Enzyme Function 
Carbonic Anhydrase Interconversion of CO2 and H2O to bicarbonate in red blood cells 
Mannose-6-Phosphate 
Isomerase 
Isomerization of mannose-6-phosphate and fructose-6-phos-
phate. 
Pyruvate Carboxylase The physiologically irreversible carboxylation of pyruvate to pro-
duce oxaloacetate to generate intermediates that necessary for 
the critic acid cycle 
Histone Deacetylase Removal of acetyl groups from N-acetyl lysine residues of histone 
proteins involved in epigenetic regulation 
aList compiled from ENZYME, the Enzyme Data Bank provided by ExPASy.  
 Of the metalloenzymes that are known to bind Zn(II), approximately 22% of these 
enzymes utilize the divalent transition metal for structural purposes.13  In addition, 86% of 
Zn(II)-binding enzymes that do not involve Zn(II) in the catalytic reaction utilize the metal 
as a structural component.  Unlike catalytic Zn(II) centers, which tend to form complexes 
with three active-site ligands consisting of His, Glu, Asp, or Cys, with His being the most 
predominant, structural Zn(II) sites comprise complexes with four amino acid ligands and 
do not coordinate water molecules.14  Moreover, structural Zn(II) sites most commonly 
prefer Cys residues for coordination, followed by His residues as the second most com-
mon.  Enzymes that bind Zn(II) for structural purposes, however, do not limit the metal ion 
solely for structural purposes.  The first enzyme that identified Zn(II) as having a structural 
role and a catalytic role was horse alcohol dehydrogenase, which features a zinc ion co-
ordinated to the thiolate functionalities of four Cys residues in a tetrahedral geometry.15   
 In structural Zn(II) sites, the general role that the metal plays is to maintain the 
local structure of the protein, which can indirectly affect the activity of a protein through 
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chemical or conformational changes in the environment of the active-site.14  One such 
structural motif of proteins that utilizes Zn(II) for stabilization is the zinc-finger motif, which 
features a conserved Cys2His2 cluster for coordinating the metal cation.  This motif has 
proved to be a ubiquitous structural component of proteins, with gene sequences that 
code for its expression comprising approximately 3% of the entire human genome.16  The 
zinc-finger motif serves a variety of roles that are either vital for maintaining normal cellular 
function or for facilitating rapid cell proliferation that include transcriptional regulation and 
activation, DNA replication and repair, RNA packaging, and even facilitating protein fold-
ing.16-19   
1.2.2 Zinc as a Neurotransmitter and Secondary Messenger 
Recently, zinc has been found to play a significant role as an extracellular and intra-
cellular signaling factor, facilitating chemical communication between cells by functioning 
as a potential neurotransmitter, translating extracellular stimuli into intracellular signaling 
cascades, and participating in the regulation of various intracellular signaling pathways.20-
21  These signaling mechanisms are engendered through fluctuations in zinc concentra-
tions in both the extracellular and intracellular milieu, which leads to the activation of mo-
lecular mechanisms that have diverse physiological and pathological implications.  For 
example, zinc that is released from presynaptic neurons into the synaptic cleft has been 
shown to bind to various membrane-bound receptors and transporters in postsynaptic 
neurons, thereby modulating neurotransmitter functions.21-23  Furthermore, glucose-medi-
ated co-release of Zn(II) and insulin from insulin secretory vesicles in pancreatic β-cells 
produces a signaling response that suppresses further insulin secretion from these cells, 
thereby acting as a direct regulator of insulin levels in the blood.  Extracellular zinc also 
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has been shown to regulate hepatic insulin secretion through suppression of insulin clear-
ance.24  
In addition to its role as a neurotransmitter, it has been suggested that zinc func-
tions as a secondary messenger in cells, similar to the roles that calcium, cyclic adenosine 
monophosphate (cAMP), cyclic guanosine monophosphate (cGMP), and protein phos-
phatases play in signaling cascades.  It has even been well established that Zn(II) acts as 
an inhibitor of protein tyrosine phosphatase activity, with an inhibition constant in the na-
nomolar range.25  In mastocytes, cross-linking of membrane-localized IgE receptors re-
sults in a large increase in cytosolic zinc levels emanating from the endoplasmic reticulum 
(ER), a phenomenon referred to as zinc wave, which is believed to inhibit protein phos-
phatase activity for MAP kinase (MAPK) activation-induced expression of cytokines.20, 26-
27   
1.3 Regulation of Zinc 
 Indeed, given the ubiquitous dependence of maintaining proper cellular function 
on zinc, regulation of zinc both within the cell and between the intracellular and extracel-
lular milieu is achieved through a sophisticated network of metal receptors, transporters, 
and chaperones (Figure 1.2).28  One of the keys to maintaining cellular zinc homeostasis 
lies in the existence and activities of two families of mammalian zinc transporters: the ZIP 
(Zrt, Irt-like protein, SLC39A family) and the ZnT (SLC30A family).  The ZIP family consists 
of 14 transmembrane proteins that are responsible for shuttling Zn(II) either from the ex-
tracellular space into the cytosol or from the organellar lumen into the cytosol.29  While 
structures of these metal ion transporters are not known, the 14 ZIP transporters consist 
of eight predicted transmembrane alpha-helical domains and a His-rich sequence within 
a variable loop region between domains III and IV, along with the N- and C-termini that 
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extend into the extracellular space (Figure 1.3, left).29-30  The highly conserved primary 
sequences of transmembrane domains (TMDs) III and IV are predicted to form channels 
through which the metal ions can pass by featuring two His residues that bind the Zn(II).30-
32 
 
Figure 1.2: Cellular distribution and direction of zinc transport of mammalian zinc transporters.  Of 
the information currently available, zinc transport and redistribution is carried out by a series of 
membrane-bound ZnT (blue receptors) and ZIP (red receptors) transporters, which are responsible 
for exporting and importing zinc relative to the cytosol, and metallothionein (MT), a cytoplasmic, 
soluble metal-binding protein that is capable of binding up to seven Zn(II) ions. Illustrations in figure 
were provided by ChemBioDraw and Servier Medical Art (www.servier.com).   
 
 Changes in expression levels of nearly every ZIP transporter in mammalian tissue 
have indicated widespread implications in disease due to mistrafficking that leads to either 
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an accumulation of or a deficiency in cellular zinc.29  ZIP4, in particular, is highly expressed 
in tissues responsible for absorption and reabsorption of Zn(II), such as the small intes-
tines, stomach, large intestines, and even the kidney, with localization to the cellular mem-
brane for importing Zn(II) into the cell from the extracellular space.33  In humans, several 
mutations in ZIP4 have been identified in acrodermatitis enteropathica (AE) patients, 
which leads to symptoms such as diarrhea, dermatitis, hair loss, inflammation, and im-
mune deficiency.   
 
Figure 1.3: Predicted transmembrane topologies and direction of Zn(II) transport of the ZIP and 
ZnT transporter families.  In the ZIP family, there exists a highly conserved His-rich region in the 
loop between domains 3, and in the ZnT family, the His-rich region lies in the loop between domains 
5 and 6.  These His-rich regions are predicted to facilitate zinc transport by binding Zn(II) to the 
histidines, which then allows the transfer of the zinc ion to the amino acid residues within the chan-
nel for export from or import into the cytosol. Arrows indicate the direction of travel of Zn(II). Figure 
adapted from reference [32].   
  
 Conversely, the ZnT family of transmembrane transporters is responsible for ex-
porting Zn(II) from the cytosol into the extracellular space or organellar lumen.  In mam-
mals, the 10 members of this family of transporters are predicted to consist of six alpha-
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helical TMDs, with a highly conserved His-rich sequence within the variable loop between 
domains IV and V, similar to ZIP proteins (Figure 1.3, right).29, 31  In addition, ZnT’s feature 
their N- and C-termini on the cytosolic face of the cell membrane rather than the extracel-
lular space/organellar lumen, as is the case with ZIP’s.  The primary amino-acid se-
quences of TMDs I, II, and V are highly conserved, which alludes to the function of these 
domains as potential channels for exporting Zn(II) from the cytosol using Asp (D) and His 
(H) residues as metal-binding sites within this channel.34   
 Several ZnT’s, including ZnT3, 5, 7, and 8, have been shown to play a significant 
role in insulin regulation with implications in diabetes.35-40  Recently, ZnT8 has become 
one of the most rigorously explored zinc transporter associated with diabetes, particular 
Type-2 (T2D).40  This metal-ion transporter is exclusively expressed in pancreatic β-cells 
and functions to export zinc from the cytosol into insulin secretory vesicles for insulin bio-
synthesis and storage.24, 41-42  Depending on expression-level regulation, overexpression 
of ZnT8 has been shown to induce glucose-stimulated insulin secretion,43 whereas re-
duced expression has led to reduced insulin secretion in hyperglycemic environments.44  
In ZnT8-KO (knockout) pancreatic β cells, the insulin secretory vesicles of these cells are 
devoid of insulin that is normally crystallized as its Insulin6Zn2 hexamer for stabilization 
and storage in vivo, suggesting that ZnT8 is crucial for transporting zinc into these vesi-
cles.45  
The complex yet inadequately understood mechanisms involved in zinc regulation 
rely not only on membrane-bound metal-ion transporters, such as ZnT’s and ZIP’s, but 
also soluble metal-binding proteins, such as metallothioneins (MTs), that facilitate the 
transport and distribution of Zn(II) and other biologically relevant transitions metals 
throughout the cytoplasm.  Metallothioneins represent a family of cysteine-rich, metal-
binding proteins of low molecular weight (6-7 kDa) that are present in nearly every living 
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organism.46  Mammalian MTs consist of a single polypeptide chain of 61-68 amino acids, 
18-23 of which are highly conserved cysteine residues that are capable of binding up 
seven divalent metal ions in a tetrahedral geometry or 12 monovalent copper ions in a 
trigonal geometry through metal-thiolate cluster formation (Figure 1.4).46-49  While mam-
malian MT in vivo tends to be present either in the Zn(II)-bound form or as a mixed metal-
form, the diversity of metals that have been found to be sequestered by MT, including 
Cu(I), Cd(II), Pb(II), Ag(I), Hg(II), Bi(II), hints at its role as a possible metal scavenger for 
controlling heavy-metal toxicity in multifarious organisms.50-51  
 
Figure 1.4: Crystal structure of mammalian (rat) metallothionein-2 (MT-2, PDB code: 4MT2), crys-
tallized with 4 Cd2+ ions (gold spheres) and 2 Zn2+ ions (indigo spheres).52 Figure was prepared 
using Mercury version 3.9.  
 
As a cytoplasmic protein, MT engages in metal-binding equilibria with thionein, the 
metal-free apo-form of MT, which does not feature a defined secondary structure; thus, 
thionein relies on the coordination of seven transition metals for achieving its three-dimen-
sional fold.  Intracellular buffered Zn(II) concentrations, therefore can be regulated through 
the biosynthesis of thionein, such that, in response to elevated intracellular zinc levels, 
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binding of the metal regulatory transcription factor (MTF)-1 to the gene sequence that 
codes for thionein can trigger its expression.53  Despite the presence of only two Zn(II)-
coordinating clusters in human MT, forming a Zn4S11 cluster and a Zn3S9 cluster within the 
α and β domains, respectively, analysis of the Zn(II)-metallothionein complexation equi-
libria using two known Zn(II)-binding fluorescent probes revealed three different magni-
tudes of Zn(II)-binding equilibria within these two clusters with stability constants are that 
separated by four logarithmic units from logK of 11.8 to 7.7.54  The presence of dynamic 
equilibria between thionein and MT that involve multiple Zn(II)-binding events corroborates 
the role of MT in zinc buffering within the cell by serving as a cytoplasmic transport vehicle 
for distributing zinc ions to endogenous cellular ligands, such as other metalloproteins and 
transcription factors, whose function is vital for cell regulation.28, 48  
Overall, the interconnected network consisting of 24 mammalian zinc transporters 
and 2 mammalian MTs that have currently been investigated contribute to the cellular 
import, export, and redistribution of cellular zinc throughout the various compartments of 
the cytoplasm and between the intracellular and extracellular milieu.  The cellular zinc 
level, which reflects the total concentration of zinc in the cell (also referred to as the zinc 
quota), can be divided into three different categories based on its availability: a static frac-
tion that remains tightly bound and therefore unavailable to participate in exchange reac-
tions, a chemically exchangeable fraction that is ligated and participates in homeostatic 
regulation, and a subpool of labile, aqua-Zn(II) ions that are devoid of coordinated ligands 
and buffered at very low concentrations.  Each of these three components is critical for 
maintaining zinc homeostasis.  While the majority of cellular zinc is tied up in metal com-
plexes with endogenous ligands, the subpool of labile zinc ions, in addition to the ligated 
yet kinetically exchangeable fraction, comprise the speciation of zinc that is implicated in 
disease.55  Because buffered Zn(II) concentrations are orders of magnitude lower than the 
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zinc quota, the quantitative analysis of these labile Zn(II) pools within the complex cellular 
environment is very challenging yet critical to understanding how changes in these metal 
ions pools are correlated to mistrafficking processes that lead to disease.  Despite its chal-
lenges, various analytical methods that rely on synthetic and genetically encoded Zn(II)-
binding ligands have estimated the concentrations of buffered Zn(II) levels in mammalian 
cells to be in the range of 60-270 picomolar (pM),55 with higher concentrations ranging 
from 110-452 pM for certain pancreatic β-cell lines,37, 56-58 and even as high as 0.614-1.25 
nM in proliferating colon cancer cells.59  Although there exist deviations between specific 
cell types and tissues, the general consensus is that the exchangeable Zn(II) pool is buff-
ered in the high picomolar to low-nanomolar concentration range.   
1.4 Microanalytical Techniques for in situ Imaging of Metals in Biology 
Elucidating the complex regulatory mechanisms involved in intracellular transition-
metal redistribution, trafficking, and storage is imperative for understanding the roles that 
metal imbalances play in certain diseases.  Accomplishing this objective ultimately re-
quires tools for identifying these metals and quantifying their concentrations in cells using 
analytical instrumentation that offers both high spatial and temporal resolution as well as 
sufficient sensitivity.60  Given the small size of a single cell, the in situ detection of biolog-
ically relevant metal ions requires extremely sensitive microanalytical instrumentation.  
However, certain conventional analytical techniques for trace-metal analysis, including 
voltammetry, potentiometry, and X-ray fluorescence, do not deliver the ability to visualize 
the distribution of metal ions in a spatial manner.61  Of the currently available microanalyt-
ical techniques that permit both the visualization and quantitation of transition metal-ion 
concentrations at the single-cell level, autometallography, visible light microscopy, and 
optical fluorescence microscopy are among the most capable methods.60   
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Amid these widely-employed methods, optical fluorescence microscopy offers the 
best balance between cost-effectiveness and high sensitivity, with submicron spatial res-
olution and sensitivity down to the single-cell level.62  Because metal ions themselves are 
not fluorescent, the utilization of optical fluorescence microscopy requires fluorescent sen-
sors that not only selectively bind the metal analyte of interest, but also induce a change 
in the emission profile (i.e. through a spectral shift) or intensity to discriminately signal the 
association of the metal ion with the sensor.  While X-ray fluorescence spectroscopy has 
the capability to measure down to the single-cell level, it only reports on the total metal ion 
concentration, including those metals that are tied up in endogenous metal-ligand com-
plexes, rather than the pool of kinetically exchangeable metal ions that are important in 
regulation.  Conversely, the use of fluorescent probes in microscopy leads only to the 
ability to report on the subpopulation of metals that are kinetically and thermodynamically 
exchangeable, or “labile,” within the cell.  However, when examining redistribution patterns 
of metals in proliferating cells over a prolonged period, for example, the use of high-inten-
sity lasers to excite the biological sample can result in photobleaching of the fluorescent 
probe.  For this reason, among others, various microscopy techniques have been devel-
oped to enable better sensitivity with deeper sample penetration.63  One such microscopy 
technique that has been widely utilized is two-photon fluorescence microscopy, which of-
fers many advantages for imaging live biological samples over prolonged periods of time.  
The following subsection describes, in detail, the principles of two-photon fluorescence 
microscopy and its advantages compared to conventional confocal fluorescence micros-
copy.   
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1.4.1 Two-Photon Excitation Microscopy (TPEM) and its Application in Biological Imag-
ing 
Since the development of the theory of two-photon absorption (2PA) in 193164 and 
the first experimental demonstration of the process in 1961,65 the invention and further 
improvement of sub-picosecond pulsed Ti:sapphire lasers to investigate the 2PA process 
facilitated the evolution of the two-photon fluorescence microscope by Webb and cowork-
ers in the early 1990’s.66  Since then, two-photon excitation microscopy (TPEM) has been 
widely adopted for the exploration of multiphoton processes not just in biological systems 
but also in various non-linear optical materials.67    
Compared to conventional one-photon absorption, two-photon absorption entails 
the simultaneous absorption of two photons at half the energy, or twice the wavelength 
(Figure 1.5).  Therefore, the probability of two photons interacting with the fluorophore 
simultaneously increases with the square of the light intensity, whereas one-photon ab-
sorption depends only linearly on the intensity of the light.68  Consequently, two-photon 
absorption demands lasers of higher, more intense laser power, such as sub-picosecond 
pulsed lasers, in order to generate a higher photon density that is sufficient for two-photon 
excitation.   
 
Figure 1.5: Simplified Jabłoński diagram for the comparison between one- (left) and two-photon 
















 With respect to the fluorophore employed in TPEM applications, the optical sensi-
tivity of the chromophore is dependent on the fluorophore brightness (ηδ, also known as 
the action cross section), which is proportional to the two-photon cross section (δ) and the 
fluorescence quantum yield (η).  Developing and utilizing fluorophores with large 2PA 
cross sections that lie at or near the two-photon resonance energy is advantageous for 
increasing the signal-to-noise ratio in microscopy applications.  Achieving large 2PA cross 
sections for fluorophores can be accomplished by incorporation of an electron-rich donor 
and an electron-deficient acceptor at opposite ends of a conjugated π-system (discussed 
further in Section 1.5.4.1)  
For a simple donor-acceptor model that comprises an electronic transition between 
only two states, the ground state (S0) and the lowest vibrational level of the lowest excited 
state (S1), the maximum cross section (δmax) of a molecule at the two-photon resonance 
energy is mathematically related to both the change in the permanent dipole moment (Δµ) 









where Γ represents a damping term associated with the one-photon transition (S0 ® S1), 
which represents the half-width at the half maximum of the two-photon absorption band, 
and L corresponds to the optical field enhancement compared to that in a vacuum, which 
is related to the refractive index n of the medium per the relationship L = (n2 + 2)/3.68-69 
Cross section values are reported in units of Göppert-Mayer (GM), named after Maria 
Göppert-Mayer who theoretically predicted the two-photon absorption process, where 1 
GM is equivalent to 1·10–50 cm2·s·photon–1.  Based on equation 1-1, the two-photon cross 
 20 
section δ increases with increasing excited-state polarization.  Therefore, in theory, max-
imizing the excited-state polarization of the fluorophore should lead to an increase in the 
two-photon absorption cross section, which in turn will increase the fluorophore brightness 
for better sensitivity.   
 The application of two-photon excitation in fluorescence microscopy can be best 
understood by comparing it to conventional laser-scanning confocal microscopy (LSCM). 
Both microscopes feature lasers that, at a specific intensity and wavelength, are used to 
irradiate the focal volume of a sample, and scanning of this focal volume throughout the 
entire sample, with collection of the emission signal, will result in construction of an emis-
sion intensity map.68  As stated above, for a one-photon process, absorption of a photon 
is proportional to the intensity of the laser, whereas the photon density of a two-photon 
absorption is proportional to the square of the light intensity, so the photon density rapidly 
decreases outside the focal volume.  Therefore, the focal volume in two-photon excitation 
is significantly smaller than in one-photon excitation, resulting in a higher resolution of the 
microscope.   
 As illustrated in Figure 1.6, photons produced from the laser travel through an epi-
luminescence light path and are reflected by a dichroic mirror to the microscope’s objec-
tive, which focuses the photons on the sample to provide maximum photon density for 
excitation.70  Because the photon density of the corresponding two-photon excitation is 
significantly smaller at the focal volume compared to the focal plane, excitation of the 
three-dimensional volume (voxel) deep within a sample can be achieved without exciting 
above or below the focal plane, thereby reducing interference from the surrounding mate-
rial.  Therefore, 2PA generates a very sharp emission point at the focus, whereas 1PA 
produces an emission stream that follows the direction of the beam path, resulting in a 
much larger excitation volume (Figure 1.6, inset).68  Photons emitted from the fluorescent 
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sample are then collected by the objective and transmitted along the emission path 
through the dichroic mirror, and before they reach the photomultiplier photon sensor, they 
are passed through a barrier filter that serves to further attenuate the light.  
  
Figure 1.6: Simplified diagram of a two-photon excitation fluorescence microscope.  A femtosecond 
pulsed laser beam is focused on the focal volume of a sample that is then excited by the simulta-
neous absorption of two photons at half the energy needed to excite the fluorophore.  The emission 
from the focal volume is then passed through a dichroic beam splitter and collected by photomulti-
plier detectors.  The insert depicts the difference between the excitation densities of one- and two-
photon microscopes.  Figure adapted from reference [68].     
  
 Overall, TPEM offers many advantages over conventional confocal fluorescence 
microscopy for biological imaging.  As previously mentioned, by exciting the sample at 
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longer wavelength (typically 700-1000 nm), the lower-energy photons produced by the 
laser source make TPEM better suited than one-photon microscopy for imaging biological 
samples that may be sensitive to UV or shorter-wavelength visible light.  This means that 
samples can be imaged for prolonged periods of time with reduced phototoxicity and pho-
tobleaching.  In addition, excitation in the near-infrared region results in improved depth 
penetration, especially in tissues that are prone to intense scattering.  TPEM also offers 
intrinsic 3D imaging capabilities by the ability to acquire equally spaced images along the 
z-axis of the biological sample.  Lastly, the excitation that is restricted to the focal volume 
using TPEM results in significantly reduced autofluorescence from endogenous intracel-
lular small molecules, such as NADPH and flavins, which is quite attractive for biological 
imaging.  These advantages have promoted the on-going development of fluorescent 
probes for application in biological imaging using TPEM.71-72  However, because one-pho-
ton and two-photon excitation are inherently different quantum-mechanical processes, flu-
orescent probes for use in TPEM applications should, therefore, be designed and opti-
mized for two-photon absorption, rather than simply using sensors designed for one-linear 
processes in two-photon absorbing processes.   
1.5 Strategies and Considerations for Designing Metal-Responsive Fluo-
rescent Probes 
Small-molecule, synthetic fluorescent probes that can engage in competitive ex-
changes with endogenous, labile metal “pools” have become indispensable tools for cel-
lular biologists for probing cellular metals due to the ubiquity of fluorescence microscopes.  
However, the development of effective probes for detecting metals in biology demands an 
extensive chemical and biological cooperation in an effort to avoid drawing conclusions 
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based on inadequate or misleading data that arise due to insufficient characterization.  For 
instance, the chemical properties of probes that must be tailored towards the demands of 
biological experimentation include high selectivity for the metal analyte of interest (as well 
as preference for oxidation state if the metal analyte of interest is redox-active) over other 
competitors within the biological environment.73  Designing cation-selective fluorescent 
probes, therefore, requires a thorough understanding of coordination chemistry, including 
coordination geometry and HSAB theory; and photophysical principles to ensure a trans-
lation of a metal-binding event into a fluorescence readout that can be detected in the 
cellular environment using fluorescence microscopy.  The following subsections describe 
the fundamental thermodynamic concepts of metal-ligand interactions and the photophys-
ical principles that lay the foundation for the development of synthetic probes that undergo 
metal ion-induced fluorescence changes.   
1.5.1 The Thermodynamics of Metal-Ligand Interactions 
For a probe whose fluorescence readout is modulated by the binding of a metal 
cation to the metal-coordinating ligand of the probe, which governs both the affinity and 
selective of the fluorescent probe, the metal cation (Mn+) participates in a reversible bind-
ing equilibrium with the probe (P) to form a metal-ligand complex (PMn+) with a 1:1 binding 
stoichiometry.  Because these reaction equilibria take place in solution, the solvation of 
both the metal cation and probe play a critical role in contributing to the stability of the 
metal-ligand complex.  For solution equilibria taking place in water as the solvent, equation 
1-2 can be written to describe the equilibrium reaction taking into account solvation effects: 
 
 





The thermodynamic stability of the metal-probe complex (PMn+) can be expressed 
as either the association equilibrium constant (Ka) or the dissociation constant (Kd) de-
pending on the direction of the equilibrium.  Translation of the equilibrium equation 1-2 






Metal-binding fluorescent probes can be designed to engage in coordination with 
multiple metal cations, or they can be designed such that more than one fluorescent ligand 
engages in coordination with one metal analyte.  These scenarios, however, make the in-
situ quantification of metal-ion concentrations difficult, in part, because these equilibria 
may not result in a fluorescence response that is proportional to the output generated from 
the 1:1 binding stoichiometry.74  
The equilibrium expressions above consider the activities of the individual species, 
which are the products of the concentrations of the species and their unit-less activity 
coefficients, γ.  However, analytical measurements to determine the equilibrium constants 
often report values as concentrations rather than activities.  However, the titrations that 
are performed to determine the thermodynamic constants for a particular equilibrium re-
action involve a change in the concentration of the species throughout the titration, which 
would therefore change the activity of the solution.  To ensure that the activity term of the 
thermodynamic expression remains constant, using a large excess of a chemically inert, 
non-complexing electrolyte that functions as an ionic background; however, it is important 
that the concentration of the species of interest does not exceed 5% of the total ionic 
background to ensure that the activity remains constant.75  In addition, since the activity 
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term γML/γM•γL is dependent on both the chemical identity and concentration of the back-
ground electrolyte, it is important to not only specify these parameters but also perform 
calibrations of the probes under identical or similar conditions to enable comparisons be-
tween previously conducted metal-ligand interactions.74  
1.5.2 Protonation as a Competing Pathway in Metal-Ligand Complexation 
Metal-ligand complexation equilibria can encounter significant challenges if the lig-
and engages in protonation equilibria that compete with the metal for binding to the ligand, 
specifically if the protonation constants lie above the pH of the solution. In such cases, the 
extent of metal-ligand complex formation is dependent on the pH of the solution; thus, at 
lower pH, the increase in [H3O+] shifts the equilibrium to disfavor the formation of ML.  For 
this reason, the protonation constants of the ligand used in the complexation equilibria 
should be well-characterized to account for this in the calculation of the equilibrium con-
stants.   
Typically, protonation constants are defined with regard to the concentrations of 
the species in solution rather than the activities, which is comparable to the stability for-
mation constants discussed in the previous section.  This means pKa values are deter-
mined based on measuring the hydronium ion concentration p[H] (also commonly written 
as pHc). Characterizing either metal-binding ligands, including fluorescent probes, to de-
termine their protonation constants is routinely performed using a combination glass elec-
trode that ideally has been calibrated according to Gran’s Method76-78 or, otherwise, cali-
brated to a series of standardized solutions of defined pH.  To ensure that the pronation 
constants are expressed in terms of their molar concentrations rather than their activities, 
the concentration-based protonation constants should be converted to mixed-mode con-
stants by correcting the values upward by 0.11 (for an ionic strength of µ = 0.1 M), which 
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is recommended by Martell and Smith79 (for derivation of this correction factor, see refer-
ence: Bagchi, P. et al.80).   
 To avoid further complications when determining the stability constants of ligands 
with various protonation states that are pH-dependent, the concept of “apparent” stability 
constants was introduced,81 which are equilibrium constants that reflect all significant pro-
tonation equilibria of the ligand and metal cation that may influence the metal-ligand inter-
action.  Consider a metal-ligand complexation equilibrium, in which ligand L interacts with 
metal M to form ML, as described in equation 1-2 (vide supra). Determination of the sta-
bility constant (logβ) of the ligand complex yielded a value of 15.0, and assuming a triprotic 
equilibrium, the corresponding protonation constants of 9.0, 6.0, and 3.0 indicate that at a 
neutral pH of 7.0, the ligand is mostly present as the monoprotonated species.  Therefore, 
the presence of a monoprotonated species results in an apparent affinity that is lower at 
neutral pH as implied by the pH-independent stability constant of 15.0. After correcting the 
protonation constants upward by 0.11 to account for the ionic strength of the solution, 
yielding values equal to 9.11, 6.11, and 3.11, respectively, the apparent affinity of the 
ligand at neutral pH is more than 100-fold lower, yielding a logβ’ of 12.8.  This concept 
illustrates the significance of protonation equilibria and their implications in determine the 
stability constants of ligands. 
1.5.3 Relating Binding Affinities to Dynamic Ranges 
The employment of metal-binding fluorescent probes in a biological environment 
involves engagement of the probe in competitive binding equilibria with endogenous lig-
ands that, too, bind the metal analyte for which the probe is responsive.  In order to effec-
tively engage in competition with these endogenous ligands, the binding affinities of the 
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fluorescent probes must closely match those of the competitive ligands.  Thus, for a mean-
ingful interpretation of biological imaging data, a thorough understanding of all metal-bind-
ing equilibria associated with the fluorescent probe is of critical importance. 
If the fluorescent probe coordinates the metal cation of interest with a 1:1 binding 
stoichiometry, equation 1-3 can be used to derive the fractional saturation f of the probe 
as a function of the buffered metal ion concentration.74 The fractional saturation is a crucial 
element for evaluating the dynamic range of the probe response and is defined as the 
ratio of the concentration of the probe-metal complex [PMn+] to the total probe concentra-







By Combing equations 1-3 and 1-4, the fractional saturation of the probe can be expressed 
as a function of the free metal ion concentration [Mn+]free and the dissociation constant of 







This relationship demonstrates that, within the biological environment, the fractional satu-
ration of the probe is governed by the buffered metal ion concentration, irrespective of the 
probe concentration, provided that it does not exceed the buffer capacity.  At the equiva-
lence point, where the fractional saturation of the probe is 50%, the free metal-ion con-
centration is equal to the dissociation constant of the metal-ligand complex.   A plot of the 
fractional saturation of probe versus the buffered metal concentration, corresponding to 
the binding isotherm, graphically illustrates this relationship (Figure 1.7).  The slope of the 
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isotherm is largest within the 90:10% fractional saturation window; thus, the dynamic 
range of a probe with a 1:1 binding stoichiometry spans approximately two logarithmic 
units.  For example, a probe whose dissociation constant Kd is 1 pM (Kd = 1•10-12), the 
ideal dynamic range therefore, would cover metal analyte concentrations between 0.1 to 
10 pM (Figure 1.7, grey box).  As evident from the shape of the binding isotherm, a change 
in fractional saturation outside this range yields only small changes in the fluorescence 
intensity, and these changes would be unsuitable for reliable quantification.     
 
Figure 1.7: Binding Isotherm depicting the relationship between free metal concentrations and the 
fractional saturation of a fluorescent probe. As the concentration of free metal ion increases, an 
increase in the fractional saturation of the probe is observed, which leads to an increase in the 
fluorescence readout. The shaded grey box represents the dynamic range within the 90:10 frac-
tional saturation window, corresponding to two logarithmic decades of free metal concentrations. 
When the free metal concentration is equivalent to the Kd of the probe, the fractional saturation of 
the ligand is 50% (dashed vertical line). 
 
The ability for a ligand to engage in complex binding equilibria can also be ex-
pressed in terms of the corresponding pM values, which are defined as –log[M]free, at a 
given total metal ion and ligand concentration.82  This concept is particularly useful when 
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comparing ligands with different metal-binding stoichiometries or ligands with basic coor-
dination sites, where a direct comparison of the corresponding stability constants would 
not be meaningful.  Because free-metal concentrations are pH-dependent, the stability 
constants of ligands can diverge quite dramatically from their respective pM values for the 
same metal ion because of competing protonation equilibria.  In addition, since fluorescent 
probes usually form metal complexes with a range of metal ions, not just the analyte of 
interest, careful evaluation of the fluorescence response towards all biologically relevant 
metal ions is of critical importance.  
Overall, a thorough analysis of the coordination chemistry and solution equilibria 
of a fluorescent probe should be conducted under conditions that mimic the biological 
environment, including temperature, ionic background, and pH, for a meaningful interpre-
tation of biological imaging data.  As the metal exchange kinetics in competition experi-
ments can often be slow, special attention should be given to ensure that full equilibration 
of the system.  Once all relevant species in solution have reached equilibrium, the data 
can be recorded using a preferred analytical method and analyzed through robust com-
putational data fitting using multivariate data analysis programs, such as Specfit.83  In ad-
dition to the dynamic range, defined by the thermodynamics of the metal-ligand interac-
tion, the fluorescence response of the probe towards analyte binding represents yet an-
other critical parameter that defines the overall detection sensitivity.  The following section 
outlines relevant photophysical concepts and strategies for optimizing the fluorescence 
response towards metal binding, with an emphasis in TPEM.      
1.5.4 Principles for Designing Fluorescent Probes for TPEM 
Metal-responsive fluorescent probes can be divided into two general categories 
based on the change in optical output: intensity-based fluorescent probes that respond 
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with a fluorescence increase or decrease (“turn-on/off” sensor) and ratiometric sensors 
that exhibit a chromatic shift in the excitation or emission spectrum upon metal-analyte 
binding.  For the first category, the metal-induced change in emission intensity can be 
used in conjunction with the experimentally determined dissociation constant to determine 




  (1-6) 
where Fmin and Fmax are the fluorescence intensities of the free and metal-saturated fluor-
ophores, respectively, determined from an independent calibration experiment with the 
probe, and F corresponds to the measured fluorescence intensity at a particular metal 
concentration [Mn+].69  Given the significant variation in probe loading from cell to cell, the 
limiting fluorescence intensity values may differ quite substantially, thus rendering the 
quantitative analysis of free metal-ion concentrations within the cell unreliable.  Therefore, 
meaningful interpretations of the fluorescence signal may be compromised due to locali-
zation or accumulation of the probe, photobleaching, non-uniform subcellular distributions, 
or intensity fluctuations from the excitation source. 
To overcome these challenges, fluorescent probes can be designed such that they 
undergo a spectral shift upon binding of the metal analyte, a feature referred to as a rati-
ometric response. The spectral shift then permits the analysis of the probe response 
based on the intensity ratio at two distinct excitation or emission wavelengths. For emis-
sion-ratiometric measurements, the emission is collected through two bandpass filters, 
commonly referred to as channels,” that function to discriminate either the metal-free or 
metal-bound probe (Figure 1.8).  The intensity ratio is related to the free metal-ion con-







  (1-7) 
where Rmin and Rmax are the minimum and maximum intensity ratios determined by an 
independent calibration of the fluorescence response, R is the calculated ratio at metal 
concentration [Mn+], and Sf and Sb are instrument-dependent calibration factors for the free 
and metal-bound probe, respectively. From equation 1-7, it is evident that ratiometric anal-
ysis does not depend on the concentration of the probe when determining the free metal-
ion concentration, providing the concentration of the probe does not exceed the buffered 
metal concentration.  This approach, therefore, allows for the reliable determination of 
buffered metal-ion concentrations based on cellular imaging data.  Nevertheless, despite 
ratiometric fluorophores boasting particular advantages over intensity-based fluorophores 
for measuring in situ free-metal concentrations, fluorophores of either response mode 
must rely on efficient two-photon absorption when imaged using TPEM to ensure a robust 




Figure 1.8: Diagram representing the generic principle of a ratiometric emission response upon 
binding a metal cation to a fluorescent probe.  The red curve represents the emission response of 
the metal-free fluorophore, and the black curve represents the emission response of the metal-
bound fluorophore.  By choosing two different bandpasses (or channels, red and grey shaded re-
gions), the ratio of the two intensities can be used to calculated the free buffered metal concentra-
tions using equation 1-13. 
 
 As alluded to in Section 1.4.1, there exist two potential limitations for applying in 
TPEM fluorescent probes that are commonly employed in linear, one-photon microscopy.  
Because the fluorophore brightness is a product of the fluorescence quantum yield and 
the 2PA cross section, a small cross section may result in a reduced brightness, which 
may compromise the detection sensitivity within the autofluorescence background of a 
cell.  Optimization of the 2PA cross section, therefore, is crucial for ensuring that fluoro-
phores employed in TPEM demonstrate robust optical sensitivity.  Furthermore, most ra-
tiometric fluorophores that are commonly employed in biological imaging undergo a spec-
tral shift in the excitation rather than the emission spectrum, which renders the probes 
unsuitable for TPEM, as the microscopes utilize a single femtosecond pulsed Ti:sapphire 
laser.  Even if a second laser would be available, the alignment of two lasers at a single 
focal volume necessary for the scanning acquisition mode is practically unrealistic.    
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1.5.4.1 Structure-Property Relationships for Maximizing the Two-Photon Absorption 
Cross Section 
Over the past few decades, several design strategies have been developed for 
maximizing the two-photon absorption cross section of fluorophores.85-89  In general, these 
include the combination of three structural elements in the fluorophore: electron-donating 
(D) and electron-accepting (A) groups at the center and ends of the chromophore that are 
linked through extended π-conjugated bridges.68 The spatial arrangement of the these 
structural elements affects the degree of charge transfer upon photoexcitation and can 
dictate the two-photon absorption cross section, thus establishing useful structure-prop-
erty relationships.  Preferably, the fluorescent probe should undergo a strong charge-
transfer while maintaining a large transition dipole moment upon photoexcitation, both for 
the metal-free and metal-bound forms.  As illustrated in Figure 1.9, depending on the spa-
tial arrangements of the structural elements, three classes of fluorophore architectures 
that offer large two-photon cross sections have emerged: asymmetric dipolar (A), sym-
metrical quadrupolar (B), and branched octupolar structures (C).68, 90-94  Because the struc-
tural complexity of non-centrosymmetric octupolar and centrosymmetric quadrupolar ar-
chitectures, only dipolar systems were considered for the development of metal-respon-
sive fluorescent probes for biological imaging.   
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Figure 1.9: Molecular architectures for designing fluorophores with large two-photon cross-sec-
tions. Adapted with permission from Reference [69]. © 2011 American Chemical Society.   
  
 In general, dipolar fluorophore architectures are characterized by a photoinduced 
intramolecular charge transfer (ICT) upon photoexcitation, which entails a significant 
charge redistribution from the electron-rich donor to the electron-deficient acceptor.  Pro-
motion of the fluorophore from the ground state leads to the formation of a nonpolarized, 
local excited state (1LE), which precedes the highly polarized charge-transfer state 1CT 
(Figure 1.10, center).75  The resulting 1CT state can then undergo radiative deactivation to 
the ground state.  In the presence of an electron-deficient metal ion, interaction of the 
metal cation with the electron-rich donor moiety induces a reduction in the degree of 
charge transfer and yields a higher-energy 1CT state from the resulting δ+ charge on the 
donor upon binding the metal cation (Figure 1.10, right). The reduced charge transfer, 






























A) Non-centrosymmetric Dipolar Architecture
B) Centrosymmetric Quadrupolar Architecture
C) Non-centrosymmetric Octupolar Architecture
AD π= Acceptor= Donor = conjugated π system
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the metal-free probe.  On the other hand, interaction of an electron-deficient metal cation 
with an electron-deficient acceptor increases the degree of ICT and lowers the energy of 
the 1CT state, resulting in red-shifted excitation and emission spectra compared to the 
metal-free probe (Figure 1.10, left).  Typically, electron-deficient acceptors do not make 
strong Lewis bases for metal coordination, which renders them less suitable for use in 
metal-binding probe design.  However, heteroaromatic groups, such as pyridine, imidaz-
ole, pyrimidine, and coumarins, can function simultaneously as sigma (σ)-donors and π-
acceptors, making them attractive components for the design of metal binding probes for 
two-photon absorption.   
 
Figure 1.10: Simplified Jabłoński diagram, depicting the change in degree of intramolecular charge 
transfer-based upon binding the metal to either the donor or acceptor site of a push-pull fluoro-
phore. Upon binding of the metal to the donor, the charge-transfer (CT) energy of the excited state 
increases, and thus a smaller intramolecular charge transfer (ICT) and blue-shifted fluorescence 
are observed.  However, binding the metal to the acceptor decreases the energy of the charge-
transfer (CT) state, and thus a larger intramolecular charge transfer (ICT) is and red-shifted fluo-
rescence are observed. Abbreviations: D, electron donor; A, electron acceptor; GS, ground state; 
1LE, local excited state (n = 1); 1CT, charge transfer excited state (n = 1); kr, rate of radiative deac-
tivation; knr, rate of non-radiative deactivation; kct, rate of charge transfer.  Adapted with permission 
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The simplest system featuring a donor and acceptor moiety that are electronically 
coupled through a linear π-conjugated bridge is the noncentrosymmetric dipolar architec-
ture, depicted in Figure 1.9A.  In the ground state, the fluorophore platform exhibits an 
uneven charge distribution by virtue of resonance stabilization from the electron-rich do-
nor, thus resulting in a considerable dipole moment (Figure 1.11).  In the excited state, the 
dipolar fluorophore undergoes a charge redistribution to produce an even-more-polarized 
charge-transfer state with an increased dipole moment compared to the corresponding 
ground state.  As mentioned above, according to equation 1-1, greater donor and acceptor 
group strengths lead to an increase in the charge transfer upon photoexcitation, which in 
turn yields an increased 2PA cross section.  However, it is important to find the optimal 
combination of donor-acceptor strength for dipolar architectures when attempting to max-
imize the 2PA cross section, as various factors, such as the degree of bond-order altera-
tion86 and solvent-solute interactions, can lead to a reduction in action cross sections 
(fluorophore brightness).69   
Figure 1.11: Resonance contributors for a simple D–A-substituted stilbene system, depicting the 
charge distribution throughout the π-system.  Adapted with permission from reference [69]. 
Centrosymmetric quadrupolar molecules (Figure 1.9B) comprise a slightly more 
complex fluorophore-architecture class that exhibits very large 2PA cross sections, often 
with δmax values (in GM units) in the hundreds to thousands.69 However, the utilization of 
the quadrupolar architecture in the construction of cation-responsive fluorescent probes 
has proved to be quite challenging for several reasons.95-97  In polar solvents, such as 






of highly polarized excited states and hamper the otherwise large 2PA cross sections and 
can also significantly reduce the fluorescence quantum yields.  These effects can result in 
a more-than-10-fold-lower action cross section compared to a less-polar environment of 
an organic solvents.95-96, 98  The 2PA cross sections and action cross sections are com-
promised even further by coordination of the metal analyte to the donor moiety, which 
reduces the degree of ICT to the acceptor group.  Lastly, centrosymmetric fluorophores 
with D-π-A-π-D architectures boast two electron-rich donors that serve as metal-binding 
sites, which complicate solution equilibria by the formation of 1:1 and 1:2 metal-ligand 
stoichiometries that further complicate ratiometric analysis.    
While the cross sections of dipolar D-A architectures are typically lower than cen-
trosymmetric quadrupolar architectures, the unsymmetrical dipolar arrangement is better 
suited for the design of ICT-based fluorescent probes with a single metal-binding site, 
which can be tethered to either the donor or the acceptor terminus of the fluorophore.  
These strategies can be applied to developing ratiometric metal-responsive fluorescent 
probes for detecting a wide variety of biologically relevant metals, but consideration of 
metal-selective chelating ligands should be made when designing metal-selective fluores-
cent probes.  For Zn(II), while a variety of ratiometric fluorescent probes have been re-
ported for the detection of Zn(II), none of the designs were optimized for TPEM.  The 
following section provides a glimpse into the ratiometric fluorescent probes developed for 




1.6 Survey of Zn(II)-Responsive Ratiometric Fluorescent Probes Developed 
for Biological Imaging 
Currently, there are only a small number of ratiometric probes available for Zn(II) 
sensing (Table 1.1).  Despite these probes exhibiting ratiometric behavior, the majority of 
these fluorescent probes experience a ratiometric shift of the excitation rather than the 
emission spectrum upon binding Zn(II), which precludes them from use in two-photon ex-
citation microscopy.   
Table 1.2: Synthetic ratiometric fluorescent probes for Zn(II) 
 Free + Zn(II) Free + Zn(II)   
Compound λex (nm) λex (nm) λem (nm) λem (nm) Kda Rmax/Rminb 
FuraZin99 378 330 510 510 2.1•10-6 9.0 
IndoZin99 350 350 480 395 3.0•10-6 n.d. 
ZnAF-R2100 365 335 495 495 2.8•10-7 7.0 
DPA-COUM-4101 400 431 481 502 5.0•10-7 n.d. 
ZNP-1102 499 499 528/624 528/624 5.5•10-10 17.8 
Zinbo-5103 337 376 407 443 2.2•10-9 33 
CZ1104 451/526c 449/518c 488/534c 488/534c 2.5•10-10 8.0 
CZ2104 450/526c 448/521c 590/535c 590/535c n.d. 1.7d 
DIPCY105 627 671 758 765 2.3•10-8 1.5 
ZnIC106 513 513 543 558 1.3•10-12 2.4 
RF3107 514 495 540 523 2.2•10-5 2.4 
aDissociation constant; bdynamic range according to equation 1-13; cwavelengths corresponding to 
the two independent fluorophores; dvalue measured in vivo   
 
 As illustrated by the corresponding structures in Figure 1.12, the majority of these 
ratiometric fluorescent probes bind the metal analyte to the donor moiety of the π-conju-
gated system rather than the acceptor; thus, metal coordination interferes with the intra-
molecular charge transfer and results in either insignificant spectral changes or a blueshift 
of the emission maximum.  In addition to the lack of emission shift necessary for emission-
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ratiometric two-photon imaging, none of these probes, regardless of the spatial arrange-
ment of the fluorophore core, have been optimized for TPEM.  Lack of optimization for 
two-photon excitation complicates matters even further because of hampered 2PA cross 
sections that result in either reduced fluorophore brightness or complete fluorescence 
quenching when applied to TPEM.   
Although not originally developed for two-photon imaging, the first fluorescent 
probe developed for the ratiometric detection of calcium, Fura-2,84 was independently 
found to have a 2PA cross section of 12 GM in aqueous buffer using two-photon excitation 
(λex = 700 nm), which decreased to 11 GM upon saturation with Ca(II).108-109  Despite being 
based on a donor-π-acceptor fluorophore architecture, integration of the metal-binding site 
into the donor moiety results in a reduced intramolecular charge transfer upon photoexci-
tation, impacting the 2PA cross section of the fluorophore. In addition, the emission shift 
was too small for emission-ratiometric imaging using TPEM.  Based on the same fluoro-
phore core as Fura-2, FuraZin (Figure 1.12) features a weaker iminodiacetic acid metal-
binding ligand integrated into the donor moiety of the push-pull fluorophore, which boasts 
too weak an affinity to engage in competition with endogenous ligands for Zn(II).99 While 
FuraZin has not been employed in TPEM, the decrease in the 2PA cross section of Fura-
2 would likely be observed with FuraZin upon binding Zn(II).  On the other hand, while 
Zinbo-5 has been employed in emission-ratiometric imaging of labile Zn(II) pools using 
TPEM,103 the limited 28% increase in the ratio upon saturation with Zn(II), in addition to a 
very narrow dynamic range, renders this probe unsuitable for robust emission-ratiometric, 
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1.7 Thesis Objectives 
Over the past few decades, there has been a surge in the development of both 
organic fluorophores and engineered fluorescent proteins as tools to investigate the role 
of metal ions, including Zn(II), in cellular processes.110-111  In addition, rapidly evolving 
innovations in microscope design and functionality have delivered advanced technological 
methods and resources to explore complex bioinorganic processes. In particular, TPEM, 
as a consequence of exciting the focal volume of a sample in the near-infrared range, 
offers significantly reduced photobleaching and phototoxicity, improved sample depth 
penetration, and reduced autofluorescence compared to conventional fluorescence mi-
croscopy; thus, this technique enables the imaging of delicate biological samples over 
prolonged periods of time.  The lack of available Zn(II)-selective, emission-ratiometric flu-
orescent probes designed for TPEM prompted the optimization of a dipolar donor-π-ac-
ceptor fluorophore architecture for the development of an emission-ratiometric fluorescent 
probe with a balanced 2PA cross section, in which the metal-analyte binding site is elec-
tronically coupled to the acceptor moiety of the fluorophore rather than the donor.   
The work in this thesis aims to broaden the availability of chemical tools for probing 
labile Zn(II) pools in mammalian cells, with further potential application in higher organ-
isms, such as zebrafish or mice.  The majority of this work focused on the optimization 
and characterization of emission-ratiometric, water-soluble, Zn(II)-selective fluorescent 
probes optimized for TPEM.  The underlying molecular-design approach is based on a 
donor-acceptor motif that was previously developed112 as the first emission-ratiometric flu-
orescent probe with a noncentrosymmetric donor-acceptor platform where the metal cat-
ion binds to the acceptor rather than the donor moiety.  Further improving the design ap-
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proach, chromis-1 was developed as a photophysically optimized probe to yield an im-
proved absorption cross section and red-shifted wavelength of excitation that is well-suited 
for excitation with Ti:sapphire laser of commercial TPEM instruments.  To improve the 
water solubility in aqueous buffer, hydrophilic groups were also incorporated into the struc-
ture of metal chelator moiety to provide relief from aggregation-induced fluorescence arti-
facts. 
Chromis-1 was strategically designed so that the hydrophilic groups of the metal-
binding ligand were first present as ester functionalities to enable plasma-membrane dif-
fusion for cellular imaging studies.  Upon internalization of the fluorescent probe into the 
cytoplasm, it was hypothesized that non-specific esterases would then hydrolyze the ester 
functionalities carboxylic acids to enable water solubility.  Quantitative determination of 
the buffered Zn(II) concentration from cellular staining data, however, negated the esti-
mated values in the literature by nearly 100-fold when calculated using the measured 
Zn(II) stability constant of the acid form of chromis-1, which suggested that the esters were 
not being hydrolyzed into their corresponding carboxylic acids as expected.  In addition, 
there were several inconsistencies in both the previous synthesis and characterization of 
chromis-1.  Therefore, the first step on this journey entailed an overhaul of the synthesis 
and characterization of the photophysical and thermodynamic properties of chromis-1. 
Because cells were incubated with the ester form of chromis-1, the Zn(II) stability constant 
of chromis-1 ester needed to be measured.  However, its lipophilicity precluded conducting 
the measurements in aqueous buffer due to potential aggregation-induced fluorescence 
changes; therefore, liposomes were employed to solubilize the lipophilic probe yet enable 
characterization in an aqueous medium.   
The main body of this work was devoted to a knowledge-driven optimization of the 
photophysical and thermodynamic properties of the first-generation probe for developing 
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the next generation of Zn(II)-responsive fluorescent sensors that enable robust emission-
ratiometric imaging capabilities by TPEM.  During the characterization of chromis-1, it be-
came evident that the probe was undergoing excited-state protonation, which could inter-
fere with ratiometric imaging by virtue of the varying pH of the cytoplasm.  Reduction in 
the senstivity of chromis-1 to fluctuations in pH, which ultimately led to eradicating its pro-
pensity for excited-state protonation, furnished chromis-2 as a water-soluble yet cell-per-
meable fluorescent probe that showed remarkable cellular staining patterns in 3T3 mouse 
fibroblasts and mouse hippocampal brain tissue.  The novel metal-binding ligand, which 
consists of a symmetrical bis(2-pyrimidylmethyl)amine, lowered the probe’s binding affinity 
by ~ two logarithmic units compared to chromis-1 but resulted in nearly perfectly balanced 
emission intensities between the metal-free and metal-bound species.   
Because Zn(II) is present at varying concentrations in cells and between cell types, 
the development of fluorescent probes that offer a range of Zn(II) binding affinities would 
be advantageous to study changes in kinetically and thermodynamically exchangeable 
Zn(II) pools.  The substantial decrease in the binding affinity of chromis-2 compared to its 
bispicolylamine-containing predecessors served as an impetus to develop a series of af-
finity-tuned fluorescent probes using a modular synthetic approach to chemically tether 
various metal-binding ligands to the fluorophore core.  This approach generated a series 
of Zn(II)-selective, affinity-tuned fluorescent probes whose binding affinities span 10 or-
ders of magnitude, potentially enabling a better understanding of Zn(II) buffering and stor-
age mechanisms.   
The discrepancies in the photophysical properties between the acid and ester 
forms of chromis-1 suggested that the polarity of the environment in which fluorescent 
probes are characterized may have a drastic effect on the fluorescence signaling behav-
 44 
iors, especially since most fluorescent probes are lipophilic and therefore localize to cel-
lular membranes and lipid droplets rather than being evenly distributed throughout the 
cytoplasm.  Most often, however, lipophilic probes are characterized ex vivo in aqueous 
buffer rather than in an environment that not only mimics the dichotomy of the cell but also 
precludes aggregation of the probes, which only leads to misleading conclusions due to 
the fluorescence dependence on the polarity of the environment in which fluorescent 
probes are tested.  To overcome these potential inaccuracies, lipophilic probes should be 
characterized in aqueous buffer supplemented with liposomes.  Departing from Zn(II)-re-
sponsive fluorescent probes, several intensity-based and ratiometric fluorescent probes 
developed for sensing Cu(I), including ones developed by members of the Fahrni group, 
were fully characterized to determine their photophysical and thermodynamic properties 
in aqueous buffer supplemented with liposomes and compare them to the properties in 
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DEVELOPMENT OF CHROMIS-1, A WATER-SOLUBLE, ZN(II)-
SELECTIVE, EMISSION-RATIOMETRIC FLUORESCENT 
PROBE FOR DYNAMIC IMAGING OF LABILE ZN(II) FLUXES IN 
THE CELL BY TWO-PHOTON EXCITATION MICROSCOPY 
All experiments and data encompassing this chapter were submitted for publication per 
reference [28]  
2.1 Introduction 
As discussed in Chapter 1, ratiometric fluorescent probes represent powerful tools 
for discerning and understanding biological processes with a wide range of complexity.  
Because biological samples are often very delicate, the use of high-intensity lasers with 
which conventional linear confocal microscopes are equipped can pose deleterious ef-
fects, such as phototoxicity and photobleaching, that are manifested by the application of 
fluorescent probes in cells.  Two-photon excitation microscopy (TPEM), which utilizes an 
ultrafast (femtosecond) pulsed Ti:sapphire laser that leads to the simultaneous absorption 
of two photons at half the energy relative to the linear, one-photon transition in conven-
tional fluorescence microscopy, resulting in not only reduced phototoxicity and photo-
bleaching but also increased sample depth penetration, reduced autofluorescence, and 
intrinsic 3D imaging resolution.1-3   
Despite a wealth of literature surrounding the application of both small-molecule 
and genetically-encoded fluorescent indicators for use in metal-ion sensing,4 most metal-
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selective fluorophores employed for cell imaging have been designed for linear, one-pho-
ton microscopy and have not been optimized for two-photon excitation.  As discussed in 
Chapter 1, Section 1.4.1, employment of fluorophores in TPEM that have not been opti-
mized for two-photon absorption can exhibit reduced brightness compared to their bright-
ness in one-photon microscopy, which can decrease even further upon binding of the 
metal cation.5  Moreover, most ratiometric metal-ion fluorophores currently available boast 
a large shift in the excitation peak but not in the emission.  Not only are the Ti:sapphire 
lasers employed in commercial two-photon microscopes not suitable to alternate between 
different excitation energies in rapid succession, but also the physical alignment of two 
excitation lasers to the same focal volume of a sample is unrealistic due to its laser-scan-
ning mode for data acquisition.  Therefore, ratiometric TPEM imaging requires sensors 
that offer not only sufficient relative brightness but also undergo a spectral shift of the 
emission profile,6 which are requirements that are currently not fulfilled by most ratiometric 
probes.3 Designing emission-ratiometric fluorophores that exhibit chromatic shifts in the 
emission rather than the excitation is, however, significantly more difficult, and as a result, 
there exists a lack of suitable emission-ratiometric fluorophores for cellular imaging of met-
als, particularly Zn(II).   
2.1.1 Designing Zn(II)-Selective, Emission-Ratiometric Sensors with Enhanced 2PA 
Cross Sections and Brightness 
To address these challenges, Sumalekshmy et al. devised a fluorophore design 
strategy that yields large 2PA cross sections as well as strong bathochromic shifts in the 
fluorescence emission upon binding of the cationic metal analyte.7  By electronically cou-
pling the analyte binding site to the acceptor moiety, rather than the donor moiety, of a 
linear noncentrosymmetric donor-acceptor (D-A) fluorophore architecture, coordination of 
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the metal cation elicits an increased intramolecular charge transfer (ICT) upon photoexci-
tation.  Inspired by the design and characterization of ratiometric pH probes,8 the emission-
ratiometric, Zn(II)-selective probe featured an anisole donor moiety and a trispicolylamine 
acceptor moiety that was bridged by an oxazole ring to prevent cis-trans isomerization 
that could otherwise lead to undesirable fluctuations in the emission response.  This fluo-
rescent probe was the first implementation of a noncentrosymmetric D-A architecture for 
developing an emission-ratiometric, Zn(II)-responsive fluorescent probe.  Due to aggrega-
tion in aqueous solution, the photophysical properties of the probe were evaluated in meth-
anol, and upon saturation with Zn(II), the probe revealed a red-shifted fluorescence emis-
sion and a more favorable 2PA cross section.  The two-photon action cross section (δη) 
increased 5-fold from 11 GM to 55 GM upon binding Zn(II), which exceeded the brightness 
of traditional fluorophore platforms, including BODIPY, fluorescein, and GFP, that are 
widely employed in biological imaging.5, 9 
Large chromatic shifts in the absorption and emission spectra of 24 and 56 nm, 
respectively, as well as a 5-fold enhancement in brightness, made the probe well-suited 
for ratiometric metal sensing using TPEM.  Despite these advantages, the excitation wave-
length at which the 2PA cross sections for both the metal-free and Zn(II)-saturated forms 
are most similar resided below the 700-nm lower limit off the Ti:sapphire laser with which 
commercial two-photon microscopes are equipped; therefore, excitation of the probe us-
ing standard TPEM lasers would result in hampered brightness.  To overcome this chal-
lenge, it was hypothesized that substitution of the oxazole ring with a thiazole ring would 
lower the HOMO-LUMO gap, thus producing a red shift in both the two-photon excitation 
spectrum, as well as the fluorescence emission spectrum, resulting in a more balanced 
TPA cross section residing above the 700-nm cut off.  In addition, in order to achieve 
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improved water-solubility, efforts were made to install hydrophilic groups on the 
bispicolylamine chelator moiety.   
Building on the prior development of the newly optimized probe design, this chap-
ter is devoted to the synthesis and characterization of a Zn(II)-selective indicator, chromis-
1, that features a balanced 2PA cross section upon saturation with Zn(II) combined with a 
large emission shift suitable for emission-ratiometric TPEM imaging.  The following sec-
tions describe the synthesis and complete characterization of the fluorescent probe, in-
cluding its application in visualizing dynamic changes in labile Zn(II) in live NIH 3T3 mouse 
fibroblast cells.   
2.2 Synthesis and Characterization of Chromis-1, a Water-Soluble, Zn(II)-
Selective, Emission-Ratiometric Fluorescent Probe Optimized for TPEM 
2.2.1 Synthesis of Chromis-1 Acid (2.1b) 
Following a convergent synthetic approach, chromis-1 was assembled from three 
building blocks, the Fmoc-protected amino acid 2.3, a-amino ketone 2.4, and isonicotinic 
acid derivative 2.10 (Scheme 2.1). While the latter two building blocks were synthesized 
based on modified literature procedures,7, 10 Fmoc-protected acid 2.3 was accessible in 
two steps from inexpensive isonicotinic acid N-oxide. O-alkylation of the N-oxide starting 
material with diethylsulfate, followed by a vicarious nucleophilic substitution with NaCN at 
the 2-position with at the 2-position yielded 2-cyanoisonicotinic acid 2.2.  This intermediate 
was then converted to the Fmoc-protected acid 2.3 via a one-pot procedure, which pro-
ceed first by the reduction of the nitrile to the primary amine via hydrogenation with Pd/C 
as a catalyst in glacial acetic acid, followed by protection of the primary amine using Fmoc-
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succinimidyl carbonate, with a 79% yield overall.  The bridging thiazole unit of the fluoro-
phore π-system was constructed by an EDCI-mediated condensation of acid 2.3 and pri-
mary amine 2.4, followed by tandem thionation-cyclization of the coupling intermediate 2.5 
with Lawesson’s reagent without any adverse reactivity towards the protecting group. 
Deprotection of 2.6 to yield the primary amine 2.7 without the need for chromatographic 
purification was effected by employing an ethanethiolate as the nucleophile in lieu of pi-
peridine, which is commonly employed for Fmoc removal; this allowed the non-basic 
dibenzofulvalene scavenger to be efficiently separated from the amine product by acid-
base extraction.  The syntheses of these intermediates were optimized to circumvent chro-
matographic purification, which is advantageous when considering the scalability of a mul-
tistep synthesis.  The synthesis was concluded by nucleophilic substitution of amine 2.7 
with bromide 2.10 (after converting the hydrobromide salt to the free base) to afford crys-
talline chromis-1 ester (2.1a), a portion of which was saponified with aqueous NaOH to 
afford chromis-1 acid 2.1b as the corresponding water-soluble disodium salt.   
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Scheme 2.1: Synthesis of chromis-1 ester (2.1a) and chromis-1 acid (2.1b).  
As mentioned above, the synthesis of bromide 2.10 (Scheme 2.2) was accom-
plished through modification of a literature procedure.10  Starting with 2,4-pyridinedicar-
boxylic acid, both carboxylic acids underwent transesterification reactions to produce the 
corresponding ethyl dicarboxylate 2.8 by refluxing with concentrated sulfuric acid in EtOH.  
The ethyl ester in the 2-position was selectively reduced to the corresponding primary 
alcohol 2.9 by reaction with NaBH4 in EtOH in the presence of CaCl2 as a Lewis acid; 
typically, NaBH4 is not reactive enough to reduce esters, however, the Lewis-acidic Ca2+ 





















































































underwent SN2 substitution with thionyl bromide (SOBr2) to afford 2-(bromomethyl)ison-
icotinic acid ethyl ester (2.10) in pure form.  The pure compound (as an oil) had the pro-
pensity to turn black in a short period of time, but the decomposed product could be easily 
purified by filtering the compound dissolved in organic solvent through basic alumina.  To 
circumvent this issue entirely, the neutral pyridine derivative was converted to the corre-
sponding hydrobromide salt by protonation from the HBr generated in situ from the reac-
tion of SOBr2 with EtOH.  Analytically pure material was then isolated as colorless crystals 
after recrystallization from boiling EtOH/MTBE.   
 
Scheme 2.2: Synthesis of the hydrobromide salt of ethyl 2-(bromomethyl)isonicotinate (2.10).  
 
2.2.2 X-Ray Crystal Structure Determination of the Zn(II) Complex of Chromis-1 Acid 
The Zn(II) complex of chromis-1 acid was crystallized in situ from a mixture of 
aqueous KCl (0.1 M), DMF, and MeOH to produce individual plate-like triclinic crystals 
suitable for X-ray crystallographic analysis. A list of selected bond angles and distances 
is provided in Appendix A., Table A.2.  As illustrated in Figure 2.1 below, the Zn(II)-com-
plex adopts a trigonal-bipyramidal coordination geometry with a chlorine atom coordinated 
to the Zn(II) center in the axial position. Compared to previously published structures of 
unsubstituted, C3-symmetric [trispicolylamine-Zn(II)Cl]+ complexes,11-13 the equatorial Zn-
N bonds are elongated by an average of 0.03 ± 0.01 Å. The slightly weaker interaction 
between the zinc atom and the pyridine ligands can be attributed to the electron-withdraw-























no significant differences for the axial Zn-Cl and Zn-N bonds, which adopt a uniform bond 
distance of 2.26 ± 0.01 Å in all three structures.  
 
Figure 2.1: ORTEP representation and atom numbering scheme for the crystal structure of the 
chromis-1-Zn(II) complex [(2.1b)Zn(II)]. Ellipsoids shown represent 50% probability. Hydrogen at-
oms and counter ions have been omitted for clarity.  Detailed crystallographic data are provided in 
Section #. Colored ellipsoids represent the following atoms: Gray, carbon; red, oxygen; blue, nitro-
gen; yellow, sulfur; light purple, zinc; green, chlorine.  Image was generated using the software 
suite Mercury, version 3.9. 
 
The unit cell of the triclinic crystals contained two conformers with notable struc-
tural differences (Figure 2.2).  In both conformers, the fluorophore architecture exhibits 
some deviation from planarity as evident from the dihedral angles of the corresponding 
aryl-aryl bonds. The largest difference is observed for the anisole ring, which is rotated out 
of plane by 35 degrees relative to the thiazole; however, this large dihedral angle is ap-
parent in only one of the two conformers, whereas the other conformer features a near-
planar dihedral angle of 14.7 degrees, suggesting that the distortion is associated with a 




Figure 2.2: ORTEP representation for the crystal structure of chromis-1-Zn(II) complex 
[(2.1b)Zn(II)], depicting the structurally different conformers within the unit cell. Ellipsoids shown 
represent 50% probability. Hydrogen atoms and counter ions have been omitted for clarity. Colored 
ellipsoids represent the following atoms: Gray, carbon; red, oxygen; blue, nitrogen; yellow, sulfur; 
light purple, zinc; green, chlorine; dark purple, calcium.  Image was generated using the software 
suite Mercury, version 3.9. 
 
2.2.3 Steady-State Absorption and Fluorescence Properties of Chromis-1 Acid 
Molar ratio titrations of chromis-1 acid (2.1b) with Zn(II) in neutral aqueous buffer 
(pH 7.0, 10 mM PIPES 0.1 M KCl, 25°C) revealed strong chromatic shifts in both the 
absorption and emission spectra together with sharp saturation at equimolar metal and 
ligand concentrations.  Consistent with Zn(II)-coordination to the pyridyl acceptor moiety 
of the fluorophore, the absorption maximum at 349 nm (ε ~ 22,000 M–1 cm–1) is red-shifted 
by 17 nm upon saturation with Zn(II) (Figure 2.3A). The appearance of clean isosbestic 
points at 285 and 353 nm combined with equimolar saturation are indicative of a well-
defined solution equilibrium involving only free probe and a Zn(II)-complex with 1:1 metal-
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ligand stoichiometry. Similarly, the fluorescence emission maximum of the probe is red-
shifted from 483 to 520 nm upon binding Zn(II) (Figure 2.3B). By exciting the probe at the 
isosbestic point, the observed emission intensities are a direct reflection of the quantum 
yield, which increases more than 2-fold from 0.32 to 0.71 upon coordination of Zn(II) (Ta-
ble 2.1). Overall, the Zn(II)-induced fluorescence changes are well suited for emission-
ratiometric measurements. For example, the ratio of the integrated fluorescence intensi-
ties between 510-570 nm and 440-495 nm increases from 0.7 to 2.6 upon saturation with 
Zn(II), corresponding to a large dynamic range with an Rmax/Rmin ratio of 3.7.  
Table 2.1: One and two-photon photophysical properties of chromis-1 ester (2.1a) and 
acid (2.1b) in aqueous buffer at pH 7.0.a  
 2.1ab,c [2.1a-Zn(II)]b 2.1bc [2.1b-Zn(II)] 
Abs lmax (nm)d 351 378 349 366 
e (104 M–1cm–1)e 2.20 2.86 2.19 2.41 
lmax (nm)f n.d. n.d. 720 740 
dmax (GM)g n.d. n.d. 19 25 
Em lmax (nm)h 438 495 483 520 
FFi 0.26 0.56 0.32 0.71 
a10 mM PIPES, 0.1 M KCl, 25°C. b buffer supplemented with 100 µM liposomes (4:1 DMPC:DMPG). 
c supplemented with 20 µM EDTA to sequester adventitious Zn(II). d lowest-energy band of the one-
photon absorption spectrum. emolar extinction coefficient at lmax. fmaximum two-photon absorption. 
g two-photon absorption cross section. h maximum fluorescence emission. I fluorescence quantum 




Figure 2.3: Spectral changes of chromis-1 acid (2.1b) upon binding Zn(II) in neutral aqueous buffer 
(pH 7.0, 10 mM PIPES, 0.1 M KCl, 25°C). (A) UV-Vis absorption spectral changes upon stepwise 
saturation with Zn(II). (B) Fluorescence emission response upon stepwise saturation with Zn(II) 
(excitation at 353 nm). Red curves indicate the spectra after complete saturation (1.0 eq.) with 
Zn(II) is achieved. Inset: fluorescence integration over the entire spectral window as a function of 
molar equivalents of Zn(II). 
 
Analogous to the UV-vis spectral properties, the two-photon absorption (2PA) 
cross section15 revealed a red-shifted maximum, which increased from 720 to 740 nm 
upon Zn(II)-coordination (Figure 2.4). Consistent with greater excited state polarization,16 
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the 2PA cross section of the Zn(II)-bound form is significantly increased compared to the 
free form. Nevertheless, in the range between 710-740 nm the probe offers balanced 
cross sections, thus allowing for excitation of the free and Zn(II)-bound probe with similar 
efficiency. 
 
Figure 2.4:  Two-photon absorption cross section of the free (black trace) and Zn(II)-bound (red 
trace) form of chromis-1 acid (2.1b). Vertical dashed line corresponds to the wavelength of excita-
tion used to image the fluorophore in live cells using the two-photon microscope, visualizing the 
balanced TPA cross section of both forms. Data acquired by Nisan Siegel, Ph.D., Joseph Perry, 
Ph.D. Figure adapted with permission from reference [28].   
 
2.2.4 Metal-Ion Selectivity of Chromis-1 Acid 
To determine the selectivity of chromis-1 acid (5 µM) in response to biologically 
relevant divalent metal ions, the fluorescence response of the metal-probe was measured 
in the presence of an excess of biologically relevant divalent metal ions.  To ensure that 
adventitious metals, including Zn(II), did not interfere with the fluorescence spectrum of 
metal-free chromis-1 acid, EDTA (ethylenediaminetetraacetic acid, 10 µM) was added be-
fore the spectrum of the free form was acquired.  To fully saturate chromis-1 acid, as well 
as the sequestrant (EDTA), 20 µM and 40 µM aliquots of the interfering divalent metals 



















were added, and emission spectra were acquired after each aliquot. Excluding Zn(II), ad-
dition of all other biologically relevant divalent metal ions invoked either no change in the 
emission response (Mg(II) and Ca(II), Figure 2.5A, B) or resulted in complete fluorescence 




Figure 2.5:  Fluorescence response of chromis-1 (2.1b 5 µM) in the presence of 4.0 equivalents 
(20 µM) of interfering divalent metal ions.  A-H) Blue traces represent free chromis-1 (5 µM) in pH 
7.0 buffer (10 mM PIPES, 0.1 M KCl, 25°C) supplemented with 10 µM EDTA.  Red and black traces 
represent the addition of 20 µM and 40 µM, respectively, of interfering divalent transition metals. 
Black arrows indicate the change in fluorescence after addition of the interfering divalent metals. 
Excitation: 358 nm. Data were acquired by Pritha Bagchi, Ph.D., and the figure was prepared by 
Christoph Fahrni, Ph.D. Figure reproduced with permission from reference [28].   
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Since both the fluorescent probe and its Zn(II) complex are brightly fluorescent, 
the quenched emission does not translate to an emission-ratiometric response, thus bind-
ing of these metal ions results only in a masking effect by competing with Zn(II) for coor-
dination to the probe. For this reason, the ratiometric response of the probe was evaluated 
in the presence of 0.8 molar equivalents (80% fractional saturation) of the interfering metal 
ion (Figure 2.6, black bars).  Under these conditions, the emission ratio of the remaining 
20% of free probe was unaffected by any of the quenching metal ions, thus addition of 
Zn(II) still produced the emission ratiometric response of the [(chromis-1)Zn(II)] complex 
observed in the molar ratio titration (Figure 2.6, red, patterned bars).   
 
Figure 2.6: Emission-ratiometric response towards selected divalent metal cations at 80% frac-
tional saturation (calculated based on ratio of the integrated fluorescence intensity between 510-
570 nm (channel 2) and 440-495 nm (channel 1)).  The black bars represent the ratio at 80% 
fractional saturation, and the corresponding red patterned bars represent the ratio after saturating 
the remaining 20% of free fluorophore with Zn(II). Excitation: 358 nm.   
 
Of all the biologically relevant transition metals tested, Mn(II) was the only metal 
that did not bind to chromis-1 with near unity fractional saturation.  Therefore, the binding 
affinity of chromis-1 for Mn(II) was measured via a fluorimetric, metal-addition titration to 













determine a stability constant for the Mn(II) complex of chromis-1 acid.  Chromis-1 acid 
(2.1b, 5 µM) was titrated with MnSO4•H2O from 0-50 µM, and non-linear, least-squares 
fitting of the emission spectral data yielded an apparent stability constant of LogKMn(II)L = 
5.04 ± 0.004 at pH 7.0 and 0.1 M KCl ionic background, corresponding to an apparent 
dissociation constant of Kd’ = 9.12 µM (Figure 2.7).  However, the micromolar affinity of 
chromis-1 for Mn(II), the ability for Zn(II) to immediately and irreversibly outcompete Mn(II), 
and the low concentration of Mn(II) in mammalian cells (typically < 10 µM)17-18 absolve 




Species Mn(II) chromis-1 H log β 
Zn(II) 1 0 0 0.0 
Chromis-1 0 1 0 0.0 
[(Chromis-1)Mn(II)] 1 1 0 5.04 ± 0.004 
Figure 2.7: A) Fluorimetric determination of the stability constant of chromis-1 acid for Mn(II) via a 
direct, metal-addition titration. Chromis-1 (2.1b, 5 µM) was equilibrated in aqueous buffer (10 mM 
PIPES, 0.1 M KCl, pH 7.0, 25ºC) treated with Chelex (1% (w/v), Biorad) and titrated with 
MnSO4•H2O from 0-50 µM.  A fluorescence spectrum (excitation: 358 nm) was acquired after the 
addition of each aliquot of Mn(II). The red curve indicates free chromis-1 before supplementation 
with Mn(II). Spectra were analyzed by non-linear least squares fitting to provide a LogKMn(II)L = 5.04± 
0.004 (n = 1).  B) Change in fluorescence response at 484 nm with corresponding fit to the equilib-
rium system model.   
 











































2.2.5 Determination of the Zn(II)-Binding Affinity of Chromis-1 Acid 
The linear emission increase, along with a sharp, equimolar saturation point ob-
served in the molar ratio titration shown in Figure 2.3, indicates tight Zn(II) binding with 
near unity fractional saturation throughout the entire titration range. Because the determi-
nation of reliable stability constants demands conditions where complex formation is in-
complete, ideally within a 10-90% fractional saturation window,19 both spectrophotometric 
and fluorimetric titrations were performed in the presence of EGTA (ethylene glycol-bis(β-
aminoethyl ether)-N,N,N',N'-tetraacetic acid) as a competing ligand with matching affinity 
(apparent Kd = 4.0 nM at pH 7.0, calculated from published pKa’s and logb values).20   
Previous titrations to determine the binding affinity of chromis-1 acid (2.1b) in neu-
tral aqueous buffer (10 mM PIPES, pH 7.0) supplemented with 100 mM KClO4 as an ionic 
background yielded an average apparent stability constant of LogKZn(II)L ≈ 9.9, correspond-
ing to an apparent dissociation constant of ~ 120 pM.21  Attempts to verify this value 
through repeated spectroscopic titrations using 100 mM KCl as an ionic background in 
neutral aqueous buffer (10 mM PIPES, pH 7.0, 25°C) resulted in an average, uniform 
apparent stability constant of LogKZn(II)L = 10.31 ± 0.13, corresponding to an apparent dis-
sociation constant of Kd’ = 49 ± 13 pM (Figure 2.8).  These thermodynamic stability con-
stants were obtained regardless of whether the preformed Zn(II)-complex of chromis-1 
acid (2.1b) was titrated with EGTA or whether Zn(II) was added to a mixture of the probe 




Definition of the Equilibrium System: 
Species Zn(II) EGTA chromis-1 acid H log β 
Zn(II) 1 0 0 0 0.0 
EGTA 0 1 0 0 0.0 



















[(EGTA)Zn(II)] 1 1 0 0 12.6 
[(chromis-1)Zn(II)] 1 0 1 0 10.31 ± 0.13 
Figure 2.8: A) Spectrophotometric determination of the stability constant of chromis-1 via a com-
petition titration with EGTA. Chromis-1 (20 µM) was equilibrated with ZnSO4•7H2O (20 µM) in 
chelexed aqueous buffer (10 mM PIPES, 0.1 M KCl, pH 7.0, 25ºC) and titrated with EGTA to a final 
concentration of 500 µM. The absorbance spectra were analyzed by non-linear least squares fitting 
to give an average LogKZn(II)L of 10.31± 0.13 (n = 8).  B) Change in fluorescence response at 367 
nm with corresponding fit to the equilibrium system model.   






































The discrepancy between the two stability constants corresponds to a ~ 0.6 log-
unit difference in the binding affinity or an ~ 80-pM difference in the apparent dissociation 
constant.  To verify the previous value obtained using KClO4 as the background electro-
lyte, a repeat competition titration of chromis-1 acid in neutral (pH 7.0) aqueous buffer 
containing KClO4 (100 mM) was performed by a fluorimetric titration of EGTA to a solution 
containing the preformed [(2.1b)Zn(II)] complex.  Fitting of the fluorescence data to the 
equilibrium model described above in Figure 2.8, yielded an apparent stability constant of 
LogKZn(II)L = 9.51 ± 0.04, corresponding to an apparent dissociation constant 310 pM (Fig-
ure 2.9), which more closely agrees with the dissociation constant of ~ 120 pM determined 
initially.   
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Figure 2.9: A) Fluorimetric determination of the stability constant-dependence of chromis-1 acid 
(2.1b) on the ionic background via competition with EGTA.  Chromis-1 (10 µM) was equilibrated 
with ZnSO4•7H2O (10 µM) in chelexed aqueous buffer (10 mM PIPES, 0.1 M KClO4, pH 7.0, 25ºC) 
and titrated with EGTA to a final concentration of 1 mM. The fluorescence spectra (excitation: 358 
nm) were analyzed by non-linear, least-squares fitting to give an apparent LogKZn(II)L of 9.51 ± 0.04 
(n = 1). The dashed black curve corresponds to free 2.1b, and the red curve corresponds to Zn(II)-
saturated 2.1b before the addition of EGTA. B) Change in fluorescence response at 520 nm with 
corresponding fit to the equilibrium system model described in Figure 2.8.   
 
Analysis of the crystal structure of chromis-1 acid (Figures 2.1, 2.2) provided in-
sight into the ionic background-dependent discrepancy between the two stability constants 
of chromis-1 acid.  While the flexible coordination sphere of Zn(II) allows the metal to 








































achieve various coordination numbers between four and six when forming metal-ligand 
complexes, coordination of a 5th ligand to the Zn(II) center of a 4-coordinate Zn(II)-ligand 
complex should provide greater stability than its 4-coordinate analog.  Although metal 
complexes with perchlorate have been prepared, their stability constants are low due to 
perchlorate’s poor coordinating capability by virtue of its delocalized charge density over 
each of its four oxygen atoms.22  On the other hand, chloride is a much more effective 
donor for coordinating metals, including Zn(II).  Therefore, the likelihood of perchlorate 
binding to Zn(II) as a fifth, auxillary ligand in the chromis-1-Zn(II) complex is less favorable 
than chloride, and the stability constants for the formation of the chromis-1-Zn(II) complex 
are direct reflections of this.   
The use of KCl(aq) as an ionic background in the aqueous buffer used for spec-
troscopic characterization provides a valuable comparison to the ionic nature of the cell, 
as [Cl–]total can range between 5 and 100 mM in mammalian cells.23  Conversely, the lack 
or negligible presence of perchlorate ions in mammalian cells due to its toxicity makes the 
use of the counteranion as a background electrolyte ineffective when best simulating in-
tracellular conditions. On the other hand, the poor coordinating ability of perchlorate 
makes it an effective background electrolyte in situations when the electrolyte may other-
wise engage in metal complexation.  In situations when the background electrolyte may 
influence the thermodynamic properties of the probe being tested, such as chromis-1, it is 
advantageous to use an ionic background that is most representative of cellular condi-
tions, provided that high concentrations of the electrolyte do not interfere with the fluores-
cence response of the probe. 
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2.3 Exploring Dynamic Zinc Fluxes in Ratiometric Imaging of Chromis-1 Es-
ter (2.1a) 
Note: All microscopy methods and data in Section 2.3 were gratefully conducted 
and acquired by Daisy Bourassa, Ph.D.  They are included in this thesis to demonstrate 
the robust application of the fluorescent probe in cellular imaging for which it was designed 
and intended. 
2.3.1 Deriving A Relationship to Calculate the Fractional Saturation of a Probe Using 
Ratios Determined from Live-Cell Imaging 
For a metal-binding fluorophore with a 1:1 binding stoichiometry, the dissociation 
constant (Kd) for the equilibrium between the metal (Mn+) and the probe (P), forming a 
complex PMn+, is defined as:  
𝐾" =
𝑀%& 𝑃
𝑃𝑀%&   (2-1) 
The Fractional saturation f of the probe can be expressed as the ratio of the concentration 
of the metal-bound probe [PMn+] to the total probe concentration [P]total.  For fluorescent 
indicators that either exhibit 1:1 binding stoichiometries between the probe and the metal 
or that bind multiple metals to one probe molecule, the ratiometric response of the probe 
does not depend on the concentration of the probe.  Therefore, the fractional saturation f 










Solving for [Mn+] yields the relationship: 
𝑀%& =
𝑓 ∙ 𝐾"
1 − 𝑓 
 (2-3) 
For ratiometric imaging, which utilizes fluorescence indicators that undergo a spectral shift 
in the emission upon binding the metal analyte, the concentration of intracellular labile Mn+ 
can be calculated using the dissociation constant (Kd), the ratio of the fluorescence inten-
sities R, and the instrument-dependent factors Sf an Sb that can be obtained from an in-
dependent microscope calibration.  This relationship24 is shown below:   





  (2-4) 
If the instrument-dependent factor is approximated to be 1, equation 2-3 can be substi-
tuted into equation 2-4 and solved for f to provide a relationship (2-5) between the frac-




  (2-5) 
The fractional saturation f from equation 2-5 can be substituted into equation 2-3 to calcu-
late a free metal concentration [Mn+]free.  Quantitative imaging analysis software packages, 
such as ImageJ25, can then be used to analyze the changes in the emission ratio of fluo-




2.3.2 Ratiometric Imaging of Dynamic Zinc Fluxes in Mouse Fibroblast Cells Using 
Chromis-1 Ester (2.1a) 
Because the anionic dicarboxylate salt of chromis-1 acid (2.1b) is not membrane 
permeable, cellular imaging studies were performed with the ester form of chromis-1 
(2.1a).  To evaluate the Zn(II)-dependent ratiometric response of chromis-1 ester in live 
cells, perfusion experiments were performed using NIH 3T3 mouse fibroblasts as a model 
mammalian model (Figure 2.10).  As evident from the differential interference contrast 
(DIC) intensity micrographs (Figure 2.10, middle), chromis-1 ester (2.1a) was readily in-
ternalized into cells and partitioned into the cellular membranes, demonstrating bright flu-
orescence throughout the cytoplasm except cellular nuclei, from which it appeared to be 
excluded.  Although the distribution of fluorescence intensities demonstrates uneven and 
distinct punctate localizations, the processed ratio images display a uniform fractional sat-
uration with an average ratio R = 0.60 ± 0.16. Upon exposure of the cells to exogenous 
zinc pyrithione, a membrane-permeable ionophore for Zn(II),26 the ratio swiftly increased 
by more than 4-fold to yield an average ratio of R = 2.53 ± 0.56, indicative of saturation of 
chromis-1 ester with Zn(II) (Figure 2.10B).  Subsequent incubation of the cells with the 
high-affinity, membrane-permeable chelator TPEN invoked a ratiometric response that 
yielded an average ratio of R = 0.54 ± 0.13, which was slightly lower compared to basal-
level (resting) conditions.  For comparison purposes, a similar ratio value of 0.52 ± 0.14 
was calculated when TPEN was supplemented to the adherent cells grown in basal me-
dium without exposure to exogenous zinc pyrithione.  As demonstrated by the plot of the 
intensity ratio versus time, the binding and dissociation events between chromis-1 ester 
and Zn(II) occurred with very rapid dynamics (Figure 2.10B, right). 
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To investigate whether chromis-1 is capable of following large, dynamic fluctua-
tions in endogenous Zn(II), NIH 3T3 cells were exposed to 2,2′-dithiodipyridine (DTDP), 
a reagent that is used to oxidize the sulfhydryl functionalities of Cys residues of endoge-
nous ligands, such as metallothionein, 27 and stimulate the dissociation of Zn(II) ions co-
ordinated to these sulfhydryl groups. Adherent 3T3 cells grown under basal conditions 
were treated with chromis-1 ester and displayed similar basal-level ratios ~ 0.5 (Figure 
2.10C, left), which progresively increased following the addition of DTDP (100 µM) and 
culminated at a maximum ratio of Rmax ~ 1.3 after 40 min (Figure 2.10, middle). Interest-
ingly, the elevated ratio that manifested from the release of endogenous Zn(II) after addi-
tion of DTDP led to a gradual decrease in the ratio without the assistance of any exoge-
nously added reagents.  The observation was accompanied by a re-equilibration of cyto-
plasmic Zn(II) levels to re-equilibrate to basal-level conditions, reaching intensity ratio of 





Figure 2.10: Ratiometric imaging of labile Zn(II) in live NIH 3T3 mouse fibroblasts with chromis-1 
ester (2.1a) by TPEM. A) Left: DIC and fluorescence intensity images respectively. Right: ratio 
image according to the equation: R = BP2/BP1. B) Left: Ratio images prior to and after the addition 
of 50 μM ZnSO4 and 5 μM pyrithione (at 10 min). Supplementation of TPEN (100 µM) resulted in 
a sharp decrease in the fluorescence intensity ratio. Right: Time trace of the change in the average 
intensity ratio for the ROI indicated by the white circle in the left panels. The asterisks correspond 
to the time points at which the respective ratio images shown to the left were acquired. C) Left: 
Ratio images prior and after addition of DTDP (100 µM). Treatment with DTDP resulted in first an 
increase in the fluorescence ratio that peaked around 40 minutes followed by a gradual decrease 
back to basal levels. Right: Plot of the time versus average fluorescence intensity ratio for the ROI 
indicated by the white circle. The asterisks designate the times corresponding to the three fluores-
cence ratio images on the left. Scale bars: 40 µm. Excitation: 720 nm. Data were acquired and 
analyzed, and the figure was prepared, by Daisy Bourassa, Ph.D.28 Figure and figure caption were 
reproduced with permission from author of the paper corresponding to this chapter. 
 
Using the limiting intensity ratio values from perfusion experiments with chromis-1 
ester and the measured Zn(II) stability constant of 10.3 for chromis-1 acid (Figure 2.8) led 
to a calculated intracellular buffered Zn(II) concentration that is inconsistent with estimated 
values previously reported.29  In addition to the punctate staining patterns observed during 
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perfusion experiments with live NIH 3T3 mouse fibroblasts, the discrepancies between the 
average calculated buffered Zn(II) concentrations would be manifested by incomplete hy-
drolysis of the ethyl ester functionalities of chromis-1 ester, as the more electron-withdraw-
ing ester groups should yield a weaker binding affinity compared to the anionic carboxylate 
groups of chromis-1 acid.  This understanding furnished momentum to determine the sta-
bility constant of chromis-1 ester to elucidate the impact of the substituent effect on the 
binding affinities of chromis-1 ester and chromis-1 acid.   
2.3.3 Determination of the Binding Affinity of Chromis-1 Ester and Comparison to 
Chromis-1 Acid 
To determine the apparent stability constant of 2.1a under conditions that mimic 
the cellular environment, fluorimetric titrations were carried out in the presence of lipo-
somes composed of a 4:1 ratio of zwitterionic dimyristoyl phosphatidylcholine (DMPC) and 
anionic dimyristoyl phosphatidylglycerol (DMPG) as model membranes. Upon dilution 
from a DMSO stock solution into pH 7.0 buffer containing 100 µM liposomes (freshly ex-
truded) and 1.0 mM EGTA as competing ligand with matching affinity, diester 2.1a was 
titrated with ZnSO4•7H2O up to a total concentration of 1 mM.  Non-linear least-squares 
fitting of the fluorescence titration data over the entire spectral range yielded an average 
apparent LogKZn(II)L = 8.62 ± 0.07, corresponding to an apparent Kd of 2.4 ± 0.4 nM at pH 
7.0 (Figure 2.11). Consistent with a stronger electron withdrawing character of the neutral 
ester groups in 2.1a compared to the anionic carboxylate substituents in 2.1b, chromis-1 
ester exhibits a Zn(II) affinity that is 1.5 orders of magnitude lower, with the two probes 
covering a total dynamic range of nearly four orders of magnitude within the 90:10 frac-
tional saturation window (Figure 2.12).  Using the ratios in the presence of TPEN and 
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Zn(II)-pyrithione as the limiting Rmin and Rmax values, respectively, NIH 3T3 mouse fibro-
blast cells that were grown under basal conditions displayed a fractional saturation of ~ 3-
6%, corresponding to an average buffered [Zn(II)] = 50-100 pM using the dissociation 





Definition of the Equilibrium System: 
Species Zn(II) EGTA chromis-1 ester H log β 
Zn(II) 1 0 0 0 0.0 
EGTA 0 1 0 0 0.0 



















[(EGTA)Zn(II)] 1 1 0 0 12.6 
[(2.1a)Zn(II)] 1 0 1 0 8.62 ± 0.07 
Figure 2.11: A) Fluorimetric determination of the stability constant of chromis-1 ester (2.1a) via a 
Zn(II)-addition titration in the presence of EGTA. Chromis-1 ester (2 µM) was equilibrated with 
EGTA (1 mM in diH2O) in aqueous buffer (20 mM PIPES, 0.1 M KCl, pH 7.0, 25ºC) supplemented 
with 100 µM 4:1 DMPC:DMPG liposomes and titrated with ZnSO4•7H2O to a final concentration of 
620 µM. Arrows indicate the change in fluorescence after each aliquot of Zn(II) added. The fluores-
cence spectra (excitation: 358 nm) were analyzed by non-linear least squares fitting to give an 
average logKZn(II)L of 8.62 ± 0.07 (n = 2).  B) Change in fluorescence response at 500 nm with 
corresponding fit to the equilibrium system model described in Figure 2.8 above. 










































Figure 2.12: Binding isotherms for the formation of the Zn(II) complexes of chromis-1 ester (2.1a) 
and chromis-1 acid (2.1b) with 1:1 stoichiometries.  The grey region displays the combined dynamic 
range for the two metal-binding fluorophores within the 90:10 fractional saturation window.   
 
2.3.4 Sensitivity of Chromis-1 Ester to Intracellular pH Fluctuations 
To examine the ratiometric response of chromis-1 ester to changes in intracellular 
pH, live 3T3 mouse fibroblasts cells were exposed to the reagent bafilomycin A1 (900 nM), 
a selective inhibitor of vacuolar-type H+-ATPases.30-31 Fibroblasts were incubated with 
both chromis-1 ester and LysoTracker Red, which is used to visualize acidic subcellular 
compartments. LysoTracker Red functions as an acidotropic fluorophore that is rendered 
membrane impermeable upon protonation, leading to the selective accumulation within 
the acidic subcellular compartments.  As illustrated in Figure 2.13, the fluorescence inten-
sity of LysoTracker Red was immediately reduced upon addition of bafilomycin A1, indi-
cating a rapid equilibration of the pH of the stained cytoplasmic components. Conversely, 
the ratiometric response of chromis-1 ester was negligibly affected under analogous con-
ditions (Figure 2.13). These results are consistent with in vitro measurements of the fluo-
rescence dependence of chromis-1 on pH using liposomes as model membranes, where 
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only minimal changes in the emission intensity and profile were observed between pH 7 
to pH 5 (Figure 2.14). 
 
Figure 2.13: Emission ratiometric response of chromis-1 to changes in the intracellular pH. Top 
panel: Live NIH 3T3 mouse fibroblast cells were co-incubated with Lysotracker Red (LTR, 50 nM) 
and chromis-1 ester (2 µM), and images were acquired simultaneously to evaluate changes in the 
LTR fluorescence and chromis-1 emission ratio upon the addition of bafilomycin A1 (900 nM) at 14 
min. Scale bar: 20 µm. Bottom: time-dependent changes of the average emission intensity of LTR 
(red trace) and intensity ratio of chromis-1 fluorescence (blue trace) for the ROI that is indicated by 
the white circles in the above images. Asterisks indicate the time points associated with the images 
in the above micrographs, and the arrow demonstrates the time corresponding to the addition of 
bafilomycin A1. Data were acquired and analyzed, and the figure was prepared, by Daisy Bourassa, 
Ph.D.28  Figure and figure caption were reproduced with permission from author of the paper cor-




Figure 2.14: Fluorescence dependence of chromis-1 ester (2.1a) on pH. Chromis-1 ester (2 µM) 
was equilibrated in aqueous buffer (10 mM PIPES, 100 mM KCl, 25°C) at pH 7.0 and 5.0, both 
supplemented with 4:1 DMPC:DMPG liposomes (100 µM), and then saturated with ZnSO4·7H2O 
(3 µM). Red traces (solid and dashed) represent the fluorescence response of chromis-1 at pH 7.0, 
and the black traces (solid and dashed) represent the fluorescence response at pH 5.0.  Excitation: 
358 nm. Figure and caption were reproduced with permission from reference [28].   
 
2.4 Conclusions 
The design of emission-ratiometric fluorescent probes for the detection of trace 
metal ions in biology by TPEM remains a significant challenge.  By incorporating the metal-
binding site into the acceptor moiety of a donor-acceptor fluorophore platform, large chro-
matic shifts of both the excitation and emission maxima were achieved while maintaining 
balanced action cross sections derived from similar 2PA cross sections between the free 
and Zn(II)-bound probe. The latter is a vital prerequisite to ensure a robust quantitative 
analysis of ratiometric images.  Because the signal-to-noise ratio is amplified in the derived 
ratio image compared to the raw fluorescence micrographs, the intensities of the individual 
emission channels should remain balanced. Although a large Rmax/Rmin ratio may seem 
advantageous for achieving a wide dynamic range, the differences in brightness between 















2.1a - pH 7.0
+ Zn(II)
2.1a - pH 5.0
+ Zn(II)
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the two emission channels would be difficult to resolve due to the limited absolute dynamic 
range of the detection system, and thus a large gain in Rmax/Rmin would be offset by a 
decreased signal-to-noise ratio.  
Implemented in the form of a Zn(II)-selective fluorescent probe, chromis-1 ester 
displayed robust emission-ratiometric imaging capabilities in live cells using TPEM.  Ini-
tially, however, using the measured Zn(II) stability constant of the acid form of chromis-1, 
cellular staining data with chromis-1 ester generated discrepancies in the calculated buff-
ered Zn(II) levels when compared to the previously published estimations, suggesting that 
the ester functionalities were not undergoing hydrolysis to their corresponding carboxylic 
acids by means of non-specific esterases, as expected.  Comparison of the Zn(II) stability 
constants of chromis-1 acid chromis-1 ester, which required the presence of liposomes to 
enable sufficient solubility for conducting the independent measurements, observed a two-
logarithmic difference between the two values. The establishment of limiting Rmin and Rmax 
values provided from in situ calibration measurements in 3T3 mouse fibroblast cells, in 
addition to the Zn(II)-binding affinity value of chromis-1 ester, enabled the determination 
of estimated buffered cytosolic Zn(II) levels between 50-100 pM under basal-level condi-
tions. This value agrees well with previous reports using genetically encoded ratiometric 
fluorescence probes,29 which indicated buffered levels of 80 pM in HeLa cells,32 270 pM 
in HEK293 cells,33 and 400 pM in pancreatic b cells INS-1cells.33  Furthermore, the calcu-
lation of this estimated buffered Zn(II) range confirmed that, indeed, the ester functionali-
ties were not hydrolyzed upon internationalization into the cytoplasm.   
As ratiometric image analysis reports only estimated buffered Zn(II) concentrations 
by determining the fractional saturation of the probe, absolute buffered Zn(II) levels must 
be derived from an independent calibration of the probe most often carried out in vitro.  
 88 
Variations in the calibration conditions, including pH, temperature, and background elec-
trolyte composition and concentration, not to mention the reliability of previously measured 
protonation constants and Zn(II)-binding affinities of the employed competitor ligands and 
metal ion buffers, only support the notion that the calculated cellular Zn(II) levels should 
serve as estimated values rather than absolute concentrations.  Nevertheless, quantitative 
ratiometric imaging enabled by the employment of metal-responsive fluorescent probes, 
including chromis-1, is particularly valuable when discerning relatively subtle changes in 
buffered Zn(II) concentrations within a particular environment.   
2.5 Experimental Section 
2.5.1 Synthesis 
Materials and Reagents. 2-amino-4’-methoxyacetophenone (2.4) was synthe-
sized according to a previously published procedure.7 Fmoc-succinimidyl carbonate 
(Oakwood Chemicals), isonicotinic acid N-oxide (Alfa Aesar), 2,4-pyridine dicarboxylic 
acid (Alfa Aesar), and 2-bromo-4’-methoxyacetophenone (Alfa Aesar) were purchased 
from commercial sources and used without further purification.  NMR: 1H NMR spectra 
were recorded at 400 MHz and referenced to an internal TMS standard (0 ppm) for all 
NMR solvents excluding D2O, which was referenced to sodium 3-trimethylsilylpropionate-
2,2,3,3-d6 (0 ppm).  13C spectra were acquired at 100 MHz and referenced to the known 
chemical shift of the solvent peak (CDCl3: 77.2 ppm; DMSO-d6: 39.5 ppm; CD3OD: 49.0 
ppm; Acetone-d6: 206.3, 29.8 ppm).  
2-Cyanoisonicotinic acid (2.2): Synthesized and optimized by M. Thomas Mor-
gan, Ph.D.  Isonicotinic acid N-oxide (87.7 mmol, 12.2 g), diethyl sulfate (1.2 eq., 105 
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mmol, 12.2 mL) and dioxane (15 mL) were added to a 100 mL round bottom flask contain-
ing a large stir bar. The flask was covered with a fritted adapter to minimize evaporation, 
and the mixture was stirred at 90°C overnight to produce a biphasic liquid. This was diluted 
with ice water (100 mL) and washed with an equal volume of ethyl acetate to remove tarry 
material and unreacted Et2SO4. The aqueous phase was neutralized with Na2CO3 (1.0 eq., 
96.5 mmol, 9.3 g) under stirring, and NaCN (1.1 eq., 96.5 mmol, 4.73 g) was added. After 
2 hours, the mixture was slowly acidified with concentrated HCl (2.1 eq., 184 mmol, 15 
mL), and the product was collected by filtration and dried by suction overnight to give a 
red-orange powder, which was recrystallized from boiling acetonitrile-water gave the pu-
rified product as a light yellow solid. Yield: 10.67 g (82%). 1H NMR (400 MHz, Acetone-
d6) d 8.19 (dd, J = 5.0, 1.6 Hz, 1H), 8.35 (dd, J = 1.6, 0.9 Hz, 1H), 8.96 (dd, J = 5.0, 0.9 
Hz, 1H). 13C NMR (100 MHz, Acetone-d6) d 117.7, 127.5, 128.7, 135.4, 140.5, 153.2, 
164.8.  
2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)isonicotinic acid 
(2.3).  A solution of 2.2 (6.76 mmol, 1.0 g) in acetic acid (5 mL) was hydrogenated for 2 
hours at 20 psi in the presence of Pd/C (5 mol %, 500 mg) as a catalyst. The reaction 
mixture was filtered through a pad of Celite and the solvent was removed under reduced 
pressure to give 950 mg (93%) of 2-(aminomethyl)isonicotinic acid. Without further purifi-
cation, the isolated product (1.32 mmol, 200 mg) was dissolved in 10% aq. Na2CO3 (1.5 
mL) and a solution of 9-fluorenylmethylsuccinimidyl carbonate (0.91 eq., 1.2 mmol, 405 
mg) in 1,4-dioxane (1 mL) was added. After stirring the reaction mixture at room temper-
ature for 12 hours, the solvent was evaporated and the residue was treated with 1 M aq. 
HCl (1.5 mL). The precipitated product was filtered off, washed with water and a small 
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amount of methanol, and dried under vacuum to afford 420 mg (85%) of the Fmoc deriv-
ative 2.3 as a white solid. 1H NMR (400 MHz, DMSO-d6, T = 373K) d 4.22 (t, J = 6.9 Hz, 
1H), 4.34 (d, J = 6.9 Hz, 2H), 4.39 (d, J = 6.1 Hz, 2H), 7.29 (t, J = 7.4 Hz, 2H), 7.38 (t, J = 
7.4 Hz, 2H), 7.55 (s, br, 1H), 7.63-7.67 (m, 3H), 7.77 (s, 1H), 7.83 (d, J = 7.5 Hz, 2H), 8.66 
(d, J = 5.0 Hz, 1H), 13.01 (s, br, 1H). Note: Due to the presence of a dynamic conformer 
equilibrium, the room temperature 1H NMR spectrum displayed an additional set of weak 
signals which merged with the main set upon heating to 100 °C). Furthermore, the dy-
namic exchange precluded the recording of a suitable 13C NMR spectrum.  MS (ESI) m/z 
375 (100, [M+H]+). HRMS (ESI) m/z calculated for C22H19N2O4 [M+H]+ 375.1345, found 
375.1356. 
Fmoc-protected Amide 2.5.  A mixture of the Fmoc-protected amino acid 2.3 
(9.62 mmol, 3.60 g), 2-amino-1-(4’-methoxyphenyl)ethanone hydrochloride 2.4 (1.1 eq., 
10.6 mmol, 2.22 g), EDCI•HCl (1.5 eq., 14.4 mmol, 2.87 g), and 1-hydroxybenzotriazole 
(HOBt, 0.5 eq., 4.81 mmol, 675 mg) was stirred in DMF (12 mL) until it turned homogene-
ous (10 min). Pyridine (1.0 eq., 815 µL) was added, and the mixture was stirred overnight. 
The mixture was diluted sequentially with water (5 mL), methanol (60 mL) and water (20 
mL) under rapid stirring. The resulting precipitate was collected by filtration, washed with 
water, dried under vacuum, and recrystallized from a solution in THF-acetonitrile by boiling 
until the temperature rose to the boiling point of pure CH3CN. After cooling to room tem-
perature, the product was collected by filtration and dried under high vacuum to afford a 
colorless crystalline powder. Yield: 4.59 g (8.80 mmol, 92%). 1H NMR (400 MHz, DMSO-
d6, T = 293 K) d 3.86 (s, 3H), 4.26 (t, J = 5.0 Hz, 1H), 4.34 (d, J = 7.0 Hz, 2H), 4.39 (d, J 
= 6.0 Hz, 2H), 4.78 (d, J = 5.6 Hz, 2H), 7.09 (d, J = 8.8 Hz, 2H), 7.33 (t, J = 7.5 Hz, 2H), 
7.41 (t, J = 7.4 Hz, 2H), 7.70-7.76 (m, 4H), 7.90 (d, J = 7.5 Hz, 2H), 8.01-8.05 (m, 3H), 
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8.69 (d, J = 5.1 Hz, 1H), 9.09 (t, broad, J = 5.6 Hz, NH). 13C NMR (100 MHz, DMSO-d6) d 
45.8, 46.1, 46.7, 55.6, 65.7, 114.1, 118.5, 119.5, 120.1, 125.3, 127.1, 127.7, 127.8, 130.3, 
140.7, 141.7, 143.9, 149.6, 156.5, 160.0, 163.5, 165.2, 193.1. MS (ESI) m/z 522 (100, 
[M+H]+), 177 (18); HRMS (ESI) m/z calculated for C31H28N3O5 [M+H]+ 522.2029, found 
522.2066. 
Fmoc-protected Thiazole 2.6. Amide 2.5 (2.01 mmol, 1.046 g) and Lawesson’s 
reagent (1.2 eq., 2.41 mmol, 973 mg) were added to a 25 mL round bottom flask equipped 
with a magnetic stir bar. The flask was clamped above a 120°C oil bath and fitted with a 
reflux condenser, which was topped with a T-shaped adapter leading to an argon supply 
and bubbler. The joint between the condenser and flask was pulled apart to leave a gap 
of a few mm, and the system was flushed with argon. Anhydrous 1,4-dioxane (4 mL) was 
added from a syringe through the gap in the joint. The joint was quickly seated, and the 
flask was lowered into the oil bath. After 30 minutes, the reaction was complete by TLC 
(5:1 CH2Cl2-MTBE). Water (~0.5 mL) was added while stirring, and the mixture was cooled 
to room temperature. The resulting orange slurry was dissolved in CH2Cl2 (12 mL) and 
stirred with 5% aqueous NaOH (6 mL, 4 equiv.) for 20 min. The resulting yellow emulsion 
was partitioned between water (50 mL) and CH2Cl2 (50 mL) and the organic layer was 
collected. The aqueous layer was extracted with CH2Cl2 (10 mL) and the combined or-
ganic layers were dried with MgSO4, diluted with MTBE (10 mL), and filtered through a 
bed of sand (~4 cm) on top of silica gel (~6 cm). The filter was washed with 3:1 CH2Cl2-
MTBE until the effluent was no longer yellow, and the combined filtrate and washings were 
concentrated to dryness. The residue was recrystallized from ethyl acetate/2,2,4-trime-
thylpentane to give pure 2.6 as light yellow fibrous crystals. Yield: 891 mg (1.72 mmol, 
86%). 1H NMR (400 MHz, CDCl3) d 3.86 (s, 3H), 4.27 (t, J = 7.1 Hz, 1H), 4.44 (d, J = 7.1 
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Hz, 2H), 4.61 (d, J = 5.4 Hz, 2H), 5.96 (t, broad, J = 4.9 Hz, 1H), 6.96 (d, J = 8.8 Hz, 2H), 
7.31 (t, J = 7.4 Hz, 2H), 7.39 (t, J = 7.4 Hz, 2H), 7.53 (d, J = 8.8 Hz, 2H), 7.64 (d, J = 7.4 
Hz, 2H), 7.71 (dd, J = 5.2, 1.4 Hz, 1H), 7.76 (d, J = 7.5 Hz, 2H), 7.79 (s, br, 1H), 7.99 (s, 
1H), 8.64 (d, J = 5.1 Hz, 1H). 13C NMR (100 MHz, CDCl3) d 46.0, 47.2, 55.4, 67.0, 114.7, 
118.1, 118.9, 119.9, 123.3, 125.1, 127.0, 127.7, 128.2, 139.0, 141.3, 141.4, 141.7, 144.0, 
149.9, 156.5, 157.9, 160.3, 162.5. MS (ESI) m/z 520 (100, [M+H]+); HRMS (ESI) m/z cal-
culated for C31H26N3O3S [M+H]+ 520.1695, found 520.1719. 
Primary amine 2.7. A 50-mL round bottom flask was charged with 2.6 (2.02 mmol, 
1.049 g), crushed cesium carbonate (2 eq., 4.04 mmol, 1.315 g) and DMSO (15 mL). 
Ethanethiol (2 eq., 4.04 mmol, 291 µL) was added drop-wise to the stirred mixture.  After 
1.5 hours, the reaction was complete by TLC (neat EtOAc).  The mixture was transferred 
to a 250-mL Erlenmeyer flask, partitioned between diH2O (50 mL) and toluene (25 mL), 
and heated gently until two homogeneous liquid phases could be separated.  The mixture 
was acidified with 1 M aq. HCl (1 eq., ~ 2 mL), and the orange aqueous layer was col-
lected, washed with toluene to remove non-basic byproducts, and then made basic (pH ~ 
9) by the addition of 5% aq. NaOH. The product was extracted with toluene (2 x 25 mL), 
and the combined extracts were dried over MgSO4, filtered, and concentrated to afford 2.7 
as a pure, pale yellow solid. Yield 454 mg (1.53 mmol, 76%). 1H NMR (400 MHz, CDCl3) 
d 3.87 (s, 3H), 4.07 (s, 2H), 6.97 (d, J = 8.9 Hz, 2H), 7.55 (d, J = 8.9 Hz, 2H), 7.68 (dd, J 
= 5.2, 1.7 Hz, 1H), 7.82-7.83 (m, 1H), 8.00 (s, 1H) 8.65 (dd, J = 5.2, 0.8 Hz, 1H). 13C NMR 
(100 MHz, CDCl3) d 47.7, 55.4, 114.6, 117.4, 118.2, 123.3, 128.1, 138.8, 140.9, 141.3, 
150.1, 160.1, 162.9, 163.0. MS (EI) m/z 297 (100, [M]+), 268 (45), 149 (10); HRMS (EI) 
m/z calculated for C16H15N3OS [M]+ 297.0936, found 297.0921. 
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Chromis-1 ester (2.1a). A mixture of 2.7 (0.67 mmol, 200 mg), ethyl 2-(bromome-
thyl)isonicotinate hydrobromide (2.10, 2.5 eq., 1.68 mmol, 459 mg), crushed anhydrous 
potassium carbonate (2.5 eq., 1.68 mmol, 232 mg), and potassium iodide (2.5 eq., 1.68 
mmol, 280 mg) in acetonitrile (12 mL) was stirred at room temperature under an argon 
atmosphere for 12 hours. The reaction mixture was diluted subsequently with EtOAc (10 
mL) followed by diH2O (10 mL). The organic layer was separated, dried over anhydrous 
Na2SO4, and evaporated under reduced pressure. The resulting residue was purified by 
column chromatography (silica gel, 1:1 dichloromethane/acetone).  The oily column prod-
uct was crystallized by redissolving in a minimal amount of EtOAc and slowly diluting with 
MTBE until cloudy, after which the mixture was heated to boiling to become homogeneous 
and concentrated until crystallization began to initialize.  The crystals were isolated by 
suction filtration, washed with MTBE and dried under vacuum to give diester 2.1a as a 
light yellow solid.  Yield 320 mg (0.513 mmol, 76%). 1H NMR (400 MHz, CDCl3) d 1.37 (t, 
J = 7.2 Hz, 6H), 3.88 (s, 3H), 4.03 (s, 2H), 4.07 (s, 4H), 4.37 (q, J = 7.1 Hz, 4H), 6.98 (d, 
J = 8.9 Hz, 2H), 7.59 (d, J = 8.9 Hz, 2H,), 7.69-7.72 (m, 3H), 7.99 (s, 1H), 8.12-8.14 (m, 
3H), 8.61 (dd, J = 5.2, 0.7 Hz, 1H), 8.69 (dd, J = 5.0, 0.8 Hz, 2H). 13C NMR (100 MHz, 
CDCl3) d 14.1, 55.4, 60.08, 60.14, 61.6, 114.5, 118.1, 119.6, 121.3, 122.4, 123.4, 128.1, 
138.2, 138.8, 141.0, 141.3, 149.76, 149.78, 160.10, 160.14, 160.2, 163.2, 165.1. MS (EI) 
m/z 623 (5, [M]+), 459 (100), 342 (77), 282 (48), 137 (10). HRMS (EI) m/z calculated for 
C34H33N5O5S [M]+ 623.2202, found 623.2193. 
Chromis-1 acid (2.1b). Sodium hydroxide (2.5 eq., 0.40 mmol, 80.4 µL of a 20 % 
(w/v) aqueous solution) was added to a stirred solution of 2.1a (1 eq., 0.16 mmol, 100 mg) 
in EtOH (4 mL), and the resulting mixture was refluxed under stirring for 2 hours. After 
cooling to room temperature, the product was filtered and dried under reduced pressure 
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to afford 90 mg (0.15 mmol, 92% yield) of 2.1b as pale yellow crystals. 1H NMR (400 MHz, 
CD3OD): d 3.85 (s, 3H), 3.95 (s, 2H), 4.00 (s, 4H), 7.03 (d, J = 8.9 Hz, 2H), 7.65-7.68 (m, 
4H), 7.75 (dd, J = 5.3, 1.8 Hz, 1H), 7.97-8.0 (m, 3H), 8.10 (s, 1H) 8.53 (d, J = 5.1 Hz, 3H). 
HRMS (ESI) m/z calculated for C30H24N5Na2O5S [M+H]+ 612.1294, found 612.1287. 
Ethyl 2,4-pyridinedicarboxylate (2.8). Adapted from a previously published pro-
cedure.10 2,4-pyidinedicarboxylic acid (1 eq., 29.9 mmol, 5.0 g) was suspended in absolute 
ethanol (50 mL), and concentrated H2SO4 (1.5 eq., 47.1 mmol, 2.62 mL) was added drop-
wise to the stirred mixture.  After refluxing overnight, the EtOH was removed under re-
duced pressure, and the resulting oily residue was partitioned between CHCl3 (50 mL) and 
saturated Na2CO3 (20 mL).  The organic layer was removed, and the aqueous layer was 
extracted with CHCl3 (2 x 50 mL).  The combined organic layers were dried over anhy-
drous MgSO4, filtered, and concentrated to a yellow oil.  The yellow oil was slowly dis-
solved in boiling cyclohexane and crystallized while cooling to room temperature under 
constant stirring.  The product was collected by suction filtration, washed with cyclohex-
ane, and dried under vacuum to afford 2.8 as a white crystalline solid.  Yield 5.52 g (24.7 
mmol, 83%). 1H NMR (400 MHz, CDCl3) d 1.44 (t, J = 6.5 Hz, 3H), 1.48 (t, J = 6.5 Hz, 3H), 
4.46 (q, J = 7.1 Hz, 2H), 4.53 (q, J = 7.1 Hz, 2H), 8.05 (dd, J = 4.9, 1.6 Hz, 1H), 8.65 (dd, 
J = 1.6, 0.8 Hz, 1H), 8.92 (dd, J = 4.9, 0.9 Hz, 1H). 13C NMR (100 MHz, CDCl3) d 14.3. 
14.4, 62.3, 62.4, 124.4, 126.1, 139.2, 149.3, 150.8, 164.4, 164.7.  MS (EI) m/z 223 (4, 
[M]+), 179 (35), 178 (40), 152 (33), 151 (100), 150 (45), 123 (30), 78 (18), 77 (21). HRMS 
(EI) m/z calculated for C11H13NO4 [M]+ 223.0845, found 223.0842. 
Ethyl 2-(hydroxymethyl)isonicotinate (2.9). Adapted from a previously pub-
lished procedure.10 To a solution of ethyl 2,4-pyridinedicarboxylate (2.8, 1 eq., 24.6 mmol, 
5.50 g) in EtOH (50 mL) at 0˚C was added crushed anhydrous CaCl2 (1 eq., 24.6 mmol, 
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2.73 g).  While stirring under argon, NaBH4 (1 eq., 24.6 mmol, 932 mg) was added slowly 
to the slightly opaque mixture, and upon the complete addition of NaBH4, the color of the 
mixture turned bright pink.  The reaction mixture was stirred for 2.5 hours at 0˚C when 
TLC (3:7 EtOAc:hexanes) determined that the reaction was complete.  The reaction was 
quenched with the addition of 6 N HCl (1 eq., 4.1 mL), the white precipitate that formed 
was filtered off, and filtrate was concentrated under reduced pressure to remove most of 
the EtOH.  The product was portioned between dichloromethane (50 mL) and saturated 
Na2CO3 to neutralize the HCl, followed by the addition of 1 M aq. disodium citrate to dis-
solve the inorganic salts that precipitated upon basification of the aqueous phase.  The 
aqueous phase was extracted with dichloromethane (2 x 50 mL), and the combined or-
ganic layers were dried over anhydrous Na2SO4, filtered, and concentrated to a colorless 
oil.  Residual CH2Cl2 was removed azeotropically with hexanes under reduced pressure, 
and the compound was dried under high vacuum to afford 2.9 as colorless crystals.  Yield: 
4.47 g (24.7 mmol, 72%). 1H NMR (400 MHz, CDCl3) d 1.48 (t, J = 7.2 Hz, 3H), 4.12 (s, 
broad, 1H), 4.42 (q, J = 7.2 Hz, 2H), 4.85, (s, 2H), 7.77 (ddt, J = 5.1, 1.6, 0.7 Hz, 1H), 7.87 
(ddt, J = 1.6, 0.8, 0.7 Hz, 1H), 8.69 (dd, J = 5.1, 0.9 Hz, 1H). 13C NMR (100 MHz, CDCl3) 
d 14.3, 62.0, 64.4, 120.0, 121.6, 138.5, 149.4, 160.9, 165.1.  MS (EI) m/z 182 (20), 181 
(85, [M]+), 180 (100), 178 (40), 153 (45), 152 (95), 151 (34), 136 (54), 124 (58), 123 (29), 
108 (20), 78 (44), 51 (44). HRMS (EI) m/z calculated for C9H11NO3 [M]+ 181.0749, found 
181.0736.  
Ethyl 2-(bromomethyl)isonicotinate (2.10). A 25-mL round bottom flask 
equipped with a stir bar was charged with 2.9 (1 eq., 5.52 mmol, 1.0 g), fitted with a rubber 
septum, evacuated under high vacuum, and backfilled with argon.  Anhydrous dichloro-
methane (10 mL) was added via an argon-flushed syringe, and the flask was cooled to 
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0˚C in an ice bath.  Under rapid stirring, thionyl bromide (3 eq., 16.6 mmol, 1.28 mL) was 
added, and the solution was stirred for 1.5 hours at 0°C.  Unreacted thionyl bromide was 
quenched by the addition of EtOH (20 mL), followed by stirring for an addition 20 min.  
After concentrating the solution under reduced pressure, the residue was redissolved in a 
minimal amount of EtOH, and then diluted slowly with methyl tert-butyl ether (MTBE) until 
the solution became cloudy.  The compound was then crystallized from boiling 
EtOH/MTBE to afford hydrobromide 2.10 as a white crystalline solid. Yield 1.46 g (4.5 
mmol, 81%).  1H NMR (400 MHz, CDCl3) d 1.48 (t, J = 7.2 Hz, 3H), 4.54 (q, J = 7.2 Hz, 
2H), 5.19 (s, 2H), 8.48 (dd, J = 5.9, 1.5 Hz, 1H), 8.55 (s, 1H), 9.14 (d, J = 5.9 Hz, 1H).  13C 
HMR (100 MHz, CDCl3) d 14.1, 24.1, 63.9, 125.9, 128.0, 142.6, 146.3, 153.4, 161.4. Note: 
1H and 13C NMRs were acquired of the hydrobromide salt of 2.10 in CDCl3 because of 
stability issues with the free base.  MS (EI) m/z 244 (20), 243 (20, [M]+), 165 (19), 164 
(100), 120 (33), 82 (18), 80 (20), 64 (19). HRMS (EI) m/z calculated for C9H10NO2Br [M]+ 
242.9895, found 242.9889.  
2.5.2 X-Ray Crystallography Methods 
2.5.2.1 Crystallization of the Zn(II) Complex of Chromis-1 Acid 
Chromis-1 acid (1b, 20 mg) was reacted with a stoichiometric quantity of ZnCl2 
(4.46 mg) in a mixture of DMF, 0.1 M KCl in H2O, and HPLC-grade MeOH (2 mL). The 
precipitated Zn(II) complex was then redissolved by gentle heating, and the resulting so-
lution was supplemented with crushed anhydrous CaCl2 (0.5 eq., 1.8 mg) and filtered 
through a 0.2 µm nylon filter into a clean vial.  Slow evaporation of the corresponding 




2.5.2.2 Crystallographic Determination of the Chromis-1-Zn(II) Complex 
A single suitable plate-shaped crystal (0.22 x 0.09 x 0.03 mm) of the [(2.1b)Zn(II)] 
complex formed by slow evaporation from DMF, H2O, and MeOH was selected and 
mounted on a loop with paratone oil on a Bruker APEX-II CCD diffractometer.  The se-
lected crystal was cooled to T = 100(2) K (Oxford Cryosystems low-temperature device) 
during data collection.  Data were measured using ω scans of 0.5° per frame for 60.0 s 
using MoKα radiation (fine-focus sealed X-ray tube, 45 kV, 35 mA). The total number of 
runs and images was based on the APEX2 (Bruker) program (2015).  The structure was 
solved and the space group P-1 (#2) was determined by the ShelXT-2014/4 structure so-
lution program34 using combined Patterson and dual-space recycling methods and by us-
ing Olex235 as the graphical interface.  The crystal structure was refined with version 
2014/7 of ShelXL36 using least-squares minimization, and all hydrogens were refined ani-
sotropically. 
2.5.3 Steady-State Absorption and Fluorescence Spectroscopy 
2.5.3.1 General Spectroscopic Methods 
All buffers and stock solutions used for spectroscopic measurements were pre-
pared using either HPLC-grade water (JT Baker) or 18.2 MΩ•cm Mili-Q water and filtered 
to remove interfering dust particles or fibers.  UV-Vis measurements were performed on 
a Varian Cary Bio50 spectrophotometer with a constant temperature accessory (Peltier) 
at 25°C.  Fluorescence measurements were performed with a PTI fluorimeter equipped 
with a 75 W xenon arc lamp excitation source and model 814 photomultiplier detection 
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system (PMT voltage was 1100 V for all experiments).  Fluorescence spectra were cor-
rected for the spectral response of the detection system and for the spectral irradiance of 
the excitation source (via a calibrated photodiode).  For all experiments, both UV-Vis and 
fluorescence, a 1-cm path length quartz cuvette was used, except for quantum yield de-
terminations, which were performed with a 10-cm path length quartz cuvette for absorb-
ance measurements.   
2.5.3.2 Fluorescence Quantum Yield Measurements of Chromis-1 Ester and Chromis-1 
Acid 
Fluorescence quantum yields of 2.1a were determined in aqueous buffer (10 mM 
PIPES, 0.1 M KCl) at pH 7.0 by a 4-point measurement over an OD range of 0.1-0.4 at 
365 nm.  The solution containing the free form of chromis-1 was supplemented with 20 
µM EDTA (30 mM stock solution in diH2O) to sequester adventitious Zn(II), whereas the 
Zn(II)-bound form was supplemented with 20 µM ZnSO4•7H2O to fully saturate the fluoro-
phore.  Fluorescence quantum yields were determined using quinine sulfate (Φf = 0.546 
in 1.0 N H2SO4).  To determine the quantum yield of 2.1b, single-point measurements 
were performed in aqueous buffer (10 mM PIPES, 0.1 M KCl, pH 7.0) supplemented with 
100 µM 4:1 DMPC:DMPG liposomes and a probe concentration of 2 µM.  The quantum 
yields were also referenced to quinine sulfate with an OD matching that of 2.1a (2 µM) in 
liposomes.     
2.5.3.3 Determination of Stability Constants 
A) Determination of Zn(II)-Binding Affinity of Chromis-1 Acid (2.1b).  The 
Zn(II) stability constant for 2.1b was measured via a spectrophotometric competition titra-
tion against ethylene glycol-bis(2-aminoethyl-ether)-N,N,N′,N′-tetraacetic acid (EGTA). 
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Chromis-1 (20 µM) in chelexed aqueous buffer (10 mM PIPES, 0.1 M KCl, pH 7.0, 25°C) 
was saturated with 1 eq. (20 µM) Zn(II) (6 mM ZnSO4·7H2O in diH2O) and then titrated 
with EGTA from 20 µM to 7 mM (using 20 and 300 mM EGTA stock solutions in diH2O).  
Absorbance spectra were acquired after each aliquot over the range of 250-500 nm.  The 
data were analyzed by non-linear least squares fitting using Specfit.    
B) Determination of Zn(II)-Binding Affinity of Chromis-1 Ester (2.1a) in Pres-
ence of 4:1 DMPC:DMPG Liposomes 
I. Preparation of Liposomes.  A 2 mM solution of a 4:1 mixture of 1,2-dimyristoyl-
sn-glycero-3-phosphocholine (DMPC): 1,2-dimyristoyl-sn-glycero-3-phospho-(1’-rac-glyc-
erol) (DMPG) was prepared according to the thin film hydration method.  DMPC (32.3 mg) 
and DMPG (8.21 mg) were dissolved in 4:1 dichloromethane:methanol (20 mL), and the 
solvent was removed under reduced pressure (rotary evaporator) to afford a thin film of 
lipids.  The thin film was then dried via high vacuum for 2 hours to remove traces of resid-
ual solvent.  The thin film was then hydrate by the addition of 29.8 mL of aqueous buffer 
(20 mM PIPES, 0.1 M KCl, pH 7.0).  The aqueous lipids were sonicated for 5 minutes and 
left to hydrate for 5 hours.  The resulting solution was diluted to a concentration of 500 µM 
and passed 21 times through an extruder (Liposofast, Avestin) that was equipped with a 
polycarbonate membrane (200 nm pore size).  Freshly extruded lipids were used immedi-
ately for the experiments described below.    
II. Determination of Liposome Size Distribution. Liposome particle sizes were de-
termined based upon the Tunable Resistance Pulse Sensing (TRPS) principle using the 
Izon qNano particle analyzer (Izon Science, Ltd., Burnside, New Zealand). Per the manu-
facturer’s recommendations, the liposomes were calibrated against monodisperse carbox-
ylated polystyrene particles (Izon, 200-nm diameter).  Liposomes and calibration particles 
were passed through a Nanopore membrane (NP150) with a pore stretch of 46.00 mm, 
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an electric potential of 0.50 V, and a pressure of 20 mm Hg using a variable pressure 
module. Each measurement was conducted by detecting a minimum of 1000 particles.  
The data were analyzed using the Izon Control Suite 3.0 software to determine the mean 
diameter and size distribution of the liposomes.  The mean diameter of the liposomes was 
determined to be 122 nm.   
III. Competition Titration. The Zn(II) stability constant for chromis-1 ester was meas-
ured via a fluorimetric competition titration against EGTA.  A freshly extruded 2 mM 4:1 
DMPC:DMPG liposome solution in aqueous buffer (20 mM PIPES, 0.1 M KCl, pH 7.0, 
chelexed) was diluted into PIPES buffer containing 1.0 mM EGTA (from 300 mM stock 
solution in diH2O) in a 1-cm quartz cuvette to yield a final concentration of 100 µM of 
liposomes. To ensure liposomes were solely in the gel phase, the solution (3.0 mL) was 
gently stirred at 25°C for a minimum of 10 minutes. To the buffered liposomes was added 
chromis-1 ethyl ester (3 mM stock solution in DMSO) to yield a final concentration of 2 
µM, and the solution was stirred at 25°C for another 10 minutes. The solution was then 
titrated with Zn(II) (from 15 mM and 60 mM ZnSO4·7H2O stock solutions in diH2O).  After 
each aliquot of Zn(II), solution was equilibrated for 5 minutes, and a fluorescence spectrum 
was acquired over the spectral window of 380-680 nm with excitation at 358 nm.   The 
data were analyzed by non-linear least squares fitting using Specfit.  
2.5.3.4 Fluorescence Dependence of Chromis-1 Ester on pH 
Two batches of 2 mM 4:1 DMPC:DMPG liposomes were prepared according to 
the procedure described above, with one batch being prepared in pH 5.0 buffer (10 mL of 
10 mM PIPES, 0.1 M KCl) and the other being prepared in pH 7.0 buffer (10 mL of 10 mM 
PIPES, 0.1 M KCl).  After freshly extruding through polycarbonate membranes (200 nm 
diameter), the resulting unilamellar liposomes (500 µM) were diluted into a 1-cm path 
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length quartz cuvette containing aqueous buffer of respective pH to a final concentration 
of 100 µM.  The buffered liposome solution (3.0 mL total) was equilibrated for 15 minutes 
by stirring at 25°C (Peltier), after which EDTA (3 mM stock solution in diH2O at pH 7.0) 
was added to achieve a final concentration of 1 µM to sequester an adventitious Zn(II).  
The solution was then supplemented with chromis-1 ester (3 mM stock solution in DMSO) 
to yield a final concentration of 2 µM, followed by an additional 10-minute equilibration 
period to ensure the dye was fully dissolved in the liposomes.  A fluorescence spectrum 
was acquired of the free form of chromis-1 ester in liposomes over the spectral window of 
380-700 nm with excitation at 358 nm.  To fully saturate the probe, ZnSO4•7H2O (3 mM 
stock solution in diH2O) was added to yield a final concentration of 4 µM.  A fluorescence 
spectrum of the Zn(II)-bound form of the probe was then acquired.  This experiment was 
performed identically at pH 7.0 and pH 5.0 for comparison purposes.   
2.5.3.5 Metal-Ion Selectivity Measurements of Chromis-1 Acid 
In a 1-cm quartz cuvette, a 5 µM solution of chromis-1 acid (3.0 mL) was prepared 
in 10 mM PIPES-K+ pH 7.0 buffer that had been previously treated with Chelex® (1% w/v) 
overnight and filtered through a 0.2 µm membrane filter.  A fluorescence spectrum was 
acquired over the spectral window of 380-680 nm with excitation at 358 nm.  For each 
divalent transition metal tested, chromis-1 acid was titrated with the divalent metal ion until 
80% of the free fluorophore (4 µM) was saturated with the metal, and a fluorescence spec-
trum was acquired after each addition and a one-minute equilibration. To saturate with 
remaining 20% of free probe, 1 µM (0.2 eq.) of Zn(II) was added to the solution, and a 
fluorescence spectrum was acquired.  Responses to Mg(II) and Ca(II) were measured in 
the presence of 2 mM of each metal (from 1 M stock solutions in H2O). Metal cations were 
supplied as aqueous stock solutions (1 mM for all metals excluding Mg(II) and Ca(II), 
 102 
which were 1 M) of the following metal salts: Mn(II), Fe(II), Cu(II), and Zn(II) as sulfates; 
Co(II), and Ni(II) as nitrates; Mg(II) and Ca(II) as chlorides.  Emission intensities were 
integrated in two bandpass channels: channel 1 (440-495 nm) and channel 2 (510-570 
nm).  The ratio of the two channels was plotted for each metal tested, including the re-
sponse to Zn(II).   
To show the fluorescence response of chromis-1 upon complete quenching of the 
fluorophore, chromis-1 acid (5 µM) was prepared in pH 7.0 buffer (3.0 mL, 10 mM PIPES, 
0.1 M KCl, 25°C) supplemented with EDTA (10 µM) in a 1-cm path length quartz cuvette.  
A fluorescence spectrum was acquired over the spectral window of 400-700 nm with ex-
citation at 358 nm.  The fluorophore was saturated with interfering divalent metal ions (20 
µM), and a fluorescence spectrum was acquired.  For Mn(II), because the fluorescence 
response was not completely quenched, a second 20 µM aliquot of Mn(II) was added to 
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SUPPRESSING EXCITED-STATE PROTONATION OF THE 
PYRIDYL ACCEPTOR OF CHROMIS-1 DRIVEN BY ACCEP-
TOR-MODIFIED DESIGN STRATEGIES 
3.1 Introduction 
In the previous chapter, the synthesis and characterization of chromis-1, a water-
soluble, emission-ratiometric, Zn(II)-selective fluorescence sensor based on a noncentro-
symmetric donor-π-acceptor architecture, which coordinates the metal analyte to the ac-
ceptor moiety rather than the donor moiety, was reported.  This design strategy, compared 
to other molecular architectures, permits larger bathochromic shifts in both the absorption 
and emission, as well as large and balanced TPA cross sections, by inducing an increased 
intramolecular charge transfer upon photoexcitation when the metal analyte is bound.   
Because protonation of the fluorophore can interfere with ratiometric imaging by 
distorting the ratiometric readout, the macroscopic protonation constants of chromis-1 acid 
were measured based on spectrophotometric and fluorimetric titrations1 to ensure that the 
probe was suitable for ratiometric imaging in the complex cellular environment.  During 
the fluorimetric pH titration of chromis-1 acid, as the pH was incrementally lowered from 
7.0 to 5.2, the fluorescence intensity was reduced by 50% compared to the intensity at pH 
7.0, manifesting a fluorescence profile with two emission maxima, one at 483 nm and the 
other at 560 nm, suggesting the presence of two species in solution (Figure 3.1A).  As the 
pH was lowered further from 5.2 to 2.0, the emission band with a maximum at 483 nm 
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completely disappeared, and the 560-nm emission maximum shifted to ~ 580 nm.  How-
ever, in the equivalent spectrophotometric pH titration, as the pH was incrementally low-
ered from 7.0 to 5.2, the absorbance maximum of the spectrum corresponding to pH 5.2 
was negligibly red-shifted, and the intensity was reduced only slightly compared to the 
spectrum at pH 7.0 (Figure 3.1B).  Significant changes in the absorption were not observed 
until the pH was lowered below 3.0, when the formation of a species with a red-shifted 
absorption maximum was manifesting, consistent with the protonation of the pyridine of 
the chromophore.   
 
Figure 3.1: Fluorimetric (A) and UV-Vis spectrophotometric (B) spectra at selected pH values to 
illustrate the change in fluorescence and absorbance of chromis-1 acid (2.1b) as the pH of the 
solution is lowered.   Data acquired by Dr. S. Sumalekshmy, and figure prepared by the author. 








































Deconvolution of the spectrophotometric data to obtain absorbance spectra corre-
sponding to each protonation state (Figure 3.2A) demonstrated that the minimal spectral 
changes between the dianionic (LH2–) and the monoanionic (L–) species is likely a result 
of an electrostatic effect from protonation of the one of the pyridines of the chelator moiety. 
However, generation of the zwitterionic (LH2) species by protonation of the second pyri-
dine, whose pKa is two orders of magnitude lower than the other pyridine of the chelating 
ligand, gives rise to an absorbance spectrum that boasts a molar absorptivity that is nearly 
50% lower than that of LH– species.  Least-squares fitting of the spectrophotometric data 
to a triprotic equilibrium model using the Specfit® software package2 yielded pKa’s for 
chromis-1 acid of 1.1, 3.4 and 5.5 (Figure 3.2B). 
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Figure 3.2: Protonation equilibria of chromis-1 acid (2.1b) in aqueous solution. (A) Deconvoluted 
spectra of UV-Vis titration data, depicting the absorbance spectra corresponding to each protona-
tion state. B) Species distribution diagram for the protonation equilibria of chromis-1 acid. L: ligand, 
chromis-1. Data acquired by Dr. S. Sumalekshmy, and figure prepared by the author. 
 
 
It should be noted that the protonation constants obtained from fitting of the spec-
trophotometric data yield only the macroscopic pKa’s rather than microscopic pKa’s.  As 
illustrated in Figure 3.3A, protonation of the monoanionic (L–) species leads to two proto-
nation equilibria between two different species with the same overall charge, by protonat-
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ing either the carboxylate group or the pyridine nitrogen.  However, the uncertainty in dis-
cerning the spectrophotometric or potentiometric differences between the two LH species 
present in equilibrium precludes the ability to determine microscopic pKa’s, or the precise 
protonation site of the species.  In fact, the neutral (LH) species that results from proto-
nating the monoanionic species is most likely a mixture of the zwitterionic species and the 
neutral carboxylic acid that too has its own equilibrium constant.  Therefore, the protona-
tion constants are considered macroscopic pKa’s, in which only the protonation state is 
taken into consideration rather than the protonation site (Figure 3.3B).   
 
 
Figure 3.3: Schematic illustrating the difference between determining microscopic (A) and macro-
scopic (B) protonation constants.   
 
 
However, 14N and 15N NMR analysis of trispicolylamine (TPA) was able to deter-
mine the microscopic pKa’s of the tripodal ligand, discovering that the most basic sites are, 



























pyridines were protonated before the tertiary amine, suggesting that the three pyridine 
rings induce enough of an electron-withdrawing effect to significantly reduce the pKa of 
the aliphatic amine.  Upon analysis of the spectrophotometric pH titration data of chromis-
1 acid (2.1b) and comparison to the NMR data of TPA, the third pKa of 5.5 is likely asso-
ciated with protonation of the pyridine of the bispicolylamine chelator (Figure 3.4).  Proto-
nation of the first pyridine of the chelator moiety results in a pKa perturbation that lowers 
the pKa of the second pyridine by two log units due to an electrostatic repulsion from the 
existing positive charge.  In order to protonate the chromophore pyridine, the presence of 
the two positive charges derived from protonation of both bispicolylamine pyridines results 
in an electrostatic repulsion that lowers the pKa of the pyridine more than four orders of 
magnitude from 5.5 to 1.1, relative to the first pyridine. The pKa of 1.1 that is associated 
with protonation of the fluorophore pyridine is also supported by the manifestation of a 
strong red-shift of more than 60 nm in the absorbance relative to the dianionic species 
and is a colorimetric indication that is consistent with protonation of an electron-deficient 
chromophore.   
 
Figure 3.4: Protonation equilibria of chromis-1 acid (2.1b) and the predicted species that corre-
spond to the three individual protonation constants determined from the UV-Vis pH titration. Data 



















































Comparing the absorption data to the fluorescence data, the spectrum with an 
emission maximum at 580 nm is consistent with the formation of the monoprotonated spe-
cies, in which all three pyridines of the trispicolylamine acceptor unit are protonated, 
whereas the emission maximum at 481 nm is representative of the dianionic chromis-1 
acid.  However, not only does the emergence of a second emission maximum at 560 nm 
within the emission spectrum at pH 5.2 not complement the spectral changes observed in 
the absorption between pH 7.0 and 5.2, but also the emission maximum is blue shifted by 
20 nm relative to the monoprotonated species that is not formed until the pH drops below 
2.   
The discrepancies between the absorption and fluorescence measurements are 
likely the result of protonation of the chromophore’s pyridine nitrogen in the excited state, 
producing a species that is not present in the ground state, regardless of pH (Figure 3.5).  
It was hypothesized that as the pH is lowered to ~ 5, the increase in [H3O+] results in 
protonation of pyridyl moiety of the fluorophore core in the excited state, leading to partial 
quenching of the fluorescence through increased radiationless decay to the ground state.   
 
Figure 3.5: Schematic depicting the protonation of the pyridyl acceptor of chromis-1 (2.1b) in the 
excited state to produce a monoanionic species that is not produced in the ground-state.       
 
Even at neutral pH, fluorimetric measurements of chromis-1 acid in aqueous buffer 
revealed a broadening of the fluorescence emission profile on the red edge, which alluded 
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(Figure 3.1A). It was hypothesized that the second emissive species at pH 7.0 was the 
same species with the emission maximum at 560 nm that is distinctly present at pH ~ 5.0.  
To further corroborate that the emission band at 560 nm is due to excited-state protona-
tion, solvent deuterium isotope effect studies were conducted to compare the shapes and 
intensities of the fluorescence profiles of chromis-1 acid in deuterated versus non-deuter-
ated buffer (10 mM PIPES, 100 mM KCl, pH/D 7.0, 25°C).  In deuterated buffer, a 16% 
fluorescence enhancement was observed relative to the fluorescence intensity in non-
deuterated buffer (Figure 3.6A).  In addition, upon normalization of the fluorescence spec-
tra of fully deprotonated chromis-1 in both buffers, a sharpening of the fluorescence profile 
of chromis-1 acid in deuterated buffer relative to non-deuterated buffer was observed, 
alluding to inhibition of formation of the second emissive species that emits at longer wave-
length (Figure 3.6B).   
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Figure 3.6: A) Solvent deuterium isotope effect for chromis-1 acid (2.1b) in deuterated versus non-
deuterated buffer (10 mM PIPES, 0.1 M KCl, pH/D 7.0) at 25°C.  Solid lines represent the fluores-
cence spectra in non-deuterated buffer, whereas the dashed lines represent the fluorescence spec-
tra in deuterated buffer.  B) Normalization of the emission intensities for the metal-free form of 
chromis-1 as shown in (A).   
 
Because the intracellular pH varies between the cytosol and subcellular compart-
ments and organelles,4 fluorescent probes, such as chromis-1, should not respond to fluc-
tuations in pH when imaging live cells. Despite the development of chromis-1 as a water-
soluble, Zn(II)-selective fluorescent probe that demonstrated robust emission-ratiometric 














































imaging capabilities in live cells using TPEM, the sensitivity towards fluctuations in pH 
could prove challenging for studying biological processes where changes in Zn(II) levels 
are also accompanied by a change in pH.  Therefore, this chapter serves to address the 
challenges encountered by the undesired emission response of chromis-1 upon acidifica-
tion by exploring optimizations in the design of the D-π-A architecture of the fluorophore 
core to reduce the driving force for excited-state protonation while maintaining an in-
creased ICT necessary for inducing large bathochromic shifts in the emission upon binding 
of Zn(II), thus maintaining its robust emission-ratiometric imaging capabilities.     
3.2 Elucidating the Intrinsic Photobasicity of the Donor-Acceptor Fluoro-
phore Platform of Chromis-1  
Although the pyridyl acceptor moiety of chromis-1 acid has a very low ground-state 
pKa (~ 1.1), the excited-state polarization of chromis-1 places an increased localized 
charge density on the pyridine nitrogen of the fluorophore, promoting an excited-state pro-
tonation of the pyridine nitrogen at a pH significantly higher than its pKa. It was expected 
that the ground-state pKa of the fluorophore pyridine without the bispicolylamine chelator 
moiety attached would be higher due to the absence of the two additional protonation 
sites, resulting in an electrostatic repulsion that would otherwise increase the acidity of the 
chromophore pyridine.  To explore the intrinsic photobasicity of the fluorophore core, a 
model compound of chromis-1, lacking the bispicolylamine chelating group, was synthe-
sized and characterized for its photophysical and thermodynamic properties. To ensure 
sufficient solubility at micromolar concentrations necessary to perform these characteri-
zations in aqueous buffer, a sulfonate group was tethered to the anisole donor of the fluor-
ophore.  To minimize interferences with the ICT strength of the donor, the sulfonate group 
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was separated from the oxygen donor via a trimethylene bridge.  The result was the gen-
eration of model compound 3.1 (Scheme 3.1).   
3.2.1 Synthesis of Model Compound 3.1 
Model compound 3.1 was assembled in 4 steps from commercially available, in-
expensive starting materials with an overall yield of 29% (Scheme 3.1).  Using an EDCI-
mediated condensation reaction, 2-amino-4’-methoxyacetophenone hydrochloride 2.4 
was coupled to isonicotinic acid to form the amide intermediate 3.6, which was then sub-
jected to a tandem thionation-cyclization reaction using Lawesson’s reagent to form the 
corresponding thiazole 3.7 in relatively good yield.  To functionalize the fluorophore with 
a water-solubilizing group, the anisole’s methoxy group was demethylated using BBr3 to 
form the corresponding phenol 3.8, which was then deprotonated by sodium tert-butoxide 
in THF and subsequently alkylated using 1,3-propanesultone to afford the water-soluble 




Scheme 3.1: Synthesis of Model Compound 3.1, with an overall yield of 29% after four steps. 
3.2.2 Photophysical Properties of Model Compound 3.1 
Upon protonation of the pyridyl acceptor, the absorption maximum of model com-
pound 3.1 is red-shifted by 51 nm from 346 nm (ε = 18,000 M-1•cm-1) to 397 nm (ε = 
19,600 M-1•cm-1) for the fully protonated pyridine (Table 3.1).  The presence of two clean 
isosbestic point at 288 and 370 nm are indicative of a well-defined solution equilibrium 
between the neutral and monoprotonated species.  Similarly, the emission maximum of 
3.1 in pH neutral buffer (10 mM PIPES, 0.1 M KCl, pH 7.0, 25°C) is red-shifted 93 nm from 
489 nm to 582 nm when fully protonated, consistent with the 580-nm emission maximum 
of observed for the triprotonated species (LH3+) of chromis-1 acid (Figure 3.2A).  The lack 
of the dicarboxylate-substituted bispicolylamine has a substantial effect on the fluores-













































Table 3.1: Photophysical and thermodynamic properties of model compound 3.1 
 Neutrala Protonatedb 
Absorbance lmax (nm) c 346 397 
e (104 M–1cm–1)d 18.0 19.6 
Emission lmax (nm)e 489 582 
FF f 0.65 n.d. 
pKa - 4.49 
pKa*g - 11.7 
a10 mM PIPES, 0.1 M KCl, 25°C. b0.1 N HCl (aq).  clowest-energy band of the one-photon absorp-
tion spectrum.  dmolar extinction coefficient at lmax. e maximum fluorescence emission. f fluores-
cence quantum yield, referenced to quinine sulfate (ΦF = 0.546).5 gexcited-state pKa. n.d. = not 
determined.  
 
3.2.3 Determination of the Protonation Constant of the Pyridine Moiety of Model Com-
pound 3.1 
The presence of an electron withdrawing group (thiazole) in the para position rel-
ative to the heterocyclic nitrogen was expected to lower the pKa of the pyridine nitrogen in 
model compound 3.1 relative to unsubstituted pyridine (pKa = 5.2)6.  Taking advantage of 
the colorimetric shift upon protonation of the fluorophore pyridine, the protonation constant 
of model compound 3.1 was measured by a spectrophotometric pH titration where the 
solution pH was varied between 3.3 and 5.6.  Spectral deconvolution through non-linear, 
least-squares fitting of the absorption and potentiometric data to a monoprotic equilibrium 
model yielded a pKa = 4.49 ± 0.002 (Figure 3.7).  While this value agrees more closely to 
the pKa of unsubstituted pyridine, it is more than three logarithmic units higher than the 
pKa of the pyridyl acceptor of chromis-1.     
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Figure 3.7: Spectrophotometric pH titration of model compound 3.1 (10 µM) at 25 °C in aqueous 
buffer (5 mM PIPBS, 0.1 M KCl, 5 mM KOH, pH 5.6). Black arrows indicate the change in absorb-
ance after each aliquot of HCl was added. The absorbance from 250-500 nm was recorded as a 
function of pHc (–log[H3O+]), and the data were analyzed by non-linear least squares fitting to a 
single protonation model to yield an average pKH1 = 4.49 ± 0.002 (n = 3).  
 
3.2.4 Employing the Förster Cycle to Estimate the Photobasicity of Model Compound 
3.1 
For a given chromophore, the Brønsted-Lowry basicity in the ground state can be 
vastly different than the corresponding basicity in the excited state because of greater 





































excited-state polarization derived from charge redistribution upon excitation.  It was hy-
pothesized that the increase in localized charge density on the pyridyl acceptor of model 
compound 3.1 upon excitation renders the pyridine as a much stronger base in the ex-
cited-state compared to the ground state.  Therefore, it was important to determine the 
excited-state pKa of model compound 3.1 to establish the degree of photobasicity of the 
pyridyl acceptor of the fluorophore core and compare it to its ground-state basicity.   
The thermodynamic values that represent protonation and the change in energy 
due to electronic excitation of a fluorophore are related in both the ground state and ex-
cited state by a thermodynamic cycle, known as the Förster cycle, that can be used to 
estimate the driving force for protonation of a species in the electronically excited state.7-8  
In solution, model compound 3.1 behaves as a weak base (denoted as B) in the excited-
state, forming the corresponding conjugate acid (denoted as BH+) and a hydroxide ion. 
The formation of the protonated species results in an increase in enthalpy in both the 
ground state and the excited state, denoted as ΔH and ΔH*, respectively (Figure 3.8).  
Both the free base and its corresponding conjugate acid in the ground state can be pro-
moted to their respective excited states by the absorption of photons hvB and hvBH+, re-
spectively.  These electronic transitions between the ground state and the excited state 
are referred to as 0-0 (zero-zero) transitions after vibrational relaxation to the ν0 vibrational 








Figure 3.8: Generalized Förster cycle diagram for estimating the excited-state pKa from the ground-
state pKa and the energies corresponding to the excitation of both the free base (B) and its conju-
gate acid (BH+). ΔGPT refers to the free energy of proton transfer.   
 
 Considering the Förster Cycle as a sum of each thermodynamic event (absorption, 
protonation in the excited state, emission, and deprotonation in the ground-state), the fol-
lowing relationship9 can be derived under the assumption that the molar entropies of dis-
sociation are equal: 
 
𝑁" h𝑣$ + ∆H* −  𝑁" h𝑣$&' −  ∆H  = 0  (3-1) 
   
where NA is Avogadro’s constant and hνB and hνBH+ correspond to the energy differences 
of the 0-0 electronic transitions.  Rearrangement of equation 3-1 provides the following 
relationship: 
Δ𝐻°∗ − Δ𝐻° = 𝑁"(ℎ𝑣$ − ℎ𝑣$&')  (3-2) 
Using equation 3-2, the differences in the protonation constants of the excited-state and 




















p𝐾1*		– p𝐾1 = 𝑁" 𝑣$ −	𝑣$&'   (3-3) 
Under the assumption that the entropies (ΔS and ΔS*) of dissociation for the ground state 
and excited state of BH+ to B are equal,9 the difference between enthalpies (ΔH* – ΔH) 
can be replaced by the difference in Gibb’s free energies, ΔG* – ΔG, for the excited-state 
and ground-state protonation equilibria, respectively, yielding the following equation after 
considering the relationships between Gibbs free energy and pKa: 
𝑝𝐾1∗ = 𝑝𝐾1 −
𝑁"ℎ𝑐Δ𝑣
2.303𝑅𝑇
  (3-4) 
Where R is the universal gas constant, T is the temperature (absolute, in Kelvin), and c is 
the speed of light, which are incorporated into the expression to convert the 0-0 electronic 
transition frequencies (νB and νBH+) into wavenumbers (𝑣$ and 𝑣$&').  The experimental 
determination of these values in wavenumbers are difficult to accurately determine.  Most 
often, these values are estimated as the average energy (in wavenumbers) corresponding 






However, the values can also be estimated by the energy, in wavenumbers, correspond-
ing to the intersection between the normalized excitation and emission spectra.  If the 
Stokes shift is too large to accurately approximate this value, the average of the energy 
corresponding to half the intensities of the excitation and emission bands. 
 Nonetheless, experimental measurements of the 0-0 energetic transitions between 
the ground state and the excited state for both the free base and its conjugate acid of the 
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pyridyl acceptor of model compound 3.1, as well as the pKa corresponding to the protona-
tion of the pyridine in the ground state, were used to estimate the Ka in the excited state 
(Ka*) from the three experimental measurements.  Using this Förster cycle, an excited-
state pKa (pKa*) of 11.7 was calculated, a value that is seven orders of magnitude higher 
than the ground-state pKa.  However, it should be noted that not only is the Förster cycle 
an estimation, but also the use of the thermodynamic cycle should be taken with caution, 
as at an excitation wavelength of 300 nm, a 4-nm error in the wavelength corresponds to 
a one-unit-discrepancy in the pKa.10   
3.2.5 Solvent Deuterium Isotope Effect of Model Compound 3.1 
The solvent deuterium isotope effect of model compound 3.1 was evaluated in 
deuterated versus non-deuterated buffers (10 mM PIPES, 0.1 M KCl, pH/D 7.0, 25°C), 
and integration of the emission spectra revealed an 18% increase in fluorescence in D2O 
relative to H2O buffer (Figure 3.9A).  Furthermore, upon normalization of the two spectra 
(Figure 3.9B), the spectrum of model compound 3.1 in D2O is narrower and features less 
of a red-edge tail, alluding to the presence of excited-state protonation as a competitive 




Figure 3.9: Solvent deuterium isotope effect of 3.1 (10 µM) in deuterated versus non-deuterated 
buffer (10 mM PIPES, 0.1 M KCl, pH/D 7.0) at 25°C. (A) Effect of buffer composition on the fluo-
rescence intensity and profile of model compound 3.1.  (B) Normalization of fluorescence spectra 
of model compound 3.1 shown in (A).  Excitation: 346 nm 
 
3.3 Optimization of the Fluorophore Design for Reducing the Basicity of the 
Pyridyl Acceptor 
Previously published literature data of oxazolyl-pyridine fluorophores bearing 
structural similarities to model compound 3.1 revealed that isomerization of the pyridine 
from the 4-position to the 2-position relative to the oxazole ring reduced the ground-state 











































pKa from 4.3 to 2.6, a nearly 2 log-unit reduction in the proton basicity of the pyridine.11  
Although the substitution of the oxazole with a thiazole ring was implemented to shift the 
wavelength of excitation further into the red to be more useful for TPEM, this literature 
precedent served as a design strategy for decreasing the basicity and ultimately the pho-
tobasicity of chromis-1 by isomerizing the pyridyl acceptor from the 4-position to the 2-
position relative to the thiazole ring.  Assuming the additional π-electron donation from the 
thiazole sulfur would not have a large effect on the polarization of the fluorophore com-
pared to the oxazole, it was hypothesized that this isomerization would lower the basicity 
of the pyridine by a comparable ~ 2 log units.  This rationale led to the synthesis of model 
compound 3.2 for spectroscopic characterization.   
3.3.1 Synthesis of Model Compound 3.2 
Model compound 3.2 was synthesized identically to 3.1, except that amide 3.9 was 
prepared using picolinic acid rather than isonicotinic acid, and the overall yield for the 4-
step synthesis was 48%, almost double that of 3.1 (Scheme 3.2).  Despite the structural 
similarities, including the identical counterion (Na+) used, the 1H and 13C NMR spectra of 
3.2 could be acquired in MeOD, whereas 3.1 required DMSO-d6 for sufficient solubility at 
concentrations required to achieve a suitable signal-to-noise ratio.   
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Scheme 3.2: Synthesis of model compound 3.2, with an overall yield of 48% after four steps.   
3.3.2 Steady-State Absorption and Fluorescence Measurements of Model Compound 
3.2 
Fluorescence quantum yield measurements of 3.2 yielded an astounding ΦF = 0.80 
when referenced to quinine sulfate (ΦF = 0.546 in 1N H2SO4)5, up 15% from that of 3.1 (ΦF 
= 0.65) (Table 3.2).  The absorbance maximum of the neutral molecule was not shifted 
relative to 3.1, but upon protonation, 3.2 demonstrated an 11-nm blue shift in the absorp-
tion compared to its constitutional isomer.  In the emission, however, 3.2 displayed a 22-







































Table 3.2: Photophysical and thermodynamic properties of model compound 3.2.   
 Neutrala Protonatedb 
Absorbance lmax (nm) c 345 386 
e (104 M–1cm–1)d 2.25 2.05 
Emission lmax (nm)e 467 565 
FF f 0.80 n.d. 
pKa - 2.34 
pKa* - 9.4 
a10 mM PIPES, 0.1 M KCl, 25°C. b 0.1 N HCl (aq). c lowest-energy band of the one-photon absorp-
tion spectrum. d molar extinction coefficient at lmax. e maximum fluorescence emission. I fluores-
cence quantum yield, referenced to quinine sulfate (ΦF = 0.546 in 1N H2SO4).5 n.d. = not deter-
mined. 
 
3.3.3 Model Compound 3.2 Boasts a 100-Fold Decrease in the Ground-State and Ex-
cited-State Basicity of the Pyridyl Acceptor 
Spectrophotometric pH titrations of 3.2 analogous to 3.1 demonstrated a more than 
two logarithmic-unit decrease in the ground-state pKa of the pyridyl acceptor from 4.49 ± 
0.002 for the 4-thiazolyl isomer to 2.34 ± 0.002 for the 2-thiazolyl isomer, consistent with 
the nearly two logarithmic-unit decrease observed with the oxazolyl fluorophores reported 
previously (Figure 3.10).  Using the Förster Cycle, the calculated excited-state pKa of 3.2 
also dropped more than two log units from 11.7 to 9.4, which indicated a substantial re-
duction in the photobasicity of the pyridine nitrogen due to the isomerization from the 4-
position to the 2-position.    
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Figure 3.10: Spectrophotometric pH titration of model compound 3.2 (10 µM) at 25 °C in 0.1 M 
KCl.  Black arrows indicate the change in absorbance after each aliquot of HCl was added.  The 
absorbance (250-500 nm) was recorded as a function of pHc (–log[H3O+]), and the data were ana-
lyzed by non-linear least squares fitting to a single protonation model to yield an average pKH1 = 
2.34 ± 0.002 (n = 3).  
3.4 Confronting the pH Sensitivity of Chromis-1 through the Implementa-
tion of the Isomerized Fluorophore Core 
Solvent deuterium isotope studies of model compound 3.2 revealed identical over-
lapping emission spectra when comparing the fluorescence response in deuterated ver-
sus non-deuterated buffers, alluding to the potential eradication of ESPT (Figure 3.11).  




































These findings, in addition to the reduced ground- and excited-state basicity, as well as 
the significant increase in quantum yield of 3.2 compared to 3.1, provided promising in-
sight into the development of a chromis-1 analog that is less sensitive to fluctuations in 
pH.  Therefore, the isomerized pyridyl acceptor moiety was incorporated into the design 
of a new Zn(II)-selective, emission-ratiometric fluorescent probe (3.3a/b) for use in two-
photon excitation microscopy.   
 
Figure 3.11: Solvent deuterium isotope effect of model compound 3.2 (10 µM) in deuterated and 
non-deuterated buffer (10 mM PIPES, 0.1 M KCl, pH/D 7.0, 25°C). Excitation: 345 nm 
 
3.4.1 Synthesis of the 2-Thiazolyl, Zn(II)-Binding Probe 3.3b 
Compound 3.3b was synthesized in 8 steps from commercially available starting 
materials with an overall yield of 10% (Scheme 3.3).  Beginning with ethyl 6-bromopico-
linate, a Rosenmund-von Braun reaction12-13 with cuprous cyanide (CuCN) in pyridine se-
lectively substituted the bromine with a nitrile group, followed by selective hydrolysis of the 
ethyl ester 3.12 in boiling 1N HCl(aq) to afford the corresponding carboxylic acid 3.13. EDCI-
mediated condensation of the nitrile acid 3.13 with 2-amino-4’-methoxyacetophenone hy-
drochloride (2.4) yielded amide 3.14, which was isolated by precipitating the product with 




















the addition of H2O, leaving the byproducts and other reagents solubilized in the DMF/H2O.   
Amide 3.14 underwent a tandem thionation-cyclization reaction to the corresponding thi-
azole nitrile 3.15 using Lawesson’s reagent.  In contrast to 3.15, the thionation-cyclization 
reaction to afford Fmoc-protected thiazole 2.6 in the synthesis of chromis-1 (Chapter 2) 
did not result in side-reactivity with the Fmoc-protected amine.  However, the nucleophilic 
nature of Lawesson’s reagent, in combination with the high temperature and increased 
electrophilicity of the 2-picolylnitrile moiety, created a time-dependent functional group in-
terconversion of the expected thiazole nitrile product to a thioamide.  The thioamide was 
first discovered by TLC, by which the Mn-Zn complex present as the UV-active in fluores-
cent TLC plates converted the thioamide to the nitrile directly on the TLC plate, sparking 
motivation to explore literature methods for converting thioamides to nitriles in high yield.  
Using a modification of a literature procedure to convert aromatic thioamides to nitriles,14 
the thioamide was converted back to the nitrile within ~ 10 minutes by reacting the crude 
isolated mixture with potassium permanganate in acetone, which surprisingly did not oxi-
dize the fluorophore during the reaction time.  Upon recrystallization to afford the pure 
nitrile 3.15, lithium diisobutyl-tert-butoxyalumunium hydride (LDBBA)15 was used to selec-
tively reduce the aromatic nitrile to the aldehyde 3.16 at room temperature.  Although 
DIBAL is often used for reductions of nitriles to aldehydes, reaction with DIBAL afforded 
exclusively the corresponding primary amine, suggesting that the pyridine nitrogen could 
act as a Lewis base for coordinating the aluminum and augmenting its reactivity. 
 131 
 
Scheme 3.3: Synthesis of 3.3a and 3.3b.  
In the synthesis of chromis-1 ester (2.1a), assembly of the final probe was 
achieved by double alkylation of primary amine 2.7 with the brominated isonicotinic acid 
derivative 2.10.  However, in the synthesis of 3.3a, the aldehyde functionality of 3.16 re-
quired the availability of a secondary amine in order to attach the metal-binding ligand.  
Therefore, synthesis of a bispicolylamine chelator that bears water-solubilizing carboxylic 
acids was accomplished by a one-pot dimerization of 2-cyanoisonicotinic acid (2.2) in eth-
anol:water, which is believed to proceed through a palladium-catalyzed hydrogenation of 
the nitrile to the primary amine, followed by a reductive coupling of the primary amine with 
the 2-formylisonicotinic acid that was generated from the in situ hydrolysis of the imine 










































































formation of the reductively coupled product, the pKa discrepancies between the fully re-
duced primary amine and the secondary amine of bispicolylamine dicarboxylic acid 3.17 
was exploited to selectively extract 3.17 into the organic layer using 1 M citrate buffer, thus 
washing out the primary amine that remained protonated in the aqueous layer.    
 
Scheme 3.4: One-pot synthesis and proposed mechanism for the reductive coupling of 2-cyanoi-
sonicotinic acid (2.2) to prepare the bispicolylamine derivative 3.17.   
 
After preparation of 3.17, the carboxylic acids were esterified using trimethylsilyl 
chloride (TMSCl) in MeOH to afford the dimethyl ester-substituted bispicolylamine 3.18 
(Scheme 3.5) for solubility in organic solvents when coupling the chelator to the fluoro-
phore core.    
 
 
Scheme 3.5: Synthesis of dimethyl ester-substituted bispicolylamine 3.18. 








































Exploiting aldehyde 3.16 as a versatile scaffold, fluorophore 3.3a was assembled 
via reductive amination with the dimethyl ester-substituted 3.18 in anhydrous 1,2-dichlo-
roethane to afford a glassy yellow solid in 77% yield.  A portion of 3.3a was saponified to 
the corresponding sodium dicarboxylate salt 3.3b by refluxing with NaOH(aq) in MeOH, 
followed by recrystallization from a MeOH:EtOH mixture, to provide an analytical-grade, 
water-soluble analogue for spectroscopic measurements.     
3.4.2 X-Ray Crystallographic Characterization of the 2-Thiazolyl Fluorophore 
Due to the availability of only 4 donor atoms for coordination in the structure of 
chromis-1 acid, the coordination of a chloride ion to the zinc center as an auxillary ligand 
manifested a characteristic trigonal bipyramidal geometry of Zn(II) complexes often ob-
served in biological complexes as a result of Zn(II)’s flexible coordination sphere.16-17  
However, the presence of the carboxylic acids of chromis-1 made it difficult to obtain high-
quality crystals due to a Ca2+ ion-mediated dimerization of chromis-1 acid.  To avoid this 
when attempting to crystallize probe 3.3b, a derivative of 3.3b lacking the carboxylic acids 
on the metal-binding ligand was synthesized through a reductive amination coupling of 
aldehyde 3.16 with di(2-pyridylmethyl)amine (Scheme 3.6), which afford probe 3.3c for 
use in crystallizing the corresponding Zn(II) complex of the 2-thiazolyl isomer. 
 
Scheme 3.6: Synthesis of probe 3.3c for use in crystallizing the Zn(II) complex of the 2-thiazolyl 


















As originally hypothesized, isomerization of the pyridyl acceptor moiety from the 4-
position to the 2-thiazolyl position resulted in the engagement of the thiazole nitrogen in 
Zn(II) binding, permitting the formation of a five-coordinate Zn(II) that does not entail ter-
nary complex formation with an auxillary ligand, as observed with chromis-1 acid (2.1b, 
Figure 2.1). The Zn(II) complex of 3.3c was crystallized in situ from a mixture of DMSO 
and H2O by reacting with a stoichiometric amount of Zn(ClO4)2 to generate triclinic color-
less crystals suitable for X-ray crystallography.  As illustrated in Figure 3.12A, the 
[(3.3c)Zn(II)] complex adopts a trigonal bipyramidal coordination geometry about the Zn(II) 
center.  Given the Hammett parameter of isonicotinicate (σp = 0.0), it was hypothesized 
that the lack of the anionic carboxylates would not distort the N-Zn bond lengths of the 
bispicolylamine chelator moiety.  To assess this, the N-Zn bond lengths for the bispicolyla-
mine pyridines of the [(3.3c)Zn(II)] complex were compared to [(chromis-1)Zn(II)] complex.  
Analysis of the two bispicolylamine N-Zn bonds of both conformers in the [(chromis-
1)Zn(II)] complex’s unit cell yields an average N-Zn bond length of 2.099 ± 0.01 Å.  The 
analogous N-Zn bonds of the [(3.3c)Zn(II)] complex displayed an average bond length 
2.038 ± 0.001 Å, corresponding to a bond elongation of 0.06 Å compared to chromis-1.  
This bond elongation suggests that the carboxylic acids render the pyridine(N)-Zn bonds 
of chromis-1 less basic, thus translating to a weaker interaction with the Zn(II) ion.  In 
addition, comparison of the pyridyl acceptor N-Zn bond of chromis-1 (2.100 ± 0.002 Å) 
and 3.3c (2.044 Å) demonstrates a stronger interaction between the pyridine and the zinc 
ion due to the shortened (by 0.56 Å) bond distance.  In contrast to chromis-1, the unit cell 
of the triclinic crystals of [(3.3c)Zn(II)] displayed well-ordered packing, as evidenced by 
Figure 3.12B.  Analysis of each of the four molecules within the unit cell indicated identical 
bond distances angles between the nitrogen donors and Zn(II) center (Table 3.6). in addi-
tion, the fluorophore core displayed identical torsional angles, which deviated negligibly 
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from planarity, in contrast to chromis-1, in which the anisole moiety of one of the two con-
formers was rotated out of plane by 35° relative to the thiazole ring.  For further information 




Figure 3.12: (A) ORTEP representation and atom number scheme for the Zn(II) complex of 3.3c: 
[(3.3c)Zn(II)]. Ellipsoids shown represent 50% probability. Hydrogen atoms and counter ions have 
been omitted for clarity. (B) ORTEP presentation of the unit cell packing for [(3.3c)Zn(II)], showing 








































3.4.3 Steady-State Absorption and Fluorescence Properties of Probe 3.3b 
Analogous to chromis-1 acid (2.1b), the anionic carboxylates of 3.3b permitted the 
preparation of aqueous stock solutions at millimolar concentrations without the need for 
organic solvents as cosolvents.  When diluted into aqueous buffer (10 mM PIPES, 100 
mM KCl, 25°C, pH 7.0) at micromolar concentrations, the coordination of Zn(II) resulted in 
large bathochromic shifts in both the absorption and emission, as evidenced by the molar 
ratio titration of 3.3b with Zn(II) (Figure 3.13).  Consistent with a strong intramolecular 
charge transfer upon coordination of Zn(II) to the pyridyl acceptor, the absorbance maxi-
mum of 348 nm (ε = 23,600 M-1 cm-1) is red-shifted by 17 nm when fully saturated with 
Zn(II) to 365 nm (ε = 21,700 M-1 cm-1) (Table 3.3).  While the absorbance spectra of free 
and Zn(II)-saturated 2.1b and 3.3b have nearly identical absorbance maxima, the absorb-
ance maximum of Zn(II)-saturated chromis-1 acid (2.1b) increases relative to free 
chromis-1, whereas the absorbance maximum of Zn(II)-saturated 3.3b decreases relative 
to free 3.3b.  The presence of clean isosbestic points at 284 and 361 nm, in addition to 
equimolar saturation of the probe with Zn(II), indicated an unambiguous equilibrium be-
tween free 3.3b and its corresponding Zn(II) complex with a 1:1 binding stoichiometry. 
Comparably, the emission maximum of free 3.3b undergoes a 50-nm batho-
chromic shift from 465 to 515 nm, 12 nm larger than chromis-1, with a single isosbestic 
point at 466 nm.  By exciting the fluorophore at its isosbestic point, the effected emission 
intensities are a direct reflection of the quantum yield, which increases more than 2-fold 
from 0.25 to 0.69.  The isomerization of the pyridyl acceptor from the 4-position to the 2-
position realized a modest decrease in the quantum yield from 0.32 to 0.25, despite the 
significant increase in quantum yield from 0.65 to 0.80 for model compounds 3.1 and 3.2, 
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respectively, whereas [(3.3b)Zn(II)] only decreased 2% from the corresponding Zn(II) 
complex of chromis-1.    
 
Figure 3.13: Spectral changes of 3.3b (20 µM) in neutral aqueous buffer (10 mM PIPES, 100 mM 
KCl, 25°C, pH 7.0) upon stepwise saturation with Zn(II). (A) Absorption (UV-Vis) spectral changes 
upon saturation with Zn(II). (B) Fluorescence emission response upon saturation with Zn(II) (exci-
tation at 361 nm). Red curves indicate the spectra after complete saturation (1.0 eq.) with Zn(II) is 
achieved. Inset: fluorescence integration over the entire spectral window as a function of molar 
equivalents of Zn(II). 
 
 










































Table 3.3: One- and two-photon photophysical properties of 3.3a and 3.3b in aqueous 
buffer at pH 7.0.a  
 3.3ab,c [(3.3a)Zn(II)]b 3.3bc [(3.3b)Zn(II)] 
Absorbance lmax (nm)d 351 367 348 365 
e (104 M–1cm–1)e 2.11 2.22 2.36 2.17 
Emission lmax (nm)f 434 480 465 515 
δmax (GM)g n.d. n.d. n.d. n.d. 
lmax (nm)h n.d n.d. n.d. n.d. 
ΦF i 0.20 0.27 0.25 0.69 
a10 mM PIPES, 0.1 M KCl, 25°C. b buffer supplemented with 100 µM liposomes (4:1 DMPC:DMPG). 
c supplemented with 20 µM EDTA to sequester adventitious Zn(II). dlowest-energy band of the one-
photon absorption spectrum. emolar extinction coefficient at lmax. fmaximum fluorescence emission. 
gtwo-photon absorption cross section. hmaximum two-photon absorption. ifluorescence quantum 
yield, referenced to quinine sulfate (ΦF = 0.546 in 1N H2SO4).5 n.d. = not determined. 
 
In an effort to mimic the lipid-rich environment of the cell, as well as to provide a 
medium in which to dissolve 3.3a, spectroscopic analysis of the dimethyl ester was per-
formed in the presence of 100 µM liposomes composed of anionic dimyristoyl phosphati-
dylglycerol (DMPG) lipids.  Initial attempts to obtain absorption and emission spectra of 
free and metal-bound 3.3a in a 4:1 mixture of zwitterionic dimyristoyl phosphatidylcholine 
(DMPC) and anionic dimyristoyl phosphatidylglycerol (DMPG) observed a 17-nm red-shift 
in the absorption upon binding of Zn(II), consistent with the bathochromic absorption shift 
of 3.3b in aqueous buffer without liposomes (Figure 3.14A).  However, in the emission, 
binding of Zn(II) to methyl ester 3.3a demonstrated a dramatic decrease in the fluores-
cence intensity as well as a vivid broadening of the emission band, which may be indica-
tive of the Zn(II) complex of the probe dissociating from the lipid bilayer (Figure 3.14B).  
The behavior observed in the emission is most likely attributed to reduced phospholipid 
solvation due to a smaller lipophilic surface area that can interact with the fatty acid chains.  
It was hypothesized that increasing the overall anionic charge density of the liposomes 
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may help stabilize the Zn(II) complex of 3.3a without adversely affecting the fluorescence 
response of the free form.  Therefore, the absorbance and fluorescence properties of 3.3a 
were acquired in 100% DMPG liposomes.   
 
Figure 3.14: Comparison of the absorbance and emission spectral changes of probe 3.3a upon 
saturation with Zn(II) between a 4:1 DMPC:DMPG (A,B) lipid mixture and 100% anionic DMPG  
lipids (C,D) in aqueous buffer (10 mM PIPES, 100 mM KCl, 25°C, pH 7.0).  Excitation: 361 nm.  
 
Surprisingly, the anionic liposomes did not induce any absorption shifts of either 
the free or metal-bound 3.3a relative to the absorbance maxima in the 4:1 DMPC:DMPG 
mixture (Figure 3.14C), observing absorbance maxima of 351 nm (ε = 21,100 M-1 cm-1) 
and 367 nm (ε = 22,200 M-1 cm-1) for the free- and Zn(II)-bound forms, respectively, in the 
anionic liposomes (Table 3.3).  Conversely, the emission maxima of 3.3a are blue shifted 
relative to 3.3b, demonstrating a 31-nm hypsochromic shift from 465 nm to 434 nm for the 
free form and a 35-nm blue shift from 515 to 480 nm for the Zn(II)-bound form.  In contrast 
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to the 4:1 DMPC:DMPG liposome mixture, the fluorescence response of Zn(II)-saturated 
3.3a displayed very balanced emission intensities in the anionic liposomes (Figure 3.14D).  
The presence of the para-methyl esters decreased, albeit negligibly, the fluorescence 
quantum yield of the free form of 3.3a from 25% (free form of 3.3b) to 20%, whereas the 
quantum yield of the Zn(II) significantly decreased to 27%, down 42% relative to the Zn(II)-
bound form of 3.3b (69%).  
3.4.4 The Thiazole Nitrogen of Probe 3.3b Engages in Zn(II) Coordination to Yield a 
Higher Affinity than Chromis-1 Acid 
As illustrated in Figure 3.13B (inset) above, a linear fluorescence increase, in con-
junction with a sharp saturation at 1.0 equivalent of Zn(II) relative to 3.3b, indicates Zn(II) 
binding with near unity fractional saturation over the entire titration range.  As mentioned 
in Chapter 2, reliable stability constants must be determined within a 10-90% fractional 
saturation window.  The additional coordination of the fluorophore’s thiazole nitrogen was 
expected to increase the stability constant for the formation of the Zn(II) complex, therefore 
demanding a competing ligand with higher affinity for Zn(II) to compete with 3.3b for co-
ordination.  Spectrophotometric and fluorimetric titrations were initially performed using 
HEDTA (2-(hydroxyethyl)ethylenediaminetriacetic acid) as a competing ligand with an ap-
parent formation constant of logβ = 11.60 at pH 7.0, µ = 0.1 M (calculated from published 
pKa’s and logβ values).18  However, the unmatched affinity of HEDTA resulted in a subpar 
data fit, so a ligand with a slightly weaker apparent affinity for Zn(II) (TMDTA: trimethylene-
dinitrilotetraacetic acid; logβ = 10.76 at pH 7.0, calculated from published pKa’s and logβ 
values)18 was also used to confirm the apparent stability constant of 3.3b. However, no 
matter whether EGTA, TMDTA, or HEDTA were titrated against the preformed 
[(3.3b)Zn(II)] complex,  non-linear, least-squares fitting of all spectroscopic data afforded 
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a uniform apparent stability constant of logKZn(II)L = 10.8 ± 0.05, equivalent to an apparent 




Definition of Equilibrium System: 
Species Zn(II) TMDTA 3.3b H log β 
Zn(II) 1 0 0 0 0 
TMDTA 0 1 0 0 0 
3.3b 0 0 1 0 0 
TMDTA(H) 0 1 0 1 10.41 
TMDTA(H2) 0 1 0 2 18.42 
TMDTA(H3) 0 1 0 3 21.16 
[(TMDTA)Zn(II)] 1 1 0 0 15.22 
[(3.3b)Zn(II)] 1 0 1 0 10.8 ± 0.05 
Figure 3.15: A) Fluorimetric determination of the Zn(II) stability constant of 3.3b via a competition 
titration with TMDTA.  Probe 3.3b (10 µM) was equilibrated ZnSO4·7H2O (10 µM) in aqueous buffer 
(10 mM PIPES, 0.1 M KCl, pH 7.0, 25ºC, treated with Chelex (1% (w/v), Biorad) and titrated with 
TMDTA to a final concentration of 80 µM. The fluorescence spectra (excitation: 361 nm) were an-
alyzed by non-linear least squares fitting to give an average logKZn(II)L of 10.8 ± 0.05 (n = 3).  Red 
curve corresponds to free 3.3b before saturation with Zn(II). B) Change in fluorescence response 
at 515 nm with corresponding fit to the equilibrium system model.   









































Because the anionic carboxylate groups render 3.3b cell membrane-impermeable, 
live-cell, two-photon microscopy was performed with the dimethyl ester derivative 3.3a, 
which is readily internalized into the cell.  Compared to 2.1a, it was hypothesized that 
substitution of the ethyl esters with methyl esters would enable faster rates of hydrolysis 
of the esters to the corresponding water-soluble carboxylic acids by means of non-specific 
intracellular esterases.  However, incubation and subsequent imaging studies with 3.3a 
showed punctate staining patterns indicative of membrane partitioning, demonstrating that 
hydrolysis of the methyl esters did not occur within the time frame of cellular imaging.  
Therefore, it was imperative that the apparent stability constant of 3.3a be determined to 
correlate the ratio values calculated directly from the live-cell imaging data with the frac-
tional saturation.  Upon incubation (~ 10 minutes) in pH 7.0 buffer (20 mM PIPES, 100 
mM KCl, 25°C) supplemented with 200 µM EGTA and 100 µM of the liposome mixture 
used with 2.1a, fluorophore 3.3a (2 µM) was titrated with ZnSO4•7H2O from 0-180 µM.  
Non-linear least squares fitting of the fluorimetric emf data (3 titrations) yielded an average 
logKZn(II)L = 9.57 ± 0.05, corresponding to an apparent Kd of 309 ± 0.3 nM (Figure 3.16).  
Due to the presence of the stronger electron-withdrawing ester substituents relative to the 
anionic dicarboxylate substituents in 3.3b, 3.3a exhibits a logK that is ~ 1.5 log units lower 
than 3.3b.  
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Definition of Equilibrium System: 
Species Zn(II) EGTA 3.3a H log β 
Zn(II) 1 0 0 0 0 
EGTA 0 1 0 0 0 
3.3a 0 0 1 0 0 
EGTA(H) 0 1 0 1 9.51 
EGTA(H2) 0 1 0 2 18.41 
EGTA(H3) 0 1 0 3 21.22 
[(EGTA)Zn(II)] 1 1 0 0 12.6 
[(3.3a)Zn(II)] 1 0 1 0 9.57 ± 0.05 
Figure 3.16: A) Fluorimetric determination of the Zn(II) stability constant of 3.3a via a metal-addition 
titration in the presence of EGTA in liposomes.  Methyl ester 3.3a (2 µM) was equilibrated with 
EGTA (100 µM) in aqueous buffer (20 mM PIPES, 0.1 M KCl, pH 7.0, 25ºC and supplemented with 
DMPG liposomes (100 µM) and titrated with ZnSO4·7H2O to a final concentration of 90 µM. The 
fluorescence spectra (excitation: 361 nm) were analyzed by non-linear least squares fitting to give 
an average logKZn(II)L of 9.57 ± 0.05 (n = 3).  B) Change in fluorescence response at 500 nm with 
corresponding fit to the equilibrium system model described above.   







































3.4.5 Metal-Ion Selectivity of Probe 3.3b 
As observed with chromis-1 acid (2.1b), the addition of an excess (4.0 and 8.0 eq.) 
of biologically relevant divalent metals resulted in no change in the fluorescence response 
(with Mg(II) and Ca(II), Figure 3.17A, B) or elicited a complete quenching of the fluores-
cence response (with all transition metals excluding Zn(II), Figure 3.17C-G) of 3.3b.   
Therefore, to evaluate the metal-ion selectivity of 3.3b, the 80:20 fractional saturation 
method developed for determining the metal-ion selectivity of chromis-1 (Chapter 2) was 
employed for 3.3b.  The ratiometric response of the probe was evaluated in the presence 
of 0.80 molar equivalents (80% fractional saturation) of the interfering divalent transition 
metal ions (Figure 3.18, black bars), which resulted in quenching of the probe’s fluores-
cence stoichiometrically, while the remaining 20% of free probe remained unaffected by 
any of the quenching metal ions.  Saturation of the remaining 0.2 molar equivalents of the 
probe with Zn(II) produced a ratiometric readout consistent with the emission response of 
the [(3.3b)Zn(II)] complex that was observed in the molar ratio titration (Figure 3.18, red 
patterned bars).   
Despite the lack of influence of 20 and 40 µM Ca(II) on the emission response of 
3.3b (Figure 3.17B), the addition of 2 mM Ca(II) resulted in an increase in and broadening 
of the emission profile of the probe (Figure 3.19B) and engendered a slight increase in the 
emission ratio compared to the probe before the addition of Ca(II).  While the response of 
the probe to millimolar concentrations of Ca(II) could be attributed to the engagement of 
the thiazole nitrogen in coordinating the metal cation, supplementation of 1.0 equivalent 
of Zn(II) immediately outcompeted the Ca(II) and restored the fluorescence to the 
[(3.3b)Zn(II)] complex, as expected.  The higher affinity of 3.3b derived from metal coor-
dination to the thiazole nitrogen resulted in a stoichiometric quenching of Mn(II) similar to 
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the other divalent transition metals tested, whereas chromis-1 acid did not observe stoi-
chiometric quenching by Mn(II).  Despite the appearance of tight Mn(II) binding with near 
unit fractional upon the addition of Mn(II), supplementation of 1 µM Zn(II) to saturate the 
remaining 20% of free 3.3b did not indicate a complete shift to the emission maximum of 
the Zn(II) complex in the absence of any interfering metal ions, suggesting that the affinity 
of the probe for Mn(II) is weak enough for Zn(II) to outcompete Mn(II).  Therefore, in the 
presence of 0.8 molar equivalents of Mn(II), the addition of 5 µM Zn(II) immediately re-
stored the emission response to that of the [(3.3b)Zn(II)] complex (Figure 3.19C).  Fe(II) 
displayed similar effects, although the kinetics for exchange were significantly slower and 
required ~ 30 to reach equilibrium (Figure 3.19D)   
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Figure 3.17:  Fluorescence response of 3.3b in the presence of an excess (4.0 and 8.0 
equivalents) of interfering divalent metal ions.  A-H) Black traces represent free 3.3b (5 µM) in pH 
7.0 buffer (10 mM PIPES, 0.1 M KCl, 25°C) supplemented with 10 µM EDTA.  Red and blue 
traces represent the addition of 20 µM and 40 µM, respectively, of divalent metal ions. Excitation: 
361 nm.   


















































































































Figure 3.18: Emission-ratiometric response of 3.3b (5 µM) towards selected divalent metal cations 
at 80% fractional saturation (calculated based on the ratio of the integrated fluorescence intensity 
between 510-570 nm (channel 2) and 440-495 nm (channel 1)). The black bars represent the ratio 
at 80% fractional saturation, and the corresponding patterned red bars represent the ratio after 
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Figure 3.19:  Fluorescence spectral response of 3.3b (5 µM) to selected interfering divalent metal 
ions in aqueous buffer (10 mM PIPES, 0.1 M KCl, pH 7.0 25°C). A-H) Black dashed traces repre-
sent free 3.3b, and the corresponding solid black traces indicate the response upon incremental 
supplementation with interfering divalent metal ions. Upon quenching 80% of 3.3b with interfering 
metal ions (C-G), the remaining 20% of 3.3b was saturated with Zn(II) (red traces). Excitation: 361 
nm.   









































































































3.4.6 Spectrophotometric Determination of the Protonation Constants of Probe 3.3b 
Analogous to the 3.4 log-unit difference in the ground-state pKa of the pyridyl ac-
ceptor between chromis-1 acid and its corresponding model compound (3.1), the pres-
ence of the bispicolylamine chelator of 3.3b was expected to significantly decrease the 
pKa of its pyridyl acceptor by several orders of magnitude compared to that of model com-
pound 3.2.  However, since the pKa of the pyridyl acceptor of chromis-1 acid already has 
a significantly acidic pKa (pKa = 1.1), the structural change between chromis-1 and 3.3b 
was not expected to manifest a pKa difference comparable to the two log-unit decrease 
between model compound (3.1) and its corresponding 2-thiazolyl isomer 3.2.   
Spectrophotometric and fluorimetric pH titrations of 3.3b to determine the protona-
tion constants of the probe observed quite different spectroscopic properties upon incre-
mental acidification of the solution.  As illustrated in Figure 3.20A below, as the pH was 
lowered from 7.0 to 5.0, minimal changes in the absorbance were observed with 3.3b, 
which is consistent with those observed with chromis-1 acid.  Interestingly, while the ab-
sorbance spectra of both 3.3b and chromis-1 acid had similar molar absorptivity coeffi-
cients at pH 2.0, 3.3b observed a minimal ~ 8-nm red shift between pH 7.0 and pH 2.0, 
whereas chromis-1 acid demonstrated a significant 50-nm red-shift from 350 nm at pH 7.0 
to 400 nm at pH 2.0.  Further acidification from pH 2.0 to 1.0 revealed a ~ 50% increase 
in the absorbance yet a negligible 2-nm red shift of the absorption maxima from 356 to 
358 nm.  In the emission, however, while the analogous pH change from 7.0 to 5.0 ob-
served a similar ~ 50% decrease in the emission intensity compared to chromis-1 acid, 
the intensity of the emission band at 560 nm was significantly reduced compared to the 
fluorescence intensity of the same emission band in the titration with chromis-1 acid (Fig-
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ure 3.20B).  Nevertheless, fitting of the spectrophotometric emf data to a triprotic equilib-
rium model and spectral deconvolution (Figure 3.20C) yielded pKa values for 3.3b of 0.9, 
3.1 and 5.9 (Figure 3.20D).  Using previously discussed rationale, the pKa of 0.9 most 
likely corresponds to the pKa of the pyridyl acceptor of 3.3b, revealing a negligible 0.2 log-
unit reduction in the pKa compared to the pyridyl acceptor chromis-1 acid (Figure 3.20E).  
Otherwise, the two macroscopic pKa’s that most likely correspond to protonation of the 
two chelator pyridines agree well with those of chromis-1 acid.   
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Figure 3.20: Spectrophotometric determination of the macroscopic protonation constants of 3.3b 
(20 µM). A) Spectrophotometric (UV-Vis) and B) fluorimetric spectral changes over the pH range 
of 7.0-1.0.  C) Species distribution of chromis-1 throughout the spectrophotometric (UV-Vis) titra-
tion. D) Deconvoluted spectra of UV-Vis titration data, depicting the absorbance spectra of each 
species shown in (A). E) Schematic representing the species corresponding to the three individual 
protonation constants, determined from the UV-Vis spectrophotometric titration shown in (A). L: 
ligand, 3.3b.  
 
 



























































































































3.4.7 Solvent Deuterium Isotope Effect of Probe 3.3b 
The elimination of a deuterium isotope effect with model compound 3.2, in addition 
to a reduction in both the ground-state basicity and photobasicity as a consequence of 
isomerization of the acceptor pyridine, demonstrated auspicious rationale for incorporating 
the new fluorophore design into the development of 3.3b as a fluorescent probe with re-
duced pH sensitivity.  However, when the fluorescence response of the probe was com-
pared in both deuterated and non-deuterated buffers, 3.3b saw a 10% increase in the 
fluorescence intensity of free 3.3b in deuterated buffer compared to non-deuterated buffer, 
despite identical emission intensities of the Zn(II)-saturated species to rule out pipetting 
error (Figure 3.21A).  Not only was the increase in fluorescence intensity of 3.3b lower 
than that of chromis-1 (10% compared to 16%) between deuterated and non-deuterated 
buffers, but also normalization of both the two spectra of metal-free 3.3b revealed super-
imposable spectra, unlike chromis-1, which displayed a more-narrow emission band in 
D2O relative to H2O (Figure 3.21B).      
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Figure 3.21: A) Solvent deuterium isotope effect of 3.3b (5 µM) in deuterated versus non-deuter-
ated buffer (10 mM PIPES, 100 mM KCl, pH/D 7.0, 25°C). B) Comparison of the normalized emis-
sion spectra of the free form of 3.3b in (A) to chromis-1 acid from Figure 3.6B. Excitation: 361 nm.     
 
Based on these observations, it was deduced that isomerization of the pyridyl ac-
ceptor of chromis-1 to the 2-thiazolyl position did not fully eliminate the excited-state pro-
tonation.  The discrepancies between the deuterium isotope effects of fluorophore 3.3b 
and model compound 3.2 furnished speculation that the excited-state protonation was, in 
fact, a proton-transfer phenomenon that was manifested from partial protonation of one of 














































the bispicolylamine pyridines even at neutral pH, inducing an excited-state intramolecular 
proton transfer (ESIPT) rather than direct protonation of the fluorophore pyridine from the 
aqueous buffer.  This hypothesis led to examining the effect of the chelator moiety on 
ESPT.    
3.5 Suppressing Excited-State Proton Transfer with The Development of 
Chromis-2 
The electron-withdrawing capacity of the both the p-ester and the p-carboxylate 
substituents of the bispicolylamine chelator can have a dramatic effect on the basicity of 
the pyridine nitrogens, which are hypothesized to play a role in ESPT to the pyridyl accep-
tor of the fluorophore.  Considering the differences in the Hammett parameters (sp)19 be-
tween the para-ethyl ester (sp = 0.45) and the anionic carboxylate (sp = 0.0) substituents, 
the more strongly electron-withdrawing methyl esters render the pyridine nitrogens less 
basic and thus less likely to be protonated at or near neutral pH.  To put this into perspec-
tive, analysis of the emission spectral response of chromis-1 ester (2.1a) in liposomes 
displayed more balanced emission intensities for the free and metal-bound species (Fig-
ure 2.11) compared to those of chromis-1 acid (2.1b), even with excitation at the isosbestic 
point to ensure that the emission intensities directly reflected the quantum yields of both 
species in solution.   
The more balanced emission intensities for the free and metal-bound species of 
chromis-1 ester (2.1a) compared to chromis-1 acid (2.1b) can be attributed to the less 
basic nitrogens of 2.1a resulting in a less-favorable ESPT process, thus increasing the 
emission intensity of the metal-free species.  Because the fluorescence intensity of 3.3a 
significantly decreases upon saturation with Zn(II) relative to the metal-free species in the 
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4:1 DMPC:DMPG liposome mixture used previously, which is most likely attributed to re-
duced phospholipid solvation due to a smaller lipophilic surface area for interacting with 
the lipid bilayer, the comparison of the emission responses of both free and Zn(II)-satu-
rated 3.3a is less convincing than 2.1a.  Nonetheless, the emission spectra responses 
between the ester and acid derivatives furnished momentum to explore less-basic, nitro-
gen-containing heterocycles to replace the bis(2-pyridylmethyl)amine in the chelator moi-
ety, while still permitting the selective binding of Zn(II) with sufficient affinity to be applica-
ble for imaging live cells.     
The search for nitrogen-containing heteroaromatic groups with significantly lower 
basicities than pyridine led to exploring the effect of substituting the pyridine rings of the 
bispicolylamine chelator with pyrimidine (pKa = 1.3).20  Since a pyrimidine analog of 
bispicolylamine had neither been previously synthesized nor used as a Zn(II) chelator, the 
methods implemented in the synthesis of 3.17 from 2-cyanoisonicotinic acid were 
adopted, albeit modified, for the synthesis of a bis(2-pyrimidylmethyl)amine chelator that 
was coupled to the aldehyde of the 2-thiazolyl fluorophore core to generate a Zn(II)-selec-
tive probe for elucidating the mechanism of ESPT.   
3.5.1 Synthesis of Chromis-2 
Aldehyde 3.16 was designed to serve as a platform to facilitate the facile synthesis 
of various Zn(II)-binding fluorophores through trivial reductive couplings with primary or 
secondary amine-containing chelators.  Because the envisioned bis(2-pyrimidylme-
thyl)amine chelator had not been synthesized before, a similar dimerization method used 
in the preparation of the dimethyl ester-substituted bispicolylamine 3.17 was adopted and 
further optimized to be applicable for the preparation of the new chelator moiety.  Synthe-
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sis of the bis(2-pyrimidinylmethyl)amine chelator 3.19 was accomplished by a one-pot di-
merization of 2-pyrimidinecarbonitrile in 1:1 dioxane:water (Scheme 3.7).  Despite using 
EtOH:H2O as the solvent mixture in the assembly of 3.17, adoption of these reaction con-
ditions for the preparation of 3.19 furnished a significant amount of the imine ethyl ester, 
suggesting that the kinetics of nucleophilic addition of EtOH to 2-pyrimidinecarbonitrile are 
faster than the reduction of the nitrile to the corresponding imine. It was hypothesized that 
the addition of a weak acid, such as AcOH, would facilitate the hydrolysis of the imine 
intermediate to the corresponding aldehyde, thus shifting the equilibrium towards the re-
ductively coupled intermediate.  Interestingly, the addition of 1.0 equivalent of AcOH re-
sulted in a modest 13% yield of bis(2-pyrimidinylmethyl)amine, whereas the absence of 
any weak acid resulted in a 45% yield, suggesting that the AcOH may favor reduction of 
the imine intermediate to the primary amine before reductive coupling can occur.   
 
Scheme 3.7: One-pot synthesis of bis(2-pyrimidylmethyl)amine 3.19 from commercially available 
2-pyrimidylcarbonitrile.   
 
Upon preparation of bis(2-pyrimidylmethyl)amine 3.19, reductive amination with 
aldehyde 3.16 afforded in analytical purity chromis-2 (3.4) in 70% yield after recrystalliza-
tion from boiling cyclohexane:MTBE (Scheme 3.8).   
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Scheme 3.8: Synthesis of chromis-2 (3.4) from aldehyde 3.16.   
3.5.2 Chromis-2 Demonstrates the Absence of a Solvent Deuterium Isotope Effect 
To experimentally determine whether the Zn(II)-binding ligand of the probe partic-
ipated in ESPT to the pyridyl acceptor of the fluorophore, the emission response of 
chromis-2 was measured in deuterated versus non-deuterated buffer (10 mM PIPES, 100 
mM KCl, 25°C, pH/D 7.0) and compared to the emission responses of 3.3b under identical 
conditions. While 3.3b exhibited a 10% increase in the fluorescence intensity in deuterated 
compared to non-deuterated buffer (Figure 3.22A), substitution of bis(2-pyridylmethyl)-
amine with bis(2-pyrimidylmethyl)amine in the development of chromis-2 (3.4) engen-
dered no change in the emission intensity or profile between deuterated and non-deuter-
ated buffer (Figure 3.22B).  In addition, examination of the emission intensities of the free- 
and Zn(II)-bound species in aqueous buffer revealed a nearly completely balanced emis-
sion response (blue/purple solid/dashed curves).  These observations corroborated the 






















Figure 3.22: Comparison of the solvent deuterium isotope effects between 3.3b and chromis-2 
(3.4). (A) Measurement of the fluorescence intensity of 3.3b (5 µM) in deuterated and non-deuter-
ated aqueous buffer (10 mM PIPES, 0.1 M KCl, pH/D 7.0, 25°C). (B) Comparison between chromis-
2 and 3.3b (5 µM each) in deuterated and non-deuterated aqueous buffer, demonstrating the in-
crease in quantum yield of free and Zn(II)-saturated chromis-2, as well as the eradication of the 
solvent isotope effect for chromis-2 and its balanced emission intensities.   
 
3.5.3 X-Ray Crystallographic Characterization of Chromis-2 
The [(chromis-2)Zn(II)] complex was crystallized in situ as the tetrafluoroborate 
adduct from a mixture of water and methanol to produce monoclinic crystals with the for-
mula [(chromis-2)•Zn(II)](BF4)2•2H2O.  A list of selected bond angles and distances is 
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listed Table A.8 of Appendix A. As illustrated in Figure 3.23A, crystallization of the 
[(chromis-2)Zn(II)] complex revealed a heteroleptic ternary complex with a water molecule 
coordinated to the Zn(II) center in the axial position, resulting in a six-coordinate Zn(II) that 
adopts a slightly distorted octahedral geometry about the metal ion.  Unlike the 
[(3.3c)Zn(II)] complex (Figure 3.12), which displayed a binary ligand-metal complex with 
a 5-coordinate Zn(II), the coordination of a water molecule to Zn(II) in the [(chromis-
2)Zn(II)] complex suggests that the less-basic pyrimidine nitrogens that contribute to a 
lower affinity for Zn(II) result in a ligand-metal complex with higher metal coordination 
numbers, as is the case with [Zn(OH2)6]2+.   
The absence of any aromatic substituents on the bispicolylamine chelator of 3.3c 
provides an excellent comparison of the crystallographic data of its Zn(II) complex to those 
for the [(chromis-2)Zn(II)] complex.  Analysis of the pyrimidine N-Zn bond distances of 
[(chromis-2)Zn(II)] shows an average bond elongation of 0.60 ± 0.007 Å relative to the 
corresponding pyridine N-Zn bonds in the [(3.3c)Zn(II)] complex, signifying a weaker 
metal-ligand interaction as a consequence of pyrimidine’s reduced basicity compared to 
the pyridine nitrogen donors.  In addition, the aliphatic tertiary amine N-Zn bond distance 
is elongated by 0.13 Å compared to the analogous N-Zn bond in 3.3c, which provides 
evidence that the electron-withdrawing character of the pyrimidines has a substantial ef-
fect on the basicity of the tertiary amine.  Surprisingly, the N-Zn bond distances for both 
the fluorophore pyridine and the thiazole nitrogen are elongated by 0.07 Å and 0.05 Å, 
respectively, in the [(chromis-2)Zn(II)] complex compared to the [(3.3c)Zn(II)] complex.  
The unit cell of the [(chromis-2)Zn(II)] complex also displayed textbook symmetry, as evi-
dent from the packing diagram shown in Figure 3.23B.   
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Figure 3.23: (A) ORTEP representation and atom number scheme for the Zn(II) complex of 
chromis-2: [(3.4)Zn(II)]. Ellipsoids shown represent 50% probability. Hydrogen atoms and counter 
ions have been omitted for clarity. (B) ORTEP presentation of the unit-cell packing for [(3.4)Zn(II)], 





































3.5.4 Steady-State Absorption and Fluorescence Properties of Chromis-2 
The lack of water-solubilizing carboxylic acid groups in the structure of chromis-2 
was a potential issue when investigating the spectroscopic properties of the ligand in 
aqueous buffer. Because concentrated (millimolar concentrations) stock solutions of fluo-
rescent probes are often diluted to micromolar concentrations into aqueous buffer, it was 
necessary to ensure that the spectroscopic responses of chromis-2 were not affected in 
the concentration regime employed for characterization in either aqueous buffer or in cel-
lular media.  Spectral overlap experiments of chromis-2 conducted under dilute and con-
centrated conditions (1 µM versus 10 µM) confuted any potential aggregation-induced flu-
orescence and absorbance changes in the concentration range used for any experiment 
involving the probe.   
Chromis-2 exhibited large bathochromic shifts in both the absorption and emission 
upon the coordination of Zn(II), with molar ratio titrations demonstrating a sharp saturation 
of the probe at equimolar concentrations of probe and metal being indicative of a clean 
1:1 binding stoichiometry (Figure 3.24A&B).  Consistent with metal coordination to the 
acceptor moiety of the fluorophore, chromis-2 underwent a 20-nm spectral shift from an 
absorbance maximum at 348 nm for the free form (ε = 23,400 M-1•cm-1) to 368 nm (ε = 
20,800 M-1•cm-1) upon the binding of Zn(II) (Table 3.4).  In addition, the emission maximum 
of the free form of chromis-2 underwent a 50-nm red shift from 465 nm to 515 nm upon 
saturation with Zn(II).  Comparing the emission-ratiometric shift of chromis-2 to that of 
chromis-1 acid, the free form of chromis-2 is blue-shifted by 18 nm, whereas the Zn(II)-
saturated form is blue-shifted by only 5 nm.  Therefore, the metal binding-induced batho-
chromic shift of chromis-2 is 13 nm larger than that of chromis-1 acid, which facilitates 
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better species discrimination when selecting optimal bandpass ranges for ratiometric im-
aging using two-photon microscopy. Substitution of the bis(2-pyridylmethyl)amine chelator 
with bis(2-pyrimidylmethyl)amine in chromis-2 led to an almost 2-fold increase in the fluo-
rescence quantum yield of the free form from 0.25 to 0.47, while the Zn(II)-saturated form 
increased only 8% from 0.61 to 0.69 (Table 3.4).  The 22% increase in the quantum yield 
of the free form of chromis-2 can be attributed to the suppression of ESPT-mediated fluo-




Figure 3.24: Spectral changes of chromis-2 (10 µM) in neutral aqueous buffer (10 mM PIPES, 100 
mM KCl, 25°C, pH 7.0) upon stepwise saturation with Zn(II). (A) Absorption (UV-Vis) spectral 
changes upon saturation with Zn(II). (B) Fluorescence emission response upon saturation with 
Zn(II) (excitation at 361 nm). Red curves indicate the spectra after complete saturation (1.0 eq.) 
with Zn(II) is achieved. Inset: fluorescence integration over the entire spectral window as a function 
of molar equivalents of Zn(II). 
  

































Table 3.4: One and two-photon photophysical properties of chromis-2 (3.4) in aqueous 
buffer at pH 7.0.a  
 Chromis-2 (3.4) [(3.4)Zn(II)] 
Abs λmax (nm)b 348 368 
ε (104 M-1 cm-1)c 2.34 2.08 
Em λmax (nm)d  465 515 
δmax (GM)e n.d. n.d. 
ΦFg 0.47 0.69 
a10 mM PIPES, 0.1 M KCl, 25°C. blowest-energy band of the one-photon absorption spectrum. 
cmolar extinction coefficient at lmax. dmaximum two-photon absorption. etwo-photon absorption 
cross section. fmaximum fluorescence emission. gfluorescence quantum yield, referenced to qui-
nine sulfate (ΦF = 0.546 in 1N H2SO4).5   
 
3.5.5 Metal-Ion Selectivity of Chromis-2 
As illustrated in Figure 3.25, supplementation of chromis-2 with excess biologically 
relevant divalent transition metal ions, except Zn(II) and Mn(II), also revealed either no 
change in the emission response (with Mg(II) and Ca(II), Figure 3.25A, B) or a complete 
quenching of the probe’s fluorescence response (with all transition metals excluding Zn(II), 
Figure 3.25C-G).  Because binding of the interfering metals did not elicit a ratiometric 
response, which is consistent with both 3.3b and chromis-1 acid (2.1b), the quenching of 
the fluorescence serves only as a masking effect by competing with Zn(II) for binding.  By 
evaluating the metal-ion selectivity of the probe in the presence of 0.80 molar equivalents 
of the interfering metal ions, the emission ratio of the remaining 20% of free probe was left 
unaltered (Figure 3.26, black bars); therefore, saturation of the 0.20 equivalents of probe 
with Zn(II) produced an emission ratio that was consistent with the emission ratio of the 
[(chromis-2)Zn(II)] complex in the absence of any interfering metal ions (Figure 3.26, red 
patterned bars). 
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Interestingly, the addition of millimolar Mg(II) produced a slight decrease in the 
fluorescence intensity of the probe (Figure 3.27B).  Consistent with observations of the 
metal-ion selectivity of 3.3b, millimolar Ca(II) produced a slight increase and red-edge 
broadening of the emission profile, which negligibly increased the calculated emission ra-
tio (Figure 3.27C).  Despite the additional nitrogen donor from the thiazole, the lower af-
finity manifested by the less basic pyrimidines of chromis-2 also resulted in a non-quanti-
tative fluorescence quenching with Mn(II).  The lower affinity for Mn(II) enabled it to be 
immediately outcompeted by supplementation of 1.0 equivalent of Zn(II) to restore the 
emission response to that of the [(chromis-2)Zn(II)] complex in the absence of any inter-
fering metals (Figure 3.27D).  Analogous to 3.3b, despite initial observations of tight Fe(II) 
binding with near unity fractional saturation, the 0.8 molar equivalents of Fe(II) was out-
competed by Zn(II) over the course of ~ 30 minutes at 25°C (Figure 3.27E).  Therefore, 
the emission response of the probe to the addition of Zn(II) was measured in the presence 
of 1.0 molar equivalent of Zn(II).  Furthermore, the addition of Ni(II) resulted in a time-
dependent fluorescence quenching (Figure 3.27G, Insert) that reached equilibrium after ~ 
10 minutes.   
To evaluate the stability constant for the formation of the Mn(II) complex of 
chromis-2, a fluorimetric titration was performed by the direct addition of MnSO4•H2O to a 
solution containing chromis-2.  Fitting of the fluorimetric titration data from the metal-addi-
tion titration resulted in a stability constant of LogKMn(II)L = 5.87 ± 0.01 (Figure 3.28), cor-
responding to an apparent dissociation constant of 1.36 µM, which is nearly one log-unit 
higher than Mn(II) stability constant of chromis-1 acid (2.1b).  
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Figure 3.25: Fluorescence response of chromis-2 in the presence of excess (4.0 and 8.0 equiva-
lents) of interfering divalent metal ions. A-H) Black traces represent free chromis-2 (5 µM) in pH 
7.0 buffer (10 mM PIPES, 0.1 M KCl, 25°C) supplemented with 10 µM EDTA. Red and blue traces 
represent the addition of 20 µM and 40 µM, respectively, of divalent metal ions. Excitation: 361 nm.   
















































































































Figure 3.26: Emission-ratiometric response of chromis-2 (5 µM) towards selected divalent metal 
cations at 80% fractional saturation (calculated based on ratio of the integrated fluorescence inten-
sity between 510-570 nm (channel 2) and 440-470 nm (channel 1)). The red bars represent the 
ratio at 80% fractional saturation, and the corresponding red patterned bars represent the ratio after 
saturating the remaining 20% of free fluorophore with Zn(II). Excitation: 361 nm.   















Figure 3.27: Emission spectral response of chromis-2 towards selected divalent metal cations at 
80% fractional saturation. A,B) Fluorescence response of chromis-2 (5 µM) in pH 7.0 buffer (10 
mM PIPES, 100 mM KCl, 25°C) in the presence of 2 mM alkaline earth metals, with corresponding 
saturation of probe with 1.0 eq. Zn(II). C-H) Fluorescence response of chromis-2 in the presence 
of 80% fractional saturation (solid black curves) of interfering divalent metal ions, with correspond-
ing saturation of remaining 20% probe with Zn(II) (red curves). Inset: Kinetics of equilibration of 
chromis-2 with Ni(II). Excitation: 361 nm.   




























































































































Definition of Equilibrium System: 
Species Mn(II) chromis-2 H log β 
Zn(II) 1 0 0 0.0 
Chromis-2 0 1 0 0.0 
[(Chromis-2)Mn(II)] 1 1 0 5.87 ± 0.01 
Figure 3.28: Fluorimetric determination of the apparent Mn(II) stability constant of chromis-2 (3.4) 
via a direct, metal-addition titration. Chromis-2 (5 µM) was equilibrated in chelexed pH 7.0 buffer 
(10 mM PIPES, 0.1 M KCl, 25ºC) and titrated with MnSO4•H2O in aliquots from 0-40 µM.  The red 
curve indicates free chromis-2 before the addition of Mn(II). The fluorescence spectra were ana-
lyzed by non-linear least squares fitting to yield an average logKZn(II)L of 5.87 ± 0.01 (n = 1).  B) 
Change in fluorescence response at 465 nm with corresponding fit to the equilibrium system model.   
 
 






































3.5.6 Zn(II)-Binding Affinity Measurements of Chromis-2 
Despite the inherent correlation between the binding affinity and proton basicity, 
the statistical effect associated with coordinating Zn(II) to either of the two pyrimidine ni-
trogens provides an additional 0.6 log units (0.3 log units per pyrimidine ring) to the stability 
constant.  In addition, eradication of ESPT effectively permits emission spectral data, that 
would otherwise be of concern due to potential distortions in emission intensity or spectral 
shape, to be analyzed in determining robust stability constants. To reliably determine the 
stability constant of chromis-2, spectrophotometric and fluorimetric titrations were per-
formed in the presence of EGTA as a competing ligand with matching affinity 
(LogKEGTA•Zn(II) = 8.34, Kd = 4.6 nM at pH 7.0, µ = 0.1 M, 25°C).  However, initial efforts to 
determine the Zn(II) stability constant of chromis-2 via a fluorimetric competition titration 
in the presence of EGTA at pH 7.0 revealed a slight mismatch in the affinity between the 
two ligands.  
As will be discussed more extensively in Chapter 4, the two protonation constants 
of EGTA that lie above 7.0 produce a strong pH dependence on the stability constant of 
EGTA, with a 0.5 log-unit change in pH corresponding to a one log-unit change in the 
affinity.  On the other hand, given the expectedly low pKa’s of chromis-2, changes in the 
pH of the solution are not expected to considerably affect the apparent stability constant 
of chromis-2.  Therefore, fluorimetric determination of the stability constant of chromis-2 
was performed at pH 6.5, reducing the affinity of EGTA by one log unit and providing a 
better matching affinity between the two components to provide a more reliable equilibrium 
constant.  Non-linear least-squares fitting of the fluorimetric titration data provided an ap-
parent stability constant of 7.97 ± 0.03, corresponding to an apparent dissociation constant 
of Kd’ = 10.7 ± 1 nM at pH 6.5 with an ionic background of 0.1 M (KCl) at 25°C (Figure 
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3.29).  In spite of thiazole’s propensity to engage in coordinating Zn(II), as well as the 
statistical effect associated with Zn(II) binding to either of the two pyrimidine nitrogens, the 
significantly reduced basicity of chromis-2’s pyrimidine rings results in a binding affinity 
that is three log units lower than its predecessor 3.3b and that is comparable to that of 




Definition of Equilibrium System: 
Species Zn(II) EGTA Chromis-2 (3.4) H log β 
Zn(II) 1 0 0 0 0 
EGTA 0 1 0 0 0 
3.4 0 0 1 0 0 
EGTA(H) 0 1 0 1 9.51 
EGTA(H2) 0 1 0 2 18.41 
EGTA(H3) 0 1 0 3 21.22 
[(EGTA)Zn(II)] 1 1 0 0 12.6 
[(3.4)Zn(II)] 1 0 1 0 7.97 ± 0.03 
Figure 3.29: A) Fluorimetric determination of the Zn(II) stability constant of chromis-2 (3.4) via a 
competition titration with EGTA.  Chromis-2 (10 µM) was equilibrated with ZnSO4•7H2O (10 µM) in 
chelexed aqueous buffer (10 mM MES, 0.1 M KCl, pH 6.5, 25ºC) and titrated with EGTA to a final 
concentration of 300 µM. The fluorescence spectra (excitation: 361 nm) were analyzed by non-
linear least squares fitting to give an average logKZn(II)L of 7.97 ± 0.03 (n = 2).  B) Change in fluo-
rescence response at 530 nm with corresponding fit to the equilibrium system model.   






































3.5.7 Development of Chromis-2-Ctrl as a Non-Zn(II)-Binding Fluorescent Probe for Elu-
cidating the Fluorescence Dependence of Chromis-2 on the Polarity Environment 
of the Cell 
The structure of lipophilic fluorescent probes can dictate their fluorescence signaling 
behaviors within the lipid-rich environment of a cell, such that the signaling behaviors may 
differ quite dramatically from those observed in the aqueous buffer in which they are ana-
lyzed spectroscopically.  While this phenomenon will be discussed more in detail in Chap-
ter 5, the cellular employment of ratiometric fluorescent sensors for probing labile metal 
pools can often result in a ratiometric readout under disparate conditions, namely oxida-
tion, change in pH, and/or a change in the polarity environment, such as varying compo-
sitions of phospholipids that compose the lipid bilayers of cells.  While this phenomenon 
is profoundly unexplored, Deleers et. al. observed that changes in the lipid composition of 
liposomes containing varying concentrations of phosphatidylserine, ethanolamine, and in-
ositol affected the fluorescence response of the fluorescent probe 3,3-dipropylthiodicar-
bocyanine due to the changes in the membrane potential.21  Therefore, the development 
of a control compound that not only displays the same ratio as the free form of the metal-
responsive fluorescent probe, but also does not coordinate the metal analyte of interest is 
imperative for determining whether the lipid environment of a particular cell line is interfer-
ing with the fluorescence properties of the indicator. Because chromis-2 does not boast 
hydrophilic groups for increase water-solubility, thus likely resulting in an association with 
lipid membranes, to ensure that the fluorescence properties in the cell match those in 
aqueous buffer, a control compound that does not bind Zn(II) was synthesized and char-
acterized in aqueous buffer, as well as in mammalian cells and brain tissue. 
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3.5.7.1 Synthesis of Chromis-2-Ctrl 
Exploiting the commercial availability of 5-formylpyrimidine, chromis-2-ctrl was 
synthesized via a double reductive amination using amine 3.20 that was synthesized via 
DIBAL (diisobutylaluminum hydride) reduction of nitrile 3.15 (Scheme 3.9).  Typically, 
DIBAL is not used to reduce aromatic nitriles to amines, as the reduction stops at the imine 
intermediate after 1.0 equivalent of DIBAL reacts.  However, upon the addition of 2.0 
equivalents of DIBAL, the nitrile was reduced to the corresponding primary amine, which 
then reacted as a crude mixture with 2.0 equivalents of 5-formylpyrimidine to furnish 
chromis-2-ctrl in only 13% yield.  The low yield was most likely due to the lack of purifica-
tion of the primary amine.   
 
Scheme 3.9: Synthesis of chromis-2-ctrl (3.5) 
3.5.7.2 Absorbance and Fluorescence Properties of Chromis-2-Ctrl 
Analysis of the spectral properties of chromis-2-ctrl showed surmised similarities 
to the spectral response of chromis-2.  In the absorption, the absorbance maximum shifts 
a negligible 2 nm from 348 nm (chromis-2) to 350 nm, an effect most likely due to a change 
in the dipole moment of the molecule as a result of the change in polarity of the pyrimidine 
rings.  The emission maximum, however, does not change relative to chromis-2, with a 
















Chromis-2-ctrl (3.5)3.15  R = CN
3.20  R = CH2NH2
(13%)
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3.30A).  Interestingly, when the two emission spectra are normalized, the fluorescence 
emission profile of the control compound is slightly narrower than that of chromis-2, which 
could be the result of a potentially lower acidity due to the isomerization of the pyrimidine 
rings (Figure 3.30B).  The result is a negligible 5% decreased in the calculated ratio from 
0.45 to 0.40 between chromis-2 and chromis-2-ctrl based on spectroscopic measurements 
in aqueous buffer.  Given the likelihood that the probe will partition into cellular mem-
branes, the modest ratio discrepancy between chromis-2 and its control compound will 




Figure 3.30: A) Emission spectral comparison between chromis-2 (10 µM) and chromis-2-ctrl (10 
µM) in pH 7.0 buffer (10 mM PIPES, 100 mM KCl, 25°C). B) Normalized emission spectra of free 
chromis-2 and chromis-2-ctrl to reveal the spectral change between the two compounds.   
 
To ensure that the control compound does not coordinate Zn(II), spectrophotomet-
ric and fluorimetric titrations were performed in aqueous buffer (10 mM PIPES, 100 mM 
KCl, 25°C, pH 7.0), in which Zn(II) was titrated from 500 µM to 2 mM.  Under these con-
ditions, chromis-2-ctrl did not bind Zn(II) up to 2 mM, thus no ratiometric readout was 
observed in the absorption (Figure 3.31A) or the emission (Figure 3.31B).   














































Figure 3.31: Spectrophotometric (A) and fluorimetric (B) titration of chromis-2-ctrl (10 µM) with 
Zn(II) in pH 7.0 aqueous buffer (10 mM PIPES, 100 mM KCl, 25°C). The red curves depict the free 
probe in solution, and the corresponding black curves indicate the incremental addition of Zn(II).  
Excitation: 350 nm.   
 
3.6 Conclusions 
Designing emission-ratiometric fluorescent probes for detecting trace metals in bi-
ological systems requires a thorough understanding of the underlying photophysical prop-
erties of the probe and how the fluorescence properties are affected once employed in the 
cell.  One particular property is the change in the fluorescence properties upon protonation 









































of the fluorophore.  The highly-compartmentalized environment of eukaryotic cells enables 
protection from rapid, dynamic fluctuations in pH between the localized pH buffering ca-
pacity of organelles and vesicles and the cytosol.4  Dramatic deviations in the pH of the 
cell, by virtue of compartmentalization, can have deleterious effects on ratiometric imaging 
should the fluorescent probe be sensitive to changes in pH.  The localized charge density 
on the pyridyl acceptor of chromis-1 acid facilitated an excited-state protonation, which not 
only led to fluorescence quenching but also led to a broadening of the emission profile on 
the red edge of the emission.  The development of a model compound (3.1) for chromis-
1 established a profound effect of the metal-binding ligand on the pKa of the pyridyl ac-
ceptor of chromis-1 by the observation of a three logarithmic-unit perturbation compared 
its model compound. The localized charge density of the pyridyl acceptor of model com-
pound 3.1 is only exacerbated in the excited state by behaving as a 10 million-fold stronger 
base than in the ground state. be 
The rearrangement of the pyridyl acceptor of chromis-1 demonstrated a substan-
tial decrease in the ground-state basicity and photobasicity based on the photophysical 
and thermodynamic characterization of model compound 3.2.  The reduction in basicity, 
as well as the eradication of a deuterium isotope effect with model compound 3.2, provided 
an impetus to incorporate the new fluorophore design into a metal-binding fluorescent 
probe.  However, incorporation of a metal-binding ligand into the new fluorophore enabled 
the reappearance of a deuterium isotope effect studies with 3.3b, which revealed a 10% 
increase in the fluorescence intensity of the probe in D2O compared to H2O, as well as 
only a minute 0.2 pH-unit decrease in the ground-state pKa of the pyridyl acceptor com-
pared to chromis-1 acid.   
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To gauge the role of the metal-binding ligand on the excited-state protonation of 
the fluorophore pyridine, a pyrimidine-containing analog of bispicolylamine was synthe-
sized and incorporated into the structure of a new 2-thiazolyl metal-binding fluorophore 
(chromis-2).  This subtle modification in the structure of the chelating group resulted in a 
nearly 2-fold increase in the fluorescence quantum yield of the metal-free fluorophore and 
almost perfectly balanced fluorescence intensities of the free and metal-bound forms, cor-
roborating the chelator’s role in promoting an excited-state intramolecular proton transfer 
to the pyridyl acceptor of the fluorophore core.  The significantly lower proton basicity of 
pyrimidine compared to pyridine also demonstrated a three logarithmic-unit decrease in 
the stability constant of chromis-2 from logK of 10.8 to 8.0 relative to 3.3b, despite the 
statistical effect associated with coordinating Zn(II) to either of the two nitrogens of pyrim-
idine.  Nevertheless, the development of chromis-2 as an emission-ratiometric, water-sol-
uble, Zn(II)-selective fluorescent probe that is insensitive to fluctuations in pH represents 
a remarkable effort in tailoring the photophysical properties of the indicator to the environ-
ment in which it will be employed.  The comparable affinity to chromis-1 ester enabled 
remarkable emission-ratiometric imaging of 3T3 mouse fibroblast cells, as well as of 
mouse hippocampal brain tissue, where Zn(II) is present in significantly higher concentra-
tions compared to other regions of the brain.22-23  Indeed, the outlook of chromis-2 in help-







3.7 Experimental Section 
3.7.1 Synthesis 
Materials and Reagents. Intermediates 2-cyanoisonicotinic acid (2.2) and 2-
amino-4’-methoxyacetophenone (2.4) were synthesized according to procedures availa-
ble in Chapter 2. Picolinic acid (Chem-Impex Int’l, Inc.), isonicotinic acid (Eastman), ethyl 
6-bromo-picolinate (Combi-Blocks, Inc.), 2-pyrimidinecarbonitrile (Oxchem Corp.) and 5-
pyridinecarbaldehyde (Ark Pharm, Inc.) were purchased commercially and used without 
further purification.  Flash chromatography purification was performed on general purpose 
silica gel (60 Å pore size, 250 mesh, Sorbent Technologies).  NMR: 1H NMR spectra were 
recorded at 400 MHz at ambient temperature (20-23°C), unless state otherwise, and ref-
erenced to an internal TMS standard (0 ppm) for all solvents except D2O, which was ref-
erenced to externally added sodium 3-trimethylsilylpropionate-2,2,3,3-d6 (0 ppm).  13C 
spectra were acquired at 100 MHz and referenced to the known chemical shift of the sol-
vent peak (CDCl3: 77.0 ppm; DMSO-d6: 39.5 ppm; CD3OD: 49.0 ppm; Acetone-d6: 206.3, 
29.8 ppm), excluding D2O, which was referenced to sodium 3-trimethylsilylpropionate-
2,2,3,3-d6 (0 ppm). NMR spectra are provided in Appendix A.2. Mass spectra were rec-
orded by the Georgia Tech Mass Spectrometry Facility. 
N-(2-(4-methoxyphenyl)-2-oxoethyl)isonicotinamide (3.6). A 250 mL round 
bottom flask equipped with a stir bar was charged with 2-amino-4’-methoxyacetophenone 
hydrochloride 2.4 (1.1 eq., 4.96 mmol, 1.00 g), isonicotinic acid (1 eq., 4.51 mmol, 555 
mg), EDCI×HCl (1.5 eq., 6.77 mmol, 1.30 g), and HOBt (0.5 eq., 2.26 mmol, 305 mg).  The 
contents were dissolved in DMF (15 mL), pyridine (1 eq., 4.51 mmol, 0.363 mL) was added 
to the reaction solution via a syringe, and the solution was allowed to stir magnetically 
overnight.  The product was crystallized from the solution by the slow addition of 60 mL of 
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diH2O, after which the contents of the flask were filtered through a glass frit, washed with 
cold diH2O, and dried over vacuum to afford pure 3.6 as a white crystalline solid.  Yield: 
1.01 g (3.75 mmol, 83%).  1H NMR (CDCl3, 400 MHz) δ 3.91 (s, 3H), 4.90 (d, J = 4.2 Hz, 
2H), 7.01 (d, J = 9.0 Hz, 7.49 (s, 1H), 7.73 (dd, J = 4.5, 1.5 Hz, 2H), 8.01 (d, J = 9.0 Hz, 
2H), 8.79 (d, J = 4.9 Hz, 2H). 13C NMR (CDCl3, 100 MHz) δ 46.3, 55.5, 114.1, 121.0, 
127.0, 130.3, 141.0, 150.5, 163.4, 165.3, 192.0. EI-MS m/z 270 ([M]+, 5%), 241 (45%), 
135 (100%), 77 (20%). EI-HRMS m/z calc’d for C15H14N2O3 270.1006, found 270.1004.  
5-(4-methoxyphenyl)-2-(pyridin-4-yl)thiazole (3.7).  To an oven-dried 2-neck 
100 mL round bottom flask equipped with a stir bar was added isonicotinamide 3.6 (1 eq., 
3.36 mmol, 908 mg) and Lawesson’s Reagent (1.3 eq., 4.37 mmol, 1.77 g).  The flask was 
connected to a reflux apparatus, and using a glass frit connected to the top of the reflux 
condenser, the system was flushed with argon for several minutes to remove moisture.  
Using an argon-filled syringe, butryonitrile (15 mL, dried over 0.4 Å molecular sieves and 
filtered) was added through the top of the reflux condenser.  The flask was lowered into 
an oil bath at 140°C and allowed to magnetically stir under reflux for 30 min.  After cooling 
to room temperature, saturated NaHCO3 (aq) solution (2 mL) was added to the deep red 
solution under stirring, and the mixture was diluted with ethyl acetate (40 mL), transferred 
to a separatory funnel, and washed with additional 5% (w/v) NaOH (aq) and brine.  The 
organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure 
to afford a yellow solid residue.  The crude solid was recrystallized from a 1:1 mixture of 
2,2,4-trimethylpentane:toluene, collected by suction filtration, washed with hexanes, and 
dried under vacuum to afford 3.7 as an pale-yellow solid. Yield: 670 mg (2.50 mmol, 74%). 
1H NMR (CDCl3, 400 MHz) δ 3.83 (s, 3H), 6.94 (d, J = 8.8 Hz, 2H), 7.54 (d, J = 8.8 Hz, 
2H) 7.77 (dd, J = 4.6, 1.6, 2H), 7.97 (s, 1H), 8.69 (dd, J = 4.6, 1.6 Hz, 2H). 13C NMR 
(CDCl3, 100 MHz) δ 55.3, 114.6, 119.8, 123.2, 128.1, 138.8, 140.3, 141.3, 150.5, 160.1, 
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162.7. EI-MS m/z 268 ( [M]+, 100%), 253 (40%), 164 (23%), 149 (43%), 121 (33%), 77 
(25%). EI-HRMS m/z calc’d for C15H12N2OS 268.0670, found 268.0670. 
4-(2-(pyridin-4-yl)thiazol-5-yl)phenol (3.8).  Thiazole 3.7 (1 eq., 0.373 mmol, 100 
mg) was added to a 10 mL round bottom flask equipped with a stir bar.  The flask was 
sealed with a rubber septum, evacuated under high vacuum, and backfilled with argon.  
Via an argon-filled syringe, anhydrous dichloromethane (2 mL) was transferred to the flask 
to dissolve the starting material.  The flask was then lowered into an ice bath at 0°C, and 
upon thermal equilibration (~10 minutes), boron tribromide (3 eq., 1.12 mmol, 1.12 mL of 
a 1 M solution in dichloromethane) was added drop-wise to the stirred solution.  After 
stirring at 0°C for 6 hours, the mixture was diluted with ethyl acetate (10 mL), quenched 
with diH2O (10 mL), and the pH was adjusted to ~7 to neutralize the excess HBr using 
saturated aqueous NaHCO3. The aqueous layer was then extracted with ethyl acetate (2 
x 10 mL), and the combined organic layers were dried over MgSO4, filtered, and concen-
trated to a blood orange solid. The crude solid was recrystallized from boiling methanol 
afford 3.8 as a burnt orange solid. Yield: 55 mg (0.216 mmol, 58%).%). 1H NMR (DMSO-
d6, 400 MHz) δ 6.88 (d, J = 8.6 Hz, 2H), 7.58 (d, J = 8.6 Hz, 2H), 7.86 (dd, J = 4.6, 1.5 
Hz, 2H), 8.27 (s, 1H), 8.71 (dd, J = 4.6, 1.5 Hz, 2H). 9.92 (s, 1H). 13C NMR (DMSO-d6, 
100 MHz) δ 116.1, 119.6, 121.1, 128.2, 138.9, 139.6, 141.5, 150.7, 158.4, 161.4. EI-MS 
m/z 254 ([M]+, 100%,), 150 (73%), 121 (28%). EI-HRMS m/z calc’d for C14H10N2OS 
254.0514, found 254.0511. 
Sodium 3-(4-(2-(pyridin-4-yl)thiazol-5-yl)phenoxy)propane-1-sulfonate (3.1).  
In a 10 mL round bottom flask equipped with stir bar, phenol 3.8 (1 eq., 0.236 mmol, 60 
mg) was suspended in anhydrous THF (5 mL) under argon.  Sodium tert-butoxide 
(NaOtBu, 1.0 eq., 0.236 mmol, 22.7 mg) was added to a separate, 4-mL vial sealed with 
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a septum, and the vial was evacuated and backfilled with argon to remove potential mois-
ture.  The NaOtBu was suspended in anhydrous THF (2 mL), transferred to an argon-
flushed syringe body, and the suspension was added dropwise to the stirred solution con-
taining phenol 3.8, which immediately precipitated the phenolate anion intermediate.  After 
30 minutes of stirring, 1,3-propanesultone (1.1 eq., 0.260 mmol, 32 mg) was added, and 
the solution stirred vigorously overnight.  The THF was removed under reduced pressure 
to yield a crude yellow solid, which was purified by column chromatography (silica gel, 4:1 
dichloromethane:methanol) to afford sulfonate 3.1 as a yellow crystalline solid.  Yield: 76 
mg (0.201 mmol, 81%).  1H NMR (DMSO-d6, 500 MHz) δ 2.02-2.1 (m, 2H), 2.61 (t, J = 
7.3 Hz, 2H), 4.17 (t, J = 6.6 Hz, 2H), 7.09 (d, J = 8.8 Hz, 2H), 7.73 (d, J = 8.8 Hz, 2H), 
7.93 (dd, J = 4.5, 1.7 Hz, 2H), 8.38 (s, 1H), 8.75 (dd, J = 4.5, 1.6 Hz, 2H). 13C NMR (DMSO-
d6, 100 MHz) δ 25.2, 47.8, 66.9, 115.3, 119.7(2), 119.7(3), 128.1, 139.4(9), 139.5(6), 
141.0, 150.7, 159.3, 161.8. ESI-HRMS m/z calc’d for C17H15N2O4S2 375.0479, found 
375.0478. 
N-(2-(4-methoxyphenyl)-2-oxoethyl)picolinamide (3.9). A 250 mL round bottom 
flask equipped with a stir bar was charged with 2-amino-4’-methoxyacetophenone hydro-
chloride 2.4 (1.1 eq., 14.9 mmol, 3.00 g), picolinic acid (1 eq., 13.5 mmol, 1.66 g), 
EDCI×HCl (1.5 eq., 20.3 mmol, 3.89 g), and HOBt (0.5 eq., 6.76 mmol, 913 mg).  After 
dissolving the contents in 40 mL of DMF, pyridine (1 eq., 13.5 mmol, 1.09 mL) was added 
to the reaction solution via a syringe, and the solution was allowed to stir magnetically 
overnight.  The product was crystallized out of solution by the slow addition of 100 mL of 
diH2O, after which it was filtered by suction filtration, washed with cold diH2O, and dried 
over vacuum to afford 3.9 as a white crystalline solid.  Yield: 3.48 g (12.9 mmol, 95%). 1H 
NMR (CDCl3, 400 MHz) δ 3.88 (s, 3H), 4.92 (d, J = 4.76 Hz, 2H), 6.98 (d, J = 8.8 Hz, 2H), 
7.45 (ddd, J = 7.6, 4.8, 1.2 Hz, 1H), 7.85 (td, J = 7.7, 1.0 Hz, 1H), 8.02 (d, J = 8.8 Hz, 1H), 
 186 
8.20 (dt, J = 7.8, 1.0 Hz, 1H), 8.63 (ddd, J = 4.8, 1.7, 0.9 Hz, 1H), 8.97 (s, 1H). 13C NMR 
(CDCl3, 100 MHz) δ 45.9, 55.5, 114.0, 112.1, 126.2, 127.6, 130.2, 137.1, 148.3, 149.6, 
164.1, 164.5, 192.1. EI-MS m/z 270 ([M]+, 5%), 135 (100%), 78 (23%). EI-HRMS m/z 
calc’d for C15H14N2O3 270.1004, found 270.1002.   
5-(4-methoxyphenyl)-2-(pyridin-2-yl)thiazole (3.10).  To an oven-dried 2-neck 
100 mL round bottom flask equipped with a stir bar was added picolinamide 3.9 (1 eq., 
6.66 mmol, 1.80 g) and Lawesson’s Reagent (1.3 eq., 8.65 mmol, 3.50 g).  The flask was 
connected to a reflux apparatus, and using a glass frit connected to the top of the reflux 
condenser, the system was flushed with argon for several minutes to remove moisture.  
Using an argon-filled syringe, butryonitrile (40 mL, dried over 0.4 Å molecular sieves and 
filtered) was added through the top of the reflux condenser.  The flask was lowered into 
an oil bath at 140°C and allowed to magnetically stir under reflux for 20 min.  After cooling 
to room temperature, saturated NaHCO3 (aq) solution (2 mL) was added to the deep red 
solution under stirring, and the mixture was diluted with ethyl acetate (40 mL), transferred 
to a separatory funnel, and washed with additional saturated NaHCO3 and brine.  The 
organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure 
to afford a yellow solid.  The crude solid was purified via column chromatography (silica 
gel) using 7:2:1 hexanes:dichloromethane:MTBE as the elution solvent to afford pure 3.10 
as a yellow solid.  Yield: 1.36 g (5.07 mmol, 76%). 1H NMR (CDCl3, 400 MHz) δ 3.83 (s, 
3H), 6.94 (d, J = 8.8, 2H), 7.29 (ddd, J = 7.7, 5.0, 1.3 Hz, 1H), 7.56 (d, J = 8.9 Hz, 2H), 
7.78 (td, J = 7.8, 1.7 Hz, 1H), 7.97 (s, 1H), 8.16 (dt, J = 8.0, 1.0, 1H), 8.61 (ddd, J = 4.9, 
1.6, 0.9, 1H). 13C NMR (CDCl3, 100 MHz) δ 55.3, 114.5, 119.2, 124.0, 124.1, 127.9, 136.9, 
138.5, 141.5, 149.4, 151.5, 159.8, 166.9. EI-MS m/z 268 (100%, [M]+), 253 (40%), 149 
(25%), 121 (20%). EI-HRMS m/z calc’d for C15H12N2OS 268.0670, found 268.0668.   
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4-(2-(pyridin-2-yl)thiazol-5-yl)phenol (3.11). Thiazole 3.10 (1 eq., 0.373 mmol, 
100 mg) was added to a 10 mL round bottom flask equipped with a stir bar.  The flask was 
sealed with a rubber septum, evacuated under high vacuum, and backfilled with argon.  
Via an argon-filled syringe, anhydrous dichloromethane (2 mL) was transferred to the flask 
to dissolve the starting material.  The flask was then lowered into a dry ice/acetone bath 
at -78°C, and upon thermal equilibration (~20 minutes), boron tribromide (3 eq., 1.12 
mmol, 1.12 mL of a 1 M solution in dichloromethane) was added drop-wise to the stirred 
solution.  The mixture was allowed to stir at -78°C for 5 minutes followed by 2.5 hours at 
room temperature.  The mixture was diluted with ethyl acetate (10 mL), washed with diH2O 
(10 mL), and the pH was adjusted to 7 to neutralize the excess BBr3 using saturated Na-
HCO3. The aqueous layer was then extracted with ethyl acetate 2x more (10 mL each), 
and the combined organic layers were dried over MgSO4, filtered, and concentrated to an 
orange-yellow crude solid. The crude solid was then purified via column chromatography 
(silica gel) using 1:1 ethyl acetate:hexanes, followed by recrystallization from 1:1 tolu-
ene:cyclohexane to afford 3.11 as a yellow crystalline solid. Yield: 73 mg (0.287 mmol, 
77%). 1H NMR (MeOD, 400 MHz) δ 6.86 (d, J = 8.8, 2 H), 7.41 (ddd, J = 7.5, 4.9, 1.2 Hz, 
1H), 7.53 (d, J = 8.9, 2H), 7.90 (ddd, J = 7.9, 7.6, 1.7 Hz, 1H), 8.00 (s, 1H), 8.13 (dt, J = 
8.0, 1.1 Hz, 1H), 8.56 (ddd, J = 4.9, 1.7, 1.0 Hz, 1H). 13C NMR (MeOD, 100 MHz) δ 117.0, 
120.3, 123.7, 125.7, 129.1, 138.6, 139.0, 143.7, 150.5, 152.4, 159.5, 167.7. EI-MS m/z 
254 (100%, [M]+), 150 (45%), 121 (20%). EI-HRMS m/z calc’d for C14H10N2OS 254.0514, 
found 254.0513.   
Sodium 3-(4-(2-(pyridin-2-yl)thiazol-5-yl)phenoxy)propane-1-sulfonate (3.2).  
To a 10 mL round bottom flask equipped with a stir bar was added phenol 3.11 (1 eq., 
0.248 mmol, 63 mg) and 1,4-dioxane (2 mL).  Under magnetic stirring, NaOH (75 μL of a 
20% (w/v) aqueous solution) was added to the solution, precipitating the phenolate anion 
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intermediate.  The precipitate was redissolved by adding a few drops of water to the stirred 
mixture.  After 15 minutes, 1,3-propanesultone (1 eq., 0.248 mmol, 30.3 mg) was added, 
and the solution was allowed to stir vigorously for 4 hours.  The 1,4-dioxane/water mixture 
was removed by gentle evaporation, and the product was crystallized from a 3:1 isopro-
panol:methanol mixture to afford 3.2 as a yellow crystalline solid.  Yield: 72 mg (0.181 
mmol, 73%). 1H NMR (DMSO-d6, 400 MHz) δ 2.00-2.06 (m, 2H), 2.58 (t, J = 7.4 Hz, 2H), 
4.13 (t, J = 6.6 Hz, 2H), 7.03 (d, J = 8.8 Hz, 2H), 7.49 (ddd, J = 7.5, 4.8, 1.2 Hz, 1H), 7.69 
(d, J = 8.8 Hz, 2H), 7.97 (td, J = 7.7, 1.7 Hz, 1H), 8.13 (dt, J = 7.9, 1.0 Hz, 1H), 8.27 (s, 
1H), 8.64 (ddd, J = 4.8, 1.6, 1.0 Hz, 1H). 13C NMR (DMSO-d6, 100 MHz) δ 25.2, 47.8, 
66.9, 115.2, 118.8, 123.1, 124.9, 127.9, 137.7, 139.2, 140.9, 149.7, 150.6, 159.1, 166.0. 
ESI-HRMS m/z calc’d for C17H15N2O4S2 ([M+H]+) 375.0479, found 375.0476. 
6-cyanopicolinic acid ethyl ester (3.12).  Solid ethyl 6-bromopicolinate (1 eq., 
65.2 mmol, 15.0 g) and cuprous cyanide (2 eq., 130.4 mmol, 11.68g) were added to a 
250-mL round bottomed flask equipped with a stir bar.  To the round bottomed flask was 
added anhydrous pyridine (60 mL). Under rapid stirring, the mixture was refluxed under 
argon for 6 hours.  The flask was removed from the hot oil bath, and the black tarry mixture 
that remained in the flask was diluted with hot toluene (100 mL).  To the diluted mixture 
was added celite powder (~20 g), and the mixture was allowed to stir for ~20 minutes to 
allow the toluene to penetrate the tarry residue, then the celite/tar was filtered through a 
bed of celite and washed with hot toluene (50 mL).  The filtrate was decanted into a 500-
mL round bottom flask, and the solvents were removed under reduced pressure to yield a 
thick, black residue.  The residue was redissolved in ethyl acetate (400 mL), and the so-
lution was transferred to a separatory funnel, diluted with 1 M citric acid (300 mL), and the 
aqueous layer was extracted with ethyl acetate (2 x 200 mL).  The combined organic lay-
ers were dried over MgSO4 and filtered, and concentrated under reduced pressure to yield 
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an orange solid, which was recrystallized from boiling hexanes to yield a white crystalline 
solid.  The white solid was collected by suction filtration, washed with cold hexanes, and 
dried under high vacuum to give.  Yield: 8.23 g (46.7 mmol, 72%). 1H NMR (CDCl3, 400 
MHz) δ 1.46 (t, J = 7.1 Hz, 3H), 4.52 (q, J = 7.1 Hz, 2H), 7.90 (dd, J = 7.8, 1.1 Hz, 1H), 
8.06 (t, J = 7.9 Hz, 1H), 8.34 (dd, J = 8.0, 1.1 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 14.2, 
62.6, 116.3, 127.9, 131.1, 133.9, 138.4, 149.7, 163.5. ESI-MS m/z 177 ([M+H]+, 46%), 
149 (90%). ESI-HRMS m/z 177 calc’d for C9H9O2N2 ([M+H]+) 177.0659, found 177.0656.   
6-cyanopicolinic acid (3.13). To a 100-mL round bottom flask was added 40 mL 
of 1N HCl (aq). The flask was lowered into a 100°C oil bath until the aqueous solution 
began to boil.  While rapidly stirring, solid ethyl 6-cyanopicolinate (3.12, 28.95 mmol, 5.10 
g) was added to the boiling solution, and a vacuum adapter equipped with a glass frit was 
inserted into the top joint to limit the rate of water evaporation but allow for the removal of 
ethanol as the starting material was hydrolyzed.  Because of the low melting point of the 
starting material, the reaction mixture was initially biphasic, but the biphasic mixture was 
slowly converted to a homogeneous solution as the starting material was consumed.  The 
solution was stirred for one hour, and then the flask was removed from the oil bath and 
allowed to cool to room temperature under medium stirring to permit crystallization of the 
product.  To complete crystallization, the mixture was stirred at 0°C for another hour.  The 
white precipitate was collected by suction filtration, washed with ice cold water (30 mL), 
followed by one portion (30 mL) of hot hexanes and one portion (30 mL) of 1:1 hexanes:di-
chloromethane.  The white solid was then recrystallized from boiling toluene, collected by 
vacuum filtration, washed with additional toluene, and dried under vacuum. Yield: 3.50 g 
(23.63 mmol, 82%).  1H NMR (Acetone-d6, 400 MHz) δ 8.22 (dd, J = 7.7, 1.2 Hz, 1H), 
8.34 (t, J = 7.8 Hz, 1H), 8.42 (dd, J = 8.0, 1.2 Hz, 1H), 11.96 (s, br, 1H). 13C NMR (Acetone-
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d6, 100 MHz) δ 117.4, 128.7, 132.6, 133.9, 140.5, 150.2, 164.6. ESI-HRMS m/z 149 calc’d 
for C7H5O2N2 ([M+H]+) 149.0346, found 149.0342. 
6-cyano-N-(2-(4-methoxyphenyl)-2-oxyethyl)picolinamide (3.14).  To a clean, 
dry 100-mL round bottom flask was added 6-cyanopicolinic acid 3.13 (1 eq., 19.93 mmol, 
2.95 g), 2-amino-4’-methoxyacetophenone hydrochloride 2.4 (1.1 eq., 21.92 mmol, 4.42 
g), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI×HCl, 1.5 eq., 29.9 
mmol, 5.73 g), and 1-hydroxybenzotriazole (HOBt, 0.5 eq., 9.97 mmol, 1.35 g) with a stir 
bar. The starting materials and reagents were dissolved in N,N-dimethylformamide (DMF, 
60 mL), and upon dissolution (~ 5 min), pyridine (1 eq., 19.93 mmol, 1.61 mL) was added 
drop-wise to the stirring solution, and the solution was allowed to stir for 6 hours.  The 
solution was then decanted into a 250-mL round bottom flask, diluted with 100 mL of de-
ionized water to precipitate the product.  The product was then collected by suction filtra-
tion, washed with cold deionized water and allowed to dry under vacuum.  Yield: 6.47 
(21.91 mmol, 68%). 1H NMR (CDCl3, 400 MHz) δ 3.90 (s, 3H), 4.93 (d, J = 4.8 Hz, 2H), 
7.00 (d, J = 8.9 Hz, 2H), 7.87 (dd, J = 7.7, 1.1 Hz, 1H), 8.02 (d, J = 8.9 Hz, 2H), 8.06 (t, J 
= 7.8 Hz, 1H), 8.44 (dd, J = 8.0, 1.1 Hz, 1H), 8.75 (t, J = 4.6 Hz, 1H). 13C NMR (CDCl3, 
100 MHz) δ 46.0, 55.6, 114.1, 116.5, 125.5, 127.3, 130.3, 130.6, 132.4, 138.7, 151.0, 
162.5, 164.2, 191.6. EI-MS m/z 295 ([M]+, 1%), 135 (100%).  EI-HRMS m/z calc’d for 
C16H13N3O3 295.0957, found 295.0954.   
6-(5-(4-methoxyphenyl)thiazol-2-yl)picolinonitrile (3.15). To a round-bottomed 
flask containing vacuum-dried picolinamide 3.14 (1 eq., 14.97 mmol, 4.42 g) and Lawes-
son’s Reagent (1.3 eq., 19.46 mmol, 7.87 g) was added to an oven-dried 100-mL round 
bottom flask equipped with a stir bar.  The flask was connected to a reflux condenser, and 
the system was flushed with argon for several minutes to remove moisture.  Through the 
top of the reflux condenser was added butryonitrile (60 mL) that had been previously dried 
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over 0.4 Å molecular sieves and filtered. The apparatus was flushed further with argon 
and then capped with a glass frit.  The flask was lowered into an oil bath at 130°C, and 
the mixture was refluxed for 30 minutes. The solution was then removed from the oil bath, 
allowed to cool to room temperature, and the butryonitrile was removed under reduced 
pressure to yield a dark orange solid residue.  The residue was transferred to a 500-mL 
flask and dissolved in reagent-grade acetone (400 mL). In a 2-L round bottom flask was 
dissolved 23.7 g of potassium permanganate in acetone (600 mL).  The crude residue 
solution was decanted into a 1-L flask, and the dark purple solution was allowed to stir 
vigorously for 10 minutes to convert the thioamide byproduct back to the desired nitrile.  
The reaction was quenched by the addition of 1 M citric acid (aq) (500 mL).  The teal-
colored solution was filtered through a pad of celite, and the filtrete was concentrated 
under reduced pressure. The resulting solution was neutralized with saturated aqueous 
NaHCO3 and extracted with dichloromethane (3 x 300 mL).  The combined organic layers 
were dried over MgSO4, filtered, and concentrated under reduced pressure to yield a yel-
low solid.  The solid was then redissolved in a minimal amount of dichloromethane, loaded 
onto a 5-cm bed of silica gel, and purified over silica gel using dichloromethane as the 
eluent.  The column product was recrystallized from boiling n-dibutyl ether (purified by 
stirring with crushed KOH pellets to remove any potential peroxide contamination, followed 
by filtration through a glass frit), collecting the pure yellow crystals by suction filtration and 
washing with addition n-dibutyl ether. Yield 2.55 g (8.68 mmol, 58%). 1H NMR (CDCl3, 400 
MHz) δ 3.87 (s, 3H), 6.98 (d, J = 8.9 Hz, 2H), 7.59 (d, J = 8.9 Hz, 2H), 7.69 (dd, J = 7.6, 
1.1 Hz, 1H), 7.93 (t, J = 8.1 Hz, 1H), 8.00 (s, 1H), 8.38 (dd, J = 8.1 Hz, 1.1 Hz, 1H). 13C 
NMR (CDCl3, 100 MHz) δ 55.4, 114.7, 116.8, 122.5, 123.6, 128.2, 128.3, 133.4, 138.0, 
138.9, 143.3, 153.2, 160.2, 164.2. EI-MS m/z 293 ([M]+, 100%), 278 (30%), 250 (10%), 
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149 (15%), 121 (16%), 77 (12%).   EI-HRMS m/z calc’d for C16H11N3OS 293.0623, found 
293.0623.   
6-(5-(4-methoxyphenyl)thiazol-2-yl)picolinaldehyde (3.16). Solid picolinonitrile 
3.15 (1 eq., 8.37 mmol, 2.46 g) was added to a 250-mL round bottom flask equipped with 
a stir bar.  Via a rubber septum, the flask was evacuated and backfilled with argon several 
times to ensure exclusion of moisture.  Once the starting material was nearly completely 
dissolved in anhydrous THF (80 mL), lithium diisobutyl tert-butoxyaluminum hydride 
(LDBBA, 1.5 eq., 12.56 mmol, 25.12 mL of a freshly prepared 0.5 M solution), that was 
prepared according to a published literature procedure,15 was added dropwise to the rap-
idly stirred suspension.  The deep blue solution that emerged after complete addition of 
the LDBBA reagent was stirred for 1 hour at room temperature.  The reaction was 
quenched with the addition of 30 mL of 1 M citric acid and stirred for 20 minutes.  The 
turbid mixture was extracted with EtOAc (3 x 50 mL), and the combined organic layers 
were dried over MgSO4, filtered, and concentrated to afford a yellow-orange solid.  The 
solid residue was purified by column chromatography (silica gel) using 1:1 EtOAc:hexanes 
as the eluent.  The yellow column product was then recrystallized from boiling cyclohex-
ane, and the pale yellow crystals were collected by suction filtration, washed with cold 
cyclohexane and dried over vacuum.  Yield: 1.54 g (5.20 mmol, 62%).  1H NMR (CDCl3, 
400 MHz) δ 3.87 (s, 1H), 6.98 (d, J = 8.9 Hz, 2H), 7.60 (d, J = 8.9 Hz, 1H), 7.95-8.01 (m, 
2H), 8.02 (s, 1H), 8.39 (dd, J = 6.7, 2.3 Hz, 1H), 10.14 (s, 1H). 13C NMR (CDCl3, 100 MHz) 
δ 55.4, 114.6, 121.6, 123.3, 123.8, 128.1, 138.0, 138.8, 142.5, 152.2, 152.4, 160.1, 165.4, 
193.0. EI-MS m/z 296 ( [M]+100%), 281 (33%), 149 (27%), 121 (26%). EI-HRMS m/z calc’d 
for C16H12N2O2S 296.0619, found 296.0624. 
2,2’-[iminobis(methylene)]diisonicotinic acid (3.17).  Synthesis and optimiza-
tion performed by M. Thomas Morgan, Ph.D. 2-cyanoisonicotinic acid (21.7 mmol, 3.21 g) 
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and 50% water wet 10% Palladium on activated carbon (1 mol%, 0.217 mmol, 461 mg) 
were stirred together in water (10 mL) in a 100 mL round-bottom flask. Methanol (20 mL) 
was added, followed by trimethylamine (1.2 eq., 26.0 mmol, 3.62 mL), and the flask was 
connected to a 3-way stopcock adapter, evacuated, and quickly back-filled with hydrogen 
gas from a 1-L gas burette. The burette was refilled to 1000 mL, and the mixture was 
vigorously stirred. After 250 mL of H2(g) had been consumed, a further 50 mL of hydrogen 
was added to the burette to provide the full theoretical amount required (1040 mL at 22°C 
and 1 atm). H2(g) consumption proceeded steadily for approximately 3 hours, then ab-
ruptly stopped with 35 mL remaining in the burette, corresponding to consumption of 98% 
of the theoretical amount. The flask was purged with argon, the mixture was filtered 
through celite, and the filter cake was washed with ethanol. The combined filtrate was 
concentrated to a viscous residue, which was taken up in ethanol (100 mL), diluted with 
toluene (50 mL), and concentrated again. The resulting partially solidified material was 
taken up in ethanol, filtered through a glass frit to remove the precipitated primary amine 
byproduct, and concentrated to dryness. The residue from the filtration was taken up in 
water (25 mL) and the product was precipitated by addition of 90% formic acid, collected 
by filtration, washed with ice water, and dried by suction overnight. Yield: 1.44 mg (5.01 
mmol, 44%). Note: to dissolve in MeOD, two drops of potassium deuteroxide (KOD, 40% 
w/v in D2O) were added, the solution was blown dry under a stream of argon to remove 
the D2O, and the compound was redissolved in MeOD. 1H NMR (MeOD, 400 MHz) δ 3.98 
(s, 4H), 7.72 (dd, J = 5.1, 1.4 Hz, 2H), 7.90 (s, 2H), 8.54 (d, J = 5.5 Hz, 2H). 13C NMR 
(MeOD, 100 MHz) δ 54.9, 123.2, 123.5, 148.4, 150.0, 160.5, 172.7. ESI-HRMS m/z 288 
calc’d for C14H14O4N3 ([M+H]+) 288.0979, found 288.0980.  
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2,2’-[iminobis(methylene)]diisonicotinic acid dimethyl ester (3.18).  To a 25 
mL round bottom flask equipped with a magnetic stir bar was added the starting dicarbox-
ylic acid 3.17 (1 eq., 2.78 mmol, 800 mg) and methanol (12 mL).  While stirring under a 
gentle stream of argon, trimethylsilyl chloride (TMSCl, 3 eq., 8.35 mmol, 1.06 mL) was 
added drop-wise into the mixture at room temperature, followed by vigorous stirring under 
reflux overnight.  The following day, the methanol was removed under reduced pressure, 
the residue was reconstituted in dichloromethane (25 mL), washed with saturated Na-
HCO3 (25 mL), and the organic layer was dried over MgSO4, filtered, and concentrated to 
an amber-colored oil. The pure oil was crystallized by the addition of cyclohexane and 
subsequently recrystallized from boiling cyclohexane to afford 3.18 as yellow solid.  Note: 
the crystallization was relatively insufficient, so the remainder of the pure compound was 
kept as an oil.  Yield: 800 mg (2.54 mmol, 91%).  1H NMR (CDCl3, 400 MHz) δ 3.96 (s, 
6H), 4.06 (s, 4H), 7.23 (dd, J = 5.1, 1.6 Hz, 2H), 7.91 (s, 1H), 8.72 (d, J = 5.1 Hz, 2H). 13C 
NMR (CDCl3, 100 MHz) δ 52.5, 54.1, 121.1, 121.3, 137.6, 149.9, 160.4, 165.4. EI-MS m/z 
165 (53%), 151 (100%,), 137 (12%), 92 (10%). EI-HRMS m/z calc’d for C16H17N3O4 
315.1219, found 315.1208.   
Fluorophore dimethyl ester 3.3a.  To an oven-dried 10-mL round bottom flask 
equipped with a stir bar was added aldehyde 3.16 (1 eq., 0.506 mmol, 150 mg), 
bispicolylamine dimethyl ester 3.18 (1.07 eq., 0.542 mmol, 171 mg), and Na(OAc)3BH (1.5 
eq., 0.759 mmol, 161 mg).  Via a rubber septum, the flask was evacuated for several 
minutes and backfilled with argon to exclude moisture, and through an argon-filled needle 
was added 2 mL of anhydrous 1,2-dichloroethane to dissolve the reagents.  The reaction 
was allowed to stir at room temperature for 24 hours.  The reaction was quenched by the 
addition of 2 mL of diH2O and allowed to stir for ~ 20 minutes.  The organic layer was 
removed, dried over MgSO4, filtered, and concentrated under reduced pressure to afford 
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a yellow oily residue.  The residue was purified by column chromatography (neutral alu-
mina) using 9:1 dichloromethane:methanol to afford 3.3a as a glassy yellow solid.  Yield: 
232 mg (0.39 mmol, 77%). 1H NMR (CDCl3, 400 MHz) δ 3.86 (s, 3H), 3.92 (s, 6 H), 3.98 
(s, 2H), 4.07 (s, 4H), 6.96 (d, J = 8.8 Hz, 2H), 7.51 (d, J = 7.7 Hz, 1H), 7.60 (d, J = 8.7 Hz, 
2H), 7.70 (dd, J = 5.0, 1.5 Hz, 2H), 7.76 (t, J = 7.8 Hz, 1H), 7.97 (s, 1H), 8.01 (d, J = 7.7 
Hz, 8.18 (s, 2H), 8.69 (d, J = 5.0 Hz, 2H). 13C NMR (CDCl3, 100 MHz) δ 52.6, 55.4, 59.7, 
60.1, 114.5, 117.5, 121.2, 122.2, 123.7, 124.1, 128.0, 137.7, 137.8, 138.5, 141.5, 149. 9, 
150.8, 158.7, 159.8, 160.5, 165.7, 167.4. ESI-HRMS m/z calc’d for C32H30O5N5S ([M+H]+) 
596.1956, found 596.1962.    
Fluorophore dicarboxylate 3.3b.  Fluorophore dimethyl ester 3.3a (1 eq., 0.167 
mmol, 100 mg) was added to a 10 mL round bottom flask and dissolved in methanol (3 
mL).  While stirring, NaOH (2.8 eq., 0.468 mmol, 62 µL of a 30% (w/v) solution in H2O) 
was pipetted into the solution, and the mixture was refluxed for 1 hour.  The solution was 
cooled to room temperature, and the methanol was removed under a gentle stream of 
argon.  Absolute ethanol (6 mL) was added to the flask, the mixture was heated until 
concentrated enough to allow for crystallization of the product.  The crystals were collected 
by vacuum filtration, washed with ethanol, and dried over vacuum to afford dicarboxylate 
3.3b as a yellow crystalline solid.  Yield: 97.3 mg (0.159 mmol, 95%).  1H NMR (MeOD, 
400 MHz) δ 3.83 (s, 3H), 3.92 (s, 2H), 3.99 (s, 4H), 7.00 (d, J = 8.9 Hz, 2H), 7.56 (dd, J = 
7.7, 0.9 Hz, 1H), 7.63 (d, J = 8.9 Hz, 2H), 7.68 (dd, J = 5.1, 1.5 Hz, 2H), 7.82 (t, J = 7.7 
Hz, 1H), 7.90 (dd, J = 7.8, 0.9 Hz, 1H), 8.01 (s, 2H), 8.05 (s, 1H), 8.53 (dd, J = 5.1, 0.7 
Hz, 2H). 13C NMR (MeOD, 100 MHz) δ 55.9, 60.3, 61.7, 115.8, 118.9, 123.2, 124.5, 125.0, 
125.5, 129.1, 139.1, 139.4, 143.1, 148.6, 150.0, 151.6, 160.1, 160.6, 161.7, 168.5, 172.7. 
ESI-HRMS m/z calc’d for C30H24N5O5S ([M+H]+) 566.1504, found 566.1506. 
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Fluorophore 3.3c. A 10-mL round-bottom flask containing aldehyde 3.16 (1 eq., 
0.675 mmol, 200 mg) and a stir bar was charged with Na(OAc)3BH (1.5 eq., 1.01 mmol, 
215 mg) and bispicolylamine (1.2 eq., 0.81 mmol, 161 mg). After sealing with a rubber 
septum, the flask was evacuated under high vacuum and backfilled with argon. The con-
tents of the flask were dissolved in anhydrous 1,2-dichloroethane (2 mL), and the reaction 
mixture was vigorously stirred overnight at room temperature. The following day, the re-
action mixture was quenched with 1 M citric acid (1 mL) for ~ 10 minutes, the aqueous 
phase as made basic by the addition of saturated NaHCO3(aq), and the product was ex-
tracted with dichloromethane (2 x 10 mL). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated to a light brown solid residue. The product was dis-
solved in dichloromethane and purified by column chromatography (silica gel) using 3:10 
acetone:DCM as the eluent, affording the product as a pure oil, which was crystallized and 
subsequently recrystallized from MTBE to yield 3.3c as off-white, fibrous crystals.  Yield: 
226 mg (0.471 mmol, 70%).  1H NMR (CDCl3, 400 MHz) δ 3.84 (s, 3H), 3.93 (s, 2H), 3.95 
(s, 4H), 6.95 (d, J = 8.8 Hz, 2H), 7.12-7.16 (m, 2H), 7.53 (d, J = 7.6 Hz, 1H), 7.57 (d, J = 
8.9 Hz, 2H), 7.64-7.68 (m, 4H), 7.40 (t, J = 7.8 Hz, 1H), 7.95 (s, 1H), 8.00 (d, J = 7.8 Hz, 
1H), 8.54 (d, J = 4.8 Hz, 2H). 13C NMR (CDCl3, 100 MHz) δ 55.4, 59.5, 60.2, 114.5, 117.4, 
122.0, 122.9, 123.4, 124.2, 128.0, 136.4, 137.3, 138.5, 141.4, 149.1, 150.8, 159.3, 159.4, 
159.8, 167.4. ESI-HRMS m/z calc’d for C28H26N5OS ([M+H]+) 480.1844, found 480.1853. 
Bis(2-pyrimidylmethyl)amine (3.19).  In a 250 mL round-bottom flask, 2-cyano-
pyrimidine (1 eq., 57.1 mmol, 6.00 g) was dissolved in a 1,4-dioxane:diH2O (3:1) mixture, 
and to the solution was added palladium (10%) on activated carbon (50% wet by H2O, 2 
mol %, 2.43 g). The flask was equipped with a 3-way stopcock adapter connected to an 
H2 burette, which was filled with 1000 mL of H2 (g).  After repeated evacuation and back-
filling with H2 from the gas burette, the mixture was rapidly stirred while H2 (2 eq., 114.2 
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mmol, 2.762 L) consumption from the gas burette proceeded steadily over the course of 
48 hours. After complete consumption of the 2.8 L of H2, the hydrogen-filled flask was 
carefully purged with argon, the palladium was filtered through a celite filter cake, washed 
with additional 1,4-dioxane, and the 1,4-dioxane/H2O was removed under reduced pres-
sure to leave an amber-colored oil residue. The residue was purified by column chroma-
tography (silica gel, 1:4 EtOH:DCM) to afford 3.19 as an amber-colored oil. Yield: 2.58 g 
(12.83 mmol, 45%).  Note: For 1H/13C NMR characterization, the oxalate salt of 3.19 was 
crystallized from MeOH/EtOH by the addition of 2.0 eq. of oxalic acid, followed by subse-
quent recrystallization from the boiling mixture. The product was filtered, dried under ar-
gon, and then redissolved in D2O for NMR characterization. 1H (D2O, 400 MHz) δ 3.98 (s, 
4H), 7.72 (dd, J = 5.1, 1.5 Hz, 2H), 7.90 (s, 2H), 8.54 (dd, J = 5.1, 0.7 Hz, 2H). 13C NMR 
(D2O, 100 MHz) δ 54.9, 123.2, 123.5, 148.4, 150.0, 160.5, 172.7.  EI-MS m/z 201 (10%, 
[M]+), 122 (23%,), 108 (100%), 94 (98%). EI-HRMS m/z calc’d for C10H11N5 201.1014, 
found 201.1004. 
Chromis-2 (3.4).  To a 10-mL round-bottom flask containing bis(2-pyrimidylme-
thyl)amine (3.19, 1.2 eq., 0.956 mmol, 193 mg) was added aldehyde 3.16 (1 eq., 0.797 
mmol, 236 mg), Na(OAc)3BH (1.5 eq., 1.20 mmol, 253 mg) and a stir bar.  The flask was 
sealed with a rubber septum, evacuated under high vacuum, and backfilled with argon.  
The contents were dissolved in anhydrous 1,2-dichloroethane (5 mL), and the reaction 
was stirred vigorously at room temperature for 24 hours. The reaction mixture was 
quenched with 1 M disodium citrate (2 mL), followed by extraction with dichloromethane 
(2 x 10 mL).  The combined organic layers were dried over Na2SO4, filtered, and concen-
trated to an amber color oil residue, which was purified by column chromatography (silica 
gel) using 1:1 acetone:DCM as the eluent.  The pure column product (pale yellow oil) was 
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crystallized by the addition of MTBE, followed by recrystallization from boiling MTBE:cy-
clohexane to afford 3.4 as an off-white crystalline solid.  Yield: 270 mg (0.561 mmol, 70%). 
1H NMR (CDCl3, 400 MHz) δ 3.85 (s, 3H), 4.26 (s, 2H), 4.35 (s, 4H), 6.95 (d, J = 8.8 Hz, 
2H), 7.16 (t, J = 4.9 Hz, 2H), 7.56 (d, J = 8.7 Hz, 2H), 7.71-7.76 (m, 2H), 7.94 (s, 1H), 7.97 
(dd, J = 5.9, 3.0 Hz, 1H), 8.72 (d, J = 4.9 Hz, 4H). 13C NMR (CDCl3, 100 MHz) δ 55.4, 
59.9, 60.4, 114.5, 117.2, 119.1, 123.8, 124.2, 128.0, 137.2, 138.4, 141.2, 150.5, 157.0, 
159.6, 159.8, 167.6, 168.5. EI-MS m/z 481 ([M]+, 6%), 388 (40%,), 282 (100%), 200 (73%). 
EI-HRMS m/z calc’d for C26H23N7OS 481.1685, found 481.1699.   
Primary amine 3.20.  A 25-mL round-bottom flask containing nitrile 3.15 (1 eq., 
1.1 mmol, 327 mg) and a magnetic stir bar was sealed with a rubber septum and evacu-
ated under high vacuum to remove any residual moisture.  After backfilling with argon, 
anhydrous THF (10 mL) was added to the flask through an argon-flushed syringe and 
needle.  The flask was lowered into an ice bath and left to thermally equilibrate to 0°C, 
after which DIBAL-H (2.1 eq., 2.12 mmol, 1.77 mL of a 1.2 M solution in toluene) was 
added dropwise into the rapidly stirred mixture.  After complete addition, the resulting dark 
amber-colored solution was stirred for 3 hours at 0°C until TLC analysis (9:1 
CH2Cl2:MeOH) confirmed the complete consumption of the starting nitrile.  The reaction 
was quenched by the addition of 1M citric acid, and after stirring for 20 minutes, the citric 
acid was neutralized by the addition of saturated Na2CO3 (aq) until the pH was above 8.  
The mixture was diluted with diH2O and extracted with DCM (3 x 50 mL), and the combined 
organic layers were dried over Na2SO4, filtered, and concentrated to an amber-colored 
solid.  The crude product was used in the next synthetic step without further purification.  
Yield: 284 mg (0.834 mmol). ESI-HRMS m/z calc’d for C28H26N5OS ([M+H]+) 480.1844, 
found 480.1853.  
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Chromis-2-Ctrl (3.5).  To a 10-mL round-bottom flask containing crude amine 3.20 
(1 eq., 0.834 mmol, 248 mg) was added 5-formylpyrimidine (2.1 eq., 1.75 mmol, 189 mg), 
Na(OAc)3BH (2.5 eq., 2.09 mmol, 442 mg) and a stir bar.  The flask was sealed with a 
rubber septum, evacuated under high vacuum, and backfilled with argon.  The contents 
were suspended in anhydrous 1,2-dichloroethane (5 mL), and the reaction was stirred 
vigorously at room temperature overnight. The reaction mixture was quenched with 1 M 
disodium citrate (1 mL) for ~ 15 minutes, followed by extraction with dichloromethane (3 x 
10 mL).  The combined organic layers were dried over Na2SO4, filtered, and concentrated 
to an amber-colored oil. The oily residue was purified by column chromatography (silica 
gel) using 7:3 acetone:DCM as the eluent.  The pure column product (pale yellow oil) was 
crystallized by the addition of MTBE, followed by recrystallization from boiling MTBE:cy-
clohexane to afford 3.5 as an off-white solid.  Yield: 54 mg (0.112 mmol, 13%). 1H NMR 
(CDCl3, 400 MHz) δ 3.82 (s, 4H), 3.84 (s, 2H), 3.86 (s, 3H), 6.97 (d, J = 8.8 Hz, 2H), 7.30 
(dd, J = 7.7, 0.8 Hz, 1H), 7.60 (d, J = 8.8 Hz, 2H), 7.79 (t, J = 7.8 Hz, 1H), 7.99 (s, 1H), 
8.09 (dd, J = 7.8, 0.8 Hz, 1H), 8.82 (s, 4H), 9.17 (s, 2H). 13C NMR (CDCl3, 100 MHz) δ 
53.1, 55.4, 58.1, 114.6, 118.1, 123.5, 124.0, 128.1, 131.7, 137.7, 138.7, 141.8, 151.3, 
157.6, 158.1, 160.0, 166.8. EI-MS m/z 481 ([M]+, 3%), 282 (100%,). EI-HRMS m/z calc’d 
for C26H23N7OS 481.1685, found 481.1676. 
3.7.2 X-Ray Crystallographic Methods 
3.7.2.1 Crystallization of the Zn(II) Complexes of Probes 3.3c and Chromis-2 (3.4) 
[(3.3c)Zn(II)] Complex: A solution of probe 3.3c (20 mg) in a DMSO:acetone mix-
ture (1.0 mL) was supplemented with a stoichiometric amount of ZnClO4•7H2O (15.5 mg), 
precipitating the Zn(II) complex of 3.3c. The mixture was supplemented with ~ 0.5 mL of 
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water, and the mixture was gently heated to dissolve the metal-ligand complex.  The so-
lution was cooled to room temperature, and the heating and cooling procedure was re-
peated once more.  The solution was filtered through a 0.2 µm nylon filter into a clean vial, 
and the complex was left to crystallize by slow evaporation to afford single, colorless, 
prism-shaped crystals suitable for X-ray crystallographic analysis.   
 [(Chromis-2)Zn(II) Complex: Chromis-2 (20 mg) was dissolved in HPLC-grade 
MeOH (2.0 mL), and the resulting solution was supplemented with a stoichiometric amount 
of ZnBF4•xH2O  (9.9 mg), precipitating the Zn(II) complex of chromis-2. The mixture was 
supplemented with ~ 0.5 mL of water, and the mixture was gently heated to dissolve the 
metal-ligand complex.  After the solution cooled to room temperature, the solution was 
filtered through a 0.2 µm nylon filter into a clean vial, and the complex was left to crystallize 
by slow evaporation to afford single, colorless crystals suitable for X-ray crystallographic 
analysis. 
3.7.2.2 X-Ray Crystal Structure Determination 
[(3.3c)Zn(II)] Complex:  a single, prism-shaped crystal (0.40 x 0.37 x 0.18 mm3) 
was selected using a loop with paratone oil and mounted on a Bruker D8 diffractometer 
with an APEX2 detector.  The crystal was cooled to T = 100(2) K during data collection.  
Data were measured using ω scans of 1.0° per frame for 25.0 s using MoKα radiation (fine-
focus sealed X-ray tube, 45 kV, 35 mA).  The total number of runs and images collected 
was based on the strategy calculation from the APEX2 program (Bruker).  The maximum 
resolution that was achieved was Θ = 30.508°C.  The structure was solved and the space 
group P21/c (#14) was determined by the ShelXT-2014/4 structure solution program24 us-
ing Intrinsic Phasing and refined by least-squares minimization using ShelXL-2014/7.25  All 
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non-hydrogens were refined anisotropically, and hydrogen atoms were calculated geo-
metrically and refined using the riding model.   
[(3.4)Zn(II)] Complex:  a single crystal (0.265 x 0.246 x 0.206 mm3) was selected 
using a loop with paratone oil and mounted on an XtaLAB Synergy Dualflex (Rigaku) dif-
fractometer with a HyPix HPC detector.  The crystal was cooled to T = 100(2) K during 
data collection.  Data were measured using using CuKα radiation. The structure was 
solved and the space group P21/c (#14) was determined by the ShelXT-2014/4 structure 
solution program24 using Intrinsic Phasing and refined by least-squares minimization using 
the ShelXL-2014/7 refinement package.25  All non-hydrogens were refined anisotropically, 
and hydrogen atoms were calculated geometrically and refined using the riding model. 
3.7.3 Determination of Protonation Constants 
3.7.3.1 Glass Electrode Calibration 
The protonation equilibrium constants were measured as concentration constants 
(logKH) based on potentiometric titrations using a combination double junction glass elec-
trode. The double-junction electrode was calibrated via the titration of a strong acid (5 mM 
HCl, prepared by dilution of a 0.1 M standardized solution, Sigma-Aldrich) with a strong 
base (0.1 M KOH, standardized solution, Sigma-Aldrich) in a solution of 0.1 M KCl in a 
water-jacketed, temperature-controlled titration vessel (Metrohm) at 25°C under an argon 
atmosphere. From the experimental emf data, the endpoint, electrode potential, and slope 
were calculated according to Gran’s Method using the GLEE software package (pKw = 
13.78, µ = 0.1 M KCl).26  This calibration procedure was performed, on the same day, prior 
to the potentiometric titration of each compound, and the experimental electrode potential 
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and slope used to calculate the experimental p[H] were the result of the average of the 
emf data from the three independent acid-base calibration titrations.  
3.7.3.2 Determination of the Protonation Constant of Model Compound 3.1 
A 10 μM solution of model compound 3.1 (diluted from a 3 mM stock solution in 
diH2O) was prepared in 3.0 mL of aqueous buffer (5 mM PIPBS, 0.1 M KCl, 5 mM KOH, 
25°C, pH 5.6) in a quartz fluorescence cuvette with a 1-cm pathlength. A combined po-
tentiometric and spectrophotometric titration was carried out in the cuvette by the addition 
of HCl(aq) using various aliquot volumes and concentrations with absorption spectra ac-
quired of the compound in ~ 0.1 pH-unit increments over the pH window between 5.6 and 
3.8 (thermostat accessory set to 25°C). After the addition of each aliquot of acid, the so-
lution was equilibrated by magnetic stirring until the pH electrode stabilized, the potential 
was recorded (in mV), and an absorbance spectrum was acquired over the spectral win-
dow of 250-500 nm. After correcting for dilution, the absorbance data were analyzed by 
non-linear least-squares fitting to a monoprotic equilibrium model.  The protonation con-
stant for model compound 3.1 was calculated based on the average calculated monoprotic 
equilibrium constant of three independent titrations. 
3.7.3.3 Determination of the Protonation Constant of Model Compound 3.2 
A 10 μM solution of model compound 3.2 (diluted from a 3 mM stock solution in 
diH2O) was prepared in 3.0 mL of aqueous 0.1 M KCl (filtered through a 0.2 µm filter) in a 
quartz fluorescence cuvette with a 1-cm pathlength, and the pH was adjusted to 4.0 using 
aqueous HCl (0.05 M). A combined potentiometric and spectrophotometric titration was 
carried out in the cuvette by the addition of HCl using various aliquot sizes and concen-
trations with absorption spectra acquired of the compound in ~ 0.1 pH-unit increments 
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over the pH window between 4.0 and 1.2 (thermostat accessory set to 25°C). After addi-
tion of each aliquot acid, the solution was equilibrated via magnetic stirring until the pH 
electrode stabilized, the potential was recorded (in mV), and an absorbance spectrum was 
acquired over the spectral window of 250-500 nm. After correcting for dilution, the absorb-
ance data were analyzed by non-linear least-squares fitting to a monoprotic equilibrium 
model.  The protonation constant for model compound 3.2 was calculated based on the 
average calculated monoprotic equilibrium constant of three independent titrations. 
3.7.3.4 Determination of the Protonation Constants of Probe 3.3b 
A 20 μM solution of probe 3.3b (diluted from a 3 mM stock solution in diH2O) was 
prepared in 3.0 mL of aqueous buffer (10 mM PIPES, 0.1 M KCl, 25°C, pH 7.0) in a quartz 
fluorescence cuvette with a 1-cm pathlength. A combined potentiometric and spectropho-
tometric titration was carried out in the cuvette by the addition of HCl(aq) using various 
aliquot volumes and concentrations with absorption spectra acquired of the compound in 
~ 0.2 pH-unit increments over the pH window between 7.0 and 0.70 (thermostat accessory 
set to 25°C). After the addition of each aliquot of acid, the solution was equilibrated by 
magnetic stirring until the pH electrode stabilized, the potential was recorded (in mV), and 
an absorbance spectrum was acquired over the spectral window of 250-500 nm. After 
correcting for dilution, the absorbance data were analyzed by non-linear least-squares 





3.7.4 Steady-State Absorption and Fluorescence Spectroscopy 
3.7.4.1 General Spectroscopic Methods 
All buffers and stock solutions used in spectroscopic measurements were pre-
pared using HPLC-grade water (JT Baker) or 18.2 MΩ•cm Mili-Q water and filtered to 
remove interfering particles or fibers.  UV-Vis absorption measurements were performed 
on a Varian Cary Bio50 spectrophotometer equipped with a thermostat accessory (Peltier) 
at 25°C.  Fluorescence spectroscopy measurements were performed using a Photon 
Technology International (PTI) fluorimeter equipped with a 75 W xenon arc lamp excitation 
source and a photomultiplier detection system (PMT voltage set to 1100 V for all experi-
ments).  Fluorescence spectra were corrected for the spectral response of the detection 
system and for the spectral irradiance of the excitation source (via a calibrated photodi-
ode).  For both UV-Vis absorption and fluorescence measurements, a 1-cm path length 
quartz fluorescence cuvette was utilized, except for fluorescence quantum yield determi-
nations, which used a 10-cm path length quartz cuvette when collecting absorbance 
measurements.   
3.7.4.2 Determination of Fluorescence Quantum Yields 
 Fluorescence quantum yields of compounds 3.1, 3.2, 3.3b and chromis-2 (3.4) 
were determined in aqueous buffer (10 mM PIPES, 0.1 M KCl) at pH 7.0 by a 4-point 
measurement over an OD range of 0.1-0.4 using a 10-cm cuvette, with fluorimeter excita-
tion at 365 nm.  For probes 3.3b and 3.4, the solutions containing the free forms were 
supplemented with 20 µM EDTA (from a 30 mM stock solution in diH2O) to sequester 
adventitious Zn(II), whereas to determine the Zn(II)-bound forms, the solutions were sup-
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plemented with 20 µM ZnSO4•7H2O to ensure complete saturation of the fluorophore.  Flu-
orescence quantum yields for all fluorophores were determined using quinine sulfate (Φf 
= 0.546 in 1.0 N H2SO4) as a fluorescence standard.5 To determine the quantum yield of 
3.3a, single-point measurements were performed in aqueous buffer (10 mM PIPES, 0.1 
M KCl, pH 7.0) supplemented with 100 µM 4:1 DMPC:DMPG liposomes and at a probe 
concentration of 2 µM.  The fluorescence quantum yields reported were calculated as an 
average of two independent measurements for both the metal-free and metal-saturation 
species.  The quantum yields were also referenced to quinine sulfate with an OD matching 
that of 3.3a (2 µM) in liposomes.    
3.7.4.3 Measurements of the Solvent Deuterium Isotope Effects 
Comparison of the fluorescence intensities of model compounds 3.1 and 3.2 were 
conducted in deuterated and non-deuterated buffer (10 mM PIPES, 100 mM KCl, pH/D 
7.0, 25°C).  A 3.0 mL solution of aqueous buffer was supplemented with 10 µM of each 
compound (diluted from 3 mM stock solutions in H2O), and after thorough mixing via mag-
netic stirring, fluorescence spectra of model compound 3.1 were acquired over the spec-
tral window of 380-700 nm with excitation at 346 nm, while analogous fluorescence spec-
tra of 3.2 were acquired over the spectral window of 380-650 nm with excitation at 345 
nm.  This procedure was repeated identically using deuterated buffer (10 mM PIPES, 100 
mM KCl, pD 7.0, 25°C).   
Comparison of the fluorescence intensities of probes 3.3b and 3.4 were also per-
formed in deuterated and non-deuterated buffer (10 mM PIPES, 100 mM KCl, pH/D 7.0, 
25°C).  A 3.0 mL solution of aqueous buffer was supplemented with 5 µM of each com-
pound (diluted from 3 mM stock solutions in either H2O (3.3b) or DMSO (3.4)), and after 
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thorough mixing via magnetic stirring, fluorescence spectra of each compound were ac-
quired over the spectral window of 380-700 nm with excitation at 361 nm.  This procedure 
was repeated identically using deuterated buffer (10 mM PIPES, 100 mM KCl, pD 7.0, 
25°C).   
3.7.4.4 Molar Ratio Titrations of Probes 3.3b and 3.4 
A 20 µM solution of 3.3b in pH 7.0 buffer (3.0 mL, 10 mM PIPES, 0.1 M KCl, 25°C) 
prepared in a quartz fluorescence cuvette with a 1-cm pathlength was titrated with 
ZnSO4•7H2O (from a 3 mM aqueous stock solution) in 2 µM (0.1 eq.) increments. After 
each aliquot of Zn(II), the solution was equilibrated for 30 seconds by magnetic stirring, 
and an absorbance (spectral window: 250-500 nm) and fluorescence spectrum (excitation: 
361 nm, spectral window: 380-700 nm) were acquired. 
For chromis-2 (3.4), a 10 µM solution of the probe in pH 7.0 buffer (3.0 mL, 10 mM 
PIPES, 0.1 M KCl, 25°C) prepared in a quartz fluorescence cuvette with a 1-cm pathlength 
was titrated with ZnSO4•7H2O (from a 3 mM aqueous stock solution) in 1 µM (0.1 eq.) 
increments. After each aliquot of Zn(II), the solution was equilibrated for 30 seconds by 
magnetic stirring, and an absorbance (spectral window: 250-500 nm) and fluorescence 
spectrum (excitation: 361 nm, spectral window: 380-700 nm) were acquired. 
3.7.4.5 Metal-Ion Selectivity Measurements of Probes 3.3b and 3.4 
A 5 µM solution (30 mL) of each probe was prepared in pH 7.0 aqueous buffer (10 
mM PIPES, 100 mM KCl, 25°C) that had been previously equilibrated overnight with 
Chelex® to sequester adventitious metal ions, after which the Chelex settled to the bottom 
and the supernatant was filtered through a 0.2 µm filter.  An aliquot (2.0 mL) of the solution 
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was transferred to a quartz fluorescence cuvette with a 1-cm path length, and a fluores-
cence spectrum was acquired over the spectral window of 380-700 nm with excitation at 
361 nm.  Under magnetic stirring, the solution was supplemented with each divalent metal 
cation (4 µM for transitions metals, corresponding to 80% fractional saturation of the 
probes, or 2 mM Ca(II) and Mg(II)), and a fluorescence spectrum was immediately ac-
quired.  The solution was then supplemented with ZnSO4•7H2O (from a 1 mM stock solu-
tion in H2O) to yield a final concentration of 1 µM (with Co(II), Ni(II), and Cu(II)) or 5 µM 
(with all other metals: Mg(II), Ca(II), Mn(II), Fe(II)), and a fluorescence spectrum was im-
mediately acquired.  With Fe(II), the fluorescence spectrum was acquired after a 30-min 
equilibration to ensure complete formation of the [(3.3b)Zn(II)] complex, as Zn(II) slowly 
outcompeted Fe(II).  The emission spectra corresponding to 80% fractional saturation of 
the probes by the interfering metal ions, as well as those corresponding to the addition of 
Zn(II), were integrated over the ranges of 440-495 nm (CH1) and 510-570 nm (CH2), and 
the resulting intensities were computed as a ratio of CH2/CH1 (CH1 for chromis-2 was 
440-470 nm).  Metal cations were supplied as aqueous stock solutions of the following 
salts: Mg(II), Ca(II) as chlorides (1 M stocks); Co(II) as Co(NO3)2 (1 µM stock); Mn(II), 
Fe(II), Cu(II), and Zn(II) as sulfates (1 µM stocks).  To avoid aerial oxidation of Fe(II), the 
stock solution was freshly prepared in 10 mM H2SO4 before use.   
To measure the fluorescence responses of each probe upon complete saturation 
of the probe, a 5 µM solution (15 mL) of the probe was prepared in aqueous buffer (10 
mM PIPES, 100 mM KCl, 25°C, pH 7.0) that had been supplemented with 2.0 equivalents 
(10 µM, from a 30 mM stock solution in H2O) of EDTA. A fluorescence spectrum was 
acquired of the free probe over the spectral window of 380-700 nm with excitation at 361 
nm.  The solution was supplemented with interfering divalent metal ions (30 mM stocks 
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solutions of each metal in H2O) to yield final concentrations of 20 and 40 µM, with a fluo-
rescence spectrum acquired immediately after each aliquot. 
The stability constant for the formation of the chromis-2-Mn(II) complex was deter-
mined through a fluorimetric titration by direct addition of Mn(II).  A 5 µM solution of 
chromis-2 was titrated with MnSO4•H2O from 0-40 µM, with a fluorescence spectrum ac-
quired immediately after each aliquot of Mn(II) added.  The fluorescence data were ana-
lyzed by non-linear least-squares fitting using the Specfit software package.2   
3.7.4.6 Zn(II)-Binding Affinity Measurements of Probe 3.3a 
The Zn(II) stability constant of 3.3a was determined through a fluorimetric titration 
in the presence of EGTA as a competing ligand.  A freshly extruded solution (500 µM) of 
DMPG liposomes (prepared according to the protocol described in the experimental sec-
tion of Chapter 2) in neutral aqueous buffer (20 mM PIPES, 100 mM KCl, pH 7.0) was 
equilibrated at 25°C for 10 minutes.  The liposome solution was supplemented with 100 
µM EGTA (from a 300 mM stock solution in water at pH 7.0), and after a 10 minute equi-
libration, probe 3.3a was diluted into the buffer from a 3 mM stock solution in DMSO to a 
final concentration of 2 µM.  After another 20-minute equilibration to dissolve the probe in 
the liposomes, the solution was titrated with ZnSO4•7H2O from 0-90 µM by dilution from 3 
and 15 mM stock solutions in H2O.  The fluorimetric data were analyzed by non-linear, 
least-squares fitting using the Specfit software package.2 
3.7.4.7 Zn(II)-Binding Affinity Measurements of Probe 3.3b 
The Zn(II) stability constant of 3.3b was determined through a fluorimetric titration 
using TMDTA (trimethylenedinitrilotetraacetic acid] as the competing ligand.  A 10 µM so-
lution of 3.3b (from a 3 mM stock solution in H2O) was equilibrated with 10 µM 
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ZnSO4•7H2O (from a 5 mM analytical stock solution in H2O) in 3.00 mL of aqueous buffer 
(10 mM PIPES, 0.1 M KCl, pH 7.0) at 25°C.  The in situ-generated [(3.3b)Zn(II)] complex 
was then titrated with TMDTA (from 3 and 20 mM analytical stocks solution in H2O) from 
0-80 µM.  After the addition of each aliquot of TMDTA, the solution was equilibrated by 
magnetic stirring for 50 minutes, and a fluorescence spectrum was acquired over the spec-
tral window of 250-500 nm. The fluorescence data were analyzed by non-linear least-
squares fitting using Specfit.2  
3.7.4.8 Zn(II)-Binding Affinity Measurements of Chromis-2 (3.4) 
The Zn(II) stability constant of chromis-2 was determined via a fluorimetric titration 
using EGTA [Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid] as the 
competing ligand.  A 10 µM solution of chromis-2 (from a 3 mM stock solution in DMSO) 
was equilibrated with 10 µM ZnSO4•7H2O (from a 5 mM analytical stock solution in H2O) 
in 3.00 mL of aqueous buffer (10 mM PIPES, 0.1 M KCl, pH 7.0) at 25°C.  The in situ-
generated [(chromis-2)Zn(II)] complex was then titrated with EGTA (from 3, 20, and 300 
mM analytical stock solutions in H2O) from 0-300 µM.  After the addition of each aliquot of 
EGTA, the solution was equilibrated by magnetic stirring, and a fluorescence spectrum 
was acquired over the spectral window of 380-700 nm with excitation at 361 nm. The 
fluorescence data were analyzed by non-linear least-squares fitting using the Specfit soft-
ware package.2 
3.7.4.9 Fluorescence Comparison of Probes 3.3b and Chromis-2 
Fluorescence comparison measurements of 3.3b and chromis-2 were conducted 
in deuterated and non-deuterated buffer (10 mM PIPES, 100 mM KCl, pH/D 7.0, 25°C).  
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A quartz cuvette with a 1-cm path length containing 3.0 mL of aqueous buffer was supple-
mented with 5 µM of 3.3b (from a 3 mM stock solution in H2O), and after a 30-second 
equilibration via magnetic stirring, a fluorescence spectrum was acquired over the spectral 
window of 380-700 nm with excitation at 361 nm.  The probe was then saturated with 5 
µM ZnSO4•7H2O (from a 3 mM stock solution in H2O), and a fluorescence spectrum was 
acquired.  This was repeated for 3.3b in deuterated buffer, but with supplementation of 5 
µM ZnSO4•7H2O from a 3 mM stock solution prepared in D2O (Cambridge Isotopes). To 
compare the fluorescence intensities and profiles of 3.3b to chromis-2, these procedures 
were repeated, except that the buffers were supplemented with 5 µM chromis-2 from a 3 
mM stock solution in DMSO.    
3.7.4.10 Absorbance and Fluorescence Response of Chromis-2-Ctrl (3.5) to Zn(II) 
The absorbance and fluorescence response of chromis-2 ctrl (3.5) to Zn(II) was 
measured by a tandem fluorimetric and spectrophotometric titration.  A 10 µM solution of 
chromis-2 (from a 3 mM stock solution in DMSO) was equilibrated in 3.00 mL of aqueous 
buffer (10 mM PIPES, 0.1 M KCl, pH 7.0, filtered through a 0.2 µM filter) at 25°C in a 
quartz cuvette with a 1-cm pathlength.  Both a fluorescence spectrum (spectral window of 
380-700 nm with excitation at 361 nm) and an absorbance spectrum (spectral window of 
250-500nm) were acquired.  The solution was titrated with ZnSO4•7H2O (from a 500 mM 
stock solution in H2O) from 0.5-2 mM, and after the addition of each aliquot of 
ZnSO4•7H2O, the solution was equilibrated by magnetic stirring for 5 minutes, and fluo-




3.7.4.11 Fluorescence Spectral Comparison of Chromis-2 (3.4) and Chromis-2-Ctrl (3.5) 
A 10 µM solution of each probe (from 3 mM stock solutions in DMSO) was equili-
brated in 3.00 mL of aqueous buffer (10 mM PIPES, 0.1 M KCl, pH 7.0, filtered through a 
0.2 µM filter) at 25°C in a quartz fluorescence cuvette with a 1-cm pathlength.  A fluores-
cence spectrum (spectral window of 380-700 nm with excitation at 361 nm) was acquired 
of the probe in solution.  With chromis-2, the solution supplemented with 10 µM 
ZnSO4•7H2O (from a 3 mM stock solution in H2O), and equilibration by magnetic stirring 
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CHAPTER 4  
AFFINITY MISMATCH: TUNING THE AFFINITY OF EMISSION-RA-
TIOMETRIC FLUORESCENT PROBES USING INTERCHANGEA-
BLE METAL-BINDING LIGANDS FOR PROBING KINETICALLY 
EXCHANGEABLE INTRACELLULAR ZN(II) 
4.1 Introduction 
The physiological regulation of Zn(II) entails a complex array of endogenous Zn(II)-
binding ligands, including membrane-localized transporters, cytoplasmic metal-binding 
proteins, and low-molecular-weight biomolecules that tightly regulate the storage, im-
port/export, and subcellular localization of the metal ion to ensure proper cellular function.  
The miscellany of these Zn(II)-binding molecules gives rise to a broad range of affinities 
that spans several orders of magnitudes.  The corresponding affinities of these ligands 
are manifested by their chemical diversity, which encompasses not only the coordination 
environment but also the molecular location of the bound metal ion (i.e. whether the metal 
ion is surface-exposed or buried within the molecule), thus the chemical nature of these 
Zn(II)-binding sites dictates whether the metal ions are freely exchangeable between lig-
ands or are hindered by a large kinetic barrier for exchange.   
As discussed in Chapter 1, human metallothioneins (MT), which contain ~ 20 con-
served cysteine residues that participate in binding up to seven Zn(II) ions per protein, 
constitute a prominent example of one Zn(II)-binding protein that may play a central role 
in intracellular zinc regulation.  Metallothionein displays a range of Zn(II) affinities that 
spans four orders of magnitude, which is made possible through two chemically distinct 
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Zn(II) cluster binding sites of the two subunits of the protein.1-3  One of the binding sites 
results in the formation of a Zn4S11 cluster with an average apparent logK of 11.8, corre-
sponding to a picomolar dissociation constant.4  One the other hand, the second cluster, 
denoted as the Zn3S9 cluster, is characterized by weaker affinities, with one Zn(II) ion 
coordinating with an apparent logK of 7.7 and the other two Zn(II) ions displaying two 
apparent logK’s of ~ 10 and 10.5.  To establish the binding affinities of the weakly bound 
Zn(II) ions, fluorescent probes with varying affinities for Zn(II) were employed in competi-
tion titrations with thionein, the apo form of metallothionein, and evaluated through fluori-
metric titrations.  However, elucidating the binding affinity of the more-tightly bound Zn(II) 
ions required chelating ligands with tighter binding affinities, such as nitriloacetic acid 
(NTA), in order to compete with the MT for Zn(II) binding.  These experimental observa-
tions suggest that the availability of Zn(II) for biological processes is dependent on not 
only the redox state of MT but also the thermodynamic and kinetic accessibilities, which 
in turn depend on the molecular structure of the ligands involved in metal exchange.  
Therefore, an associative exchange between various metal-binding ligands requires that 
the ligands participating in the metal-transfer equilibria boast similar dissociation con-
stants.  
To probe intracellular Zn(II) that exists in an environment with a higher thermody-
namic stability, fluorescent indicators must be designed with sufficiently high binding af-
finities to be able to participate in associative exchanges with the endogenous ligands.  At 
the same time, probing intracellular Zn(II) pools that are much more dynamic and labile 
requires fluorescent indicators with lower affinities. Tuning the affinity of fluorescent indi-
cators to achieve a wide dynamic range of affinities, therefore, is critical for exploring highly 
dynamic and more static Zn(II)-transfer equilibria involved in regulating the complex traf-
ficking and homeostasis processes in cells.  
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Experimentally determining the dissociation constants that result from tuning the 
affinity of fluorescent indicators demands the employment of Zn(II)-chelating ligands with 
matching affinities to compete with the fluorescent indicators for the metal analyte.  If the 
binding affinity of the chelating ligand is well-characterized, competition titrations, in which 
the solution containing the preformed metal complex of the fluorescent indicator is sup-
plemented with the competing ligand, can be performed, and the data can be analyzed 
computationally to establish the binding affinity of the fluorescent indicator. Important cri-
teria, however, include not only the availability of a suitable competing reference ligand 
but that also the coordination chemistry, protonation constants, and binding affinity of the 
ligand have been well-established.  
4.1.1 Affinity Standards for Determining the Stability Constants of Zn(II)-Responsive Flu-
orescent Probes 
The most commonly employed of the available affinity standards for Zn(II) are pre-
sented in Table 4.1. With the exception of TEDTA, all ligands are commercially available 
in analytically pure grades, and protonation constants and absolute stability constants for 
Zn(II) have been well-established.  Although the most commonly reported intracellular pH 
is 7.2,5 the experimentally determined cytosolic pH ranges between 6.8 and 7.4,6-15 thus 
a neutral pH of 7 corresponds to a representative average for characterizing the stability 
constants of fluorescent indicators.  Considering an ionic background of I = 0.1 M (K+ ion), 
the pH-independent stability constants of the affinity standards can be converted into ap-
parent stability constants at pH 7.0 using the corresponding protonation constants tabu-
lated in Table 4.1.  
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Table 4.1: Thermodynamic properties of affinity standards for Zn(II) at 25°C.a   
Ligand pKa4 pKa3 pKa2 pKa1 logβ logβ’b Kd’b 
DTPA 10.50 8.50 4.28 2.70 18.2 13.0 0.1 pM 
EDTA 10.19 6.13 2.69 2.00 16.5 13.1 79 fM 
EGTA 9.40 8.79 2.70 1.90 12.6 8.2 6.3 nM 
HEDTA 9.87 5.38 2.62 1.60 14.6 11.6 2.5 pM 
TEDTA 9.31 8.37 2.68 2.00 13.4 9.5 0.32 nM 
TMDTA 10.30 7.90 2.63 2.09 15.2 10.7 20 pM 
TPEN 7.12 4.81 3.30 2.88 15.4 15.0 1 fM 
a All values are acquired from reference [21]. b pH 7.0, 25°C, 0.1 M ionic background.  Acronyms: 
DTPA = diethylenetriaminepentaacetic acid; EDTA = ethylenediaminetetraacetic acid; EGTA = eth-
ylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid; HEDTA = N-(2-hydroxyethyl)eth-
ylenediamine-N,N′,N′-triacetic acid; TEDTA = thiobis(ethylenenitrilo)tetraacetic acid; TMDTA = tri-
methylenediaminetetraacetic acid; TPEN = N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine 
 
 As illustrated in Figure 4.1A, the Zn(II) stability constants of the affinity standards 
span a dynamic range of affinities of nearly six orders of magnitude between logβ = 12.6 
and 18.2.  Because the stability constants do not consider protonation equilibria that may 
compete for metal binding to the ligand, the pH-dependent apparent stability constants 
are typically lower protonation equilibria will inherently result in an apparent stability con-
stant that is lower, given that the pKa’s of most of these ligands reside above physiological 
pH.16  For example, diethylenetriaminepentaacetic acid (DTPA) boasts an absolute logβ 
of 18.2; however, due to the presence of two pKa’s above pH 7.0, the apparent stability 
constant decreases a dramatic five logarithmic units to 13.0 at pH 7.0, corresponding to a 
nearly 160,000-fold decrease in the dissociation constant from 0.63 aM to 0.1 pM (Figure 
4.1B).  Interestingly, despite the nearly two-logarithmic-unit decrease in the logβ of EDTA 
compared to DTPA, the presence of only one pKa above pH 7.0 results in a 0.1-logarith-
mic-unit increase in the apparent stability constant, corresponding to a 1.3-fold lower bind-
ing affinity for DTPA relative to EDTA.  This ordering is reversed, however, when the pH 
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is increased from 7.0 to 7.4, a commonly referenced physiological pH of eukaryotic cells.9  
At pH 7.4, DTPA has a 0.2-logarithmic-unit increase in the apparent stability constant, 
corresponding to a 1.6-fold lower affinity for EDTA relative to DTPA (Figure 4.1C).  Be-
cause the solution pH can dramatically affect the stability constants for these affinity stand-
ards, it is important to ensure that the pH is effectively controlled throughout the competi-
tion titration; this can be accomplished using a sufficient concentration (10 - 20 mM) of a 
non-complexing buffer17 with a buffer capacity at or near the pH of choice, as well as 
verifying the pH of the solution at the beginning and end of the competition titration.  In 
addition, when determining the apparent stability constant of the fluorescent indicator at 
the pH of interest, once an approximate binding affinity has been determined through a 
preliminary titration, it is to validate the apparent stability constant using an affinity stand-
ard whose dissociation constant is within the dynamic range (± 1 logarithmic unit) of the 




Figure 4.1: Affinity standards for determining Zn(II)-binding affinities and the effect of competing 
protonation equilibria on their Zn(II) dynamic range.  Binding isotherms depicting the dynamic range 
for Zn(II) binding are presented as absolute stability constants (A), not factoring in protonation con-
stants) and as apparent stability constants at pH 7.0 (B) and at pH 7.4 (C).  D) Chemical structures 























































































































4.1.2 Tuning the Affinity of Non-Centrosymmetric Donor-Acceptor Emission-Ratiometric 
Fluorescent Probes 
As evidenced by the three-logarithmic-unit difference in the stability constants be-
tween fluorophores 3.3b and chromis-2, the modularity of the 2-thiazolyl fluorophore core 
derived from the aldehyde functionality developed in Chapter 3 enabled facile affinity tun-
ing via the reductive coupling of various chemically diverse metal-chelating ligands with 
the fluorophore.  This chapter entails the design and synthesis of several Zn(II)-binding 
ligands that, once coupled to the 2-thiazolyl fluorophore core, led to the development of a 
series of fluorescent indicators offering a broad dynamic range of binding affinities span-
ning several orders of magnitude for exploring the thermodynamic and kinetic barriers 
availability of labile Zn(II) pool in biological systems.   
4.2 Development of a Low-Affinity Fluorescent Probe for Accessing Dy-
namic Labile Zn(II) Pools buffered in the Pico- to Nanomolar Concentra-
tion Range 
The intricate cellular machinery, such as the metallothionein/thionein couple and 
other endogenous proteins, that helps regulate the cytoplasmic “labile” Zn(II) pool in the 
picomolar regime results in an environment that is nearly devoid of free Zn(II) present as 
the aquo-complex.  Nonetheless, Zn(II) may accumulate at much higher concentrations 
within subcellular structures.  To probe this Zn(II) pool, fluorescent probes with significantly 
lower affinity are required, thus demanding a new ligand system that would coordinate 
Zn(II) much weaker compared to the previously employed pyridine or pyrimidine-based 
ligands.  Considering the substitution of a carboxylate group with a hydroxyl group results 
in a two-logarithmic-unit decrease in the stability constant of HEDTA relative to EDTA, 
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hydroxyl groups represented a promising modification for designing ligands with weaker 
Zn(II) affinity.  The search for potential ligands incorporating a secondary amine and hy-
droxyl groups led to investigating the use of commercially available diethanolamine as a 
ligand offering a low affinity for Zn(II).  The result of this design approach was the synthesis 
and characterization of probe 4.1.   
4.2.1 Synthesis of Probe 4.1 
As shown in Scheme 4.1, the synthesis of 4.1a was accomplished in one step by 
coupling commercially available bis(2-hydroxyethyl)amine to aldehyde 3.16 through a re-
ductive amination using sodium cyanoborohydride (NaCNBH3) in MeOH.  Previous reduc-
tive aminations to synthesize various fluorophores in Chapters 2 and 3 were successful 
using sodium triacetoxyborohydride (Na(OAc)3BH) in 1,2-dichloroethane, as the reduced 
reactivity of the triacetoxyborohydride reagent helps to prevent reduction of the aldehyde 
to the corresponding alcohol; however, the reactivity of Na(OAc)3BH has proven to be very 
inconsistent in protic solvents18, and given the presence of the hydroxyl groups of bis(hy-
droxyethyl)amine, it is possible that these functional groups could have an influence on 
the stability of the hydride reagent.   
 




















 The reaction of the bis(hydroxyethyl)amine with aldehyde 3.16 to form the corre-
sponding iminium intermediate had the susceptibility to undergo a reversible, intramolec-
ular acyl-like substitution reaction to generate the corresponding oxazolidine ring interme-
diate, which inhibits reduction of the intermediate by the hydride reagent (Scheme 4.2).  
To overcome this challenge, one equivalent of AcOH was added to promote the elimina-
tion of the alcohol, reforming the iminium intermediate, and to increase the reactivity of the 
cyanoborohydride, as the reduction of imines are much faster at weakly acidic to neutral 
pH’s.19  Despite these precautions, the synthesis of 4.1 was accomplished with only a 54% 
yield, suggesting that the equilibrium to form the iminium intermediate was not favorable 
enough to permit isolation of the product in high yield.    
 
Scheme 4.2:  Proposed mechanism for the formation of the oxazolidine intermediate, which can 
reversibly undergo elimination in the presence of a weak acid to reform the iminium intermediate 
that is reactive towards [H–].  
 
4.2.2 Probe 4.1 Binds Zn(II) with Low Micromolar Affinity 
As detailed in Chapter 1, Zn(II) has an intermediate hard/soft acidic character, thus 
the nature of the ligands used for selective complexation of Zn(II) in aqueous solution tend 
to be nitrogenous bases, such as imidazole and pyridine, given their analogous borderline 




























the donor-acceptor fluorophore introduces two hard Lewis bases as donors for coordinat-
ing Zn(II), which was expected to significantly lower the affinity for Zn(II), while still main-
taining a 1:1 binding stoichiometry through the formation of a trigonal bipyramidal geom-
etry from the five available donor atoms.  Before the stability constant of 4.1 for Zn(II) could 
be determined, a fluorimetric, metal-addition titration was performed to establish whether 
the probe would bind Zn(II) with near unity fractional saturation, thus permitting a molar 
ratio titration to be performed.  However, the metal-addition titration confirmed a substan-
tially lower affinity compared to 3.3b, thus determination of the stability constant was per-
formed through a fluorimetric metal-addition titration by 4.1 (20 µM) with ZnSO4•7H2O from 
0-220 µM.  Non-linear least-squares fitting of the fluorimetric data yielded a uniform ap-
parent stability constant of logKZn(II)L = 5.34 ± 0.04 at pH 7.0 and 0.1 M KCl ionic back-
ground, corresponding to an apparent dissociation constant of 4.6 ± 0.4 µM (Figure 4.2).   
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Definition of Equilibrium System: 
Species Zn(II) 4.1 H logβ’ 
Zn(II) 1 0 0 0.0 
4.1 0 1 0 0.0 
[(4.1)Zn(II)] 1 1 0 5.34 ± 0.04 
Figure 4.2: Fluorimetric determination of the Zn(II) stability constant of 4.1 by a direct, metal-addi-
tion titration.  Probe 4.1 (20 µM) was equilibrated in chelexed aqueous buffer (10 mM PIPES, 0.1 
M KCl, pH 7.0, 25ºC) and titrated with ZnSO4·7H2O from 0-220 µM.  The fluorescence spectra 
(excitation: 360 nm) were analyzed by non-linear least squares fitting to give an average apparent 
logKZn(II)L of 5.34 ± 0.04 (n = 3) at pH 7.0, µ = 0.1 M (KCl).  B) Change in fluorescence response at 
502 nm with corresponding fit to the equilibrium system model described above.   
 
4.2.3 Absorbance and Fluorescence Properties of Probe 4.1 
The discovery of the micromolar affinity of 4.1 for Zn(II), manifested by the lack of 
a linear emission increase upon incremental addition of Zn(II), revealed weaker chromatic 
shifts in both the absorption and emission compared to chromis-2 (3.4).  Upon complete 
saturation, 4.1 underwent a 14-nm bathochromic shift in the absorbance maximum from 
350 nm (ε = 22,400 M-1•cm-1) to 364 nm (ε = 20,800 M-1•cm-1) (Table 4.2).  The presence 
of two clean isosbestic points at 289 and 360 nm, in addition to the tight correlation of the 
fluorimetric titration data to the corresponding equilibrium model, are indicative of a well-
defined equilibrium between the free- and Zn(II)-saturated species with a 1:1 binding stoi-
chiometry.   
Comparably, the fluorescence emission of the free- and Zn(II)-saturated 4.1 re-
vealed a weaker bathochromic emission shift of only 27 nm from 475 nm to 502 nm, nearly 
half that of chromis-2 and probe 3.3b.  Interestingly, the quantum yield of free 4.1 only 
increased from 0.25 to 0.29, with Zn(II)-saturated 4.1 decreasing from 0.69 to 0.65, relative 
to 3.3b, despite the lack of the bispicolylamine moiety to foster an ESPT that can lead to 
a fluorescence quenching.  However, the two hydroxyl groups of the chelating moiety of 
4.1 likely influence the pKa of the tertiary nitrogen due to sigma donation from the oxygen 
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lone pairs, resulting in an increase in the pKa to a value that is near or above physiological 
pH, which is evident when comparing the emission response of 4.1 in deuterated and non-
deuterated buffer (Figure 4.3). 
 
Figure 4.3: A) Solvent deuterium isotope effect of probe 4.1 (5 µM) in deuterated versus non-
deuterated buffer (10 mM PIPES, 100 mM KCl, pH/D 7.0, 25°C). B) Normalization of the fluores-
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Table 4.2: Photophysical properties of probe 4.1a 
 4.1 [(4.1)Zn(II)] 
Absorbance lmax (nm)b 350 364 
e (104 M–1cm–1)c 2.24 2.0 
Emission lmax (nm)d 475 502 
FF e 0.29 0.65 
δmax (GM)f n.d. n.d. 
lmax (nm)g n.d. n.d. 
a10 mM PIPES, 0.1 M KCl, 25°C. blowest-energy band of the one-photon absorption spectrum. 
cmolar extinction coefficient at lmax. dmaximum fluorescence emission. efluorescence quantum 
yield, referenced to quinine sulfate (ΦF = 0.546).20 fmaximum two-photon absorption. gtwo-photon 
absorption cross section. n.d. = not determined.  
 
4.2.4 Exploring the Performance of Probe 4.1 in Mouse Fibroblast Cells 
To explore whether 4.1 can be utilized to follow dynamic fluctuations of endoge-
nous free Zn(II) pools, adherent NIH 3T3 fibroblast cells grown under basal conditions 
were incubated with the probe (10 µM) and imaged by TPEM over the course of 30 
minutes before supplementing the incubation medium with zinc pyrithione.  However, 
treatment of the NIH 3T3 cells with the probe induced acute cytotoxicity that resulted in 
uniform cell death, which prevented the monitoring of basal Zn(II) levels.   
4.3 Development of a Non-Phototoxic, Low-Affinity Fluorescent Probe for 
Zn(II) 
The unpredicted cytotoxicity of 4.1 precluded its use as a fluorescent indicator in 
live cells.  Because the structural deviation between chromis-2 and probe 4.1 is evident 
only in the chelator group, it was hypothesized that the presence of the diethanolamine 
chelator was responsible for its phototoxicity.  Although the substitution of one of the eth-
anolamine arms of the diethanolamine chelator with a pyridine moiety would increase its 
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affinity for Zn(II), it was expected that the remaining, weakly donating hydroxyl group 
would maintain an affinity at or near that of chromis-2.  This presumption led, first, to the 
synthesis of a new chelating ligand, which was then incorporated into the synthesis of a 
new fluorescent probe (4.2a/b) for imaging dynamically exchangeable Zn(II) in cells.   
4.3.1 Synthesis of Probe 4.2b 
The conception of a chelator whose binding affinity would theoretically lie between 
that of the bis(hydroxyethyl)amine-containing probe 4.1 and probe 3.3b stimulated the 
design of a hybrid chelator, whose structure featured an asymmetric secondary amine, 
with one arm incorporating an isonicotinic acid methyl ester moiety and the other arm 
incorporating a hydroxyethyl moiety.  The asymmetry of the new hybrid chelator de-
manded the synthesis of a new isonicotinic acid derivative that could be easily scaled up 
for future synthesis of diverse chelators without the need for conversion to a hydrogen 
halide salt, as in the synthesis of bromide 2.10.  Given the chemical versatility of the re-
ductive amination reaction, the design of an aldehyde-containing isonicotinate derivative, 
that could be employed as a chemical foundation for the preparation of ligands of varying 
affinities, was conceived.  
The synthesis of the aldehyde building block benefited from the already-estab-
lished chemistry used in the synthesis of alcohol 2.9, and preparation proceeded through 
a double esterification of 2,4-pyridinedicarboxylic acid to generate the corresponding di-
methyl ester 4.5 (Scheme 4.3), which crystallized as pure white crystals significantly more 
easily than the analogous diethyl ester prepared in the synthesis of the metal-binding lig-
and of chromis-1.  The esterification was accomplished by refluxing the dicarboxylic acid 
in MeOH using TMSCl as a catalyst, generating HCl in situ from the reaction of methanol 
with TMSCl, rather than the conventional concentrated H2SO4 or HCl.  The reductive 
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chemistry used to synthesized alcohol 2.9 was adopted for use in preparation of methyl 
2-(hydroxymethyl)isonicotinate 4.6; however, reduction of the o-methyl ester of 4.5 using 
NaBH4 (1.0 equivalent) in MeOH was completed in less than 40 minutes, whereas the 
analogous reduction of 2.8 to the corresponding alcohol 2.9 required 2.5 hours for com-
plete conversion.  Despite TLC confirmation that complete conversion occurred without 
the formation of any side products, in addition to the added lipophilicity of the p-methyl 
ester, the isolated yield of 4.6 was only 69%, most likely due to the incomplete extraction 
by virtue of the hydrophilic nature of the 2-pyridinemethanol unit.  Finally, oxidation of the 
benzylic alcohol to the corresponding aldehyde was accomplished by refluxing 4.6 with 
5.0 equivalents of precipitated active MnO2, which selectively oxidizes benzylic alcohols 
to aldehydes, in toluene.  A literature substructure survey of MnO2 oxidations demon-
strated the use of solvents such as acetone or chloroform with reaction times between 14-
24 hours due to the solvents’ low boiling points; however, the use of toluene as the solvent 
permitted complete conversion to aldehyde 4.7 in only 1.5 hours without the formation of 
any side products and with a yield after recrystallization of 91%.  
 






















To promote the addition of only one molecule of 2-aminoethanol to aldehyde 4.7, 
a solution of aldehyde 4.7 in MeOH was supplemented with 3.0 equivalents of the primary 
amine and left to react overnight, thereby building up the imine intermediate, which, upon 
the addition of NaCNBH3, was reduced to the corresponding secondary amine (4.8) within 
20 minutes at room temperature (Scheme 4.4).  Despite TLC confirmation that the reaction 
had completed, purification by flash column chromatography on silica gel revealed an 
overall yield of only 40%.   
 
Scheme 4.4: Synthesis of metal-binding ligand 4.8. 
 Using similar chemistry employed in the preparation of 4.1, amine 4.8 was reacted 
with aldehyde 3.16 using NaCNBH3 as the reducing agent to furnish fluorophore 4.2a.  
Unfortunately, the substitution of one hydroxyethyl “arm” of bis(2-hydroxylethyl)amine with 
a methyl isonicotinate group did not observe an improved yield in the preparation of 4.2a 
compared to 4.1, despite addition of AcOH to prevent the potential formation of a potential 
oxazolidine intermediate.  Nonetheless, probe 4.2a was successfully prepared with a yield 
of 39%, and upon purification, a portion of the pure material was saponified by refluxing 
with 1.5 equivalents of NaOH(aq) in MeOH to afford the corresponding pure sodium car-
boxylate salt 4.2b in high yield (91%), which was isolated by crystallization from and sub-

















Scheme 4.4: Synthesis of probes 4.2a and 4.2b.   
4.3.2 Absorption and Fluorescence Properties of Probe 4.2b 
Consistent with coordination of Zn(II) to the pyridyl acceptor of the fluorophore, 
4.2b also underwent a 14-nm bathochromic absorbance shift from a λmax of 349 nm (ε = 
22,200 M-1•cm-1) to 363 nm (ε = 20,500 M-1•cm-1) for the Zn(II)-saturated form (Table 4.3).  
The presence of two clean isosbestic points at 286 and 359 nm, in addition to an equimolar 
saturation of the probe with metal, are indicative of a well-defined equilibrium between the 
free- and Zn(II)-saturated species with a 1:1 binding stoichiometry (Figure 4.4A).  Not sur-
prisingly, the substitution of one of the hydroxyethyl arms with an isonicotinate moiety had 
a profound effect on the fluorescence quantum yield of the free form of 4.2b, down 10% 
from 0.25 to 0.15 relative to probe 4.1.  Analysis of the structure of 4.2b suggests that the 
hydroxyl group of the chelator could participate in the transfer of a proton from the chelator 
pyridine to the pyridyl acceptor of the fluorophore, a process that may be more efficient 
than an intermolecular, water-mediated transfer, thus resulting in a greater fluorescence 
quenching of the free form. The fluorescence emission of free 4.2b revealed a similar 
emission maximum (467 nm) to chromis-2 and 3.3b, which underwent a 38-nm emission 
shift to 505 nm for the Zn(II)-saturated form, while boasting a more-than-4-fold increase in 







4.2a  R = CH3



















Figure 4.4: Spectral changes of 4.2b in neutral aqueous buffer (10 mM PIPES, 100 mM KCl, 25°C) 
at pH 7.0 upon stepwise saturation of Zn(II). (A) Absorption (UV-Vis) spectral changes upon satu-
ration with Zn(II). (B) Fluorescence emission response upon saturation with Zn(II) (excitation at 359 
nm). The red curves indicate the spectra after complete saturation (1.0 eq.) with Zn(II) is achieved. 
Inset: fluorescence integration over the entire spectral window as a function of molar equivalents 


















































Table 4.3: Photophysical properties of probe 4.2ba 
 4.2b [(4.2b)Zn(II)] 
Absorbance lmax (nm)b 349 363 
e (104 M–1cm–1)c 2.22 2.05 
Emission lmax (nm)d 467 505 
FF e 0.15 0.65 
δmax (GM)f n.d. n.d. 
lmax (nm)g n.d. n.d. 
a10 mM PIPES, 0.1 M KCl, 25°C. blowest-energy band of the one-photon absorption spectrum. 
cmolar extinction coefficient at lmax. dmaximum fluorescence emission. efluorescence quantum 
yield, referenced to quinine sulfate (ΦF = 0.546 in 1N H2SO4).20 fmaximum two-photon absorption. 
gtwo-photon absorption cross section. n.d. = not determined.  
 
4.3.3 Zn(II)-Binding Affinity Measurements of Probe 4.2b 
In contrast to probe 4.1, a molar ratio titration of probe 4.2b that demonstrated a 
linear emission increase, along with a sharp, equimolar saturation point indicative of tight 
Zn(II) binding, permits the determination of a reliable stability constant through spectro-
scopic titrations of the probe with a competing ligand whose protonation and stability con-
stants are well established.  Substitution of a hydroxyl group with a pyridine in the structure 
of the chelator was expected to increase the stability constant of 4.2b by a few orders of 
magnitude over 4.1, thus EGTA as the lowest-affinity, commercially available Zn(II) che-
lator with a 1:1 binding stoichiometry was employed as a competing ligand to measure the 
affinity of 4.2b.  Attempts to determine the affinity in neutral aqueous buffer (10 mM PIPES, 
100 mM KCl, pH 7.0, 25°C) using EGTA revealed a sharp decrease in the fluorescence 
intensity upon addition of 1.0 equivalent of EGTA.  After further supplementation of EGTA 
to complete the competition titration within the 10-90% fractional saturation window, fitting 
of the fluorimetric titration data to the 1:1 binding equilibrium model resulted in a poor data 
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fit with a less-than-ideal standard deviation (Figure 4.5A, B), which was likely due to an 
affinity mismatch between probe 4.2b and EGTA at pH 7.0 that resulted in a ~ 50% frac-
tional saturation of the probe after equimolar addition of the competing ligand. 
By virtue of the two protonation constants of EGTA that reside above 7, decreasing 
the pH by 0.5 logarithmic units translated to an apparent affinity for Zn(II) that is one log-
arithmic unit lower than at pH 7.0, as a higher percentage of protonated EGTA inevitably 
decreases its affinity for binding the metal.  Therefore, the fluorimetric competition titration 
with 4.2b was performed at pH 6.5 rather than pH 7.0, thereby engendering a better affinity 
match between the two components of the equilibrium. Non-linear, least-squares fitting of 
the fluorimetric data from the competition titration performed at pH 6.5 afforded an appar-
ent stability constant of logKZn(II)L’ = 7.75 ± 0.06, corresponding to an apparent dissociation 
constant of Kd’ = 18 ± 3 nM and yielding a more robust fit with a lower standard deviation 




Definition of Equilibrium System: 
Species Zn(II) EGTA 4.2b H log β 
Zn(II) 1 0 0 0 0 
EGTA 0 1 0 0 0 
4.2b 0 0 1 0 0 
EGTA(H) 0 1 0 1 9.51 
EGTA(H2) 0 1 0 2 18.41 
EGTA(H3) 0 1 0 3 21.22 
[(EGTA)Zn(II)] 1 1 0 0 12.6 
[(4.2b)Zn(II)] 1 0 1 0 7.75 ± 0.06 
Figure 4.5: A) Fluorimetric determination of the Zn(II) stability constant of 4.2b via competition with 
EGTA at pH 7.0 and 6.5. Probe 4.2b (10 µM) was equilibrated with ZnSO4·7H2O (10 µM) in 
chelexed aqueous buffer (10 mM PIPES, 0.1 M KCl, pH 7.0, 25ºC) and titrated with EGTA from 0-
400 µM.  The fluorescence spectra (excitation: 359 nm) were analyzed by non-linear least squares 
fitting to give an average apparent logKZn(II)L of 7.75 ± 0.06 (n = 3) at pH 6.5, µ = 0.1 M (KCl).  B) 
Change in fluorescence response at 505 nm with corresponding fit to the equilibrium system model 






















































































4.3.4 Metal-Ion Selectivity of Probe 4.2b 
As illustrated in Figure 4.6, the metal-ion selectivity of probe 4.2b was evaluated 
in the presence of the excess of biologically relevant divalent metal ions.  Identical to the 
methods for evaluating the metal-ion selectivity of the previous Zn(II)-binding fluorescent 
probes, the fluorescence response to probe 4.2b was measured in the presence of 4.0 
and 8.0 equivalents of the biologically relevant divalent metal ions to completely saturate 
both the fluorescent probe and the EDTA that was introduced to sequester any adventi-
tious metal ions in solution.  As expected, Mg(II) and Ca(II) had no influence on the fluo-
rescence response of the probe (Figure 4.6A&B), whereas all divalent transition metal 
ions, except Zn(II) and Mn(II), completely quenched the fluorescence (Figure 4.6C-H).  
However, the quenching did not translate into a ratiometric readout that would otherwise 
interfere with ratiometric imaging.   
Therefore, to evaluate the selectivity of 4.2b, the ratiometric response was meas-
ured in the presence of 0.8 molar equivalents (80% fractional saturation of the probe) of 
the interfering metal ion (Figure 4.7, black bars), yielding an average ratio (Ravg) = 0.39 ± 
0.02.  The remaining 20% of the available probe was then saturated with Zn(II), which 
elicited a ratiometric response (Ravg = 1.46 ± 0.05), consistent with the emission response 
of the Zn(II)-saturated 4.2b observed in the absence of any interfering metal ion (Figure 
4.7, red patterned bars).  Therefore, the quenching of the probe’s fluorescence in the 
presence of the interfering metal ions render does not affect the ratiometric readout of 
4.2b when saturated with Zn(II).   
Supplementation of millimolar concentrations of Mg(II) to 4.2b did not elicit a 
change in fluorescence, as expected (Figure 4.8A).  On the other hand, addition of milli-
molar Ca(II) led to a substantial 39% increase in the fluorescence response, along with a 
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6-nm shift in the emission maximum, indicating that the hydroxyl group engages in binding 
of Ca(II) at higher (millimolar) concentrations (Figure 4.8B).  However, even in the pres-
ence of a 400-fold excess of Ca(II), supplementation of 1.0 Zn(II) shifts the emission re-
sponse to that of the [(4.2b)Zn(II)] complex in the absence of any interfering metals.  All 
other divalent transition metals, excluding Zn(II) and Mn(II), exhibited a stoichiometric flu-
orescence quenching behavior consistent with the previously tested Zn(II)-responsive flu-
orescent probes (Figure 4.8C-G).  Comparable to chromis-2, the nanomolar affinity of 4.2b 
for Zn(II), manifested by the hydroxyethyl moiety of the metal-binding ligand, resulted in a 
non-quantitative fluorescence quenching when supplemented with Mn(II).  Although the 
Mn(II)-induced fluorescence quenching indicated a binding, albeit weak, interaction with 
the probe, Mn(II) was immediately outcompeted by supplementation of 1.0 equivalent of 
Zn(II) to restore the emission response to that of the [(4.2b)Zn(II)] complex observed in 
the molar ratio titration. Furthermore, addition of Ni(II) to the solution containing probe 
4.2b led to a time-dependent fluorescence quenching that reached equilibrium after ~ 10 
minutes (Figure 4.8G, inset), consistent with chromis-2 observations.   
As a consequence of a non-quantitative binding of Mn(II) to 4.2b, a fluorimetric, 
metal-addition titration was performed to determine the stability constant for the formation 
of the [(4.2b)Mn(II)] complex.  Fitting of the fluorimetric titration data from the metal-addi-
tion titration yielded a Mn(II) stability constant of logKMn(II)L’ = 5.21 ± 0.008 (Figure 4.9), 
corresponding to an apparent dissociation constant of Kd’ = 6.17 µM at pH 7.0, which is 





Figure 4.6: Fluorescence response of 4.2b in the presence of 4.0 and 8.0 equivalents of interfering 
divalent metal ions.  A-H) Blue traces represent free 4.2b (5 µM) in pH 7.0 buffer (10 mM PIPES, 
0.1 M KCl, 25°C) supplemented with 10 µM EDTA.  Red and blue traces represent the addition of 
20 µM and 40 µM, respectively, of interfering divalent transition metals.  Excitation: 355 nm.   












































































































Figure 4.7: Emission-ratiometric response of 4.2b (5 µM) towards selected divalent metal cations 
at 80% fractional saturation (calculated based on ratio of the integrated fluorescence intensity be-
tween 510-570 nm (channel 2) and 440-495 nm (channel 1)). The red bars represent the ratio at 
80% fractional saturation, and the corresponding red patterned bars represent the ratio after satu-
rating the remaining 20% of free fluorophore with Zn(II). Asterisks denote that the ratio was calcu-
lated after the addition of 5 µM Zn(II) rather than 1 µM (20%) Zn(II). Excitation: 359 nm.   
 















Figure 4.8: Emission spectral response of 4.2b (5 µM) towards selected divalent metal cations at 
80% fractional saturation. A&B) Fluorescence response of 4.2b in pH 7.0 buffer (10 mM PIPES, 
100 mM KCl, 25°C) in the presence of 2 mM alkaline earth metals, with corresponding saturation 
of probe with 1.0 eq. Zn(II). C-H) Fluorescence response of 4.2b in the presence of 80% fractional 
saturation (solid black curves) of interfering divalent metal ions, with corresponding saturation of 
remaining 20% probe with Zn(II) (red curves). Inset: Kinetics of equilibration of 4.2b with Ni(II). 
Excitation: 355 nm.   





















































































































Definition of Equilibrium System: 
Species Mn(II) 4.2b H log β 
Zn(II) 1 0 0 0.0 
4.2b 0 1 0 0.0 
[(4.2b)Mn(II)] 1 1 0 5.21 ± 0.008 
Figure 4.9: A) Fluorimetric determination of the Mn(II) stability constant of 4.2b via a direct, metal-
addition titration. Probe 4.2b (5 µM) was equilibrated in aqueous buffer (10 mM PIPES, 100 mM 
KCl, pH 7.0, 25ºC) treated with Chelex and titrated with MnSO4•H2O from 0-60 µM, and a fluores-
cence spectrum was acquired after the addition of each aliquot of Mn(II). The red curve indicates 
free chromis-1 before supplementation with Mn(II). Emission spectra were analyzed by non-linear 
least squares fitting to provide a stability constant of logKMn(II)L = 5.21± 0.008 (n = 1).  B) Change in 
fluorescence response at 467 nm with corresponding fit to the equilibrium system model.   
 
 









































4.4 Gleaning from the Arsenal of Zn(II) Affinity Standards: Development of 
a High-Affinity Ratiometric Fluorescent Probe for Zn(II) 
The widespread prevalence of ethylenediamine bridges in the structures of various 
Zn(II)-binding ligands, including EDTA, TPEN, HEDTA, and DTPA, all of which boast 
Zn(II)-binding stability constants of 12.6 and above, demonstrates the utility of this biden-
tate unit for developing high-affinity ligands for binding Zn(II).  However, altering the struc-
ture of the fluorophore core to increase the affinity for Zn(II) could alter its photophysical 
properties.  To achieve a higher Zn(II)-binding affinity than 3.3b, a new metal-binding lig-
and featuring an ethylenediamine unit coupled to the secondary amine of the bispicolyla-
mine chelator employed in 3.3b was synthesized and incorporated into the structure of a 
new high-affinity, Zn(II)-binding fluorescent probe intended for detecting less dynamic 
Zn(II) fluxes in the cell.  This led to the development of fluorophores 4.3a and the corre-
sponding water-soluble disodium salt of 4.3b.     
4.4.1 Synthesis of Probe 4.3b 
To incorporate the ethylenediamine bridge into the structure of a new chelator, 
commercially available N-boc-N-methylethylenediamine underwent a double reductive 
amination with methyl 2-formylisonicotinate (4.7) to afford the corresponding N-boc-N-me-
thyl-N’,N’-bis(2-pyidylmethyl)ethylenediamine 4.9 (Scheme 4.5).  The presence of the me-
thyl group on the carbamate nitrogen of the boc group led to the observation of two distinct 
conformers that were not freely interchangeable at room temperature on the NMR time-
scale, similar to what was observed with the characterization of several Fmoc-protected 
intermediates in the synthesis of chromis-1 (Chapter 2).  To corroborate this observation, 
characterization of 4.9 in DMSO-d6 at various elevated temperatures (60°C, 80°C and 
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100°C), demonstrated the convergence of the two conformers as the temperature was 
incrementally increased.  To remove the boc protecting group, 4.9 was reacted with freshly 
distilled trifluoroacetic acid (TFA) in anhydrous dichloromethane to prevent the saponifi-
cation of the methyl esters by residual water, affording the deprotected secondary amine 
4.10 in high yield (97%). The available secondary amine was then used immediately after 
characterization in order to prevent intermolecular polymerization reactions of the amine 
with the methyl esters.   
 
Scheme 4.5: Synthesis of metal-binding ligand 4.10 used to synthesize fluorophore 4.3a. 
 Using the newly synthesized N-methylethylenediamine bispicolylamine chelator 
4.10, synthesis of fluorophore 4.3a proceeded through a reductive amination with alde-
hyde 3.16 at room temperature using sodium triacetoxyborohydride (Na(OAc)3BH) in an-
hydrous 1,2-dichloroethane (Scheme 4.6).  After column purification, a portion of the ma-
terial was saponified by refluxing with NaOH(aq) in MeOH, followed by dilution with EtOH 
and crystallization upon cooling to room temperature, to afford pure 4.3b as the disodium 





























Scheme 4.6: Synthesis of probes 4.3a and 4.3b. 
4.4.2 Absorption and Fluorescence Properties of Probe 4.3b 
In comparison to 3.3b, the additional ethylenediamine bridge between the fluoro-
phore and the bispicolylamine chelating moiety was employed to increase the affinity of 
the metal-binding fluorophore and results in a weaker bathochromic shift in both the ab-
sorption and emission. Upon coordination of Zn(II) to the metal-acceptor moiety, 4.2b un-
derwent a 16-nm bathochromic shift in the absorption from a λmax of 351 nm (ε = 21,200 
M-1•cm-1) to 367 nm (ε = 22,500 M-1•cm-1) for the Zn(II)-saturated form (Table 4.4).  The 
presence of two clean isosbestic points at 288 and 355 nm, in addition to an equimolar 
saturation of the probe with Zn(II), are indicative of a well-defined equilibrium between the 
free- and Zn(II)-saturated species with a 1:1 binding stoichiometry (Figure 4.10A).  In ad-
dition, comparison of the UV-Vis spectra of 4.3b to the preceding 2-thiazolyl fluorophores 
(3.3b, chromis-2, 4.1, and 4.2b) revealed an increase in the molar absorptivity (ε) of 4.3b 
upon Zn(II) binding relative to the free form, whereas the others realized a decrease in the 
molar absorptivity of the Zn(II)-bound species.   
Comparably, the fluorescence emission maximum of 4.3b was red-shifted from 
474 nm to 500 nm upon Zn(II) binding, corresponding to a modest 26 nm (Figure 4.10B).  
The installation of the ethylenediamine bridge led to a slight (4%) increase in the fluores-



















4.3a  R = CH3










quantum yield of the Zn(II)-bound form of 4.3b was reduced from 0.69 to 0.57.  Interest-
ingly, the fluorescence profiles of the free and metal-bound species revealed balanced 
emission intensities between the two species, which may indicate a less favorable ESPT 
process.   
 
Figure 4.10: Spectral changes of 4.3b (20 µM) in neutral aqueous buffer (10 mM PIPES, 100 mM 
KCl, 25°C) at pH 7.0 upon stepwise addition of Zn(II). (A) Absorption (UV-Vis) spectral changes 
upon saturation with Zn(II). (B) Fluorescence emission response upon saturation with Zn(II) (exci-
tation at 355 nm). Red curves indicate the spectra after complete saturation (1.0 eq.) with Zn(II) is 
achieved. Inset: fluorescence integration over the entire spectral window as a function of molar 
equivalents of Zn(II). 
 









































Table 4.4: Photophysical properties of probe 4.3ba 
 4.3b [(4.3b)Zn(II)] 
Absorbance lmax (nm)b 351 367 
e (104 M–1cm–1)c 2.12 2.25 
Emission lmax (nm)d 474 500 
FF e 0.29 0.57 
δmax (GM)f n.d. n.d. 
lmax (nm)g n.d. n.d. 
a10 mM PIPES, 0.1 M KCl, 25°C. blowest-energy band of the one-photon absorption spectrum. 
cmolar extinction coefficient at lmax. dmaximum fluorescence emission. efluorescence quantum 
yield, referenced to quinine sulfate (ΦF = 0.546).20 fmaximum two-photon absorption. gtwo-photon 
absorption cross section. n.d. = not determined.  
4.4.3 Probe 4.3b Binds Zn(II) with Low Femtomolar Affinity 
The addition of the N-methylethylenediamine bridge between the fluorophore and 
the bispicolylamine chelator moiety was expected to increase the affinity of 4.3b compared 
to its ethylenediamine bridge-less analog 3.3b (logKZn(II)L = 10.8), which demanded a 
stronger competing ligand for determination of the fluorophore’s Zn(II) stability constant.  
As described in Section 4.1, examination of the Zn(II)-binding ligands that have been ex-
tensively characterized for their formation and protonation constants, EDTA (ethylenedia-
minetetraacetic acid) and DTPA (diethylenetriaminepentaacetic acid) were the two ligands 
with the best matching apparent affinities (logKZn(II)L’ = 13.13, 12.87, respectively) at pH 
7.0 relative to the expected apparent affinity of 4.3b.  Preliminary attempts at determining 
the kinetics of equilibration upon addition of both EDTA and DTPA (500 µM) to solutions 
containing the preformed Zn(II) complex of 4.3b (20 µM) observed an associative ex-
change that reached equilibrium after ~ 15 hours for EDTA (Figure 4.11A) and ~ 18 hours 
for DTPA (Figure 4.11B) at 25°C.  Because spectroscopic titrations to determine the sta-
bility constant for a metal-binding ligand ideally requires 10-15 data points for calculating 
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a reliable value with a robust fit to its corresponding equilibrium binding model, it was not 
readily feasible to titrate EDTA or DTPA in successive aliquots of increasing concentration 
into one solution of the preformed Zn(II) complex of 4.3b.   
 
Figure 4.11: Spectrophotometric determination of the kinetics of equilibration of  [(4.3b)Zn(II)] (20 
µM) in the presence of 500 µM EDTA (A) and DTPA (B) in pH 7.0 aqueous buffer (10 mM PIPES, 
100 mM KCl, 25°C). EDTA required ~ 15 hours to reach equilibrium, whereas DTPA required ~ 18 
hours to reach equilibrium.  Dotted line represents the absorbance spectrum of free 4.3b before 
saturation with Zn(II). 































Because of the slow kinetics of equilibration, a buffer method was attempted, by 
which a working solution of the [(4.3b)Zn(II)] complex was prepared in pH 7.0 aqueous 
buffer (10 mM PIPES, 100 mM KCl) and aliquoted into vials that were then supplemented 
with various, predetermined concentrations of EDTA.  Fluorescence spectra were ac-
quired of each solution after a 17-hour equilibration at 25°C, and the spectra were fitted to 
an equilibrium model with EDTA as the competing ligand in order to determine the stability 
constant of 4.3b. Non-linear, least-squares fitting of the fluorimetric data yielded an appar-
ent stability constant of logKZn(II)L’ = 14.0 ± 0.1, corresponding to an apparent dissociation 




Definition of Equilibrium System: 
Species Zn(II) EDTA 4.3b H logβ 
Zn(II) 1 0 0 0 0 
EDTA 0 1 0 0 0 
4.3b 0 0 1 0 0 
EDTA(H) 0 1 0 1 10.30 
EDTA(H2) 0 1 0 2 6.24 
EDTA(H3) 0 1 0 3 2.80 
[(EDTA)Zn(II)] 1 1 0 0 16.50 
[(4.3b)Zn(II)] 1 0 1 0 14.0 ± 0.1 
Figure 4.12: A) Fluorimetric determination of the Zn(II) stability constant of 4.3b via a competition 
titration with EDTA.  The preformed [(4.3b)Zn(II)] complex (10 µM) in aqueous buffer (10 mM 
PIPES, 0.1 M KCl, pH 7.0, 25ºC) was aliquoted into multiple vials and supplemented with various 
aliquots of EDTA that ranged from 0-900 µM.  After a 17-hour equilibration, the fluorescence spec-
tra (excitation: 355 nm) were analyzed by non-linear least squares fitting to yield an average ap-
parent logKZn(II)L of 14.0 ± 0.1 (n = 2) at pH 7.0, µ = 0.1 M (KCl). B) Change in fluorescence response 
at 500 nm with corresponding fit to the equilibrium system model described above.   
 
4.4.4 Metal-Ion Selectivity Measurements of Probe 4.3b 
As expected, the additional ethylenediamine bridge of 4.3b did not adversely affect 
the Zn(II) selectivity of the fluorophore, serving only as an additional donor to engage in 
coordination of both Zn(II) and interfering divalent metals. Although EDTA is capable of 
undergoing exchange reactions with the probe, the slow kinetics of exchange did not affect 


















the use of EDTA (10 µM) as a Zn(II) sequestrant prior to addition of 4.3b (5 µM) to the 
buffer solution.  As expected, addition of 20 and 40 µM (4.0 and 8.0 equivalents) of Mg(II) 
and Ca(II) did not affect the fluorescence response of 4.3b (Figure 4.123&B), whereas 
supplementation of the probe with the same concentrations of interfering divalent transi-
tion metal ions resulted in the complete fluorescence quenching of the fluorescence re-
sponse (Figure 4.13C-G), including Mn(II).  Consistent with the 80-20 fractional saturation 
method to measure the selectivity of the previously synthesized ligands, the ratiometric 
response of 4.3b was evaluated in the presence of 0.8 molar equivalents (80% fractional 
saturation) of the interfering metal ion, leading to a uniform average emission ratio (Ravg) 
of 0.46 ± 0.007 (Figure 4.14, black bars).  The quenching by the interfering metals does 
not result in a ratiometric readout and only leads to a masking effect that reduces the 
amount of probe availability of the probe for binding Zn(II).  Therefore, the emission ratio 
of the remaining 20% of free probe was unaffected by any of the interfering divalent metal 
ions (Figure 4.14, red patterned bars), producing a ratiometric response comparable to 
the [(4.3b)Zn(II)] complex observed in the absence of any interfering metal, with an aver-
age ratio of Ravg = 1.17 ± 0.06 upon saturation with Zn(II).  The individual spectra for the 
fluorescence responses addition of all eight divalent metal ions tested is provided in Figure 
4.3.     
Interestingly, supplementation of 4.3b with millimolar concentrations (2 mM) of 
both Mg(II) and Ca(II) did not elicit a change in the fluorescence response, which deviates 
from analogous measurements of chromis-2, 3.3b, and 4.2b in the presence of millimolar 
Mg(II) and Ca(II) (Figure 4.15A&B).  Although Mn(II) stoichiometrically quenched the flu-
orescence of the probe in the same capacity as the other interfering divalent transition 
metal ions, supplementation of the in situ-generated [(4.3b)Mn(II)] complex with 1.0 equiv-
alent of Zn(II) immediately outcompeted Mn(II) for binding to the fluorophore and restored 
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the fluorescence profile and the corresponding emission ratio to that of the [(4.3b)Zn(II)] 
complex both in the presence and absence of interfering divalent metals (Figure 4.155D).  
Consistent with selectivity measurements of the other ligands in response to interfering 
divalent metal ions, binding of Ni(II) to the probe led to a time-dependent fluorescence 
quenching that plateaued after ~ 10 minutes (Figure 4.15G, inset), indicating that, while 
the coordination of Ni(II) results in quantitative quenching of the fluorophore, the kinetics 





Figure 4.13: Fluorescence response of 4.3b in the presence of 4.0 and 8.0 equivalents of interfer-
ing divalent metal ions.  A-H) Blue traces represent free 4.3b (5 µM) in pH 7.0 buffer (10 mM PIPES, 
0.1 M KCl, 25°C) supplemented with 10 µM EDTA.  Red and blue traces represent the addition of 
20 µM and 40 µM, respectively, of interfering divalent transition metals.  Excitation: 355 nm.   
 


















































































































Figure 4.14: Emission-ratiometric response of probe 4.3b (5 µM) towards selected divalent metal 
cations at 80% fractional saturation (calculated based on ratio of the integrated fluorescence inten-
sity between 510-570 nm (channel 2) and 440-495 nm (channel 1)). The red bars represent the 
ratio at 80% fractional saturation, and the corresponding red patterned bars represent the ratio after 
saturating the remaining 20% of free fluorophore with Zn(II). Excitation: 355 nm. 
 

















Figure 4.15: Emission spectral response of 4.3b (5 µM) towards selected divalent metal cations at 
80% fractional saturation. A-B) Fluorescence response of 4.3b in pH 7.0 buffer (10 mM PIPES, 100 
mM KCl, 25°C) to 2 mM alkaline earth metals, with corresponding saturation of probe with 1.0 eq. 
Zn(II). C-H) Fluorescence response of 4.3b in the presence of 80% fractional saturation (solid black 
curves) of interfering divalent metal ions, with corresponding saturation of remaining 20% probe 
with Zn(II) (red curves). Inset: Kinetics of equilibration of 4.3b with Ni(II). Excitation: 355 nm.   































































































































4.5 Exploiting the Structure-Derived Femtomolar Affinity of TPEN for the 
Development of a High-Affinity Zn(II)-Selective Fluorescent Probe  
Analysis of the stability constants of 4.1, 4.2b, 3.3b, and 4.3b revealed an approx-
imate trend in the influence of pyridine on the Zn(II)-binding affinity, demonstrating that the 
substitution of a hydroxyl group with an isonicotinate group yielded a ~ three-logarithmic-
unit increase in the stability constant. Given the pervasive use of TPEN as a high-affinity 
chelator for sequestering Zn(II) in biological imaging, it became evident that the similarities 
between the structure of the metal receptor ligand of probe 4.3b and the structure of TPEN 
supported the incorporation of an additional pyridine group into probe 4.3b to generate a 
new Zn(II)-binding fluorophore whose metal-binding ligand resembles the structure of 
TPEN.  Taking advantage of the trend to increase the affinity of a ligand by the addition of 
a pyridine moiety, the new Zn(II)-responsive fluorescent probe (4.4b), which was expected 
to boast an even higher affinity than 4.3b, was developed.  
4.5.1 Synthesis of Probe 4.4b 
In order to incorporate a TPEN-like chelator into the design of a fluorescent probe 
with comparable affinity to TPEN, the chemistry used to synthesize the chelator of 4.3 was 
adopted and modified to permit the incorporation of a third pyridine group.  However, the 
presence of the methyl group of N-boc-N-methyl-N’,N’-bis(2-pyidylmethyl)ethylenedia-
mine (4.9) that was used to synthesize 4.10 results in a secondary amine once depro-
tected, thereby impeding both the installation of a third pyridine moiety and coupling the 
chelator to the fluorophore’s aldehyde functionality.  To overcome this hurdle, aldehyde 
4.7 underwent a double reductive amination with N-boc-ethylenediamine to afford the in-
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termediate N-boc-N’,N’-bis(2-pyridylmethyl)ethylenediamine (4.11) under identical condi-
tions, including purification procedures, compared to the preparation of 4.9 (Scheme 4.7).  
The lack of a methyl group on the carbamate nitrogen circumvented the unexpected con-
formational rotation barrier observed when characterizing 4.11, thus NMR characterization 
of the compound was performed in CDCl3 under standard conditions.  Deprotection of the 
boc group using anhydrous TFA in anhydrous CH2Cl2 to provide the primary amine 4.12 
was performed under identical conditions as in the preparation of 4.9.  Coupling of 4.12 
with aldehyde 4.7 to yield the secondary amine 4.13 was then performed using an excess 
(1.5 equivalents) of the amine relative to the aldehyde to prevent a double reductive ami-
nation that otherwise would have yielded a tetracarboxylated TPEN derivative and re-
sulted in a lower yield of the desired 4.13.   
 
Scheme 4.7: Synthesis of metal-binding ligand 4.13.   
 Reductive amination of secondary amine 4.13 with the aldehyde functionality of 













































to the preparation of 4.3a, and a portion of the product underwent saponification by reflux-
ing the trimethyl ester with 3.5 equivalents of NaOH (aq) in MeOH to provide the corre-
sponding water-soluble sodium tricarboxylate salt with a 96% yield (Scheme 4.8).   
 
Scheme 4.8: Synthesis of probes 4.4a and 4.4b.   
4.5.2 Absorption and Fluorescence Properties of Probe 4.4b 
Not surprisingly, the structural variation between the N-methylethylenediamine 
functionality of 4.3b and the N-pyridylmethylethylenediamine functionality of 4.4b did not 
influence the magnitude of the bathochromic shift in the absorption, with the free form 
undergoing a consistent 16-nm red shift from 351 nm (ε = 21,200 M-1•cm-1) to 367 nm (ε 
= 19,600 M-1•cm-1) upon saturation with Zn(II) (Table 4.5).  Consistent with the other Zn(II)-
binding fluorescent probes developed, the presence of two clean isosbestic points at 290 
and 362 nm, in addition to an equimolar saturation of the probe with Zn(II), are indicative 
of a well-defined equilibrium between the free- and Zn(II)-saturated species with a 1:1 
binding stoichiometry (Figure 4.16A).  The emission maximum of the free form of 4.4b is 
also red-shifted 34 nm from 471 nm to 505 nm upon binding Zn(II), corresponding to an 
8-nm larger shift than its predecessor 4.3b (Figure 4.16B).  Excitation at the absorption’s 
isosbestic point ensured that the emission intensities are a direct reflection on the quantum 



















1,2-dichloroethane 4.4a  R = CH3










Figure 4.16: Spectral changes of 4.4b (20 µM) in neutral aqueous buffer (10 mM PIPES, 100 mM 
KCl, 25°C, pH 7.0) upon the stepwise saturation with Zn(II). (A) Absorption (UV-Vis) spectral 
changes upon saturation with Zn(II). (B) Fluorescence emission response upon saturation with 
Zn(II) (excitation at 362 nm). Red curves indicate the spectra after complete saturation (1.0 eq.) 
with Zn(II) is achieved. Inset: fluorescence integration over the entire spectral window as a function 
of molar equivalents of Zn(II). 
  










































Table 4.5: Photophysical properties of probe 4.4ba 
 4.4 [(4.4)Zn(II)] 
Absorbance lmax (nm)b 351 367 
e (104 M–1cm–1)c 2.12 1.96 
Emission lmax (nm)d 471 505 
FF e 0.24 0.73 
δmax (GM)f n.d. n.d. 
lmax (nm)g n.d. n.d. 
a10 mM PIPES, 0.1 M KCl, 25°C. blowest-energy band of the one-photon absorption spectrum. 
cmolar extinction coefficient at lmax. dmaximum fluorescence emission. efluorescence quantum 
yield, referenced to quinine sulfate (ΦF = 0.546).20 fmaximum two-photon absorption. gtwo-photon 
absorption cross section. n.d. = not determined.  
 
4.5.3 Determination of the Zn(II)-Binding Affinity of Probe 4.4b 
The substitution of the N-methylethylenediamine unit of the chelator of 4.3b with 
an N-pyridylmethylethylenediamine unit in 4.4b was expected to further increase the bind-
ing affinity compared to its predecessor by ~ two orders of magnitude, based on the trends 
observed during the determination of the stability constants of the previous affinity-tuned 
probes.  A two logarithmic-unit increase in the affinity over 4.3b would demand the em-
ployment of a competing ligand whose apparent affinity at pH 7.0, µ = 0.1 M is a minimum 
of one logarithmic unit higher than EDTA.  Surveying the inventory of ligands with an ap-
parent affinity higher than EDTA led to the application of TPEN (N,N,N’,N’-tetrakis(2-pyri-
dylmethyl)ethylenediamine; logKTPEN·Zn(II) = 14.96 ± 0.06, Kd = 1 fM at pH 7.0 µ = 0.1 M)21 
as a competing ligand with matching affinity relative to the hypothesized binding affinity of 
4.4b.  Fluorimetric and spectrophotometric titrations were performed in the presence of 
both 4.4b and TPEN (30 µM) with incremental supplementation of Zn(II), and non-linear, 
least-squares fitting of the spectroscopic data yielded a uniform apparent stability constant 
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of logK4.4b·Zn(II)’ = 15.1 ± 0.06, corresponding to an apparent dissociation constant of Kd’ = 
37 fM at pH 7.0, µ = 0.1 M (Figure 4.17).     
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Definition of Equilibrium System: 
Species Zn(II) TPEN 4.4b H logβ 
Zn(II) 1 0 0 0 0 
TPEN 0 1 0 0 0 
4.4b 0 0 1 0 0 
TPEN(H) 0 1 0 1 7.23 
TPEN(H2) 0 1 0 2 12.15 
TPEN(H3) 0 1 0 3 15.56 
[(TPEN)Zn(II)] 1 1 0 0 15.4 
[(4.4b)Zn(II)] 1 0 1 0 15.1 ± 0.06 
Figure 4.17: A) Spectrophotometric determination of the Zn(II) stability constant of 4.4b via a Zn(II)-
addition titration in the presence of TPEN as a competing ligand. Probe 4.4b (10 µM) was equili-
brated in aqueous buffer (10 mM PIPES, 100 mM KCl, pH 7.0, 25ºC) supplemented with TPEN (30 
µM), and the probe solution was titrated with ZnSO4•7H2O from 0-40 µM, with an absorbance spec-
trum acquired after the addition of each aliquot of Zn(II). Spectra were analyzed by non-linear least 
squares fitting to provide a logKZn(II)L = 15.1 ± 0.06 (n = 3).  B) Change in fluorescence response at 
467 nm with corresponding fit to the equilibrium system model.   





































4.5.4 Metal-Ion Selectivity Measurements of Probe 4.4b 
Compared to probe 4.3b, the additional pyridine ring did not affect the Zn(II) selec-
tivity of the fluorophore, despite the additional donor serving to engage in coordination of 
both Zn(II) and interfering divalent metals.  As expected, addition of 20 and 40 µM (4.0 
and 8.0 equivalents, respectively) of Mg(II) and Ca(II) did not affect the fluorescence re-
sponse of 4.4b (Figure 4.18A,B), whereas the supplementation of the probe with the same 
concentrations of interfering divalent transition metal ions resulted in the complete fluo-
rescence quenching of the probe (Figure 4.18C-G), including Mn(II), which could not be 
reversed upon the addition of Zn(II).  Consistent with the 80-20 fractional saturation 
method to determine the selectivity of the previously synthesized probes, the ratiometric 
response of 4.4b was evaluated in the presence of 0.8 molar equivalents (80% fractional 
saturation) of the interfering metal ion (Figure 4.19, black bars), leading to a uniform av-
erage emission ratio (Ravg) of 0.49 ± 0.04.  Under these conditions, the emission ratio of 
the remaining 20% of free probe was unaffected by any of the quenching metal ions (Fig-
ure 4.19, red patterned bars), yielding an average ratio of Ravg = 1.40 ± 0.04 upon satura-
tion of Zn(II), which is consistent with the [(4.4b)Zn(II)] complex observed in the absence 
of any interfering metal. The spectral data for these selectivity measurements are dis-
played in Figure 4.20.   
Comparable to the other fluorophores, except 4.3b, whose selectivities were 
measured under identical conditions, supplementation of 4.4b with millimolar concentra-
tions of Mg(II) did not elicit a change in the fluorescence profile (Figure 4.20A), whereas 
addition of millimolar Ca(II) resulted in a 77% increase in the fluorescence intensity but 
yielded a negligible 15% increase in the emission ratio (Figure 4.20B). The higher affinity 
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of 4.4b compared to the other affinity-tuned probes manifested a greater degree of fluo-
rescence quenching in response to the all interfering divalent transition metals, which 
could not be reversed by the addition of Zn(II), even for Mn(II) and Fe(II).  Furthermore, 
supplementation of the probe with Ni(II) also demonstrated an expected time-dependent 
fluorescence quenching because of slow binding kinetics, which was observed with all 
previously characterized Zn(II)-binding fluorescent probes.    
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Figure 4.18: Fluorescence response of 4.4b in the presence of 4.0 and 8.0 equivalents of interfer-
ing divalent metal ions.  A-H) Blue traces represent free 4.4b (5 µM) in pH 7.0 buffer (10 mM PIPES, 
0.1 M KCl, 25°C) supplemented with 10 µM EDTA.  Red and blue traces represent the addition of 
20 µM and 40 µM, respectively, of interfering divalent transition metals.  Excitation: 362 nm.   
 











































































































Figure 4.19: Emission-ratiometric response of probe 4.4b (5 µM) towards selected divalent metal 
cations at 80% fractional saturation (calculated based on ratio of the integrated fluorescence inten-
sity between 510-570 nm (channel 2) and 440-495 nm (channel 1)). The black bars represent the 
ratio at 80% fractional saturation, and the corresponding patterned red bars represent the ratio after 
saturating the remaining 20% of free probe with Zn(II). Excitation: 362 nm.   
 















Figure 4.20: Emission spectral response of 4.4b (5 µM) towards selected divalent metal cations at 
80% fractional saturation. A,B) Fluorescence response of 4.4b in pH 7.0 buffer (10 mM PIPES, 100 
mM KCl, 25°C) in the presence of 2 mM alkaline earth metals, with corresponding saturation of 
probe with 1.0 eq. Zn(II). C-H) Fluorescence response of 4.4b in the presence of 80% fractional 
saturation (solid black curves) of interfering divalent metal ions, with corresponding saturation of 
remaining 20% probe with Zn(II) (red curves). Excitation: 362 nm.   


















































































































The highly complex regulation of intracellular Zn(II) that entails endogenous lig-
ands displaying Zn(II)-binding affinities spanning many orders of magnitude demands the 
development and application of fluorescent indicators that cover the intrinsic dynamic 
range of the Zn(II)-transfer equilibria between endogenous ligands with which the indica-
tors can compete.  Utilizing the donor-acceptor fluorophore core developed for probe 3.3b 
and chromis-2, a series of fluorescent probes, whose binding affinities for Zn(II) span 
nearly 10 orders of magnitude from 5.4 to 15.1 (Figure 4.21), were developed using a 
knowledge-driven application of metal-ligand coordination chemistry tailored towards 
Zn(II).  Using the 90:10 fractional saturation window16, this dynamic range increases by 
one logarithmic unit to provide a biologically relevant window of affinities that spans 11 
orders of magnitude for sensing varying concentrations of intracellular Zn(II).  By exploiting 
the inherent modularity of the fluorophore’s aldehyde functionality, the metal-binding fluor-
ophores were synthesized through facile reductive amination reactions with chelating lig-
ands boasting secondary amines to which the pyridine acceptor of the fluorophore can be 




Figure 4.21: Binding isotherms illustrating the dynamic range for affinity-tuned fluorescent probes 
4.1, 4.2b, 4.3b, 4.4b based on their apparent stability constants determined at pH 7.0, µ = 0.1 M 
KCl.  The grey box represents the ~ 11-logarithmic-unit dynamic range of the series of affinity-tuned 
fluorescent probes within the 90:10 fractional saturation window.  
 
Including probe 3.3b, the water-soluble fluorescent probes whose affinities span 
ten logarithmic units within the biologically relevant regime display very comparable pho-
tophysical properties.  As illustrated in Figure 4.22A, the absorbance spectra of the metal-
free fluorophores display notable differences in the UV region below 300 nm, while the 
region above 300 nm reveals nearly identical spectra with absorbance maxima that 
demonstrate only a 3-nm span.  In the emission, the corresponding fluorescence spectra 
display a slightly larger range of emission maxima of 9 nm from 465 to 474 nm.  Consistent 
with Zn(II) coordination to the pyridyl acceptor of the fluorophore, the absorbance maxima 
shift to higher wavelength with an average absorbance maximum of 366 nm upon satura-
tion with Zn(II), and the profiles of the absorbance spectra below 300 nm become more 
similar compared to the Zn(II)-free spectra, which is characteristic of the formation of or-
dered metal-ligand complexes (Figure 4.22B).  Comparably, the fluorescence spectra of 
the Zn(II)-saturated fluorophores display bathochromic shifts of the emission maxima to 
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an average wavelength of 505 nm with a 15-nm range from 500 to 515 nm, and the emis-
sion profiles are much more uniform compared to corresponding Zn(II)-free emission 
spectra.  Interestingly, while Zn(II)-free 3.3b presents the most blue-shifted emission spec-
trum, saturation with Zn(II) results in an emission spectrum that is signficiantly more red-
shifted than the other fluorophores.  Nevertheless, these fluorescent probes, upon binding 
Zn(II), exhibit large shifts in both the absorption and emission, the latter of which is an 
essential prerequisite for performing quantitative ratiometric imaging analysis using TPEM 
(Figure 4.22C).   
Each of these fluorescent indicators, including probe 3.3b, is the product of innova-
tive design strategies to tune the affinity of Zn(II)-responsive fluorophores through the de-
velopment of metal-binding ligands that take advantage of widely-investigated Zn(II) co-
ordination chemistry.  Although the metal-binding ligands that are tethered to the acceptor 
moiety of the fluorophore utilize either pyridine moieties, which incorporate anionic car-
boxylate groups to increase water-solubility, or aliphatic hydroxyl groups, these affinity-
tuning strategies can be applied to the design of pyrimidine- and pyrazine-containing, 
Zn(II)-binding ligands to overcome the issue of ESPT that can interfere with ratiometric 
imaging.  While pyrimidine and pyrazine chemistries are more difficult to perform because 
of the higher electron-withdrawing nature of the aromatic rings compared to pyridine, ex-
ploration of ligands incorporating these heteroaromatic groups can be advantageous for 
cell imaging using either one- or two-photon excitation microscopy by expanding the avail-





Figure 4.22: Normalized absorption and emission spectra of the affinity-tuned, Zn(II)-responsive 
fluorescent probes developed for probing labile Zn(II).  A) Normalized absorption and emission 
spectra for the metal-free probes 4.1, 4.2b, 3.3b, 4.3b, and 4.4b. B) Normalized absorption and 
emission spectra for the Zn(II)-bound probes. C) Overlay of the normalized absorption and emis-
sion spectra shown in (A) and (B), with the black lines representing the metal-free species, and the 
red lines representing the Zn(II)-bound species.  Probes were excited at their respective absorption 
isosbestic points.   













































































































4.7 Experimental Section 
4.7.1 Synthesis 
Materials and Reagents. 2,4-pyridinedicarboxylic acid (Alfa Aesar), diethanola-
mine (Fisher Scientific), 2-aminoethanol (TCI), tert-butyl 2-aminoethylcarbamate (Matrix 
Scientific), N-boc-(2-aminoethyl)-N-methylamine (Ark Pharm, Inc.), methyl 2-pyrimidine-
carboxylate (Ark Pharm, Inc.), and 2-pyrazinecarboxylic acid (Chem-Impex Int’, Inc.) were 
purchased commercially and used without further purification.  Flash chromatography pu-
rification was performed on general purpose silica gel (60 Å pore size, 250 mesh, Sorbent 
Technologies).  NMR: 1H NMR spectra were recorded at 400 MHz at ambient temperature 
(20-23°C), unless state otherwise, and referenced to an internal TMS standard (0 ppm) 
for all solvents except D2O, which was referenced to externally added sodium 3-trime-
thylsilylpropionate-2,2,3,3-d6 (0.0 ppm).  13C spectra were acquired at 100 MHz and refer-
enced to the known chemical shift of the solvent peak (CDCl3: 77.0 ppm; DMSO-d6: 39.5 
ppm; CD3OD: 49.0 ppm), excluding D2O, which was referenced to sodium 3-trimethylsi-
lylpropionate-2,2,3,3-d6 (0.0 ppm). The 13C spectrum of compound 4.4b, however, was 
acquired at 125 MHz for improved sensitivity.  NMR Spectra are provided in Appendix A2. 
Mass spectra were recorded by the Georgia Tech Mass Spectrometry Facility.   
Bis(2-hydroxyethyl)amine fluorophore (4.1). To an oven-dried 10-mL round bot-
tom flask equipped with a stir bar was added aldehyde 3.16 (1 eq., 0.270 mmol, 80 mg), 
diethanolamine (2 eq., 0.540 mmol, 56.8 mg), and NaCNBH3 (1.5 eq., 0.405 mmol, 25.5 
mg).  Upon dissolution with anhydrous methanol (1 mL), glacial acetic acid (0.2 eq., 0.054 
mmol, 3.1 µL) was pipetted into the solution, and the solution was stirred overnight.  The 
reaction was quenched with 1 M citric acid (1 mL) by stirring for ~20 minutes.  The mixture 
was made basic by the addition of 30% (w/v) K2CO3 (1 mL), and the aqueous layer was 
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extracted with dichloromethane (3 x 5 mL).  The combined organic layers were dried over 
MgSO4, filtered, and concentrated to a pale yellow oil residue. The residue was redis-
solved in 1:1 EtOAc:EOH, heated to boiling, and while cooling to room temperature, con-
centrated HCl (2.0 eq, 52 µL) was added.  The product was left to crystallize overnight at 
4ºC, collecting the bright yellow crystals by suction filtration and drying under a steady 
argon stream, as the hydrochloride product is hygroscopic and deliquesces in the pres-
ence of moisture from the air. Note: the product was isolated as the pure dihydrochloride. 
Yield: 55 mg (0.120 mmol, 45%). 1H NMR (CDCl3, 400 MHz) δ 2.91 (t, J = 5.2 Hz, 4H), 
3.66 (t, J = 5.2 Hz, 4H), 3.85 (s, 3H), 3.96 (s, 2H), 6.94 (d, J = 8.9 Hz, 2H), 7.26 (d, J = 8.5 
Hz, 1H), 7.58 (d, J = 8.9 Hz, 2H), 7.77 (t, J = 7.8 Hz, 1H), 7.97 (s, 1H), 8.09 (d, J = 8.5 Hz, 
1H).  13C NMR (CDCl3, 100 MHz) δ 55.4, 57.3, 59.1, 59.7, 114.4, 118.2, 123.1, 123.9, 
128.2, 137.9, 138.7, 141.9, 151.5, 159.5, 159.9, 166.4.  ESI-MS m/z 386 ([M+H]+, 100%), 
221 (20%).  ESI-HRMS m/z calc’d for C20H24N3O3S ([M+H]+) 386.1533, found 386.1531.  
Methyl 2,4-pyridinedicarboxyate (4.5). To a 500-mL round bottom flask charged 
with 2,4-pyridinedicarboxylic acid (1 eq., 59.8 mmol, 10.0 g) was added methanol (200 
mL), followed by trimethylsilyl chloride (TMSCl, 3 eq., 180 mmol, 22.9 mL).  The reaction 
mixture was vigorously stirred under reflux for 12 hours, after which the majority of the 
methanol was removed by gentle evaporation to azeotropically remove water.  The solu-
tion was diluted with additional methanol, and the reaction was stirred under reflux for 
another 12 hours.  The methanol was then removed under reduced pressure, the corre-
sponding residue was taken up in dichloromethane (200 mL), and washed with 100 mL of 
saturated NaHCO3 solution.  The aqueous phase was extracted with dichloromethane (2 
x 100 mL), and the combined organic layers were dried over Na2SO4, filtered, concen-
trated under reduced pressure, and dried under vacuum to afford 4.5 as pure white crys-
tals.  Yield: 10.4 g (53.0 mmol, 89%).  1H NMR (CDCl3, 400 MHz) δ 4.01 (s, 3H), 4.06 (s, 
 273 
3H), 8.06 (dd, J = 4.9, 1.6 Hz, 1H), 8.67 (dd, J = 1.6, 0.9 Hz, 1H), 8.92 (dd, J = 4.9, 0.8 
Hz). 13C NMR (CDCl3, 100 MHz) δ 52.9, 53.1, 124.3, 126.0, 138.6, 148.9, 150.6, 164.6, 
164.5.  EI-MS m/z 195 ([M]+, 5%), 165 (18%), 137 (100%), 136 (30%), 123 (28%), 81 
(27%), 77 (24%), 69 (48%), 51 (29%). EI-HRMS m/z calc’d for C9H9NO4 195.0532, found 
195.0531. 
2-(hydroxymethyl)isonicotinic acid methyl ester (4.6).  In a 250-mL round bot-
tom flask equipped with a stir bar was added dimethyl ester 4.5 (1 eq., 51.2 mmol, 10.0 
g), anhydrous CaCl2 (1 eq., 51.2 mmol, 5.69 g as a finely crushed powder), and methanol 
(100 mL).  The flask was lowered into an ice bath containing saturated NaCl, and after 
equilibrating for ~ 20 minutes, NaBH4 (1 eq., 51.2 mmol, 1.94 g) was added in small por-
tions over the course of 2 minutes.  The reaction mixture was vigorously stirred at 0°C for 
40 minutes, after which it was quenched with 12.1 N HCl (1 eq., 4.23 mL) and stirred for 
another ~ 10 minutes at room temperature. The methanol was removed under reduced 
pressure, and the solid residue was reconstituted in dichloromethane (100 mL).  The di-
chloromethane was washed with water, and 1 M disodium citrate (prepared from citric acid 
and trisodium citrate dihydrate) to solubilize any borate ester salts.  The aqueous layer 
was extracted with dichloromethane (2 x 100 mL), heating gentle under warm water to 
help partition the product into the organic layer.  The combined organic layers were dried 
over MgSO4, filtered, and concentrated to a light yellow oil that crystallized while drying 
under vacuum.  The product was recrystallized from boiling cyclohexane, filtered, and 
dried under vacuum to afford 4.6 as a white crystalline solid.  Yield: 6.02 g (36.0 mmol, 
70%).  1H NMR (CDCl3, 400 MHz) δ 3.97 (s, 3H), 4.85 (s, 2H), 7.77 (d, J = 4.7 Hz, 1H), 
7.87 (s, 1H), 8.70 (d, J = 5.1 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 52.8, 64.3, 119.9, 
121.6, 138.1, 149.3, 160.5, 165.4. EI-MS m/z 167 ([M]+, 70%), 166 (100%), 138 (50%), 
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136 (37%), 78 (38%), 51 (38%).  EI-HRMS m/z calc’d for C8H9NO3 167.0582, found 
167.0581. 
Methyl 2-formylisonicotinate (4.7).  Methyl 2-(hydroxymethyl)isonicotinate 4.8 (1 
eq., 32.9 mmol, 5.50 g) and manganese dioxide (MnO2, 5 eq., 164.5 mmol, 14.3 g) were 
added to a 250 mL round bottom flask equipped with a stir bar.  Toluene (100 mL) was 
added, and the mixture was vigorously stirred under reflux for 1.5 hours.  After cooling to 
room temperature, the mixture was filtered through a bed of celite, the inside of the flask 
was washed with hot toluene and ethyl acetate (50 mL each), and the resulting filtrate was 
gently removed under reduced pressure to provide off-white crystals that formed after the 
flask cooled to room temperature.  The solid was then recrystallized from boiling cyclo-
hexane, collected by suction filtration, and dried under vacuum to afford aldehyde 4.7 as 
a white crystalline solid.  Yield: 4.63 g (29.8 mmol, 91%).  1H NMR (CDCl3, 400 MHz) δ 
4.02 (s, 3H), 8.10 (dd, J = 4.9, 1.7 Hz), 8.47 (dd, J = 1.6, 0.9 Hz, 1H), 8.97 (dd, J = 4.9, 
0.8 Hz, 1H), 10.15 (s, 1H). 13C NMR (CDCl3, 100 MHz) δ 52.9, 120.7, 126.7, 138.6, 150.9, 
153.5, 164.5, 192.3. EI-MS m/z 165 ([M]+, 22%), 137 (100%), 134 (25%), 122 (23%), 106 
(34%), 78 (39%), 51 (37%). EI-HRMS m/z calc’d for C8H7NO3 165.0426, found 165.0428.  
Methyl 2-(((2-hydroxyethyl)amino)methyl)isonicotinate 4.8. To a 16- mL vial 
with a PTFE-lined screw cap containing a stir bar was added aldehyde 4.7 (1 eq., 3.03 
mmol, 500 mg) and ethanolamine (3 eq., 9.09 mmol, 555 mg), and both starting materials 
were dissolved in anhydrous methanol (6 mL). Upon dissolution, glacial acetic acid (1 eq., 
3.03 mmol, 174 µL) was pipetted into the solution, and the reaction was stirred overnight 
at room temperature to build up the formation of the iminium ion intermediate.  The next 
day, NaCNBH3 (2 eq., 6.06 mmol, 381 mg) was added to the stirring solution in small 
portions over the course of ~ 2 minutes.  After vigorously stirring for 20 minutes, TLC 
 275 
analysis (4:1 EtOAc: MeOH) confirmed the complete consumption of the starting alde-
hyde, so the reaction was quenched with 1 M citric acid (1 mL), followed by 2 mL of satu-
rated Na2CO3(aq).  The aqueous layer was extracted with dichloromethane (3 x 10 mL), 
and the combined organic layers were dried over MgSO4, filtered, and concentrated to a 
light purple-colored oil residue.  The residue was purified by column chromatography (sil-
ica gel, 4:1 EtOAc:MeOH) to afford the free base of 4.8 as a pale yellow oil.  Yield: 256 
mg (1.22 mmol, 40%). 1H NMR (CDCl3, 400 MHz) δ 2.86 (t, J = 5.2 Hz, 2H), 3.10 (s, br., 
1H), 3.70 (t, J = 5.1 Hz, 2H), 3.97 (s, 3H), 4.04 (s, 2H), 7.74 (dd, J = 5.1, 1.5 Hz, 1H), 7.85 
(s, 1H), 8.71 (dd, J = 5.1, 0.7 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 50.9, 52.7, 54.2, 60.8, 
121.3, 121.5, 137.9, 150.1, 160.6, 165.6. ESI-HRMS m/z calc’d for C10H15N2O3 ([M+H]+) 
211.1077, found 211.1077.  
Fluorophore 4.2a. A 4-mL vial complete with a septum-sealed cap was charged 
with aldehyde 3.16 (1 eq., 0.34 mmol, 100 mg), secondary amine 4.8 (1.3 eq., 0.44 mmol, 
92 mg), NaBH3CN (1.5 eq., 0.51 mmol, 32 mg) and a stir bar.  The vial was sealed, evac-
uated under high vacuum, and backfilled with argon.  The reagents were dissolved in 
anhydrous MeOH (2 mL), and the solution was supplemented with glacial AcOH (0.2 eq., 
0.07 mmol, 3.85 µL) and stirred overnight at 35°C.  The following day, the reaction was 
quenched with 1 M citric acid and diluted further with EtOAc (1 mL).  The EtOAc was 
decanted, and the aqueous layer was extracted further with EtOAc (2 x 2 mL).  The com-
bined organic layers were dried over MgSO4, filtered, and concentrated under reduced 
pressure to a yellow oil residue.  The residue was purified by flash column chromatography 
(silica, 19:1 EtOAc:MeOH) to afford 4.2a as a pure pale yellow oil.  Yield: 65 mg (0.133 
mmol, 39%). 1H NMR (CDCl3, 400 MHz) δ 2.96 (t, J = 5.1 Hz, 2H), 3.73 (t, J = 5.1 Hz, 2H), 
3.83 (s, 3H), 3.86 (s, 3H), 3.99 (s, 2H), 4.07 (s, 2H), 6.96, (d, J = 8.8 Hz, 2H), 7.29 (dd, J 
= 7.6, 0.9 Hz, 1H), 7.60 (d, J = 8.8 Hz, 2H), 7.67-7.71 (m, 2H), 7.89 (s, 1H), 7.98 (s, 1H), 
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8.01 (dd, J = 7.9, 0.9 Hz, 1H), 8.70 (dd, J = 5.1, 1.1 Hz, 1H). 13C NMR (CDCl3, 100 MHz) 
δ 52.6, 55.4, 56.8, 59.5, 59.7, 59.9, 114.5, 117.7, 121.4, 122.3, 123.6, 124.1, 128.1, 137.4, 
137.9, 138.6, 141.6, 149.9, 151.1, 159.0, 159.9, 160.7, 165.6.  ESI-MS m/z 491 ([M+H]+, 
100%), 282 (17%).  ESI-HRMS m/z calc’d for C26H27N4O4S ([M+H]+) 491.1748, found 
491.1743.  
Fluorophore 4.2b. In a 10-mL round-bottom flask equipped with a stir bar, fluoro-
phore 4.2a (1 eq., 0.092 mmol, 45 mg) was dissolved in MeOH (2 mL).  NaOH (1.5 eq., 
0.14 mmol, 27.6 µL of a 20% (w/v) solution in H2O) was pipetted into the stirred solution, 
which was then vigorously stirred under reflux for 2 hours. The solution was diluted with 
isopropanol (iPrOH), and the precipitated product was then recrystallized from the 
MeOH:iPrOH mixture, filtered by suction filtration, and dried under vacuum to afford 4.2b 
as pale yellow crystals.  Yield: 43 mg (0.086 mmol, 94%). 1H NMR (MeOD, 400 MHz) δ 
2.82 (t, J = 5.8 Hz, 2H), 3.71 (t, J = 5.8 Hz, 2H), 3.84 (s, 3H), 3.93 (s, 2H), 3.98 (s, 2H), 
7.00 (d, J = 8.9 Hz, 2H), 7.58 (dd, J = 7.7, 0.8 Hz, 1H), 7.63 (d, J = 8.9 Hz, 2H), 7.70 (dd, 
J = 5.1, 1.6 Hz, 1H), 7.83 (t, J = 7.8 Hz, 1H), 7.95 (dd, J = 7.8, 0.8 Hz, 1H), 8.02 (s, 1H), 
8.03 (s, 1H), 8.51 (dd, J = 5.1, 0.7 Hz, 1H). 13C NMR (MeOD, 100 MHz) δ 55.9, 57.8, 60.7, 
61.0, 61.3, 115.7, 118.6, 123.2, 124.4, 125.0, 125.4, 129.1, 138.9, 139.3, 143.1, 148.5, 
149.7, 151.6, 160.9, 161.0, 161.7, 168.7, 172.7. ESI-MS m/z 475 ([M+H]+, 100%), 281 
(33%).  ESI-HRMS m/z calc’d for C33H31N6O5S ([M+H]+) 475.1445, found 475.1440.  
N-methyl-N-boc-protected bispicolylamine 4.9.  Aldehyde 4.7 (2.2 eq., 6.06 
mmol, 1.00 g), t-butyl-N-methyl(2-aminoethyl)carbamate (1 eq., 2.75 mmol, 480 mg), and 
Na(OAc)3BH (2.5 eq., 6.88 mmol, 1.46 g) were added to a 50 mL round bottom flask 
equipped with a stir bar.  The flask was fitted with a rubber septum, evacuated under high 
vacuum to remove moisture, and backfilled with argon.  Through the rubber septum was 
added anhydrous 1,2-dichloroethane (20 mL), and the mixture was allowed to stir at room 
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temperature overnight.  The mixture was diluted with CH2Cl2 (20 mL), quenched with 
diH2O (5 mL), the organic layer was removed.  The aqueous layer was extracted with 
CH2Cl2 (2 x 50 mL), and the combined organic layers were dried over MgSO4, filtered, and 
concentrated to a yellow oil.  The residue was purified via column chromatography (silica 
gel, neat EtOAc).  The combined column fractions were concentrated to a pale yellow oil 
residue, and the product was crystallized by heating in 2,2,4-trimethylpentane followed by 
cooling to room temperature overnight, affording the boc-protected N-methylbispicolyla-
mine 4.9 as a white solid.  Yield: 1.09 g (2.38 mmol, 82%). Note: 1H characterization of 
4.9 in CDCl3 at room temperature showed the presence of two conformers, so the 1H 
spectrum was acquired in DMSO-d6 at elevated temperatures (60, 80, 100°C). These 
conformational isomers precluded acquiring a 13C NMR spectrum.  1H NMR (DMSO-d6, 
400 MHz, 100°C) δ 1.30 (s, 9H), 2.72 (s, 3H), 3.30 (t, J = 6.6 Hz, 2H), 3.90 (s, 6H), 3.94 
(s, 4H), 7.63 (dd, J = 5.0, 1.6 Hz, 2H), 7.89 (s, 2H), 8.65 (dd, J = 5.0, 0.8 Hz, 2H). EI-MS 
m/z 472 ([M]+, 3%), 328 (74%), 179 (46%), 177 (44%), 151 (52%), 150 (25%), 137 (50%), 
97 (20%), 95 (22%), 83 (24%), 81 (22%), 69 (37%), 57 (100%). EI-HRMS m/z calc’d for 
C24H32N4O6 472.2322, found 472.2321.  
N-methyl-ethylenediamine bispicolylamine 4.10.  Boc-protected N-methyl-
bispicolylamine 4.9 (1 eq., 1.97 mmol, 932 mg) was added to a 25 mL round bottom flask 
and dissolved in anhydrous dichloromethane (1 mL). Under a gentle stream of argon was 
added freshly distilled trifluoroacetic acid (TFA, 3 mL), and the flask was fitted with a glass 
frit to allow gas effusion. The solution was stirred for 20 minutes, transferred to an Erlen-
meyer flask, diluted with dichloromethane (50 mL), and while stirring, saturated Na2CO3 
was slowly pipetted into the flask to neutralize the remaining TFA and make the aqueous 
layer basic.  The aqueous layer was then extracted with dichloromethane (2 x 50 mL), and 
the combined organic layers were dried over Na2SO4, filtered, and concentrated under 
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reduced pressure to reveal 4.10 as an amber-colored oil.  The free base was used syn-
thetically without further purification.  Yield: 714 mg (1.92 mmol, 97%). 1H NMR (CDCl3, 
400 MHz) δ 2.47 (s, 3H), 2.82-2.93 (m, 4H), 3.96 (s, 6H), 3.98 (s, 4H), 5.03 (s, br., 1H), 
7.70 (dd, J = 5.1, 1.6 Hz, 2H), 7.91 (s, 2H), 8.68 (dd, J = 5.1, 0.7 Hz, 2H). 13C NMR (CDCl3, 
100 MHz) δ 35.2, 48.7, 52.7, 53.3, 60.2, 121.3, 122.2, 137.8, 149.9, 160.4, 165.5. EI-MS 
m/z 372 ([M]+, 8%), 329 (30%), 328 (100%), 322 (36%), 191 (20%), 179 (62%), 177 (85%), 
151 (88%), 150 (43%), 92 (30%), 64 (22%). EI-HRMS m/z calc’d for C19H24N4O4 372.1798, 
found 372.1783. 
Fluorophore 4.3a. Aldehyde 3.16 (1 eq., 0.270 mmol, 80 mg), secondary amine 
4.10 (1.5 eq., 0.404, 151 mg), Na(OAc)3BH (2 eq., 0.540 mmol, 115 mg), and a magnetic 
stirring bar were added to a 10 mL round bottom flask that was sealed with a rubber sep-
tum.  The flask was evacuated under high vacuum to remove moisture and backfilled with 
argon. Anhydrous 1,2-dichloroethane (2 mL) was added through the septum, and the mix-
ture was allowed to stir overnight.  The reaction was quenched by the addition of 1 M citric 
acid, and after ~10 minutes of vigorous stirring, the mixture was made basic by the addition 
of saturated Na2CO3. The organic layer was decanted, the aqueous layer was extracted 
with dichloromethane (2 x 10 mL), and the combined organic layers were dried over 
Na2SO4, filtered, and concentrated to a yellow oil residue.  The residue was purified by 
flash column chromatography (silica gel, 20:1 EtOAc:MeOH) to afford the pure 4.3a as a 
yellow oil.  Yield: 153 mg (0.234 mmol, 87%). 1H NMR (CDCl3, 400 MHz) δ 2.29 (s, 3H), 
2.74 (t, J = 6.7 Hz, 2H), 2.85 (t, J = 6.7 Hz, 2H), 3.73 (s, 2H), 3.86 (s, 3H), 3.92 (s, 6H), 
3.98 (s, 4H), 6.95 (d, J = 8.9 Hz, 2H), 7.42 (dd, J = 7.7, 1.0 Hz, 1H), 7.55 (d, J = 8.9 Hz, 
2H), 7.66 (dd, J = 5.1, 1.6 Hz, 2H), 7.70 (t, J = 7.8 Hz, 1H), 7.95 (s, 1H), 7.99 (d, J = 7.7 
Hz, 1H), 8.07 (s, 2H), 8.64 (dd, J = 5.1, 0.7 Hz, 2H). 13C NMR (CDCl3, 100 MHz) δ 42.9, 
52.4, 52.6, 55.4, 55.5, 60.7, 63.6, 114.5, 117.3, 121.1, 122.2, 123.4, 124.2, 128.0, 137.2, 
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137.8, 138.5, 141.3, 149.8, 150.7, 159.6, 159.8, 161.1, 165.7, 167.5. EI-MS m/z 652 ([M]+, 
10%), 502 (26%), 328 (70%), 324 (100%), 282 (73%), 281 (46%), 191 (23%), 177 (45%), 
151 (42%), 150 (24%).  EI-HRMS m/z calc’d for C35H36N6O5S 652.2468, found 652.2440.   
Fluorophore 4.3b. To a 10 mL round bottom flask containing fluorophore 4.3a (1 
eq., 0.191 mmol, 125 mg) and a stir bar was added methanol (3 mL).  While stirring, NaOH 
(2.5 eq., 0.479 mmol, 96 μL of a 20% (w/v) aqueous solution) was pipetted into the solu-
tion, and the mixture was refluxed for 2 hours.  Upon completion of the saponification, the 
methanol was removed under reduced pressure, and the product was recrystallized from 
boiling ethanol to give the dicarboxylate disodium salt 4.3b as a light yellow solid.  Yield: 
119 mg (0.178 mmol, 93%).  1H NMR (MeOH, 400 MHz) δ 2.00 (s, 3H), 2.64-2.81 (m, 4H), 
3.55 (s, 3H), 3.84 (s, 3H), 3.89 (s, 4H), 7.02 (d, J = 8.9 Hz, 2H), 7.35 (dd, J = 7.6, 0.9 Hz, 
1H), 7.62-7.66 (m, 4H), 7.86-7.90 (m, 3H), 7.96 (dd, J = 7.9, 0.9 Hz, 1H), 8.15 (s, 1H), 
8.41 (dd, J = 5.1, 0.8 Hz, 2H). 13C NMR (MeOH, 100 MHz) δ 42.5, 52.7, 55.9,56.1, 61.5, 
63.7, 115.8, 120.2, 123.2, 124.5, 124.7, 125.6, 129.2, 139.6, 139.7, 143.3, 148.4, 150.4, 
151.7, 160.3, 161.9, 167.5, 172.5.  ESI-MS m/z 623 ([M+H]+, 100%), 535 (22%). ESI-
HRMS m/z calc’d for C33H31N6O5S ([M+H]+) 623.2082, found 623.2084.   
2,2'-(((2-((tert-butoxycarbonyl)amino)ethyl)azanediyl)bis(methylene))diison-
icotinic acid dimethyl ester (4.11). Aldehyde 4.7 (2.2 eq., 5.71 mmol, 943 mg), tert-butyl-
N-(2-aminoethyl)carbamate (1 eq., 2.60 mmol, 416 mg), and Na(OAc)3BH (2.5 eq., 6.49 
mmol, 1.38 g) were added to a 50-mL round bottom flask equipped with a stir bar.  The 
flask was fitted with a rubber septum, evacuated under high vacuum to remove moisture, 
and backfilled with argon.  Through the rubber septum was added anhydrous 1,2-dichlo-
roethane (20 mL), and the mixture was allowed to stir at room temperature overnight.  The 
mixture was diluted with CH2Cl2 (20 mL), quenched with diH2O (5 mL), and the organic 
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layer removed.  The aqueous layer was extracted with CH2Cl2 (2 x 50 mL), and the com-
bined organic layers were dried over MgSO4, filtered, and concentrated to a yellow oil.  
The residue was purified via column chromatography (silica gel, neat EtOAc).  The com-
bined column fractions were concentrated to a pale yellow oil residue.  Yield: 1.12 g (2.44 
mmol, 97%). 1H NMR (CDCl3, 400 MHz) δ 1.42 (s, 9H), 2.76 (t, J = 5.8 Hz, 2H), 3.25 (q, J 
= 5.7 Hz, 2H), 3.96 (s, 10H), 5.65 (s, br, 1H), 7.72 (dd, J = 5.1, 1.6 Hz, 2H), 7.93 (s, 2H), 
8.72 (dd, J = 5.1, 0.7 Hz, 2H). 13C NMR (CDCl3, 100 MHz) δ 28.4, 38.5, 52.7, 53.8, 60.0, 
78.9, 121.4, 122.3, 137.9, 150.0, 156.1, 160.3, 165.6. EI-MS m/z 458 ([M]+, 8%), 385 
(28%), 329 (29%), 328 (100%), 308 (37%), 252 (40%), 220 (27%), 206 (30%), 191 (27%), 
177 (54%), 165 (20%), 151 (58%), 150 (36%), 92 (24%), 57 (40%). EI-HRMS m/z calc’d 
for C23H30N4O6 458.2165, found 458.2157. 
2,2'-(((2-aminoethyl)azanediyl)bis(methylene))diisonicotinic acid dimethyl 
ester (4.12).  Boc-protected amine 4.11 (1 eq., 2.22 mmol, 1.02 g) was added to a 25-mL 
round bottom flask and dissolved in anhydrous dichloromethane (2 mL). Under a gentle 
stream of argon was added freshly distilled trifluoroacetic acid (TFA, 5 mL), and the flask 
was fitted with a glass frit to allow gas effusion. The solution was stirred for 20 minutes, 
transferred to an Erlenmeyer flask, diluted with dichloromethane (25 mL), and while stir-
ring, saturated Na2CO3 was slowly pipetted into the flask to neutralize the remaining TFA 
and make the aqueous layer basic (pH ~ 9).  The aqueous layer was then extracted with 
dichloromethane (2 x 25 mL), and the combined organic layers were dried over Na2SO4, 
filtered, and concentrated under reduced pressure to yield 4.12 as a light amber-colored 
oil.  The pure primary amine as the free base was used synthetically without further puri-
fication.  Note: for 1H/13C NMR characterization, a portion of the compound was converted 
to the hydrochloride salt upon the slow addition of 3 eq. of TMSCl to a solution of 4.12 in 
EtOAc:EtOH. Yield (free base): 628 mg (1.92 mmol, 79%). 1H NMR (MeOH, 400 MHz) δ 
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3.12 (t, J = 6.0 Hz, 2H), 3.33 (t, J = 6.0 Hz, 2H), 4.04 (s, 6H), 4.43 (s, 4H), 8.36 (dd, J = 
5.9, 1.6 Hz, 2H), 8.47 (d, J = 0.9 Hz, 2H), 9.01 (d, J = 5.9 Hz, 2H). 13C NMR (MeOH, 100 
MHz) δ 37.7, 53.4, 54.2, 57.4, 126.4, 127.6, 146.0, 146.2, 155.5, 164.3. ESI-MS m/z 359 
([M+H]+, 20%), 282 (100%). ESI-HRMS m/z calc’d for C18H23N4O4 ([M+H]+) 359.1714, 
found 359.1712.   
 Secondary amine (4.13). Primary amine 4.12 (1.5 eq., 1.38 mmol, 496 mg), alde-
hyde 4.7 (1 eq., 0.923 mmol, 152 mg) and Na(OAc)3BH (1.5 eq., 1.38 mmol, 293 mg) were 
added to a 25-mL round bottom flask equipped with a stir bar.  The flask was evacuated 
under high vacuum and backfilled with argon through a rubber septum. Through the sep-
tum was added anhydrous 1,2-dichloroethane (12 mL), and the mixture was stirred over-
night at room temperature.  The reaction was quenched by the addition of diH2O (4 mL), 
followed by the addition of saturated NaHCO3 (4 mL).  The organic layer was decanted, 
and the aqueous layer was extracted with dichloromethane (3 x 15 mL).  The combined 
organic layers were dried over MgSO4, filtered, and concentrated to a brown oily residue 
that was purified via flash column chromatography (silica gel, 9:1 CH2Cl2:MeOH) to afford 
the pure secondary amine as a light amber-colored oil.  Yield: 466 mg (0.918 mmol, 66%). 
1H NMR (CDCl3, 400 MHz) δ 3.93 (s, 6H), 3.95 (s, 3H), 3.97 (s, 4H), 4.00 (s, 2H), 7.69 
(dd, J = 5.1, 1.6 Hz, 2H), 7.73 (dd, J = 5.0, 1.5 Hz, 1H), 7.89 (s, 1H), 7.97 (s, 2H), 8.67 
(dd, J = 5.1, 0.6 Hz, 2H), 8.69 (dd, J = 5.1, 0.7 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 
46.6, 52.6, 52.6, 53.7, 54.1, 60.2, 121.2, 121.3, 121.5, 122.2, 137.7, 137.8, 149.8, 150.0, 
160.5, 165.5(0), 165.5(1). ESI-MS m/z 508 ([M+H]+, 100%), 342 (32%).  ESI-HRMS m/z 
calc’d for C26H30N5O6S ([M+H]+) 508.2191, found 508.2179.   
Fluorophore 4.4a.  A 10-mL round bottom flask equipped with a stir bar was 
charged with aldehyde 3.16 (1 eq., 0.25 mmol, 75 mmol), secondary amine 4.13 (1.2 eq., 
0.31 mmol, 155 mg), and Na(OAc)3BH (1.5 eq., 0.38 mmol, 81 mg).  The flask was sealed 
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with a rubber septum, evacuated under high vacuum, and backfilled with argon.  Under 
an argon atmosphere, the reagents in the flask were dissolved in anhydrous 1,2-dichloro-
ethane (2 mL), and the reaction mixture was stirred vigorously at room temperature over-
night.  The following day, the reaction was quenched with 1 M citric acid (1 mL), and then 
the aqueous layer was made basic using saturated Na2CO3(aq).  The aqueous layer was 
extracted with dichloromethane (3 x 10 mL), and the combined organic layers were dried 
over MgSO4, filtered, and concentrated to an amber-colored oil residue.  The residue was 
then purified by flash column chromatography (silica gel, 1:1 DCM:acetone) to afford pure 
4.4a as a light amber-colored oil.  Yield: 127 mg (0.161 mmol, 63%).  1H NMR (CDCl3, 400 
MHz) δ  2.89 (s, 4H), 3.86 (s, 5H), 3.87 (s, 3H), 3.90 (s, 6H), 3.91 (s, 6H), 3.94 (s, 2H), 
6.95 (d, J = 8.8 Hz, 2H), 7.42 (dd, J = 7.7, 0.9 Hz, 1H), 7.55 (d, J = 8.8 Hz, 2H), 7.63 (dd, 
J = 5.1, 1.7 Hz, 2H), 7.66 (dd, J = 5.1, 1.6 Hz, 1H), 7.70 (t, J = 7.8 Hz, 1H), 7.95 (s, 1H), 
7.97-8.00 (m, 4H), 8.60 (dd, J = 5.1, 0.8 Hz, 2H), 8.64 (dd, J = 5.1, 0.8 Hz, 1H).  Note: due 
to the high molecular weight and the chemical similarity of the carbons in 4.4a, only 30 
distinct signals were observed in the 13C NMR spectrum acquired instead of the 32 theo-
retical signals. 13C NMR (CDCl3, 100 MHz) δ 52.2, 52.3, 52.6, 55.4, 60.1, 60.6(0), 60.6(2), 
77.2, 105.0, 114.5, 117.4, 121.1, 122.1, 123.4, 124.2, 128.0, 137.3, 137.7, 138.5, 141.4, 
149.7, 150.7, 159.3, 159.8, 160.8, 161.0(5), 161.1, 165.6(5), 165.7, 167.7. ESI-MS m/z 
788 ([M+H]+, 100%), 473 (7%), 422 (100%), 346 (45%), 272 (20%). ESI-HRMS m/z calc’d 
for C42H42N7O7S ([M+H]+) 788.2861, found 788.2850.   
Fluorophore 4.4b. In a 10-mL round bottom flask equipped with a stir bar, fluoro-
phore 4.4a (1 eq., 0.095 mmol, 75 mg) was dissolved in MeOH (2 mL). While stirring, the 
solution was supplemented with NaOH (3.5 eq., 0.33 mmol, 67 µL of a 20% (w/v) solution 
in H2O), and the solution was stirred under reflux for 2 hours.  The solution was concen-
trated under a gentle stream of argon and then diluted with a minimal amount of EtOH, 
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after which the mixture was heated to boiling until the solid redissolved, and upon cooling, 
crystallization was initiated by the addition of a few drops of MTBE.  The crystals were 
collected by suction filtration and dried under vacuum to afford 4.4b as a pale yellow crys-
talline solid. Yield:  74 mg (0.091 mmol, 96%).  1H NMR (MeOD, 400 MHz) δ 2.71-2.77 
(m, 4H), 3.46 (s, 2H), 3.62 (s, 4H), 3.70 (s, 2H), 3.86 (s, 3H), 7.07 (d, J = 8.9 Hz, 2H), 7.28 
(dd, J = 7.5, 0.8 Hz, 1H), 7.51 (dd, J = 5.1, 1.4 Hz, 1H), 7.57 (dd, J = 5.0, 1.1 Hz, 2H), 7.65 
(s, 1H), 7.67 (s, 2H), 7.75 (d, J = 8.9 Hz, 2H), 7.86 (t, J = 7.7 Hz, 1H), 7.92 (dd, J = 7.8, 
0.8 Hz, 1H), 8.28-8.33 (m, 4H). 13C NMR (MeOD, 125 MHz) δ 51.9, 52.0, 55.9(1), 55.9(5), 
59.1, 60.4, 61.3, 115.9, 120.6, 123.1, 123.2, 124.3, 124.5, 124.7, 125.6, 129.4, 139.8, 
140.0, 143.4, 148.2, 150.96, 151.01, 151.7, 160.0(3), 160.0(7), 160.1, 162.0, 167.1, 172.5.  
ESI-MS m/z 744 ([M+H]+, 100%), 700 (25%), 281 (10%). ESI-HRMS m/z calc’d for C39H-
34N7O7S ([M+H]+) 744.2246, found 744.2242.   
4.7.2 Steady-State Absorption and Fluorescence Spectroscopy 
4.7.2.1 General Spectroscopic Methods 
All buffers and stock solutions used for spectroscopic measurements were pre-
pared using either HPLC-grade water (JT Baker) or 18.2 MΩ•cm Mili-Q water and filtered 
through a 0.2 µm filter to remove interfering dust particles or fibers. UV-Vis measurements 
were performed on a Varian Cary Bio50 spectrophotometer with a constant temperature 
accessory (Peltier) at 25°C.  Fluorescence measurements were performed with a PTI flu-
orimeter equipped with a 75 W xenon arc lamp excitation source and a photomultiplier 
detection system (PMT voltage was 1100 V for all experiments).  Fluorescence spectra 
were corrected for the spectral response of the detection system and for the spectral irra-
diance of the excitation source (via a calibrated photodiode).  For all experiments, both 
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UV-Vis and fluorescence, a 1-cm path length quartz cuvette was used, except for quantum 
yield determinations, which were performed with a 10-cm path length quartz cuvette for 
absorbance measurements.   
4.7.2.2 Determination of Fluorescence Quantum Yields 
Fluorescence quantum yields of 4.1, 4.2b, 4.3b, and 4.4b were determined in 
aqueous buffer (10 mM PIPES, 0.1 M KCl) treated with Chelex (1% (w/v), Biorad) at pH 
7.0 by a 4-point measurement over an OD range of 0.1-0.4 using a 10-cm cuvette, with 
fluorimeter excitation at 365 nm.  For all probes, including 4.3b and 4.4b, the solutions 
containing the free forms were supplemented with 20 µM EDTA (from a 30 mM stock 
solution in diH2O) to sequester adventitious Zn(II), whereas to determine the Zn(II)-bound 
forms, the solutions were supplemented with 20 µM ZnSO4•7H2O to ensure complete sat-
uration of the fluorophore.  Fluorescence quantum yields for all fluorophores were deter-
mined using quinine sulfate (ΦF = 0.546 in 1.0 N H2SO4) as a fluorescence standard.20  
4.7.2.3 Solvent Deuterium Isotope Effect of Probe 4.1 by Fluorescence 
Comparison of the fluorescence intensities of probe 4.1 was conducted in deuter-
ated and non-deuterated buffer (10 mM PIPES, 100 mM KCl, pH/D 7.0, 25°C).  A 3.0-mL 
solution of aqueous buffer was supplemented with 10 µM of the probe (from 3 mM stock 
solutions in H2O), and after thorough mixing via magnetic stirring, a fluorescence spectrum 
of 4.1 was acquired over the spectral window of 380-700 nm with excitation at 360 nm. To 
saturate the fluorescent probe, the solution was supplemented with 300 µM ZnSO4•7H2O 
(from a 500 mM stock solution in H2O), and another fluorescence spectrum was acquired.  
This was repeated in deuterated buffer, and the spectra were compared graphically.   
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4.7.2.4 Molar Ratio Titrations 
Molar ratio titrations were performed via spectrophotometric and fluorimetric titra-
tions to determine the stoichiometries of the fluorescent probes.  For probes 4.2b, 4.3b, 
and 4.4b, 20 µM solutions of each in pH 7.0 aqueous buffer (3.0 mL, 10 mM PIPES, 0.1 
M KCl, 25°C) were prepared in a fluorescence quartz cuvette with a 1-cm pathlength, and 
the probes were titrated with ZnSO4•7H2O (from a 3 mM aqueous stock solution) in 2 µM 
(0.1 eq.) increments. After each aliquot, the solutions were equilibrated for 30 seconds by 
magnetic stirring, and absorbance (spectral window: 250-500 nm) and fluorescence spec-
tra (spectral window: 380-700 nm, with excitation at 359 nm (4.2b), 355 nm (4.3b), and 
361 nm (4.4b)) were acquired.   
4.7.2.5 Analyte Selectivities of Probes 4.2b, 4.3b, and 4.4b 
A 5 µM solution (40 mL) of each probe was prepared in pH 7.0 aqueous buffer (10 
mM PIPES, 100 mM KCl, 25°C) that had been previously treated with Chelex (1% (w/v), 
Biorad) and filtered through a 0.2 µm filter.   An aliquot (2.0 mL) of the solution was trans-
ferred to a quartz cuvette with a 1-cm path length, and a fluorescence spectrum was ac-
quired over the emission range of 380-700 nm with excitation at the wavelengths de-
scribed in the previous protocol.  Under magnetic stirring, the solution was supplemented 
with each divalent metal cation (4 µM for transitions metals, corresponding to 80% frac-
tional saturation of the probe; 2 mM for Ca(II) and Mg(II)) under rapid magnetic stirring, 
and a fluorescence spectrum was immediately acquired.  The solution was then supple-
mented with ZnSO4•7H2O (from a 1 mM stock solution in H2O) to a final concentration of 
1 µM (for solutions containing Co(II), Ni(II), and Cu(II)) or 5 µM (for solutions containing 
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all other metals: Mg(II), Ca(II), Mn(II), Fe(II)), and a fluorescence spectrum was immedi-
ately acquired.  For probe 4.3b, the solution containing Mn(II) was supplemented only with 
1 µM Zn(II) to saturate the probe, and for probe 4.4b, the solutions containing both Mn(II) 
and Fe(II) were supplemented with 1 µM Zn(II), The emission spectra corresponding to 
the addition of 80% fractional saturation with the interfering metal ions, as well as the 
addition of Zn(II) were integrated over the ranges of 440-495 nm (CH1) and 510-570 nm 
(CH2), and the resulting intensities were computed as a ratio of CH2/CH1.  Metal cations 
were supplied as aqueous stock solutions of the following salts: Mg(II), Ca(II) as chlorides 
(1 M stocks); Co(II) as the nitrate salt (1 µM stock); Mn(II), Fe(II), Cu(II), and Zn(II) as 
sulfates (1 µM stocks).  To avoid aerial oxidation of Fe(II), the stock solution was freshly 
prepared in 10 mM H2SO4 before use.   
To measure the fluorescence response of the probes upon complete saturation of 
the probe, the working solutions that were prepared in aqueous buffer (10 mM PIPES, 100 
mM KCl, 25°C, pH 7.0) were supplemented with 2.0 equivalents (10 µM, from a 30 mM 
stock solution in H2O) of EDTA. A fluorescence spectrum was acquired of the free probe 
over the spectral window of 380-700 nm with excitation at the wavelengths corresponding 
to each probe as previously mentioned.  The probe solution was then supplemented with 
interfering divalent metal ions (from 30 mM stocks solutions of each metal in H2O) to final 
concentrations of 20 and 40 µM, with a fluorescence spectrum acquired immediately after 
the addition of each aliquot.  
4.7.2.6 Determination of the Zn(II)-Binding Affinity of Probe 4.1 
The Zn(II) stability constant of 4.1 was determined through a both a spectrophoto-
metric and fluorimetric metal-addition titration.  In a quartz fluorescence cuvette with a 1-
cm pathlength, a 20 µM solution of 4.1 (from a 3 mM stock solution in DMSO) in 3.00 mL 
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of aqueous buffer (10 mM PIPES, 0.1 M KCl, pH 7.0) at 25°C was titrated with 
ZnSO4•7H2O (from 5 and 60 mM analytical stock solutions in H2O) from 0-220 µM. After 
the addition of each aliquot of Zn(II), the solution was equilibrated by magnetic stirring, 
and both an absorbance spectrum over the spectral window of 250-500 nm and a fluores-
cence spectrum over the spectra window of 380-700 nm, with excitation at 360 nm, were 
acquired.  The spectroscopic data were analyzed by non-linear least-squares fitting using 
the Specfit22 software suite.   
4.7.2.7 Determination of the Zn(II)-Binding Affinity of Probe 4.2b 
The Zn(II) stability constant of 4.2b was determined through a both a spectropho-
tometric and fluorimetric metal-addition titration.  In a quartz fluorescence cuvette with a 
1-cm pathlength, a 20 µM solution of 4.2b (from a 3 mM stock solution in DMSO) in 3.00 
mL of aqueous buffer (10 mM PIPES, 0.1 M KCl, pH 7.0) at 25°C was titrated with 
ZnSO4•7H2O (from 5 and 60 mM analytical stock solutions in H2O) from 0-220 µM. After 
the addition of each aliquot of Zn(II), the solution was equilibrated by magnetic stirring, 
and both an absorbance spectrum over the spectral window of 250-500 nm and a fluores-
cence spectrum over the spectra window of 380-700 nm, with excitation at 360 nm, were 
acquired.  The spectroscopic data were analyzed by non-linear least-squares fitting using 
the Specfit software suite.    
4.7.2.8 Determination of the Zn(II)-Binding Affinity of Probe 4.3b 
The Zn(II) stability constant of 4.3b was determined through a fluorimetric titration 
using EGTA as the competing ligand.  A 10 µM solution (40 mL) of the probe was diluted 
from a 3 mM stock solution in H2O prepared into pH 7.0 aqueous buffer (10 mM PIPES, 
100 mM KCl, 25°C) that had been previously treated with Chelex (1% (w/v), Biorad) and 
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filtered through a 0.2 µm filter.  The probe was saturated with Zn(II) by supplementing the 
solution with 10 µM ZnSO4•7H2O (from a 60 mM analytical stock solution in H2O).  The 
working solution containing the preformed [(4.3b)Zn(II)] complex was aliquoted into 15 
separate 4-mL vials complete with PTFE-lined caps to prevent solvent evaporation, and 
each vial was supplemented with EDTA (from 6 and 60 mM analytical stock solutions in 
H2O) in various concentrations over the range of 0-900 µM.  The vials were sealed and 
placed in a shaking incubator at 25°C for 17 hours to ensure complete equilibration.  After 
the complete equilibration period, the solutions were transferred to a quartz fluorescence 
cuvette with a 1-cm pathlength, and an emission spectrum of each solution was acquired 
over the spectral range of 380-700 nm with excitation at 355 nm.  The titration data were 
analyzed by non-linear least-squares fitting using the Specfit software suite.   
4.7.2.9 Determination of the Zn(II)-Binding Affinity of Probe 4.4b 
The Zn(II) stability constant of 4.4b was determined through a spectrophotometric 
titration using TPEN as the competing ligand.  In a quartz cuvette with a 1-cm pathlength, 
a 10 µM solution of 4.4b (from a 3 mM stock solution in H2O) was prepared in 3.00 mL of 
aqueous buffer (10 mM PIPES, 0.1 M KCl, pH 7.0) at 25°C containing 30 mM TPEN (from 
a 3 mM stock solution in pH 5.0 aqueous buffer containing 10 mM PIPBS and 100 mM 
KCl.  An absorption spectrum was acquired over the spectral window of 250-500 nm.  The 
solution was titrated with ZnSO4•7H2O (from a 5 mM analytical stock solution in H2O) from 
0-42 µM.  After the addition of each aliquot of Zn(II), the solution was equilibrated by mag-
netic stirring for 30 minutes, and an absorption spectrum was acquired over the spectral 
window of 250-500 nm. The spectrophotometric data were analyzed by non-linear least-
squares fitting using Specfit.   
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EVALUATING THE PHOTOPHYSICAL AND THERMODYNAMIC 
PROPERTIES OF MONOVALENT COPPER-SELECTIVE FLUO-
RESCENT PROBES IN LIPOSOMES: ELUCIDATING THE FLUO-
RESCENCE DEPENDENCE ON POLARITY 
All experiments and data encompassing this chapter were conducted by the author un-
less state otherwise and have either been published (reference 22) or are in preparation 
for publication (reference 29) 
The design of cation-selective fluorescent probes for use as analytical tools in elu-
cidating metal-ion biochemistry requires a detailed understanding of not only the photo-
physical properties governing the signal transduction that occurs upon binding of the metal 
analyte but also how these properties compare between spectroscopic characterization 
and cellular imaging studies.  The dichotomous environment of the cell, featuring lipid-rich 
regions, such as plasma membranes and lipid vacuoles, and the aqueous cytosol and 
internal fluids of organelles that solubilize the hydrophilic components, demands probes 
bearing structural features that enable both passive diffusion across plasma membranes 
as well as water-solubility. However, characterization of fluorescent probes that are lipo-
philic enough to diffuse across the cell membrane can be challenging due to aggregation 
in aqueous buffer, which often affects the photophysical properties, including the bright-
ness and emission wavelength of the probes.1  
The delivery of small molecules into the cell to reach their cellular targets is an 
important goal in biological research.  At present, most fluorescent probes are considera-
bly lipophilic to ensure diffusion across cellular membranes, but their poor water-solubility 
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requires dilution from concentrated stock solutions of the probes at millimolar concentra-
tions, that are typically prepared in organic solvents, into the incubation buffer.  Upon di-
lution of the concentrated stock solution into aqueous buffer, often to final probe concen-
trations in the micromolar range, the appearance of a homogeneous solution does not 
necessarily preclude the formation of nanoparticles of the aggregated fluorescent probe 
with sizes residing below the diffraction limit.  The discrepancies in the emission response 
of fluorescent probes between aqueous buffer and the cellular environment often go un-
noticed due to the lack of awareness of aggregation, which can be deceiving, in part, due 
to the absence of solution turbidity when working at micromolar concentrations. 
To overcome this issue, the characterization of lipophilic fluorescent probes can 
be performed in the presence of liposomes as model membranes in order to predict their 
fluorescence spectral behaviors by providing a medium in which to dissolve the probe all 
while conducting the characterization in aqueous buffer.  Even if a fluorescent probe bears 
water-solubilizing functional groups to preclude aggregation at micromolar concentrations 
or higher, its emission response should still be evaluated in the presence of liposomes in 
case there are any lipid-mediated fluorescence enhancements or spectral shifts of the 
fluorescence that are independent of the metal analyte.  This chapter focuses on evaluat-
ing of the fluorescence dependence on the polarity environment through the characteriza-
tion, in liposomes, of Cu(I)-selective fluorescent probes that are widely employed for de-
tecting labile Cu(I) changes in various cell and tissue types.  Beforehand, however, it is 
important to establish the current state of affairs in the development of Cu(I)-responsive 




5.1 Current State of Affairs in Cu(I)-Responsive Fluorescent Probes 
5.1.1 The Hurdles Associated with Detecting Intracellular Cu(I) 
Synthetic fluorescent probes represent powerful tools with high sensitivity for the 
in situ detection of metal ions, including monovalent copper, which is the predominant 
oxidation state of copper in cells2.  In comparison to Zn(II) and Fe(II), the concentration of 
cellular copper is roughly one order of magnitude lower, amounting to 3 ~ 5 femtograms 
of total copper, for example, in 3T3 mouse fibroblast cells.3  The resulting total copper 
within a single cell, therefore, resides below the limit of detection for customarily used 
analytical instrumentation used in trace metal analysis, such as Inductively coupled 
plasma mass spectrometry (ICP-MS) or atomic emission spectroscopy (AES).4  On the 
other hand, designing fluorescent probes for detecting Cu(I) is much more challenging 
than other non-redox-active metals, such as Zn(II), Mg(II), or Ca(II), because of interfering 
quenching pathways that involve metal-to-ligand or ligand-to-metal charge-transfer states, 
leading to rapid intersystem crossing to produce non-fluorescent triplet states in the ex-
cited state.5  In addition, at micromolar concentrations, Cu(I), has the propensity to spon-
taneously disproportionate into Cu(0) and Cu(II) in acidic aqueous solution, whereas at 
neutral or basic pH, Cu(I) can precipitate as cuprous oxide (Cu2O); these reaction path-
ways only add to the difficulty of designing fluorescent sensors for the selective detection 
of aqueous Cu(I). 
5.1.2 Cu(I)-Selective Fluorescent Probes Currently Available 
Presumably due to the difficulty in designing fluorescent indicators for probing 
monovalent copper, only few fluorescent probes have been reported in the literature.6  Of 
those currently available (a selection with corresponding structures is provided in Figure 
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5.1), the majority utilize a PET (photoinduced electron transfer) mechanism for signaling 
the association of the metal with the probe and enables the discrimination of the metal-
bound probe from the metal-free probe.  The PET reaction is an electron-transfer reaction 
by which an electron is moved from a donor group to an electronically decoupled acceptor 
group in the excited state.  The donor group, which undergoes a facile a one-electron 
oxidation, is covalently linked to the fluorophore unit through an sp3-hybridized spacer, 
permitting the transfer of an electron from the donor moiety to the acceptor fluorophore in 
the excited-state and results in a non-radiative S1 ® S0 transition, thereby quenching the 
fluorescence.7  However, binding of a metal cation can obstruct the one-electron oxidation 
process, thus significantly reducing the rate of PET and producing a fluorescence “turn-
on” response.  Of the probes shown in Figure 5.1, fluorescence contrast ratios (fluores-
cence enhancement factors), which are the ratios of the fluorescence intensity of the Cu(I)-
saturated probe to the fluorescence intensity of the metal-free probe, range between 9.6 
(probe 5.7) and 75 (5.4: CS3). For fluorescence turn-on probes, the contrast ratio is an 
important component of their photophysical properties, as the increase in fluorescence 
upon binding of the metal cation is what discriminates it from its metal-free counterpart.  
Thus, the higher the contrast ratio, the more useful it will serve when probe Cu(I) in live 
cells.   
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Figure 5.1: Structures of selected fluorescent probes for sensing monovalent copper  
Table 5.1: Photophysical properties of selected fluorescent sensors for probing Cu(I) 
shown in Figure 5.1 
Cu(I) Probe Abs λmax (nm) 
Em λmax 
(nm) ΦF
a feb Buffer, pH Mechanismc 
CTAP-1 (5.1)8 365 485 0.14 4.6 PIPES, 7.2d PET 
CTAP-2 (5.2)1 396 508 0.083 65 MOPS, 7.2 PET 
CS1 (5.3)9-10  540 561 0.13 10 HEPES, 7.0d PET 
CS3 (5.4)11 540 548 0.40 75 HEPES, 7.0d PET 
Mito-CS1 (5.5)12 550 558 0.05 10 PBS, 7.4d ICT 
CS790 (5.6)13  760 790 0.072 15 HEPES, 7.0d PET 
5.714 750 792 n.d. 9.6 PBS, 10% EtOH, 7.0e ICT 
aFluorescence quantum yield of the Cu(I)-saturated species; bfluorescence enhancement factor 
(contrast ratio) between the Cu(I)-saturated metal-free species; cPET: photoinduced electron trans-
fer, CT: charge-transfer; dprobe stock solution prepared in and diluted in aqueous buffer; eprobe 
prepared in ethanol and diluted into aqueous buffer; n.d. = not determined. Table adapted from 
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The very first synthetic fluorescent turn-on probe for detecting Cu(I) in aqueous 
solution was CTAP-1 (copper triarylpyrazoline 1, 5.1), developed by Fahrni and cowork-
ers.8  CTAP-1 utilizes PET as a fluorescence quenching mechanism, which is suppressed 
upon binding of Cu(I), resulting in a nearly 5-fold fluorescence enhancement factor in 
aqueous buffer at pH 7.2.  Despite the presence of a carboxylic acid to promote water-
solubility, CTAP-1 required DMSO in order to prepare concentrated stock solutions nec-
essary for dilution into the incubation buffer for cellular and photophysical characterization.  
In addition, Yang and coworkers observed significant colocalization of the probe with the 
elemental copper topography provided by preforming X-ray fluorescence microscopy (mi-
cro-XRF).8  In order to suppress the production of colloidal aggregates, as well as improve 
the water-solubility, optimization of the structure of CTAP-1 led to the development of 
CTAP-2 (5.2), in which the thiocrown receptor unit was functionalized with four hydroxyl 
groups, and the pyrazoline fluorophore was functionalized with a sulfonic acid.  The im-
proved water-solubility permitted the preparation of stock solutions of CTAP-2 at millimolar 
concentrations in water without the need of organic cosolvents. In addition, the optimiza-
tion of the thiocrown receptor unit and pyrazoline unit led to a 65-fold fluorescence en-
hancement upon binding of Cu(I) compared to a 4.6-fold enhancement for CTAP-1, as 
well as a 10-fold increase in the binding affinity at pH 7.2.   
Based on an entirely different fluorophore architecture, the boron-dipyrrole-
methene (BODIPY)-based CS1 (coppersensor-1, 5.3) exhibited a 10-fold fluorescence 
enhancement upon binding Cu(I) to the metal-cation receptor, which is composed of a 
thioether-rich acyclic 3,6,12,15-tetrathia-9-monoazaheptadecane ligand.9-10  The signifi-
cant lipophilicity of the BODIPY fluorophore makes it membrane-permeant and thus allows 
for facile internationalization of the probe into cells for imaging labile Cu(I) pools using 
fluorescence microscopy.  In order to improve the photophysical properties of CS1, most 
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importantly the turn-on response,6 substitution of the fluorines with more electron-rich 
methoxy substituents afforded coppersensor-3 (CS3, 5.4), which was reported to boast a 
75-fold fluorescence enhancement upon saturation with Cu(I), in addition to a three-fold 
increase in the quantum yield of the Cu(I)-bound form.11  Interestingly, substitution of the 
fluorines with methoxy groups provided a nearly two logarithmic-unit increase in the ap-
parent stability constant of CS3 (logKCu(I)L = 13.1) compared to CS1 (logKCu(I)L = 11.4) at 
pH 7.2, despite the presence of identical tetrathioether-containing Cu(I) chelators. 
The BODIPY fluorophore platform of CS1 and CS3 was also used as a chemical 
foundation to develop a Cu(I)-selective fluorophore, mito-CS1, for detecting labile Cu(I) 
pools in localized subcellular compartments, such as mitochondria, by the conjugation of 
a synthetic localization tag to the BODIPY fluorophore.12  In addition, Cu(I)-selective fluo-
rescent probes based on the cyanine 7 fluorophore platform have been developed for 
application in two-photon and near-infrared imaging of Cu(I) in tissues and whole animals, 
demonstrating the versatility of designing Cu(I)-responsive fluorescent probes for employ-
ment in various types microscopy.6, 13-14   
  
5.2 Evaluating the Fluorescence Response of Cu(I)-Selective Fluorescent 
Probes in the Presence of Liposomes 
5.2.1 Assessing the Fluorescence Dependence of Coppersensor-3 (CS3) on the Polarity 
Environment 
Despite the formation of colloidal aggregates in aqueous solution, the employment 
of CS3 (5.2, Figure 5.1) for cellular imaging has been quite pervasive throughout the liter-
ature for use in detecting labile Cu(I) in a wide variety of organisms.11-12, 15-20 To verify the 
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formation of colloidal aggregates, dynamic light scattering (DLS) measurements with CS1 
and CS3 (5 µM each) in aqueous buffer (10 mM MOPS/K+, pH 7.2, 25°C) indicated the 
formation of probe nanoparticles with average sizes equal to 49 nm and 67 nm, respec-
tively.1  As previously mentioned, the formation of colloidal aggregates may alter the pho-
tophysical properties of the metal-free probe in the aggregated form relative to the mono-
meric form, including a shift in the maximum emission wavelength or an increase or de-
crease in the fluorescence intensity. To determine whether CS3 undergoes aggregation-
induced fluorescence quenching, the photophysical properties of both metal-free and 
Cu(I)-saturated CS3 were evaluated in the presence of liposomes and compared to those 
in aqueous buffer.   
Although CS3 was reported to undergo a 75-fold fluorescence enhancement upon 
saturation with Cu(I) in aqueous buffer,11 only fluorescence contrast ratios up to ~ 13 were 
achieved, despite rigorous column purification, as well as supplementation with MCL-121, 
a water-soluble high-affinity Cu(I) chelator that would sequester adventitious Cu(I) from 
the buffer (Figure 5.2A).  To compare the signaling response of CS3 in aqueous buffer 
with the fluorescence response in the presence of liposomes, the fluorescence emission 
of CS3 was evaluated in the presence of 100 µM 1,2-dimyristoyl-sn-glycero-3-phosphor-
ylcholine (DMPC) as model membranes.   
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Figure 5.2: Comparison of the fluorescence response of CS3 (2 µM) upon saturation with Cu(I) in 
the presence (A) and absence (B) of DMPC liposomes (100 µM) pH neutral aqueous buffer (10 
mM PIPES, 100 mM KCl, pH 7.0, 25°C). Inset: time-dependent fluorescence change at 555 nm 
prior to saturation of Cu(I). Excitation: 530 nm.   
 
In support of a slow kinetics of dissolution of the aggregated form into the bilayer 
of the liposomes20, CS3 displayed a time-dependent fluorescence increase in the pres-
ence of buffer containing 100 µM DMPC liposomes, reaching its maximum fluorescence 
intensity after approximately 20 minutes depending on the rate of stirring (Figure 5.2B, 
inset).  Addition of Cu(I), produced by in situ reduction of CuSO4•5H2O by excess sodium 
ascorbate (NaAsc) as a reducing agent led to a 15% decrease in the emission intensity of 






















































CS3, in sharp contrast to the 12-fold increase in the fluorescence intensity upon saturation 
with Cu(I) in buffer containing no liposomes.  In addition, CS3 underwent a blue shift of 5 
nm towards shorter wavelength upon binding to Cu(I) in both the presence and absence 
of DMPC-containing liposomes.  These observations indicate that metal-free CS3 under-
goes an aggregation-induced fluorescence quenching, which, upon deaggregation into its 
monomeric form, results in a liposome-mediated turn-on response, even in the absence 
of Cu(I) binding.   
Given the varied mixture of phospholipids present in cellular membranes across 
organisms, giving rise to deviations in the surface charge density as a consequence of the 
phospholipid head groups, the fluorescence response of CS3 was evaluated in a liposome 
mixture comprising neutral DMPC and anionic sodium 1,2-dimyristoyl-sn-glycero-3-phos-
phorylglycerol (DMPG) in a 4:1 ratio to model the surface charge density of cellular mem-
branes.  Both lipids have similar phase transition temperatures and, as a consequence of 
their fully saturated fatty acid chains, are stable towards lipid peroxidation.  To compare 
the size of newly prepared 4:1 DMPC:DMPG liposomes to that of the 100% DMPC lipo-
somes used in previous experiments with CS3, the freshly extruded liposomes measured 
by tunable resistive pulse sensing (TRPS) displayed an average diameter of 120 nm, with 
the size distribution peaking at 100 nm (Figure 5.3).   
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Figure 5.3: Size distribution of 4:1 DMPC/DMPG liposomes prepared in 10 mM PIPES buffer (pH 
7.0, 0.1 M KClO4, 25°C) through mechanical extrusion (200 nm pore size polycarbonate mem-
brane). The average diameter of the liposomes is 120 nm and the size distribution peaks at a 
diameter of 100 nm. Figure and caption reproduced with permission from reference [22]. 
 
Incubation of CS3 (2 µM) in aqueous buffer (10 mM PIPES, 100 mM KClO4, pH 
7.0) at 25°C supplemented with a 4:1 DMPC:DMPG liposomes mixture (100 µM) displayed 
a time-dependent fluorescence increase consistent with observations in liposomes com-
posed of 100% DMPC lipids (Figure 5.4).  However, the equilibrium between the aggre-
gated form and the monomeric form displayed significantly slower kinetics of dissolution 
and required nearly five hours to fully reach its maximum fluorescence intensity once fully 
dissolved in the lipid bilayer (Figure 5.4, inset).  The Cu(I)-saturated CS3 displays a 3-nm 
hypsochromic shift in the emission, as well as a ~ 40% decrease in the fluorescence in-
tensity, suggesting that the net negative charge of the liposomes influences the signaling 
 302 
response of Cu(I)-CS3.  Interestingly, the liposome-mediated fluorescence turn-on re-
sponse of Cu(I)-free CS3 is nearly 50% stronger than the fluorescence response of Cu(I)-
saturated CS3 in buffer containing no liposomes.   
 
Figure 5.4: Fluorescence response of CS3 (2 µM) upon saturation with Cu(I) in the presence and 
absence of 4:1 DMPC:DMPG liposomes (100 µM) in pH 7.0 aqueous buffer (10 mM PIPES, 100 
mM KClO4, 100 nM MCL-1, 25°C). Inset: time-dependent evolution of the fluorescence intensity at 
555 nm prior to the addition of Cu(I). Solid lines represent measurements of CS3 in liposomes, 
whereas the dashed lines represent measurements of CS3 in aqueous buffer with no liposomes. 
Excitation: 530 nm. Figure adapted with permission from reference [22]. 
 
 To corroborate the discrepancies in the signaling response of CS3 in liposomes 
versus aqueous buffer, the fluorescence response of the lipophilic Cu(I) probe was com-
pared in MeOH and octanol.  As illustrated in Figure 5.5 (dashed lines), CS3 undergoes a 
6-fold increase in fluorescence upon saturation with Cu(I).   However, analogous meas-
urements in octanol, a solvent of much lower polarity, demonstrated a very minimal 
change in the fluorescence response upon saturation with Cu(I) (Figure 5.5, solids lines), 
suggesting that in more polar organic solvents such as MeOH, the Cu(I)-induced fluores-
cence increase is accompanied by a deaggregation of the probe.  

































Figure 5.5: Comparison of the fluorescence response of CS3 (2 µM) upon saturation with CuPF6 
in MeOH and Octanol. Solid lines represent measurements of CS3 in octanol, whereas the dashed 
lines represent measurements of CS3 in octanol. Excitation: 530 nm.  
 
5.2.2 CTAP-2 is a Water-Soluble Fluorescent Probe that Interacts with Lipid Bilayers 
Dynamic light scattering measurements with CTAP-1 analogous to those per-
formed with CS1 and CS3 revealed nanoparticle formation with an average hydrodynamic 
radius of approximately 63 nm, despite the presence of the carboxylic acid on the 1-aryl 
ring of the pyrazoline unit to promote water-solubility.1  The development of CTAP-2, there-
fore, included installation of additional water-solubilizing groups to increase the solubility 
in aqueous buffer at millimolar concentrations and prevent the formation of colloidal ag-
gregates.  When diluted from an aqueous concentrated stock solutions into the identical 
buffer used for CS3 measurements, CTAP-2 underwent a ~ 60-fold fluorescence en-
hancement upon saturation with Cu(I) with an emission maximum at 512 nm (Figure 5.6, 
dashed lines), consistent with the 65-fold fluorescence enhancement reported by Morgan 
et al.1 However, upon addition of CTAP-2 to aqueous buffer supplemented with a 4:1 
DMPC:DMPG liposome mixture (100 µM), CTAP-2 exhibited a strong blueshift of 26 nm 






















relative to metal-free CTAP-2 in aqueous buffer without liposomes, indicating a strong 
interaction with the lipid bilayer of the liposomal vesicles (Figure 5.6, solid black line).  
Interestingly, upon saturation of lipid-solvated CTAP-2 with Cu(I), the emission spectrum 
underwent a 26-nm redshift (Figure 5.6, solid red line) to match that of the Cu(I)-saturated 
CTAP-2 spectrum in aqueous buffer devoid of liposomes, suggesting that the Cu(I)-bound 
form does not significantly interact with the liposomes.   
 
Figure 5.6: Fluorescence response of CTAP-2 (2 µM) upon saturation with Cu(I) in the presence 
and absence of 4:1 DMPC:DMPG liposomes (100 µM mixture) in pH 7.0 aqueous buffer (10 mM 
PIPES, 100 mM KClO4, 100 nM MCL-1, 25°C). Solid lines represent measurements of CTAP-2 in 
liposomes, whereas the dashed lines represent measurements of CTAP-2 in aqueous buffer with 






























5.3 Characterization of a Water-Soluble, Lipid-Compatible Fluorescent 
Probe for Cu(I) with Sub-Part-Per-Trillion Sensitivity 
As previously observed with CS3 and CTAP-2, de-aggregation of lipophilic fluoro-
phore colloids upon partitioning into the lipid phase of liposomes can induce a metal cat-
ion-independent fluorescence increase, rendering the interpretation of staining patterns 
challenging when imaging the probes in live cells.  The development of CTAP-2 was real-
ized with an effort to improve the fluorescence contrast ratio (fe = 4.6) and modest fluores-
cence quantum yield (ΦF = 0.14) of CTAP-1 in aqueous buffer while increasing the water-
solubility without compromising cell-membrane permeability.  While the optimization led 
to a 14-fold improvement in the fluorescence contrast ratio, the decrease in the fluores-
cence quantum yield to 8% limited its detection sensitivity.  In addition, the metal cation-
independent fluorescence increase of CTAP-2 in the presence of liposomes was likely a 
structural consequence of the 3-aryl ring of the pyrazoline fluorophore.   Therefore, further 
optimization of the structure of CTAP-2 to improve the photophysical properties in aque-
ous buffer, while permitting interactions with liposomes that do not result in analyte-de-
pendent fluorescence increases, led to the development of CTAP-3 (5.8, Figure 5.7) as a 
water-soluble, lipid-compatible, Cu(I)-selective fluorescent sensor for probing labile Cu(I) 
in biological samples.22  The following subsection describes the photophysical characteri-







Figure 5.7: Structural comparison between CTAP-2 (5.2) and CTAP-3 (5.8) 
 
5.3.1 Steady-State Absorption and Emission Properties of CTAP-3 in the Presence and 
Absence of Liposomes 
Similar to CTAP-2, the water-solubilizing ammonium sulfonate groups on the py-
razoline core permitted direct preparation of concentrated stock solutions at millimolar 
concentrations without the need for organic cosolvents. The molar absorptivity coefficients 
at the peak absorption of the free and Cu(I)-bound CTAP-3 remained relatively the same, 
however, the addition of Cu(I) shifted the absorbance maximum of the free form 3 nm 
towards shorter wavelength from 367 to 364 nm (Table 5.2).  Although PET renders the 
free form of CTAP-3 essentially non-fluorescent, titration with Cu(I) did not shift the 455-
nm emission maximum, which plateaued at 1.0 equivalent of Cu(I) relative to the probe, 
consistent with a 1:1 binding stoichiometry.  The saturation of CTAP-3 with Cu(I) resulted 
in an astounding 180-fold fluorescence enhancement factor, reaching a maximum fluo-






























Table 5.2: Photophysical properties of CTAP-3 (5.8) in aqueous buffer at pH 7.0.a  
 – Liposomes + Liposomesb 
 CTAP-3c [(CTAP-3)Cu(I)] CTAP-3c [(CTAP-3)Cu(I)] 
Absorbance lmax (nm)d 367 364 n.d. n.d. 
e (104 M–1cm–1)e 3.05 3.15 n.d. n.d. 
Emission lmax (nm)f 455 455 443 455 
ΦF g – 0.41 n.d. n.d. 
a10 mM PIPES, 0.1 M KClO4, 25°C. bbuffer supplemented with 100 µM liposomes (4:1 
DMPC:DMPG). csupplemented with 1 µM MCL-2 to sequester adventitious Cu(I). dlowest-energy 
band of the one-photon absorption spectrum. emolar extinction coefficient at lmax. fmaximum fluo-
rescence emission. gfluorescence quantum yield, referenced to norharmane (ΦF = 0.58).23 n.d. = 
not determined. 
 
 Incubation of CTAP-3 in pH-neutral aqueous buffer supplemented with the 4:1 
DMPC:DMPG liposome mixture resulted in a slight blueshift of 12 nm for the emission 
spectrum of CTAP-3 compared to the corresponding emission maximum of CTAP-3 in the 
absence of liposomes, which was expected for a fluorescent probe in a lower-polarity en-
vironment (Figure 5.8).  However, the association with the lipid bilayer effected only a 
slight increase in the baseline fluorescence intensity compared to CTAP-3 in neat buffer, 
and upon saturation with Cu(I), CTAP-3 displayed a more-than-60-fold fluorescence en-
hancement in the presence of liposomes.  As observed with CTAP-2, the presence of 
liposomes did not affect the emission spectrum of Cu(I)-bound CTAP-3, producing a 
nearly identical emission spectrum compared to Cu(I)-bound CTAP-3 in neat buffer.  In-
terestingly, control measurements of CTAP-3 in liposomes containing 100% DMPC 
demonstrated a similar 60-fold fluorescence enhancement upon saturation with Cu(I), sug-
gesting that weakness of the interaction with the liposomes cannot be attributed exclu-
sively to the electrostatic repulsion between the anionic liposomes and the dianionic 
charge of the CTAP-3.  
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Figure 5.8: Fluorescence response of CTAP-3 (2 µM) upon saturation with Cu(I) in the presence 
and absence of 4:1 DMPC:DMPG liposomes (100 µM mixture) in pH 7.0 aqueous buffer (10 mM 
PIPES, 100 mM KClO4, 100 nM MCL-1, 25°C). Solid lines represent measurements of CTAP-3 in 
liposomes, whereas the dashed lines represent measurements of CTAP-3 in aqueous buffer with 
no liposomes. Excitation: 365 nm.  Figure adapted with permission from reference [22]. 
 
5.3.2 Determination of the Protonation Constants of CTAP-3 
The presence of the N-arylthiaza ligand receptor of CTAP-3 renders the aniline 
nitrogen susceptible to protonation at lower pH, which would result in a protonation-in-
duced fluorescence increase by inhibiting photoinduced electron transfer from the donor 
group to the pyrazoline fluorophore.  To determine the protonation constant for the aniline 
nitrogen of CTAP-3, the change in the fluorescence response of the probe in 0.1 M KCl 
was measured as a function of decreasing pH.  As illustrated in Figure 5.9, the fluores-
cence emission of CTAP-3 remained quenched over the pH range of 7.0 to 4.0, after which 
the fluorescence intensity increased as a consequence of protonation of the aniline nitro-
gen.  Acidification below pH 1.5 ensued quenching of the fluorescence, suggesting the 
presence of a second protonation equilibrium most likely associated with the pyrazoline 
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ring of the fluorophore unit.  Nonetheless, non-linear, least squares fitting of the fluorimet-
ric data over the entire pH range of the titration yielded protonation constants (pKa’s) of 
2.00 ± 0.01 and 1.32 ± 0.01 for the two protonation equilibria.   
 
Figure 5.9: Fluorimetric pH titration of CTAP-3 at 25 °C in 0.1 M KCl. The fluorescence intensity at 
λmax = 455 nm was recorded as a function of pHc (–log[H3O+]), and the data were analyzed by non-
linear least-squares fitting using equation 5-1 in Section 5.6.6 to yield the average pKa values of 
pKH1 = 1.99 ± 0.01, and pKH2 = 1.32 ± 0.01. Figure and caption were adapted with permission from 
reference [22]. 
 
5.3.3 Determination of the Cu(I) Stability Constant of CTAP-3 
The transition from the NS4-thiazacrown of CTAP-1 to the NS3-thiaza ligand recep-
tor of CTAP-2 led to a one log-unit increase in the apparent binding affinity, from 10.4 to 
11.4, respectively.  Despite the presence of an NS3-thiaza ligand receptor in CTAP-3, 
optimization of the PET-driving force to increase in the fluorescence contrast ratio of 
CTAP-2 let to the fusion of the thioether-containing receptor ligand to the aniline ring of 
the donor moiety of CTAP-3, thus decreasing the conformational flexibility of the receptor 
ligand, which was expected to increase fluorescence turn-on response.  This structural 
change was also expected to influence the affinity for binding Cu(I).  Taking advantage of 


















a series of robust Cu(I) affinity standards developed by Fahrni and coworkers,21 MCL-2 
served as a Cu(I)-selective ligand to compete with CTAP-3 for Cu(I) with matching affinity.  
To determine the apparent stability constant of CTAP-3, fluorimetric titrations of CTAP-3 
with the tripodal MCL-2 affinity standard were performed by first saturating CTAP-3 with 
the Cu(I) complex of MCL-2, followed by titration with metal-free MCL-2 ligand over a 90-
10% fractional saturation window in aqueous buffer (10 mM MES, 100 mM KClO4, 25°C) 
at pH 6.0 to prevent precipitation of cuprous oxide at micromolar concentrations.  Non-
linear, least squares fitting of the fluorimetric titration data yielded a uniform apparent sta-
bility constant of logKCu()•CTAP-3 = 10.29 ± 0.06 (Figure 5.10).  Given a pKa of 2.0 for the 
aniline nitrogen, the apparent affinity of CTAP-3 for Cu(I) is expected to remain constant 
above pH 4.0.   
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Definition of Equilibrium System: 
Species Cu(I) MCL-2 CTAP-3 H logβ 
Cu(I) 1 0 0 0 0 
MCL-2 0 1 0 0 0 
CTAP-3 0 0 1 0 0 
MCL-2(H) 0 1 0 1 9.09 
[(MCL-2)Cu(I)] 1 1 0 0 13.08 
[(CTAP-3)Cu(I)] 1 0 1 0 10.29 ± 0.06 
 
Figure 5.10: A) Fluorimetric determination of the stability constant of CTAP-3 (5.8) via a competi-
tion titration with MCL-221. A solution of [(MCL-2)Cu]Na3PF6•7.5H2O (5 µM) and CTAP-3 (5 µM) 
was equilibrated in MES buffer at pH 6.0 (10 mM, 0.1 M KClO4, 25°C) and then titrated with MCL-
2 to a final concentration of 0.4 mM. The fluorescence traces (A) were analyzed by non-linear least 
squares fitting over the entire spectral range to yield an average logKCu(I)L of 10.29 ± 0.06 (n = 3). 
B) Fluorescence intensity change and corresponding fit to equilibrium model at 455 nm. Figure and 
caption were adapted with permission from [22]. 




































5.4 Characterization in Liposomes of an Emission-Ratiometric Fluorescent 
Probe for Monovalent Copper 
Previous attempts at microinjecting the Cu(I) complex of CTAP-3 into NIH 3T3 
mouse fibroblast cells to monitor fluctuations in labile Cu(I) using fluorescence microscopy 
revealed bursts of fluorescence followed by rapid decreases in the fluorescence intensity, 
indicating a swift demetallation of Cu(I)-bound CTAP-3 via the association with an endog-
enous ligand that sequesters Cu(I) from the probe.24 Present at millimolar concentrations 
in the cytosol, glutathione (GSH), a sulfur-containing, non-ribosomal tripeptide, is known 
to rapidly reduce Cu(II) to Cu(I) and is believed to function in the transport of intracellular 
Cu(I), in addition to functioning as a redox buffer25 and antioxidant for impeding oxidative 
stress from the production of reactive oxygen species (ROS).  Because of its high con-
centrations and propensities to coordinate Cu(I), it was hypothesized that GSH might have 
been responsible for stripping the Cu(I) ion from CTAP-3, leading to the rapid decrease in 
fluorescence.  The implication of this observation is that the binding affinities of current 
Cu(I) probes in the literature, including CTAP-3, are not high enough to compete with GSH 
for Cu(I) binding.  A series of spectrophotometric and potentiometric titrations performed 
by Fahrni and coworkers to establish a robust thermodynamic model for the GSH-Cu(I) 
equilibrium system indicated that GSH buffers intracellular Cu(I) at sub-femtomolar con-
centrations,26 which is consistent with buffered Cu(I) values based on the most recent 
determinations of the binding affinities of cellular Cu(I) chaperones.27-28  Therefore, in or-
der to detect cellular Cu(I) that is buffered at attomolar concentrations, a fluorescent probe 
with a Cu(I) binding affinity in the attomolar range or lower is required.   
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5.4.1 Probing Subfemtomolar Cellular Cu(I) Concentrations by Utilizing Phosphines and 
Phosphine Sulfides as Innovative Donors for Cu(I) Ligands 
To overcome the thermodynamic barrier for competing with GSH for Cu(I), both 
fluorescent probes and Cu(I) chelators needed to be redesigned to engage in stronger 
coordination with Cu(I), which entailed a complete overhaul of conventional synthetic lig-
ands to coordinate the soft metal cation.  Previous Cu(I)-selective ligands with 1:1 binding 
stoichiometries that employ amine-thioether combinations as donors for binding Cu(I) typ-
ically provide affinities in the picomolar to femtomolar range, with the tightest binder 
providing an affinity of logK ~ 16.  In comparison to these conventional donors, phosphines 
provide stronger coordination to soft metal cations, such as Cu(I), but have the propensity 
to undergo oxidation when exposed to air.   
To achieve a higher binding affinity using phosphines as stronger donors without 
undergoing aerial oxidation, phosphine sulfides, which boast a polarized P-S bond that 
was expected to increase the donor strength compared to thioethers while remaining un-
susceptible to aerial oxidation, in combination with phosphines, were employed in the de-
velopment of PSP-2, an EDTA-like chelator that was expected to bind Cu(I) with signifi-
cantly higher affinity than MCL-1 (Figure 5.11).  Molar-ratio titrations by Morgan et al. of 
PSP-2 against the preformed Cu(I) complex of BCA (2,2’-bicinchoninic acid) confirmed a 
1:1 binding stoichiometry.29  In addition, competition titrations with PSP-2 in the presence 
of excess BCS (disodium bathocuproine disulfonate) revealed an apparent stability con-
stant of logKCu(I)•PSP-2 = 20.02 ± 0.06 for the 1:1 complex, corresponding to an apparent 
dissociation constant of Kd = 10 zM (zeptomolar), categorizing the ligand as one of the 




Figure 5.11: Structures of MCL-1, MCL-2, PSP-2, and fluorescent probe 5.9 
 
Despite the extraordinary affinity for Cu(I) that exceeds the affinity range of cyto-
solic metallochaperones, such as Atox1, PSP-2 did not interact with other divalent 3d tran-
sitions metals with biological relevance, including Zn(II), Fe(II), and Mn(II), even at con-
centrations of 1 mM (Figure 5.12).  In addition, by virtue of its non-basic phosphines and 
phosphine sulfides, PSP-2 did not show any evidence of protonation at a pH as low as 1 
(100 mM HClO4); therefore, the affinity for Cu(I) is expected to remain constant, irrespec-




























Figure 5.12: Absorption spectral changes of PSP-2 (25 µM) in response to Cu(I), acidification, and 
millimolar concentrations of selected divalent transitions metals.    
 
The electron-withdrawing capacities and donor strength of both phosphines and 
phosphine sulfides when electronically coupled to aromatic rings provided rationale for 
integrating the ligand motif into the design of a noncentrosymmetric dipolar donor-accep-
tor fluorophore whose fluorophore core is similar to chromis-1 and 2.  In contrast to rati-
ometric fluorophores, the employment of turn-on fluorescent probes for probing biological 
copper inhibits the reliable quantification of cellular metal-ion concentrations, which is im-
portant for understanding intracellular copper homeostasis given its health implications. 
Taking advantage of the strategies for designing emission-ratiometric non-centrosymmet-
ric D-A fluorophores discussed in Chapter 1, in addition to synthetic developments in re-
dox-stable phosphine sulfide chemistry as substitutes for conventional thioethers for co-
ordinating Cu(I), the following subsections discuss the characterization of the emission-
ratiometric fluorescent probe (5.9, Figure 5.9) with a Cu(I)-binding motif that was adopted 
from the high-affinity PSP-2 ligand.  















PSP-2 + 1 mM Mn(II)
PSP-2 + 1 mM Fe(II)
PSP-2 + 1 mM Zn(II)
PSP-2 + 100 mM HClO4
PSP-2 + 25 µM Cu(I)
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5.4.2 Absorption and Fluorescence Properties of Probe 5.9 
Despite the presence of substantially polarized P-S bonds from the phosphine sul-
fides that increase its water solubility, all characterizations were initially performed in meth-
anol to avoid interferences in the fluorescence properties due to potential aggregation in 
aqueous buffer as a consequence of the lipophilicity of the fluorophore moiety.  Morgan et 
al established that saturation of 5.9 with [(MCL-2)Cu(I)]PF6 in an air-equilibrated, 95% 
MeOH (5% water) solution yielded a 24-nm shift in the absorption from 410 nm (ε = 27,200 
M–1•cm–1) to 434 nm (ε = 27,300 M–1•cm–1) for the Cu(I)-saturated form (Figure 5.13A).  
Similarly, in the emission, a molar-ratio titration of 5.9 with [(MCL-2)Cu(I)]PF6 in MeOH 
produced a 52-nm shift from 581 nm to 633 nm in the emission (Figure 5.13B).  Clean 
isosbestic points at 421 nm in the absorption and 634 nm in the emission, in addition to a 
sharp saturation at 1.0 molar equivalent of Cu(I) relative to probe, signified an unambigu-
ous, single-coordination equilibrium between free 5.9 and its corresponding Cu(I) complex 
with a 1:1 binding stoichiometry.  
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Figure 5.13: Spectral changes of 5.9 (5 µM) upon incremental addition of Cu(I) in MeOH. A) Se-
lected absorbance spectra of upon addition of [(MCL-2)Cu(I)]PF6 to the probe in MeOH. B) Fluori-
metric titration of 5.9 with [(MCL-2)Cu(I)]PF6 from 0-1.3 µM in 0.1 µM aliquots.  Excitation: 460 nm. 
Red traces indicate the absorption and fluorescence spectra of Cu(I)-saturated 5.9. Data acquired 
by M. Thomas Morgan, Ph.D., but figure was prepared by the author. 
 
After observing that probe 5.9 engages in coordination to Cu(I) with a 1:1 metal-
ligand stoichiometry, in addition to exhibiting a red shift of both the excitation and emission 
spectra, characterization of the fluorescent probe in aqueous buffer supplemented with 
liposomes served to provide a biologically relevant comparison to cellular imaging studies.  






























5.9 + 0.5 eq. Cu(I)




The transition from liposomes comprising 100% DMPC to a 4:1 DMPC:DMPG mixture 
served to provide a lipid mixture with a more biologically relevant charge density as ob-
served in the lipid bilayer of cell membranes.  However, cellular membranes also comprise 
myriad phospholipids with varying degrees of saturation to enable fluidity.  This under-
standing directed the characterization of the fluorescence properties of 5.9 in an even 
more biologically relevant lipid composition containing 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) and sodium 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-glyc-
erol (POPG) in a 4:1 ratio.  However, the presence of an unsaturated fatty acid chain in 
both POPC and POPG led to the slow peroxidation of the oleoyl chain of the phospholip-
ids, despite storing the liposome concentrate at 4°C in deoxygenated buffer prior to extru-
sion to prevent decomposition of the lipids.  The peroxide formation led to the in situ oxi-
dation of the probe, which was manifested by a decrease in the fluorescence intensity and 
a broadening of the emission spectrum of the free form of 5.9, leading to a change in the 
emission ratio.  Supplementation of a freshly prepared liposome concentrate with the an-
tioxidant α-Tocopherol (1 mol %), which was intended to prevent peroxidation of the fatty 
acid chains, still led to decomposition of the phospholipids over time. However, oxidation 
of the probe within the cell should not be an issue, as the cell contains complex chemical 
machinery to ensure a proper redox balance for maintaining homeostasis. 
To overcome the propensity for oxidation of the fluorophore, the liposome compo-
sition was switched back to the 4:1 DMPC:DMPG mixture for probe characterization.  
Upon dilution from a concentrated stock solution in DMSO into aqueous buffer supple-
mented with 4:1 DMPC:DMPG liposomes (100 µM), probe 5.9 underwent a 59-nm red-
shift in the emission from 556 nm to 615 nm, with corresponding fluorescence quantum 
yields of 0.21 and 0.54 for the metal-free and Cu(I)-bound species (Table 5.3), respec-
tively, when referenced to coumarin 153 (ΦF = 0.544 in EtOH).30  However, the stepwise 
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saturation of 5.9 with Cu(I) performed in aqueous buffer supplemented with liposomes 
revealed the presence two isosbestic points that formed over the course of the molar-ratio 
titration, alluding to the presence of multiple species in solution (Figure 5.14).   
Interestingly, the addition of the first aliquot (0.1 mol eq.) of Cu(I) to 5.9 observed 
a significantly larger change in the emission compared to the successive aliquots.  Fur-
thermore, the addition of 0.5 molar equivalents of Cu(I) displayed a larger change in the 
fluorescence, in addition to the formation of a second isosbestic point.  While the clean 
isosbestic point observed in the molar ratio titration of 5.9 in MeOH precluded the for-
mation of multiple metal-ligand complex equilibria, the divergent behavior of the probe in 
the presence of liposomes is likely due to the ability for 5.9, once dissolved in the lipid 
bilayer, to become exposed to a membrane-impermeable Cu(I) source.   
 
Figure 5.14: Fluorescence spectral changes of 5.9 upon incremental addition of Cu(I).  Probe 5.9 
(2 µM) was incubated in aqueous buffer (10 mM PIPES, 100 mM KCl, pH 7.0, 25°C) supplemented 
with 4:1 DMPC:DMPG liposomes (100 µM) and titrated with [(MCL-2)Cu(I)] from 0-1.2 µM in 0.1 
µM aliquots.  Excitation: 450 nm.     
 
 
















Table 5.3: Photophysical properties of ratiometric probe 5.9 in MeOH and in aqueous 
buffer at pH 7.0a. 
 MeOH Buffer + Liposomesb 
 5.9c [(5.9)Cu(I)] 5.9c [(5.9)Cu(I)] 
Absorbance lmax (nm)d 410 434 406 440 
e (104 M–1cm–1)e 2.72 2.73 2.15 2.22 
Emission lmax (nm)f 581 633 556 615 
ΦF g n.d. n.d. 0.21 0.54 
a10 mM PIPES, 0.1 M KCl, 25°C. bbuffer supplemented with 100 µM liposomes (4:1 DMPC:DMPG). 
c supplemented with 1 µM PSP-2 to sequester adventitious Cu(I). dlowest-energy band of the one-
photon absorption spectrum. emolar extinction coefficient at lmax. fmaximum fluorescence emission. 
g fluorescence quantum yield, referenced to coumarin 153 (ΦF = 0.544 in EtOH).30 
 
It was hypothesized that the divergent behavior is a result the thermodynamic bar-
rier for transverse diffusion of the probe between the two leaflets of the lipid bilayer being 
too high to allow the probe to diffuse from the inner leaflet of the liposomes to the outer 
leaflet, thus preventing exposure of the probe to Cu(I) and resulting in the formation of 
multiple metal-ligand species. It is possible that the dramatic change in the emission spec-
trum in the early stages of the molar ratio titration was due to an intramembrane associa-
tion between two probe molecules and one Cu(I) ion, and upon addition of 0.5 molar equiv-
alents of Cu(I), the formation of a species with a 1:1 stoichiometry emerged, thus mani-
festing a second isosbestic point. Nevertheless, incremental addition of Cu(I) led to the 
saturation of 5.9 at equimolar concentrations, despite alluding to the presence of three 
separate species in solution.  Molar ratio titrations of 5.9 in liposomes were not performed 
in the absorption, as the molar absorptivity coefficient of the probe is not large enough to 
provide a decent signal-to-noise ratio at a probe concentration of 2 µM.   
 To ensure that protonation of the julolidine nitrogen would not interfere with the 
ratiometric readout of the probe during both spectroscopic characterization and cellular 
staining experiments, given a pKa of aniline around 4.6,31  emission spectra of the free and 
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metal-bound probe were acquired in aqueous buffer pH 7.0 and 5.0 supplemented with 
the 4:1 DMPG:DMPC liposomes.  Comparison of the emission spectra indicated only a 
minimal narrowing of the emission response of the metal-free form at pH 5 compared to 
pH 7, whereas the Cu(I)-saturated form revealed a slightly high fluorescence intensity and 
wider profile on the red edge at pH 5 compared to 7 (Figure 5.15).     
 
Figure 5.15: Fluorescence dependence of probe 5.9 on pH.  Probe 5.9 was equilibrated in aqueous 
buffer (10 mM PIPES, 100 mM KCl, 25°C) at pH 7.0 and 5.0, both supplemented with 4:1 
DMPC:DMPG liposomes (100 µM each), and saturated with MCL-2-Cu(I).  Excitation: 450 nm.  
 
5.4.3 Metal-Ion Selectivity Measurements of Probe 5.9 
Fluorescent probe 5.9 displayed excellent selectivity for Cu(I) in the presence of 
other biologically relevant divalent transition metal ions.  In the presence of 5 equivalents 
(10 µM) of selected divalent metal ions, probe 5.9 demonstrated no change in its emission-
ratiometric response compared to free probe (Figure 5.16).  The interfering divalent metal 
ions did, however, result in a negligible decrease in the fluorescence intensity (Figure 5.16, 
solid black lines) but manifested no change in the emission ratio as a result, yielding an 















5.9 - pH 5.0
5.9 - pH 7.0
5.9 + Cu(I) - pH 5.0
5.9 + Cu(I) - pH 7.0
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average ratio of R = 6.00 ± 0.003 (Figure 5.17, orange bars).  Moreover, saturation of the 
probe with Cu(I) led to a ratiometric readout consistent with the formation of the [(5.9)Cu(I)] 
complex without any interfering divalent metal ions present in solution, with a uniform av-
erage ratio of R = 3.97 ± 0.07 (Figure 5.17, green bars).      
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Figure 5.16: Fluorescence response of 5.9 (2 µM) in the presence of 5.0 equivalents of selected 
divalent transition metal ions in pH 7.0 aqueous buffer (10 mM PIPES, 100 mM KCl, 25°C) supple-
mented with 100 µM 4:1 DMPC:DMPG liposomes. Black dashed curves represent the fluorescence 
spectrum of 5.9 in the absence of interfering metal, the solid black curves represent the spectrum 
in the presence of interfering metals, and the red solid curves represent saturation of the probe with 
Cu(I).  Excitation: 450 nm.   



























































































Figure 5.17: Fluorescence response of 5.9 (2 µM) towards selective divalent transitions metals and 
comparison to Cu(I) based on the intensities calculated from data provided in Figure 5.16. Re-
sponses were calculated based on ratio of the integrated fluorescence intensity between 590-750 
nm (channel 2) and 480-580 nm (channel 1)).  The orange bars represent the ratio in the presence 
of 5 equivalents of interfering transition metals, and the corresponding green bars represent the 
ratio after saturating fluorescent probe with Cu(I). Excitation: 450 nm.     
 
5.4.4 Probe 5.9 Boasts an Attomolar Binding Affinity for Cu(I) 
Incorporation of the phosphine-phosphine sulfide ligand motif of PSP-2 demanded 
the use of a Cu(I)-selective chelator with well-characterized thermodynamics properties 
as an affinity standard for determining the apparent stability constant of 5.9.  Of the affinity 
standards to Cu(I) available as tools to elucidate the thermodynamic properties of the flu-
orescent probe, MCL-1 possessed the best matching affinity to the expected binding af-
finity of 5.9 within the 90:10 fractional saturation window.  After incubation of the probe (2 
µM) in aqueous buffer supplemented with 4:1 DMPC:DMPG liposomes, addition of [(MCL-
1)Cu(I)] and subsequent titration of MCL-1 from 0 to 640 µM afforded fluorescence spec-
tral data that, upon non-linear least squares fitting, yielded an apparent stability constant 
of 17.0 ± 0.2, corresponding to an apparent dissociation constant of Kd = 10 ± 5 aM (Figure 
5.18). 












Definition of Equilibrium System: 
Species Cu(I) MCL-2 5.9 H log β 
Cu(I) 1 0 0 0 0 
MCL-2 0 1 0 0 0 
5.9 0 0 1 0 0 
MCL-1(H) 0 1 0 1 7.11 
[(MCL-1)Cu(I)] 1 1 0 0 16.33 
[(5.9)Cu(I)] 1 0 1 0 17.0 ± 0.2 
 
Figure 5.18: A) Fluorimetric determination of the Cu(I) stability constant of probe 5.8 via a compe-
tition titration with MCL-121. A solution of probe 5.9 (2 µM) was equilibrated in PIPES buffer at pH 
7.0 (10 mM, 100 mM KCl, 25°C) supplemented with 4:1 DMPG:DMPC liposomes.  The probe was 
saturated with [(MCL-1)Cu(I)] and titrated with MCL-1 from 0-640 µM. The fluorescence traces (A) 
were analyzed by non-linear least squares fitting over the entire spectral range to yield an average 
logKCu(I)L of 17.0 ± 0.2 (n = 3). B) Fluorescence intensity change and corresponding fit to equilibrium 
model at 640 nm. 










































Previously developed Cu(I)-responsive fluorescent probes that have become the 
cornerstone of copper biochemistry by serving as chemical tools for the cost-effective de-
tection of Cu(I) in biological samples4, 32 have been based on hydrophobic, thioether-rich 
receptor ligands that are linked to uncharged fluorophore units, which tend to aggregate 
when diluted into aqueous solution. Although it is crucial that these small-molecule fluo-
rescent probes be lipophilic enough to passively diffuse across cellular membranes, it is 
also important that they be sufficiently water-soluble to prevent aggregation that may pro-
mote hydrophobic interaction-induced changes in the fluorescence response, independ-
ent of the metal analyte.  Two of the earliest fluorescent sensors for probing monovalent 
copper, CTAP-1 and Coppersensor-1 (CS1), both aggregate in aqueous solution, which 
was discovered through dynamic light scattering experiments.1  Even the presence of the 
carboxylic acid group of CTAP-1 did not provide enough ionizable character to prevent 
aggregation.   
Modifications to the structures of the two fluorescent probes to promote increased 
water-solubility and improve the photophysical properties, such as increasing the fluores-
cence enhancement factor, afforded the second-generation fluorescent probes CTAP-2 
and Coppersensor-3 (CS3).  While polyhydroxylation of the thiazacrown ligand receptor 
and installation of a sulfonic acid group on the fluorophore unit achieved water-solubility 
in the millimolar concentration regime in aqueous solution, CTAP-2 displayed a liposome-
mediated fluorescence enhancement that yielded a fluorescence intensity nearly identical 
to that of the Cu(I)-bound form of CTAP-2 in the absence of liposomes, as well as a sub-
stantial lipid-mediated blue shift compared to aqueous buffer.  Moreover, metal-free CS3 
also displayed a liposome-mediated fluorescence turn-on response that was 2-fold higher 
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than the intensity of the Cu(I)-bound form in the absence of liposomes, and upon satura-
tion with Cu(I), the fluorescence intensity of CS3 in the presence of liposomes decreased 
roughly 40%. This observation significantly deviates not only from the 75-fold enhance-
ment originally reported but also from the ~ 12-fold enhancement that was observed when 
comparing the fluorescence responses of CS3 to CTAP-2 at equimolar concentrations in 
liposome-free aqueous buffer.      
Both CTAP-2 and CS3 represented innovative advancements in the development 
of molecular tools for probing Cu(I) biochemistry, but the weak fluorescence quantum yield 
of CTAP-2 limited its detection senstivity, and CS3’s lipid-mediated fluorescence turn-on 
response that decreases upon binding Cu(I) contradicts the cellular staining patterns ob-
served in mammalian cells.  Therefore, there exist vacancies in the availability of biologi-
cally useful fluorescent probes for Cu(I).  To overcome this, drastic improvements in the 
reduction of the PET driving force of the triarylpyrazoline unit present in both CTAP-1 and 
CTAP-2 led to the development of CTAP-3, which offered a nearly 5-fold increase in the 
fluorescence quantum yield, as well as a profound 180-fold contrast ratio in free aqueous 
buffer and a more-than-60-fold contrast ratio in the presence of liposomes.  Despite the 
knowledge-driven approach to developing a water-soluble and lipid-compatible fluores-
cent probe for Cu(I), its picomolar affinity for Cu(I) and its membrane-impermeability by 
virtue of its two sulfonic acid groups limits its application in biological imaging.    
The transition from the optical turn-on response of CTAP-3 to the emission-rati-
ometric fluorescence response of probe 5.9 enabled the ability to obtain meaningful quan-
titative data from cellular imaging studies with the probe.  Moreover, the redesign of the 
metal-acceptor ligand provided a nearly six logarithmic-unit increase in the stability con-
stant, which enables the probe to effectively compete with endogenous GSH for free Cu(I).  
However, the lack of water-solubilizing groups demanded photophysical characterization 
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to be performed in the presence of liposomes, which hampered the metal-binding equilib-
rium by allowing homoleptic ternary complex formation, despite methanolic characteriza-
tion alluding to an unambiguous 1:1 binding equilibrium. Nonetheless, probe 5.9 repre-
sents the first example of an emission-ratiometric fluorescent probe for Cu(I) that boasts 
a high-enough affinity to compete with endogenous GSH.   
While the supplementation of fluorescent probes with water-solubilizing groups 
can significantly increase hydrophilicity and preclude aggregation, a drastic change in the 
photophysical properties of the fluorophore, such as the quantum yield or enhancement 
factor, can result, which may demand further optimization.  Instead, to ensure that the 
solution chemistry is representative of the behavior in cells, photophysical characterization 
of lipophilic probes should be performed in aqueous buffer that is supplemented with lip-
osomes as model membranes to mimic the dichotomous environment of the cell.  Moreo-
ver, even if the structure of a fluorescent probe has been supplemented with hydrophilic 
groups, its lipid compatibility should be investigated extensively to ensure that the fluores-
cence response in the cuvette matches its fluorescence behavior in the cell.   
5.6 Experimental Section 
5.6.1 General Spectroscopic Methods 
All buffers and probe stock solutions were prepared using JT Baker HPLC-grade 
water or 18.2 MΩ•cm Mili-Q water. Nevertheless, an increased background fluorescence 
due to traces of adventitious copper was frequently observed. It was therefore necessary 
to add a small amount of the high affinity Cu(I) ligand MCL-1 as a sequestrant in most 
experiments as described in detail below. Deoxygenation, where specified, was achieved 
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by bubbling with argon. Initial detection limit experiments indicated that the brass gas reg-
ulator could serve as an additional source of copper contamination, which was prevented 
by passing the argon through a 5 µM filter. UV-vis absorption spectra were acquired at 
25°C with a Varian Cary Bio50 spectrophotometer with constant temperature accessory. 
Fluorescence spectra were recorded with a PTI fluorimeter equipped with a 75 W xenon 
arc lamp excitation source and model 814 photomultiplier detection system (PMT voltage 
1100 V for all measurements). The fluorescence spectra were corrected for the spectral 
response of the detection system and for the spectral irradiance of the excitation source 
(via a calibrated photodiode). The path length was 1 cm for absorbance and fluorescence 
spectra and 10 cm for absorbance measurements for determining the fluorescence quan-
tum yields.  
5.6.2 Preparation of Liposomes 
A 2 mM solution of a 4:1 mixture of 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
(DMPC): 1,2-dimyristoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DMPG) was prepared 
according to the thin-film hydration method.33 After dissolving DMPC (32.3 mg) and DMPG 
(8.21 mg) in 4:1dichloromethane:methanol (20 mL), the solvent was evaporated under 
reduced pressure (Rotavap) to produce a thin film of the lipid. Remaining solvent traces 
were removed by drying under high vacuum for 2 hours. The lipid film was then hydrated 
by addition of 29.8 mL of aqueous buffer (10 mM PIPES, 0.1 M KClO4, 100 nM MCL-1, 
pH 7.0) that had been deoxygenated by purging with argon. The resulting solution was 
sonicated for 5 min and passed 21 times through an extruder (LiposoFast, Avestin) 
equipped with a polycarbonate membrane (200 nm pore size). The freshly extruded 
DMPC liposomes were immediately used for the experiments described below.  For ex-
periments conducted in 100% DMPC liposomes, DMPC lipids (13.56 mg) were dissolved 
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in dichloromethane (10 mL), and the dichloromethane was removed under reduced pres-
sure to produce a thin film.  The film was then dried under high vacuum for 2 hours and 
then hydrated in the buffer described above.  The remaining procedure is identical com-
pared to the 4:1 DMPC:DMPG liposomes.   
5.6.3 Liposome Size Distribution 
Liposome diameters were measured based upon the Tunable Resistive Pulse 
Sensing (TRPS) principle using an Izon qNano particle analyzer (Izon Science Ltd., Burn-
side, New Zealand).  The instrument was calibrated with monodisperse carboxylated pol-
ystyrene particles (200-nm diameter) in deionized water (Izon) following the manufac-
turer’s recommendations. The membrane pore size used for these measurements was 
150-300 nm. Calibration and particle analysis runs were conducted with a 46-mm na-
nopore stretch, an electric potential of 0.44 V, and an applied pressure of 10 mm Hg (var-
iable pressure module). Each measurement was performed by detecting a minimum of 
1000 particles. The data were analyzed using the Izon Control Suite 2.1 software to de-
termine the mean diameter and size distribution of the liposomes. 
5.6.4 Fluorescence Response of CS3 in DMPC liposomes and Comparison to MeOH 
and Octanol 
The fluorescence response of CS3 upon addition of Cu(I) in the presence of DMPC 
liposomes was measured in aqueous buffer at pH 7.0 (10 mM PIPES, pH 7.0, 0.1 M KClO4, 
100 nM MCL-1). A freshly prepared 2-mM DMPC liposome concentrate in 10 mM PIPES 
(pH 7.0, 0.1 M KClO4) was diluted into PIPES buffer and mixed gently to yield a 500 µM 
liposome solution, which was extruded immediately prior to use. In a quartz cuvette with 
a 1-cm pathlength, PIPES buffer (2.40 mL) was diluted with the 500 µM extruded liposome 
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solution (600 µL), and after equilibrating at 25°C for 10 minutes by magnetic stirring, CS3 
was added (from a 3 mM stock solution in DMSO) to a final concentration of 2 µM. After 
equilibrating for 30 minutes, the solution was supplemented with 250 µM sodium ascor-
bate as reducing agent, which was directly diluted into the cuvette from a 250 mM stock 
solution (diH2O). To the solution was added CuSO4 (from a 6 mM stock solution (diH2O) 
to yield final concentration of 3 µM. A fluorescence emission spectrum was acquired over 
the spectral range from 540-700 nm with excitation at 530 nm before and after addition of 
CuSO4. The fluorescence response of CS3 towards Cu(I) in octanol and MeOH was as-
sessed under the same conditions described above. 
5.6.5 Fluorescence Response of CS3, CTAP-2, and CTAP-3 Towards Cu(I) in the Pres-
ence of DMPC:DMPG (4:1) Liposomes 
The fluorescence response of CTAP-3 upon addition of Cu(I) (prepared by in situ 
reduction of CuSO4) in the presence of 4:1 DMPC:DMPG liposomes was measured in 
PIPES buffer at pH 7.0 (10 mM, pH 7.0, 0.1 M KClO4, 100 nM MCL-1). A freshly prepared 
500 µM DMPC:DMPG (4:1) liposome stock solution in 10 mM PIPES (pH 7.0, 0.1 M 
KClO4) was diluted into PIPES buffer and mixed by gentle inversion to yield a final lipo-
some concentration of 100 µM. The resulting solution (3.0 mL) was transferred to a fluo-
rescence cuvette (1 cm pathlength) and CTAP-3 was added (300 µM stock solution in 
diH2O) to a final concentration of 2 µM. Furthermore, the solution was supplemented with 
250 µM sodium ascorbate as reducing agent, which was directly diluted into the cuvette 
from a 250 mM stock solution (diH2O). The resulting solution was equilibrated for 30 min 
and CuSO4 was added from a 6 mM stock solution (diH2O) to yield final concentration of 
3 µM. A fluorescence emission spectrum was acquired over the spectral range from 380-
700 nm with excitation at 365 nm before and after addition of CuSO4. The fluorescence 
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response of CTAP-2 and CS3 towards Cu(I) was assessed under the same conditions 
described above for CTAP-3, except that CTAP-2 was diluted into the PIPES buffer from 
a 5 mM stock solution in diH2O, and CS3 was diluted into the PIPES buffer from a 2 mM 
stock solution in DMSO. Fluorescence spectra for CTAP-2 were acquired over a spectral 
window of 400-700 nm with an excitation at 380 nm, and fluorescence spectra for CS3 
were acquired over a spectral window of 540-700 nm with excitation at 530 nm.   
5.6.6 Determination of the Protonation Constants of CTAP-3 
A 5 μM solution of CTAP-3 in aqueous 0.1 M KCl was prepared and the solution 
pH was adjusted to 6.0. To remove interfering dust particles or fibers, the solution was 
passed through a 0.2 μm membrane filter. A combined potentiometric and fluorimetric 
titration was carried out in a quartz cuvette with 1 cm pathlength by addition of HCl to 
adjust the pH between 6.0 and 0.5 (constant temperature accessory set to 25°C). After 
addition of each aliquot acid, the solution equilibrated, the potential was recorded (in mV), 
and the fluorescence intensity was measured at 455 nm with excitation at 365 nm. The 
data were analyzed by non-linear least-squares fitting using equation 5.1 below: 
𝐹 = 	
𝐹$%&𝐾%( 𝐻*𝑂, + 𝐹$./𝐾%(𝐾%0
𝐻*𝑂, 0 + 𝐻*𝑂, 𝐾%( + 𝐾%(𝐾%0
  (5-1) 
where F is the measured fluorescence intensity at pHc = –log[H3O+], Fmax and Fmin are the 
limiting fluorescence intensities, and Ka1 and Ka2 correspond to the first and second proto-





5.6.7 Determination of the Cu(I)-Binding Affinity of CTAP-3 
The Cu(I) stability constant for CTAP-3 was determined through a fluorimetric ti-
tration using the affinity standard MCL-2 as competing ligand. A solution of [(MCL-
2)Cu]Na3PF6•7.5 H2O (5 µM) and CTAP-3 (5 µM) in aqueous buffer (pH 6.0, 10 mM MES, 
0.1 M KClO4, 25°C) was equilibrated and then titrated with MCL-2 (3 mM stock solution in 
water) from 10-400 µM. After the addition of each aliquot, a fluorescence emission spec-
trum was acquired with excitation at 365 nm over the range of 380-700 nm. The data were 
analyzed by non-linear least squares fitting using Specfit.34  Based on the MCL-2 formation 
constant of logβ = 13.08 and a pKa of 8.98 (corrected upward by 0.11 units to account for 
0.1 M ionic strength)35, an average logK of 10.29 ± 0.06 was obtained. 
5.6.8 Analyte Selectivity of PSP-2 
In a quartz fluorescence cuvette with a 1-cm path length, a 25 µM solution of PSP-
2 (from a 3 mM stock solution in acetonitrile) was prepared in H2O (3.00 mL).  The solution 
was supplemented with divalent transition metal ions (from 500 mM stock solutions of 
each metal in H2O) to a final concentration of 1 mM.  An absorbance spectrum was ac-
quired from 195 to 350 nm before and after addition of each divalent metal cation tested 
(2 mM).  Divalent metal cations (Zn(II), Fe(II), and Mn(II)) were supplied as sulfate salts 
and prepared immediately before use.  To test the response of PSP-2 under acid condi-
tions, absorbance spectra of the free chelator were acquired in aqueous HClO4 (10 and 
100 mM).  For measurement of the Cu(I) complex of PSP-2, the ligand solution was sup-
plemented with [(MCL-2)Cu(I)]Na3PF6•7.5 H2O (from a 3 mM stock solution in H2O) to a 
final concentration of 25 µM, and an absorbance spectrum was acquired from 195-350 
nm.   
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5.6.9 Molar Ratio Titration of Probe 5.9 
The fluorescence response of 5.9 upon addition of [(MCL-2)Cu(I)]Na3PF6•7.5 H2O 
in the presence of 4:1 DMPC:DMPG liposomes was measured in aqueous buffer at pH 
7.0.  A freshly extruded 500 µM DMPC:DMPG (4:1) liposome stock solution in aqueous 
buffer (10 mM PIPES, 0.1 M KCl, 25°C) at pH 7.0 was diluted into PIPES buffer (2.40 mL) 
in a fluorescence quartz cuvette with a 1-cm pathlength to yield a final liposome concen-
tration of 100 µM. The resulting solution (3.0 mL) was supplemented with probe 5.9 (1 mM 
stock solution in H2O) to a final concentration of 2 µM, and the solution was equilibrated 
for 30 minutes.  A fluorescence spectrum was acquired over the spectra window of 460-
750 nm with excitation at 450 nm.  The solution was supplemented with [(MCL-
2)Cu(I)]Na3PF6•7.5 H2O (from a 3 mM stock solution in H2O) in 0.2-µM aliquots from 0-2.2 
µM, with equilibrations of 1 minute each, and fluorescence spectra were recorded after 
each aliquot addition.    
5.6.10 Fluorescence Response of Probe 5.9 at pH 7.0 and 5.0 
The fluorescence response of 5.9 upon addition of [(MCL-2)Cu(I)]Na3PF6•7.5 H2O 
in the presence of 4:1 DMPC:DMPG liposomes was compared in aqueous buffer at pH 
7.0 and pH 5.0.  A freshly extruded 500 µM DMPC:DMPG (4:1) liposome stock solution in 
aqueous buffer (10 mM PIPES, 0.1 M KCl, 25°C) at pH 7.0 was diluted into PIPES buffer 
(2.40 mL) in a fluorescence quartz cuvette with a 1-cm pathlength to yield a final liposome 
concentration of 100 µM. The resulting solution (3.0 mL) was supplemented with probe 
5.9 (1 mM stock solution in H2O) to a final concentration of 2 µM, and the solution was 
equilibrated for 30 minutes.  A fluorescence spectrum was acquired over the spectra win-
dow of 470-800 nm with excitation at 450 nm.  The solution was supplemented with 3 µM 
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[(MCL-2)Cu(I)]Na3PF6•7.5 H2O (from a 3 mM stock solution in H2O), and a fluorescence 
spectrum was acquired.  The procedure was repeated with the 4:1 DMPC:DMPG lipo-
somes prepared in aqueous buffer (10 mM PIPES, 100 mM KCl, 25°C) at pH 5.0.  
5.6.11 Analyte Selectivity of Fluorescent Probe 5.9 
A 100 µM solution (12 mL) of 4:1 DMPC:DMPG liposomes were prepared by dilu-
tion of the 2 mM liposome concentrate into buffer (10 mM PIPES-K+, pH 7.0).  While me-
chanically stirring for 15 minutes at 25°C, PSP-2 was added (1 mM stock solution in 
DMSO) to the buffered liposomes to afford a concentration of 500 nm in order to sequester 
an adventitious Cu(I). After equilibration, the liposomes were supplemented with 5.9 (2 
µM) by direct dilution from a 1 mM stock solution in DMSO, followed by a 30-min equili-
bration to ensure complete dissolution in the liposomes.  An aliquot (1.5 mL) of the result-
ing solution was transferred to a quartz cuvette (1 cm path length) and supplemented with 
each interfering divalent metal cation (10 µM), diluting directly from a 5 mM stock solution 
of each metal in H2O.  A fluorescence spectrum was acquired over the emission range of 
470 to 800 nm with 450 nm excitation after a 1-minute equilibration.  To ensure true se-
lectivity for Cu(I), each interfering metal solution was supplemented with Cu(I) (4 µM) as 
the MCL-2-Cu(I)•7.5H2O complex by diluting from a 3 mM stock solution in H2O.   The 
metal cations were supplied as aqueous solutions from the following salts: Co(II), Ni(II), 
and Pb(II) as nitrates; Mn(II), Fe(II), and Zn(II) as sulfates.  To prevent oxidation of Fe(II), 





5.6.12 Determination the Cu(I) Stability Constant of Probe 5.9 
The Cu(I) stability constant for 5.9 was determined through a fluorimetric titration 
using the affinity standard MCL-1 as competing ligand. A solution of 5.9 (2 µM) in aqueous 
buffer (pH 7.0, 10 mM PIPES, 0.1 M KCl, 25°C) containing 100 µM freshly extruded 4:1 
DMPC:DMPG liposomes (from a 500 µM liposome stock solution) was equilibrated for 30 
minutes.  The solution was supplemented with 2 µM [(MCL-1)Cu(I)] (from a 3 mM stock 
solution in H2O)  and then titrated with MCL-1 (from a 3 mM stock solution in H2O) from 0-
640 µM. After the addition of each aliquot, a fluorescence emission spectrum was acquired 
with excitation at 450 nm over the range of 470-750 nm. The data were analyzed by non-
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CONCLUSIONS AND FUTURE DIRECTION 
All the work described in this thesis is the product of strategic objectives that were 
aimed at addressing some of the key, fundamental issues regarding the tools currently 
available for elucidating zinc biochemistry in biological systems.  These issues are: 1) the 
status of suitable Zn(II)-responsive fluorescent probes designed for sensing labile Zn(II) 
in cells, and 2) the methods to characterize the photophysical and thermodynamic prop-
erties of the fluorescent probes whose application in cells is intended to yield both quali-
tative and quantitative data.  Regarding the status of suitable fluorescent indicators for 
detecting labile Zn(II) pools, the issues that plague the fluorescent probe field entail a lack 
of knowledge about the fundamental photophysical and thermodynamic properties of 
metal-binding probes and how these properties must be tailored for the particular imaging 
modality used to investigate the subtle changes in buffered Zn(II) levels in cells.  Further-
more, the lack of awareness of how the signaling responses of fluorescent probes in the 
cellular environment compare to their solution characterization often translates into mis-
leading interpretations of cellular data upon processing of the micrographs acquired from 
the fluorescence microscope.  As the fluorescent probes become more-routinely em-
ployed in multifarious biological imaging applications, these misleading interpretations of-
ten become perpetuated.  Considering these issues and the potential means to circumvent 
them, the quest for developing biologically applicable Zn(II)-responsive fluorescent probes 
optimized for TPEM led to the knowledge-driven design and optimization of a noncentro-
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symmetric dipolar donor-π-acceptor fluorophore platform whose photophysical and ther-
modynamic properties enabled the generation of quantitative data from which reliable buff-
ered Zn(II) concentrations could be calculated.   
6.1 Emission-Ratiometric Fluorescent Probes for Detecting Kinetically La-
bile Zn(II) Pools 
6.1.1 Optimizing the Photophysical Properties of Emission-Ratiometric Fluorescent 
Probes for TPEM 
Despite the difficult in designing emission-ratiometric fluorescent probes that un-
dergo shifts in the emission spectra upon binding of the metal cation, the development of 
the first emission-ratiometric probe1 for Zn(II) paved the way for a new fluorophore platform 
that offers large two-photon cross sections and elicits large chromatic shifts in both the 
excitation and emission spectra upon coordination of Zn(II), both of which are necessary 
for robust imaging capabilities using TPEM.  However, this probe served only as a proof 
of concept because the region for which the free and metal-bound species exhibited bal-
anced 2PA cross sections resided below the excitation range of the Ti:sapphire lasers of 
two-photon fluorescence microscopes.  By substituting the oxazole bridge with a thiazole 
bridge, the balanced two-photon cross section window was shifted into the range acces-
sible by the two-photon lasers, which gave rise to chromis-1, the emission-ratiometric, 
Zn(II)-selective fluorescent probe that enabled practical applications in biological imaging 
instead of remaining a proof of concept.   
The incorporation of hydrophilic groups into the structure of chromis-1 facilitated 
water-solubility while averting aggregation in the aqueous buffer in which the probe was 
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characterized.  Chromis-1 displayed a large 37-nm shift in the emission wavelength max-
imum, as well as a more-than-two-fold increase in the 2PA cross section, upon binding 
Zn(II), which are two properties necessary for effective TPEM imaging.  In addition, 
chromis-1 displayed excellent selectivity towards Zn(II) and a stability constant for the for-
mation of the corresponding Zn(II) complex in the low picomolar regime.  Chromis-1 ester, 
which served as the derivative of the probe used in biological imaging, enabled a reliable 
estimation of intracellular buffered Zn(II) concentrations between 50-100 pM based on an 
independent in situ calibration with the probe in live cells and the Zn(II) stability constant 
of the probe determined in liposomes as model membranes. This estimated concentration 
range agrees well with previously reported buffered Zn(II) levels using genetically encoded 
fluorescent probes.2 
6.1.2 Suppressing Excited-State Proton Transfer 
During the photophysical characterization of chromis-1 acid, it was evident that the 
pyridyl acceptor of the fluorophore core was undergoing an excited-state protonation, even 
at neutral pH in aqueous solution, which led to a fluorescence quenching and red-edge 
broadening of the fluorescence profile of the free form.  Literature precedent for remedying 
this phenomenon led to the rearrangement of the acceptor pyridine, which reduced the 
propensity for undergoing protonation in the excited state.  Incorporation of this newly 
optimized design into a metal-binding fluorophore, however, did not render the ESPT phe-
nomenon eradicated, but instead required tuning of the basicity of the metal-binding ligand 
that was discovered to facilitate an excited-state intramolecular proton transfer to the fluor-
ophore pyridine.  Further refinement of the photophysical properties of the 2-thiazolyl 
metal-binding fluorophore led to the incorporation of a brand-new metal-binding ligand, 
albeit with significantly reduced basicity compared to pyridine, into the structure of the 
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probe, giving rise to chromis-2 as the next generation Zn(II)-responsive, emission-rati-
ometric fluorescent probe for imaging labile Zn(II) in mammalian cells and tissue.  In ad-
dition, a control compound that does not bind Zn(II) yet still demonstrates a nearly identical 
emission response compared to the metal-free form of chromis-2 was developed to ensure 
that the fluorescence response of chromis-2 inside the cell was not the product of artifacts 
produced by the interaction of the probe with the lipid-rich environment of biological mem-
branes and lipid droplets.   
6.1.3 Tuning the Zn(II)-Binding Affinity of Emission-Ratiometric Fluorescent Probes 
The chemical identity of the metal-binding ligands that are tethered to the electron-
deficient acceptor moiety of the donor-acceptor fluorophore dictate the intrinsic binding 
affinity of the metal-binding fluorescent probe.  This was exploited in the design of the 2-
thiazolyl fluorophore core, which featured an aldehyde functionality to which any primary 
or secondary amine-containing ligand could be coupled, thereby demonstrating a modular 
synthetic approach.  This led to the development of a series of affinity-tuned fluorescent 
probes with Zn(II) stability constants that span a 10 logarithmic-unit range between logK 
of 5.35 and 15.1. However, as is the case with any associative metal-ligand exchange 
equilibrium, there exist both thermodynamic and kinetic barriers for metal exchange; there-
fore, a higher Zn(II)-binding affinity does not necessarily translate to the capability of de-
tecting tightly bound or unavailable Zn(II) if the kinetic component of the equilibrium pre-
cludes the exchange reaction at a reasonable rate.  Nonetheless, affinity tuning of fluo-
rescent probes represents a step in the right direction in terms of better understanding the 
changes in buffered Zn(II) levels and Zn(II) redistribution in the cellular environment.  
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6.1.4 Fluorescence Dependence on the Polarity Environment 
Although the majority of this work was devoted to the development and optimization 
of Zn(II)-responsive fluorescent probes, many of the strategies discussed throughout this 
thesis can be translated to the development of chemical tools for the detection of biologi-
cally relevant monovalent copper, the predominant species present inside the cell.  The 
presence of interfering quenching pathways by virtue of the rich redox chemistry of Cu(I) 
limited the number of fluorescent probes available for probing the metal ion, of which all 
utilized a fluorescence intensity-based signaling mechanism.  In addition, due to the highly 
lipophilic nature of these fluorescent probes, characterization of the photophysical and 
thermodynamic properties demonstrated divergent behavior in comparison to the corre-
sponding signaling responses inside the cell.   
To remedy this issue, the fluorescence behavior of several fluorescence turn-on 
probes were re-evaluated in the presence of liposomes that served to mimic the dichoto-
mous environment of cell.  The result was the demonstration of analyte-independent, lipid-
mediated increases in the fluorescence intensity of two Cu(I) probes, CS3 and CTAP-2, 
both of which deviated significantly from their fluorescence responses in aqueous buffer 
without liposomes.  The successor to CTAP-2, CTAP-3, did not display a lipid-mediate 
fluorescence increase and responded with a more-than-60-fold fluorescence enhance-
ment in the presence of liposomes.  The modest Cu(I)-binding affinity, however, prohibited 
its use for detecting biologically relevant Cu(I), which is believed to be buffered in the sub-
femtomolar regime due to the presence of endogenous glutathione (GSH).  This, in addi-
tion to the lack of quantitative analysis capabilities, prompted the development of probe 
5.9 as the first ratiometric Cu(I) probe.  The overall lipophilic properties of the probe de-
manded the presence of liposomes for solubility to ensure proper characterization, which 
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rendered the fluorescence behavior of the probe inconsistent between measurements.  
Despite its lipophilic nature, probe 5.9 was the first ratiometric fluorescent probe capable 
of detecting labile Cu(I) in the cell, its development constitutes a pivotal advancement in 
the design of fluorescent probes for imaging labile cellular Cu(I).   
6.2 Future Direction 
Despite its overwhelming advantages, the utilization of two-photon excitation mi-
croscopy in biological imaging has a few limitations, one of which is a lack of availability 
at most research centers because of its high cost.  The high photon flux required to in-
crease the probability of simultaneous two-photon excitation renders the optical equip-
ment, including lasers, very expensive, and for that reason, two-photon microscopes are 
not as pervasive as wide-field and confocal fluorescence microscopes, both of which uti-
lize less advanced lasers that enable one-photon excitation. The wavelength of excitation 
of the lasers in wide-fields and confocal microscopes are most often 405, 458, and 476 
nm, as well as a few others of longer wavelength, which are significantly red-shifted com-
pared to the wavelength of excitation (720 nm for two-photon) of the ratiometric fluorescent 
probes are presented in this work.  Therefore, to broaden the availability of Zn(II)-respon-
sive, emission-ratiometric fluorescent probes for biological imaging in a wide variety of 
applications, it would be advantageous to develop derivatives of these probes with red-
shifted wavelengths of excitation while still retaining many of the intrinsic photophysical 
and thermodynamic properties that overwhelmingly make these probes far superior com-
pared to the Zn(II)-binding fluorescent probes currently available.   
There are several strategies for shifting the wavelength of excitation to longer 
wavelength.  One such strategy is to increase the strength of the electron-rich donor.  
While the anisole donor of the chromis series, including the affinity-tuned analogs, serves 
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as a pH-insensitive donor group, the decreased donor strength of oxygen compared to 
nitrogen, for example, can limit the degree of charge delocalization throughout the π-sys-
tem.  Therefore, substituting the anisole for an N-alkylated aniline group to provide a 
stronger electron donor will enable a shift of the wavelength of excitation further into the 
visible range.   Another strategy is to increase the length of π-conjugation, as more ex-
tended conjugated systems boast longer wavelengths of absorption due to smaller energy 
transitions between the HOMO and LUMO.  This can be accomplished either through the 
implementation of a new fluorophore structure, such as the use of a coumarin platform, or 
through the incorporation of additional π-bonds into the π-conjugated bridge of the donor-
acceptor architecture, such as an additional thiophene or heteroaromatic group.  Depend-
ing on the degree of wavelength shift desired, the implementation of both strategies could 
prove advantageous for the development of a new Zn(II)-responsive, emission-ratiometric 
fluorophore suitable for either one-photon or two-photon microscopy, provided the photo-
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APPENDIX A  
A.1  X-Ray Crystallographic Data 
Table A.1:  Crystal data and structure refinement for the Zn(II) complex of ligand 2.1b 
[Zn(II)-(2.1b)]2Ca(DMF)(H2O)6 
Empirical formula  C63H65CaCl2N11O17S2Zn2   
Formula weight  1554.16 
Temperature  100(2) 
Wavelength  MoKα (λ = 0.71073) 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 11.8106(6) Å α = 79.625(4)° 
 b = 13.3625(6) Å β = 81.802(4)° 
 c = 22.2111(11) Å γ = 77.504(4)° 
Volume 3346.7(3) Å3 
Z 2 
Density (calculated) 1.542 g/cm3 
Absorption coefficient 1.014 mm–1 
F(000) 1604.0 
Crystal size 0.218 × 0.093 × 0.028 mm 
Theta range for data collection 1.580 to 24.712° 
Index ranges -13 ≤ h ≤ 13, -15 ≤ k ≤ 15, -26 ≤ l ≤ 26 
Reflections collected 27927 
Independent reflections 11181 [Rint = 0.1247, Rsigma = 0.1227] 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 11181/836/911 
Goodness-of-fit on F2 1.063 
Final R indices [I > 2σ(I)] R1 = 0.0899, wR2 = 0.1820 
R indices (all data) R1 = 0.1502, wR2 = 0.2195 
Largest diff. peak and hole 1.552/-0.762 e•Å-3 
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Table A.2:  Selected bond lengths and bond angles for the Zn(II) complex of ligand 2.1b 
[Zn(II)-(2.1b)]2Ca(DMF)(H2O)6.  
 
 2.1b 2.1b-B 
Zn1-Cl1 2.266(2) 2.252(2) 
Zn1-N1 2.101(7) 2.098(7) 
Zn1-N2 2.088(7) 2.116(7) 
Zn1-N3 2.097(7) 2.095(7) 
Zn1-N4 2.254(7) 2.244(7) 
   
N1-Zn1-Cl1 98.9(2) 103.6(2) 
N1-Zn1-N2 117.8(3) 117.3(3) 
N1-Zn1-N3 115.0(3) 114.6(3) 
N1-Zn1-N4 77.0(3) 76.4(3) 
N2-Zn1-Cl1 104.8(2) 101.9(2) 
N2-Zn1-N3 112.9(3) 112.2(3) 
N2-Zn1-N4 77.3(3) 76.1(3) 
N3-Zn1-Cl1 104.7(2) 105.1(2) 
N3-Zn1-N4 77.4(3) 77.0(3) 








Table A.3:  Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for the Zn(II) complex of ligand 2.1b [Zn(II)-(2.1b)]2Ca(DMF)(H2O)6. 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
Atom Label                 x             y             z U(eq) 
Zn1 7283.9(9) 8179.9(8) 7512.0(5) 15.4(2) 
Cl1 8452(2) 8238.4(17) 8225(1) 20.9(5) 
S1 3496(2) 4311.5(18) 8531.2(10) 19.1(5) 
O2 3693(6) 13138(5) 7350(3) 22.9(14) 
O4 11592(6) 5793(5) 5424(3) 25.6(12) 
O1 -177(6) 993(5) 9318(3) 23.9(13) 
N2 6382(6) 9704(5) 7305(3) 16.1(12) 
N5 4458(7) 4373(6) 9490(3) 18.4(14) 
N1 6346(6) 7080(5) 8022(3) 16.4(11) 
O5 10219(6) 6392(7) 4783(3) 44(2) 
N3 8434(6) 7671(5) 6769(3) 16.6(11) 
N4 6062(6) 8041(5) 6852(3) 16.0(8) 
C3 5074(7) 5556(6) 8604(4) 15.0(12) 
C25 7980(8) 7282(7) 6358(4) 17.4(14) 
C16 5035(8) 7738(7) 7228(4) 16.9(12) 
C8 3118(8) 3523(7) 9202(4) 18.9(14) 
C18 5722(8) 9903(7) 6839(4) 16.0(12) 
C10 2205(8) 2337(7) 8768(4) 20.1(16) 
C9 2280(8) 2845(7) 9249(4) 19.1(14) 
C27 9848(8) 6855(7) 5787(4) 18.5(14) 
C29 9590(8) 7685(7) 6679(4) 19.1(13) 
C1 5382(7) 6962(6) 7792(4) 14.4(13) 
C4 6031(8) 5714(7) 8841(4) 18.0(16) 
C14 1495(8) 2728(7) 9784(4) 20.7(16) 
C6 4403(8) 4777(7) 8910(4) 18.2(12) 
C17 5802(8) 9062(6) 6464(4) 15.4(12) 
C7 3703(8) 3691(7) 9649(4) 21.9(17) 
C22 6355(8) 10444(7) 7642(4) 20.3(18) 
C21 5626(8) 11431(7) 7537(4) 18.5(17) 
C23 4147(8) 12682(7) 6906(4) 18.6(15) 
C26 8661(8) 6896(7) 5857(4) 19.3(16) 
C13 666(8) 2109(7) 9826(4) 20.2(16) 
C12 610(8) 1606(7) 9328(4) 19.5(15) 
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C20 4964(8) 11645(7) 7046(4) 17.0(15) 
C2 4756(8) 6211(7) 8057(4) 17.9(13) 
C11 1404(8) 1708(7) 8807(4) 18.3(15) 
C5 6664(8) 6456(6) 8548(4) 15.5(14) 
C19 5023(8) 10872(7) 6689(4) 15.8(13) 
C28 10313(8) 7281(7) 6196(4) 20.2(16) 
C24 6707(7) 7221(7) 6491(4) 17.1(12) 
C30 10604(8) 6309(7) 5276(4) 22.4(16) 
C15 -1121(9) 1028(8) 9785(5) 28(2) 
Zn1B 11584.5(9) 6663.3(8) 2113.6(5) 14.8(2) 
Cl1B 12897.7(19) 7214.3(17) 1358.1(10) 21.1(5) 
S1B 8408(2) 2794.1(18) 1476.5(10) 19.8(5) 
O3B 13995(5) 4067(5) 4816(3) 20.9(13) 
O2B 15635(5) 4503(5) 4311(3) 24.1(14) 
N1B 10897(6) 5635(5) 1725(3) 16.3(14) 
N5B 8515(6) 4144(6) 498(3) 17.1(13) 
N4B 10333(6) 6060(5) 2880(3) 13.5(12) 
O1B 4755(6) -183(5) 1024(3) 27.7(14) 
N3B 10393(7) 8010(5) 2297(3) 18.6(14) 
N2B 12630(6) 6019(5) 2840(3) 14.7(13) 
C3B 9670(7) 4408(7) 1274(4) 15.9(14) 
C16B 10338(8) 4999(6) 2782(4) 14.4(16) 
C4B 10301(8) 5069(7) 879(4) 19.6(16) 
C1B 10290(8) 4990(6) 2113(4) 15.7(15) 
C17B 10763(7) 6061(6) 3464(4) 13.5(13) 
C5B 10887(8) 5667(7) 1117(4) 17.2(15) 
C6B 8912(8) 3856(7) 1039(4) 17.3(12) 
C2B 9683(8) 4367(7) 1903(4) 16.6(14) 
C18B 12075(7) 5791(7) 3410(4) 14.8(12) 
C20B 13890(8) 5066(7) 3824(4) 15.7(14) 
C25B 9413(8) 7859(7) 2663(4) 15.7(15) 
C10B 5981(8) 2189(7) 534(4) 21.9(14) 
C21B 14454(8) 5340(7) 3246(4) 18.1(16) 
C8B 7569(8) 2771(7) 905(4) 17.7(12) 
C23B 14579(8) 4509(7) 4364(4) 17.5(13) 
C14B 6897(8) 1134(7) 1393(4) 22.1(17) 
C22B 13805(8) 5808(7) 2762(4) 16.7(15) 
C9B 6803(8) 2019(7) 945(4) 16.9(14) 
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C13B 6203(8) 430(8) 1408(5) 25.7(19) 
C12B 5375(8) 593(7) 985(4) 20.3(16) 
C27B 8838(8) 9680(7) 2733(4) 16.8(15) 
C7B 7757(8) 3559(7) 423(4) 20.2(17) 
C29B 10591(8) 8976(7) 2124(4) 19.9(17) 
C19B 12678(8) 5308(7) 3905(4) 16.4(13) 
C30B 8056(8) 10579(7) 3010(4) 21.1(17) 
C26B 8615(8) 8680(7) 2898(4) 16.3(15) 
C11B 5261(8) 1483(7) 542(4) 23.9(18) 
C28B 9832(7) 9823(7) 2335(4) 17.0(15) 
C24B 9213(7) 6762(6) 2814(4) 15.7(12) 
C15B 3750(9) 31(8) 693(5) 32(2) 
O1S 1857(9) 10389(7) 4663(4) 58(2) 
N1S 1925(13) 8902(10) 4299(6) 74(3) 
C2S 2317(14) 9489(11) 4597(6) 61(3) 
C3S 2580(15) 7839(12) 4235(8) 82(4) 
C4S 797(17) 9264(15) 4083(10) 108(7) 
Ca1 13006.3(16) 4466.0(14) 5757.5(8) 17.6(4) 
O6W 12390(5) 4873(5) 6773(3) 19.0(12) 
O1W 7110(6) 13337(5) 3083(3) 25.0(15) 
O2W 2713(7) 11156(5) 5554(3) 37.9(19) 
O3W 4735(7) 11855(7) 5001(4) 57(2) 
O4W 6582(9) 11989(6) 4096(4) 62(3) 
O5W 11832(5) 3248(5) 5667(3) 22.1(13) 
O3 3969(6) 12979(5) 6350(3) 28.0(15) 
O4B 8257(6) 11461(5) 2790(3) 29.4(15) 







Table A.4:  Crystal data and structure refinement for the Zn(II) complex of ligand 3.3c: 
[(3.3c)Zn(II)](ClO4)2(H2O) 
 
Empirical formula  C28H27Cl2N5O10SZn   
Formula weight (g/mol) 761.87 
Temperature (K)  100(2) 
Wavelength (nm) MoKα (λ = 0.71073) 
Crystal system  monoclinic 
Space group  P21/c 
Unit cell dimensions a = 12.6948(4) Å α = 90° 
 b = 16.2339(5) Å β = 91.625(3)° 
 c = 15.1941(4) Å γ = 90° 
Volume 3130.03(16) Å3 
Z 4 
Density (calculated) 1.617 g/cm3 
Absorption coefficient 1.088 mm-1 
F(000) 1560.0 
Crystal size 0.40 × 0.37 × 0.18 mm 
Theta range for data collection 2.414 to 30.508° 
Index ranges -18 ≤ h ≤ 18, -23 ≤ k ≤ 23, -21 ≤ l ≤ 21 
Reflections collected 27117 
Independent reflections 9537 [Rint = 0.0367, Rsigma = 0.1483] 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9537/251/465 
Goodness-of-fit on F2 1.035 
Final R indices [I>2sigma(I)] R1 = 0.0523, wR2 = 0.1271 
R indices (all data) R1 = 0.0717, wR2 = 0.1368 





Table A.5:  Selected bond lengths and bond angles for the Zn(II) complex of ligand 3.3c: 
[(3.3c)Zn(II)](ClO4)2(H2O) 
 

































Table A.6:  Fractional atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for the Zn(II) complex of ligand 3.3c: 
[(3.3c)Zn(II)](ClO4)2(H2O). U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
Atom x y z                   Ueq 
Zn1 3348.3(2) 5252.6(2) 7736.3(2) 15.51(8) 
Cl2B 8006.4(18) 5947.8(17) 8573.7(18) 23.1(2) 
O6B 8577(4) 5285(3) 9014(3) 29.2(7) 
O7B 8745(3) 6469(3) 8126(3) 31.1(6) 
O8B 7467(3) 6432(2) 9224(2) 28.8(7) 
O9B 7248(3) 5610(2) 7949(2) 36.9(7) 
S1 4563.6(5) 6333.6(4) 5235.8(4) 17.93(13) 
O1 9632.3(15) 5977.8(12) 4153.2(12) 25.9(4) 
N2 4338.5(16) 5560.6(12) 6683.6(12) 15.5(4) 
N1 2291.4(17) 5792.4(13) 6875.9(13) 18.0(4) 
N3 1837.7(17) 5223.2(13) 8469.8(13) 18.9(4) 
N4 3223.2(17) 4012.8(13) 7910.1(13) 19.0(4) 
N5 3846.8(16) 5789.7(12) 8887.1(12) 16.0(4) 
C6 3812(2) 6005.4(14) 6083.4(14) 15.9(4) 
C8 5372(2) 5475.5(14) 6479.4(14) 16.1(4) 
C7 5659.3(19) 5855.6(14) 5712.5(14) 15.9(4) 
C5 2679(2) 6171.3(14) 6169.5(14) 16.9(4) 
C4 2047(2) 6650.3(16) 5614.9(16) 21.2(5) 
C3 984(2) 6726.9(17) 5815.5(17) 24.9(5) 
C2 584(2) 6316.2(17) 6539.1(17) 23.8(5) 
C1 1274(2) 5846.4(15) 7063.4(16) 19.5(5) 
C16 944(2) 5334.3(17) 7843.6(17) 23.1(5) 
C17 1836(2) 4414.2(16) 8916.8(17) 22.9(5) 
C18 2429(2) 3763.9(15) 8420.4(16) 20.8(5) 
C19 2200(2) 2932.0(17) 8530.7(18) 27.9(6) 
C20 2815(3) 2348.2(17) 8128.6(18) 31.1(7) 
C21 3648(3) 2602.9(17) 7619.1(18) 28.5(6) 
C22 3824(2) 3439.9(16) 7521.7(16) 22.4(5) 
C23 1951(2) 5908.4(16) 9099.2(16) 20.4(5) 
C24 3075(2) 5976.9(15) 9450.4(15) 17.7(5) 
C25 3306(2) 6265.6(16) 10296.5(16) 22.3(5) 
C26 4348(2) 6392.6(17) 10558.1(16) 23.8(5) 
C27 5134(2) 6223.2(16) 9973.3(16) 22.4(5) 
C28 4860(2) 5914.6(15) 9146.6(15) 18.6(5) 
 355 
C9 6692(2) 5900.1(14) 5296.0(14) 16.8(4) 
C14 7484(2) 5320.8(14) 5510.5(16) 19.5(5) 
C13 8459(2) 5370.4(15) 5125.0(16) 21.0(5) 
C12 8659(2) 5991.9(16) 4510.8(15) 19.3(5) 
C11 7885(2) 6575.9(16) 4300.0(15) 20.2(5) 
C10 6914(2) 6525.2(15) 4692.1(15) 19.5(5) 
C15 9911(2) 6651(2) 3589.0(18) 30.4(6) 
Cl1B 3211(3) 7941(3) 7905(2) 19.14(16) 
O2B 3703(6) 8741(3) 7876(5) 37.5(8) 
O3B 2831(6) 7769(4) 8773(3) 36.2(7) 
O4B 3964(5) 7312(4) 7685(5) 30.2(7) 
O5B 2332(5) 7897(4) 7283(4) 32.4(6) 
O10 711(2) 8685.6(15) 6393.1(17) 41.5(6) 
Cl1A 3133.5(14) 7906.5(12) 7865.3(11) 19.14(16) 
O2A 3338(3) 8758.7(16) 7662(2) 37.5(8) 
O3A 3266(3) 7751(2) 8797.1(14) 36.2(7) 
O4A 3854(3) 7383(2) 7404(2) 30.2(7) 
O5A 2069.2(19) 7687(2) 7597(2) 32.4(6) 
Cl2A 8093(4) 5920(4) 8534(4) 23.1(2) 
O6A 8729(9) 5371(7) 9080(7) 29.2(7) 
O7A 8754(8) 6567(7) 8197(8) 31.1(6) 
O8A 7277(7) 6282(6) 9056(6) 28.8(7) 
O9A 7618(8) 5464(5) 7810(5) 36.9(7) 
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Table A.7:  Crystal data and structure refinement for the Zn(II) complex of chromis-2 (3.4): 
[(chromis-2)Zn(II)](BF4)2(H2O)2.   
 
Empirical formula  C26H27B2F8N7O3SZn   
Formula weight  756.59 
Temperature  100(2) 
Wavelength  CuKα (λ = 0.154184) 
Crystal system  monoclinic 
Space group  P21/c 
Unit cell dimensions a = 9.86710(10) Å α = 90° 
 b = 19.3141(2) Å β = 100.6150(10)° 
 c = 16.4920(2) Å γ = 90° 
Volume 3089.16(6) Å3 
Z 4 
Density (calculated) 1.627 g/cm3 
Absorption coefficient 2.564 mm–1 
F(000) 1536.0 
Crystal size 0.265 × 0.246 × 0.206 mm 
Theta range for data collection 7.12 to 144.336° 
Index ranges -12 ≤ h ≤ 11, -23 ≤ k ≤ 23, -20 ≤ l ≤ 20 
Reflections collected 19414 
Independent reflections 5977 [Rint = 0.0241, Rsigma = 0.0223] 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5977/6/450 
Goodness-of-fit on F2 1.049 
Final R indices [I>2sigma(I)] R1 = 0.0295, wR2 = 0.0765 
R indices (all data) R1 = 0.0316, wR2 = 0.0777 





Table A.8:  Selected bond lengths and bond angles for the Zn(II) complex of chromis-2 
(3.4): [(chromis-2)Zn(II)](BF4)2(H2O)2.   
 




























Table A.9:  Fractional atomic coordinates (x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for the Zn(II) complex of chromis-2 (3.4): [(chromis-
2)Zn(II)](BF4)2(H2O)2. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
Atom x y                 z                     Ueq 
Zn1 3933.2(2) 5072.8(2) 2388.5(2) 11.39(7) 
S1 6470.1(4) 4422.8(2) 4870.4(2) 14.30(9) 
F2 5035.0(11) 7215.1(6) 2646.6(6) 26.4(2) 
F7 654.1(10) 5987.2(5) -264.9(6) 23.6(2) 
F4 5510.6(11) 6988.9(6) 4017.6(6) 29.4(2) 
F3 7247.9(11) 7043.5(6) 3293.7(7) 31.2(3) 
O2 4951.7(12) 5928.2(6) 1977.3(7) 18.2(2) 
F1 6098.3(13) 8023.8(6) 3527.4(9) 38.9(3) 
F6 -300.4(13) 6749.5(7) 514.9(9) 40.7(3) 
O1 11913.0(12) 6249.3(6) 6735.4(8) 22.7(3) 
F8 1997.2(13) 6542.6(7) 793.7(9) 42.7(3) 
O3 7385.4(12) 5706.5(7) 1568.1(8) 22.7(3) 
F5 1049.2(17) 7132.8(6) -368.8(10) 50.3(4) 
N1 3391.5(13) 4165.7(7) 2971.0(8) 12.9(3) 
N2 5455.3(13) 5017.5(7) 3517.7(8) 13.7(3) 
N3 1904.1(13) 4683.8(7) 1530.5(8) 13.7(3) 
N5 4662.3(13) 4517.2(7) 1466.7(8) 13.6(3) 
N4 2443.7(13) 5778.9(7) 2638.9(8) 12.8(3) 
N6 81.7(14) 6088.1(7) 2414.5(8) 15.1(3) 
N7 4063.2(14) 4124.1(8) 87.7(9) 18.9(3) 
C18 1133.1(15) 5706.0(8) 2255.6(9) 13.0(3) 
C9 8442.8(15) 5476.8(8) 5173.5(9) 13.8(3) 
C7 7239.8(16) 5186.2(8) 4629(1) 14.0(3) 
C10 9126.7(16) 5110.1(8) 5861.3(10) 14.6(3) 
C11 10277.0(16) 5380.6(9) 6369.9(10) 15.4(3) 
C12 10773.3(16) 6029.7(9) 6198.4(10) 15.9(3) 
C23 3766.8(16) 4423.0(8) 762.2(10) 14.4(3) 
C6 5291.2(16) 4475.1(8) 3968.6(9) 13.5(3) 
C19 2732.6(16) 6292.1(8) 3193.7(10) 14.8(3) 
C5 4179.7(15) 3977.9(8) 3693.4(9) 13.9(3) 
C14 8955.6(16) 6127.2(8) 5014.1(10) 16.9(3) 
C20 1713.2(17) 6718.5(8) 3387.6(10) 17.3(3) 
C24 5944.5(16) 4266.9(9) 1515.6(10) 17.6(3) 
C4 3930.5(17) 3383.0(9) 4108.3(10) 18.5(3) 
 359 
C1 2344.7(15) 3771.5(8) 2627.9(10) 14.2(3) 
C21 376.2(17) 6584.9(8) 2983(1) 17.6(3) 
C8 6548.2(16) 5418.2(8) 3883.1(10) 14.1(3) 
C2 2003.8(17) 3171.7(9) 3019.6(10) 18.7(3) 
C17 777.0(16) 5171.4(9) 1584.2(10) 16.5(3) 
C22 2320.0(16) 4697.2(9) 714.4(10) 15.8(3) 
C13 10116.1(17) 6403.2(9) 5515.6(10) 18.1(3) 
C16 1597.9(16) 3972.2(8) 1777.5(10) 17.2(3) 
C3 2798.1(18) 2980.3(9) 3763.1(11) 21.3(3) 
C26 5349.7(18) 3886(1) 138.1(11) 22.8(4) 
C25 6331.4(17) 3933.2(9) 855.2(11) 21.8(4) 
C15 12411(2) 6932.7(10) 6611.1(13) 28.4(4) 
B1 5990(2) 7328.8(10) 3382.4(12) 18.6(4) 
B2 835(2) 6613.0(11) 165.6(14) 24.9(4) 
Zn1 3933.2(2) 5072.8(2) 2388.5(2) 11.39(7) 
S1 6470.1(4) 4422.8(2) 4870.4(2) 14.30(9) 
F2 5035.0(11) 7215.1(6) 2646.6(6) 26.4(2) 
F7 654.1(10) 5987.2(5) -264.9(6) 23.6(2) 
F4 5510.6(11) 6988.9(6) 4017.6(6) 29.4(2) 
F3 7247.9(11) 7043.5(6) 3293.7(7) 31.2(3) 
O2 4951.7(12) 5928.2(6) 1977.3(7) 18.2(2) 
F1 6098.3(13) 8023.8(6) 3527.4(9) 38.9(3) 
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